Q32022FALSE0001333986--12-3151.669.676.071.655.433366.56.565.671.369.15.60.52.433366.56.500013339862022-01-012022-09-300001333986us-gaap:CommonClassAMember2022-01-012022-09-300001333986us-gaap:SeriesAPreferredStockMember2022-01-012022-09-300001333986us-gaap:SeriesCPreferredStockMember2022-01-012022-09-3000013339862022-11-01xbrli:shares00013339862022-09-30iso4217:USD00013339862021-12-310001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-31iso4217:USDxbrli:shares00013339862022-07-012022-09-3000013339862021-07-012021-09-3000013339862021-01-012021-09-300001333986us-gaap:PreferredStockIncludingAdditionalPaidInCapitalMember2022-06-300001333986us-gaap:CommonStockMember2022-06-300001333986us-gaap:AdditionalPaidInCapitalMember2022-06-300001333986us-gaap:TreasuryStockMember2022-06-300001333986us-gaap:RetainedEarningsMember2022-06-300001333986us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001333986us-gaap:ParentMember2022-06-300001333986us-gaap:NoncontrollingInterestMember2022-06-3000013339862022-06-300001333986us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001333986us-gaap:TreasuryStockMember2022-07-012022-09-300001333986us-gaap:ParentMember2022-07-012022-09-300001333986us-gaap:NoncontrollingInterestMember2022-07-012022-09-300001333986us-gaap:RetainedEarningsMember2022-07-012022-09-300001333986us-gaap:PreferredStockIncludingAdditionalPaidInCapitalMember2022-07-012022-09-300001333986us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300001333986us-gaap:PreferredStockIncludingAdditionalPaidInCapitalMember2022-09-300001333986us-gaap:CommonStockMember2022-09-300001333986us-gaap:AdditionalPaidInCapitalMember2022-09-300001333986us-gaap:TreasuryStockMember2022-09-300001333986us-gaap:RetainedEarningsMember2022-09-300001333986us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001333986us-gaap:ParentMember2022-09-300001333986us-gaap:NoncontrollingInterestMember2022-09-300001333986us-gaap:PreferredStockIncludingAdditionalPaidInCapitalMember2021-06-300001333986us-gaap:CommonStockMember2021-06-300001333986us-gaap:AdditionalPaidInCapitalMember2021-06-300001333986us-gaap:TreasuryStockMember2021-06-300001333986us-gaap:RetainedEarningsMember2021-06-300001333986us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001333986us-gaap:ParentMember2021-06-300001333986us-gaap:NoncontrollingInterestMember2021-06-3000013339862021-06-300001333986us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001333986us-gaap:TreasuryStockMember2021-07-012021-09-300001333986us-gaap:ParentMember2021-07-012021-09-300001333986us-gaap:NoncontrollingInterestMember2021-07-012021-09-300001333986us-gaap:RetainedEarningsMember2021-07-012021-09-300001333986us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300001333986us-gaap:PreferredStockIncludingAdditionalPaidInCapitalMember2021-09-300001333986us-gaap:CommonStockMember2021-09-300001333986us-gaap:AdditionalPaidInCapitalMember2021-09-300001333986us-gaap:TreasuryStockMember2021-09-300001333986us-gaap:RetainedEarningsMember2021-09-300001333986us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300001333986us-gaap:ParentMember2021-09-300001333986us-gaap:NoncontrollingInterestMember2021-09-3000013339862021-09-300001333986us-gaap:PreferredStockIncludingAdditionalPaidInCapitalMember2021-12-310001333986us-gaap:CommonStockMember2021-12-310001333986us-gaap:AdditionalPaidInCapitalMember2021-12-310001333986us-gaap:TreasuryStockMember2021-12-310001333986us-gaap:RetainedEarningsMember2021-12-310001333986us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001333986us-gaap:ParentMember2021-12-310001333986us-gaap:NoncontrollingInterestMember2021-12-310001333986us-gaap:AdditionalPaidInCapitalMember2022-01-012022-09-300001333986us-gaap:TreasuryStockMember2022-01-012022-09-300001333986us-gaap:ParentMember2022-01-012022-09-300001333986us-gaap:NoncontrollingInterestMember2022-01-012022-09-300001333986us-gaap:RetainedEarningsMember2022-01-012022-09-300001333986us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-300001333986us-gaap:PreferredStockIncludingAdditionalPaidInCapitalMember2020-12-310001333986us-gaap:CommonStockMember2020-12-310001333986us-gaap:AdditionalPaidInCapitalMember2020-12-310001333986us-gaap:TreasuryStockMember2020-12-310001333986us-gaap:RetainedEarningsMember2020-12-310001333986us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001333986us-gaap:ParentMember2020-12-310001333986us-gaap:NoncontrollingInterestMember2020-12-3100013339862020-12-310001333986us-gaap:AdditionalPaidInCapitalMember2021-01-012021-09-300001333986us-gaap:TreasuryStockMember2021-01-012021-09-300001333986us-gaap:ParentMember2021-01-012021-09-300001333986us-gaap:NoncontrollingInterestMember2021-01-012021-09-300001333986us-gaap:RetainedEarningsMember2021-01-012021-09-300001333986us-gaap:PreferredStockIncludingAdditionalPaidInCapitalMember2021-01-012021-09-300001333986us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-30eqh:segment0001333986eqh:AllianceBernsteinMember2022-01-012022-09-30xbrli:pure0001333986eqh:AllianceBernsteinMember2021-01-012021-12-310001333986eqh:CarValInvestmentsLPMembereqh:AllianceBernsteinMember2022-09-300001333986eqh:AllianceBernsteinMember2022-07-012022-07-010001333986eqh:AllianceBernsteinMember2022-09-300001333986eqh:CorporateSolutionsLifeReinsuranceCompanyMember2021-06-010001333986eqh:VenerableInsuranceAndAnnuityCompanyMembereqh:CorporateSolutionsLifeReinsuranceCompanyMember2021-06-012021-06-010001333986eqh:VenerableInsuranceAndAnnuityCompanyMembereqh:EquitableFinancialLifeInsuranceCompanyEFLICMember2021-06-010001333986eqh:CorporateSolutionsLifeReinsuranceCompanyMembereqh:AllianceBernsteinMember2021-06-010001333986us-gaap:GuaranteedMinimumWithdrawalBenefitMembereqh:CorporateSolutionsLifeReinsuranceCompanyMembereqh:AllianceBernsteinMember2021-06-010001333986eqh:EquitableInvestmentManagementGroupLLCMembereqh:VACapitalCompanyLLCMember2021-06-010001333986us-gaap:CollateralizedLoanObligationsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-09-300001333986us-gaap:CollateralizedLoanObligationsMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-12-310001333986eqh:ConsolidatedLimitedPartnershipsMember2022-09-300001333986eqh:ConsolidatedLimitedPartnershipsMember2021-12-310001333986eqh:ABSponsoredInvestmentFundsMembereqh:ConsolidatedEntityMember2022-09-300001333986eqh:ABSponsoredInvestmentFundsMembereqh:ConsolidatedEntityMember2021-12-310001333986us-gaap:ConsolidatedEntityExcludingVieMembereqh:ABSponsoredInvestmentFundsMember2022-09-300001333986us-gaap:ConsolidatedEntityExcludingVieMembereqh:ABSponsoredInvestmentFundsMember2021-12-310001333986eqh:NonConsolidatedVairableInterestEntitiesVIEMember2022-09-300001333986eqh:NonConsolidatedVairableInterestEntitiesVIEMember2021-12-310001333986eqh:ABSponsoredInvestmentFundsMembereqh:NonConsolidatedVairableInterestEntitiesVIEMember2022-09-300001333986eqh:ABSponsoredInvestmentFundsMembereqh:NonConsolidatedVairableInterestEntitiesVIEMember2021-12-310001333986eqh:ABSponsoredInvestmentFundsMembereqh:NonConsolidatedVairableInterestEntitiesVIEMember2022-09-300001333986eqh:ABSponsoredInvestmentFundsMembereqh:NonConsolidatedVairableInterestEntitiesVIEMember2021-12-310001333986eqh:LongtermLapsesPartialWithdrawalRatesAndElectionAssumptionsUpdatesMember2022-07-012022-09-300001333986eqh:LongtermLapsesPartialWithdrawalRatesAndElectionAssumptionsUpdatesMember2022-01-012022-09-300001333986eqh:LongtermLapsesPartialWithdrawalRatesAndElectionAssumptionsUpdatesMember2021-07-012021-09-300001333986eqh:LongtermLapsesPartialWithdrawalRatesAndElectionAssumptionsUpdatesMember2021-01-012021-09-300001333986us-gaap:FixedMaturitiesMember2022-09-300001333986us-gaap:FixedMaturitiesMember2021-12-310001333986us-gaap:FixedMaturitiesMember2022-07-012022-09-300001333986us-gaap:FixedMaturitiesMember2021-01-012021-09-300001333986us-gaap:FixedMaturitiesMember2021-07-012021-09-300001333986us-gaap:FixedMaturitiesMember2022-01-012022-09-300001333986us-gaap:CorporateDebtSecuritiesMember2022-09-300001333986us-gaap:USTreasuryAndGovernmentMember2022-09-300001333986us-gaap:USStatesAndPoliticalSubdivisionsMember2022-09-300001333986us-gaap:ForeignGovernmentDebtSecuritiesMember2022-09-300001333986us-gaap:ResidentialMortgageBackedSecuritiesMember2022-09-300001333986us-gaap:AssetBackedSecuritiesMember2022-09-300001333986us-gaap:CommercialMortgageBackedSecuritiesMember2022-09-300001333986us-gaap:RedeemablePreferredStockMember2022-09-300001333986us-gaap:CorporateDebtSecuritiesMember2021-12-310001333986us-gaap:USTreasuryAndGovernmentMember2021-12-310001333986us-gaap:USStatesAndPoliticalSubdivisionsMember2021-12-310001333986us-gaap:ForeignGovernmentDebtSecuritiesMember2021-12-310001333986us-gaap:ResidentialMortgageBackedSecuritiesMember2021-12-310001333986us-gaap:AssetBackedSecuritiesMember2021-12-310001333986us-gaap:CommercialMortgageBackedSecuritiesMember2021-12-310001333986us-gaap:RedeemablePreferredStockMember2021-12-310001333986eqh:NetUnrealizedGainsLossesOnInvestmentsMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-06-300001333986eqh:UnrealizedInvestmentGainsLossesAllOtherMembereqh:DacMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-06-300001333986eqh:PolicyholdersLiabilitiesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-06-300001333986eqh:DeferredIncomeTaxAssetLiabilityMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-06-300001333986eqh:AociGainLossesRelatedToNetUnrealizedInvestmentGainsLossesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-06-300001333986eqh:NetUnrealizedGainsLossesOnInvestmentsMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-07-012022-09-300001333986eqh:AociGainLossesRelatedToNetUnrealizedInvestmentGainsLossesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-07-012022-09-300001333986eqh:UnrealizedInvestmentGainsLossesAllOtherMembereqh:DacMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-07-012022-09-300001333986eqh:PolicyholdersLiabilitiesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-07-012022-09-300001333986eqh:DeferredIncomeTaxAssetLiabilityMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-07-012022-09-300001333986eqh:UnrealizedInvestmentGainsLossesAllOtherMembereqh:DacMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:FixedMaturitiesMember2022-07-012022-09-300001333986eqh:PolicyholdersLiabilitiesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:FixedMaturitiesMember2022-07-012022-09-300001333986eqh:DeferredIncomeTaxAssetLiabilityMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:FixedMaturitiesMember2022-07-012022-09-300001333986eqh:NetUnrealizedGainsLossesOnInvestmentsMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-09-300001333986eqh:UnrealizedInvestmentGainsLossesAllOtherMembereqh:DacMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-09-300001333986eqh:PolicyholdersLiabilitiesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-09-300001333986eqh:DeferredIncomeTaxAssetLiabilityMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-09-300001333986eqh:AociGainLossesRelatedToNetUnrealizedInvestmentGainsLossesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-09-300001333986eqh:NetUnrealizedGainsLossesOnInvestmentsMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-06-300001333986eqh:UnrealizedInvestmentGainsLossesAllOtherMembereqh:DacMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-06-300001333986eqh:PolicyholdersLiabilitiesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-06-300001333986eqh:DeferredIncomeTaxAssetLiabilityMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-06-300001333986eqh:AociGainLossesRelatedToNetUnrealizedInvestmentGainsLossesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-06-300001333986eqh:NetUnrealizedGainsLossesOnInvestmentsMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-07-012021-09-300001333986eqh:AociGainLossesRelatedToNetUnrealizedInvestmentGainsLossesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-07-012021-09-300001333986eqh:UnrealizedInvestmentGainsLossesAllOtherMembereqh:DacMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-07-012021-09-300001333986eqh:PolicyholdersLiabilitiesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-07-012021-09-300001333986eqh:DeferredIncomeTaxAssetLiabilityMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-07-012021-09-300001333986eqh:UnrealizedInvestmentGainsLossesAllOtherMembereqh:DacMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:FixedMaturitiesMember2021-07-012021-09-300001333986eqh:PolicyholdersLiabilitiesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:FixedMaturitiesMember2021-07-012021-09-300001333986eqh:DeferredIncomeTaxAssetLiabilityMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:FixedMaturitiesMember2021-07-012021-09-300001333986eqh:NetUnrealizedGainsLossesOnInvestmentsMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-09-300001333986eqh:UnrealizedInvestmentGainsLossesAllOtherMembereqh:DacMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-09-300001333986eqh:PolicyholdersLiabilitiesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-09-300001333986eqh:DeferredIncomeTaxAssetLiabilityMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-09-300001333986eqh:AociGainLossesRelatedToNetUnrealizedInvestmentGainsLossesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-09-300001333986eqh:NetUnrealizedGainsLossesOnInvestmentsMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310001333986eqh:UnrealizedInvestmentGainsLossesAllOtherMembereqh:DacMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310001333986eqh:PolicyholdersLiabilitiesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310001333986eqh:DeferredIncomeTaxAssetLiabilityMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310001333986eqh:AociGainLossesRelatedToNetUnrealizedInvestmentGainsLossesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310001333986eqh:NetUnrealizedGainsLossesOnInvestmentsMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-09-300001333986eqh:AociGainLossesRelatedToNetUnrealizedInvestmentGainsLossesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-09-300001333986eqh:UnrealizedInvestmentGainsLossesAllOtherMembereqh:DacMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-09-300001333986eqh:PolicyholdersLiabilitiesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-09-300001333986eqh:DeferredIncomeTaxAssetLiabilityMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-09-300001333986eqh:UnrealizedInvestmentGainsLossesAllOtherMembereqh:DacMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:FixedMaturitiesMember2022-01-012022-09-300001333986eqh:PolicyholdersLiabilitiesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:FixedMaturitiesMember2022-01-012022-09-300001333986eqh:DeferredIncomeTaxAssetLiabilityMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:FixedMaturitiesMember2022-01-012022-09-300001333986eqh:NetUnrealizedGainsLossesOnInvestmentsMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310001333986eqh:UnrealizedInvestmentGainsLossesAllOtherMembereqh:DacMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310001333986eqh:PolicyholdersLiabilitiesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310001333986eqh:DeferredIncomeTaxAssetLiabilityMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310001333986eqh:AociGainLossesRelatedToNetUnrealizedInvestmentGainsLossesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310001333986eqh:NetUnrealizedGainsLossesOnInvestmentsMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-09-300001333986eqh:AociGainLossesRelatedToNetUnrealizedInvestmentGainsLossesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-09-300001333986eqh:UnrealizedInvestmentGainsLossesAllOtherMembereqh:DacMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-09-300001333986eqh:PolicyholdersLiabilitiesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-09-300001333986eqh:DeferredIncomeTaxAssetLiabilityMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-09-300001333986eqh:UnrealizedInvestmentGainsLossesAllOtherMembereqh:DacMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:FixedMaturitiesMember2021-01-012021-09-300001333986eqh:PolicyholdersLiabilitiesMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:FixedMaturitiesMember2021-01-012021-09-300001333986eqh:DeferredIncomeTaxAssetLiabilityMembereqh:UnrealizedInvestmentGainsLossesAllOtherMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:FixedMaturitiesMember2021-01-012021-09-30eqh:issue0001333986eqh:OtherThanInvestmentGradeMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMemberus-gaap:FixedMaturitiesMember2022-09-300001333986eqh:OtherThanInvestmentGradeMemberus-gaap:ExternalCreditRatingNonInvestmentGradeMemberus-gaap:FixedMaturitiesMember2021-12-310001333986us-gaap:CommercialLoanMember2022-09-300001333986eqh:AgriculturalMortgageLoansMember2022-09-300001333986us-gaap:CommercialLoanMember2021-12-310001333986eqh:AgriculturalMortgageLoansMember2021-12-310001333986us-gaap:CommercialLoanMember2021-01-012021-09-300001333986eqh:AgriculturalMortgageLoansMember2021-01-012021-09-300001333986us-gaap:CommercialLoanMember2022-01-012022-09-300001333986eqh:AgriculturalMortgageLoansMember2022-01-012022-09-300001333986eqh:IndividuallyAssessedMortgageLoansMember2022-09-300001333986us-gaap:CommercialLoanMember2022-06-300001333986us-gaap:CommercialLoanMember2021-06-300001333986us-gaap:CommercialLoanMember2020-12-310001333986us-gaap:CommercialLoanMember2022-07-012022-09-300001333986us-gaap:CommercialLoanMember2021-07-012021-09-300001333986us-gaap:CommercialLoanMember2021-09-300001333986eqh:AgriculturalMortgageLoansMember2022-06-300001333986eqh:AgriculturalMortgageLoansMember2021-06-300001333986eqh:AgriculturalMortgageLoansMember2020-12-310001333986eqh:AgriculturalMortgageLoansMember2022-07-012022-09-300001333986eqh:AgriculturalMortgageLoansMember2021-07-012021-09-300001333986eqh:AgriculturalMortgageLoansMember2021-09-300001333986us-gaap:CommercialLoanMembereqh:ZeroToFiftyPercentMember2022-09-300001333986us-gaap:CommercialLoanMembereqh:FiftyToSeventyPercentMember2022-09-300001333986us-gaap:CommercialLoanMembereqh:SeventyToNinetyPercentMember2022-09-300001333986us-gaap:CommercialLoanMembereqh:MoreThanNinetyPercentMember2022-09-300001333986eqh:ZeroToFiftyPercentMembereqh:AgriculturalMortgageLoansMember2022-09-300001333986eqh:FiftyToSeventyPercentMembereqh:AgriculturalMortgageLoansMember2022-09-300001333986eqh:SeventyToNinetyPercentMembereqh:AgriculturalMortgageLoansMember2022-09-300001333986eqh:MoreThanNinetyPercentMembereqh:AgriculturalMortgageLoansMember2022-09-300001333986eqh:ZeroToFiftyPercentMembereqh:TotalMortgagesLoanMember2022-09-300001333986eqh:FiftyToSeventyPercentMembereqh:TotalMortgagesLoanMember2022-09-300001333986eqh:SeventyToNinetyPercentMembereqh:TotalMortgagesLoanMember2022-09-300001333986eqh:MoreThanNinetyPercentMembereqh:TotalMortgagesLoanMember2022-09-300001333986eqh:TotalMortgagesLoanMember2022-09-300001333986eqh:RatioGreaterThan2TimesMemberus-gaap:CommercialLoanMember2022-09-300001333986us-gaap:CommercialLoanMembereqh:RatioBetween18To2TimesMember2022-09-300001333986us-gaap:CommercialLoanMembereqh:RatioBetween15To18TimesMember2022-09-300001333986us-gaap:CommercialLoanMembereqh:RatioBetween12To15TimesMember2022-09-300001333986us-gaap:CommercialLoanMembereqh:RatioBetween1To12TimesMember2022-09-300001333986us-gaap:CommercialLoanMembereqh:RatioLessThan1TimesMember2022-09-300001333986eqh:RatioGreaterThan2TimesMembereqh:AgriculturalMortgageLoansMember2022-09-300001333986eqh:AgriculturalMortgageLoansMembereqh:RatioBetween18To2TimesMember2022-09-300001333986eqh:AgriculturalMortgageLoansMembereqh:RatioBetween15To18TimesMember2022-09-300001333986eqh:AgriculturalMortgageLoansMembereqh:RatioBetween12To15TimesMember2022-09-300001333986eqh:RatioBetween1To12TimesMembereqh:AgriculturalMortgageLoansMember2022-09-300001333986eqh:AgriculturalMortgageLoansMembereqh:RatioLessThan1TimesMember2022-09-300001333986eqh:RatioGreaterThan2TimesMembereqh:TotalMortgagesLoanMember2022-09-300001333986eqh:TotalMortgagesLoanMembereqh:RatioBetween18To2TimesMember2022-09-300001333986eqh:RatioBetween15To18TimesMembereqh:TotalMortgagesLoanMember2022-09-300001333986eqh:TotalMortgagesLoanMembereqh:RatioBetween12To15TimesMember2022-09-300001333986eqh:RatioBetween1To12TimesMembereqh:TotalMortgagesLoanMember2022-09-300001333986eqh:RatioLessThan1TimesMembereqh:TotalMortgagesLoanMember2022-09-300001333986us-gaap:CommercialLoanMembereqh:ZeroToFiftyPercentMember2021-12-310001333986us-gaap:CommercialLoanMembereqh:FiftyToSeventyPercentMember2021-12-310001333986us-gaap:CommercialLoanMembereqh:SeventyToNinetyPercentMember2021-12-310001333986us-gaap:CommercialLoanMembereqh:MoreThanNinetyPercentMember2021-12-310001333986eqh:ZeroToFiftyPercentMembereqh:AgriculturalMortgageLoansMember2021-12-310001333986eqh:FiftyToSeventyPercentMembereqh:AgriculturalMortgageLoansMember2021-12-310001333986eqh:SeventyToNinetyPercentMembereqh:AgriculturalMortgageLoansMember2021-12-310001333986eqh:MoreThanNinetyPercentMembereqh:AgriculturalMortgageLoansMember2021-12-310001333986eqh:ZeroToFiftyPercentMembereqh:TotalMortgagesLoanMember2021-12-310001333986eqh:FiftyToSeventyPercentMembereqh:TotalMortgagesLoanMember2021-12-310001333986eqh:SeventyToNinetyPercentMembereqh:TotalMortgagesLoanMember2021-12-310001333986eqh:MoreThanNinetyPercentMembereqh:TotalMortgagesLoanMember2021-12-310001333986eqh:TotalMortgagesLoanMember2021-12-310001333986eqh:RatioGreaterThan2TimesMemberus-gaap:CommercialLoanMember2021-12-310001333986us-gaap:CommercialLoanMembereqh:RatioBetween18To2TimesMember2021-12-310001333986us-gaap:CommercialLoanMembereqh:RatioBetween15To18TimesMember2021-12-310001333986us-gaap:CommercialLoanMembereqh:RatioBetween12To15TimesMember2021-12-310001333986us-gaap:CommercialLoanMembereqh:RatioBetween1To12TimesMember2021-12-310001333986us-gaap:CommercialLoanMembereqh:RatioLessThan1TimesMember2021-12-310001333986eqh:RatioGreaterThan2TimesMembereqh:AgriculturalMortgageLoansMember2021-12-310001333986eqh:AgriculturalMortgageLoansMembereqh:RatioBetween18To2TimesMember2021-12-310001333986eqh:AgriculturalMortgageLoansMembereqh:RatioBetween15To18TimesMember2021-12-310001333986eqh:AgriculturalMortgageLoansMembereqh:RatioBetween12To15TimesMember2021-12-310001333986eqh:RatioBetween1To12TimesMembereqh:AgriculturalMortgageLoansMember2021-12-310001333986eqh:AgriculturalMortgageLoansMembereqh:RatioLessThan1TimesMember2021-12-310001333986eqh:RatioGreaterThan2TimesMembereqh:TotalMortgagesLoanMember2021-12-310001333986eqh:TotalMortgagesLoanMembereqh:RatioBetween18To2TimesMember2021-12-310001333986eqh:RatioBetween15To18TimesMembereqh:TotalMortgagesLoanMember2021-12-310001333986eqh:TotalMortgagesLoanMembereqh:RatioBetween12To15TimesMember2021-12-310001333986eqh:RatioBetween1To12TimesMembereqh:TotalMortgagesLoanMember2021-12-310001333986eqh:RatioLessThan1TimesMembereqh:TotalMortgagesLoanMember2021-12-310001333986us-gaap:CommercialLoanMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2022-09-300001333986us-gaap:CommercialLoanMemberus-gaap:FinancingReceivables60To89DaysPastDueMember2022-09-300001333986us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberus-gaap:CommercialLoanMember2022-09-300001333986us-gaap:CommercialLoanMemberus-gaap:FinancialAssetPastDueMember2022-09-300001333986us-gaap:CommercialLoanMemberus-gaap:FinancialAssetNotPastDueMember2022-09-300001333986eqh:AgriculturalMortgageLoansMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2022-09-300001333986us-gaap:FinancingReceivables60To89DaysPastDueMembereqh:AgriculturalMortgageLoansMember2022-09-300001333986us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMembereqh:AgriculturalMortgageLoansMember2022-09-300001333986eqh:AgriculturalMortgageLoansMemberus-gaap:FinancialAssetPastDueMember2022-09-300001333986eqh:AgriculturalMortgageLoansMemberus-gaap:FinancialAssetNotPastDueMember2022-09-300001333986us-gaap:FinancingReceivables30To59DaysPastDueMember2022-09-300001333986us-gaap:FinancingReceivables60To89DaysPastDueMember2022-09-300001333986us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2022-09-300001333986us-gaap:FinancialAssetPastDueMember2022-09-300001333986us-gaap:FinancialAssetNotPastDueMember2022-09-300001333986us-gaap:CommercialLoanMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2021-12-310001333986us-gaap:CommercialLoanMemberus-gaap:FinancingReceivables60To89DaysPastDueMember2021-12-310001333986us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMemberus-gaap:CommercialLoanMember2021-12-310001333986us-gaap:CommercialLoanMemberus-gaap:FinancialAssetPastDueMember2021-12-310001333986us-gaap:CommercialLoanMemberus-gaap:FinancialAssetNotPastDueMember2021-12-310001333986us-gaap:CommercialLoanMember2021-01-012021-12-310001333986eqh:AgriculturalMortgageLoansMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2021-12-310001333986us-gaap:FinancingReceivables60To89DaysPastDueMembereqh:AgriculturalMortgageLoansMember2021-12-310001333986us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMembereqh:AgriculturalMortgageLoansMember2021-12-310001333986eqh:AgriculturalMortgageLoansMemberus-gaap:FinancialAssetPastDueMember2021-12-310001333986eqh:AgriculturalMortgageLoansMemberus-gaap:FinancialAssetNotPastDueMember2021-12-310001333986eqh:AgriculturalMortgageLoansMember2021-01-012021-12-310001333986us-gaap:FinancingReceivables30To59DaysPastDueMember2021-12-310001333986us-gaap:FinancingReceivables60To89DaysPastDueMember2021-12-310001333986us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2021-12-310001333986us-gaap:FinancialAssetPastDueMember2021-12-310001333986us-gaap:FinancialAssetNotPastDueMember2021-12-3100013339862021-01-012021-12-310001333986us-gaap:FairValueMeasurementsRecurringMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMember2021-12-310001333986us-gaap:CurrencySwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-09-300001333986us-gaap:CurrencySwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310001333986us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-09-300001333986us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310001333986us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-09-300001333986us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310001333986eqh:EquityFuturesMemberus-gaap:NondesignatedMember2022-09-300001333986eqh:EquityFuturesMemberus-gaap:NondesignatedMember2021-12-310001333986us-gaap:EquitySwapMemberus-gaap:NondesignatedMember2022-09-300001333986us-gaap:EquitySwapMemberus-gaap:NondesignatedMember2021-12-310001333986us-gaap:NondesignatedMemberus-gaap:StockOptionMember2022-09-300001333986us-gaap:NondesignatedMemberus-gaap:StockOptionMember2021-12-310001333986us-gaap:NondesignatedMembereqh:InterestRateFuturesMember2022-09-300001333986us-gaap:NondesignatedMembereqh:InterestRateFuturesMember2021-12-310001333986us-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2022-09-300001333986us-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2021-12-310001333986us-gaap:NondesignatedMemberus-gaap:InterestRateSwaptionMember2022-09-300001333986us-gaap:NondesignatedMemberus-gaap:InterestRateSwaptionMember2021-12-310001333986us-gaap:NondesignatedMemberus-gaap:CreditDefaultSwapMember2022-09-300001333986us-gaap:NondesignatedMemberus-gaap:CreditDefaultSwapMember2021-12-310001333986us-gaap:CurrencySwapMemberus-gaap:NondesignatedMember2022-09-300001333986us-gaap:CurrencySwapMemberus-gaap:NondesignatedMember2021-12-310001333986us-gaap:NondesignatedMembereqh:CurrencyFowardMember2022-09-300001333986us-gaap:NondesignatedMembereqh:CurrencyFowardMember2021-12-310001333986us-gaap:NondesignatedMembereqh:MarginMember2022-09-300001333986us-gaap:NondesignatedMembereqh:MarginMember2021-12-310001333986us-gaap:CollateralizedSecuritiesMemberus-gaap:NondesignatedMember2022-09-300001333986us-gaap:CollateralizedSecuritiesMemberus-gaap:NondesignatedMember2021-12-310001333986us-gaap:NondesignatedMember2022-09-300001333986us-gaap:NondesignatedMember2021-12-310001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMember2022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMember2021-12-310001333986us-gaap:GuaranteedMinimumWithdrawalBenefitMember2022-09-300001333986us-gaap:GuaranteedMinimumWithdrawalBenefitMember2021-12-310001333986eqh:EmbeddedDerivativeNonGMxBInsuranceProductsMember2022-09-300001333986eqh:EmbeddedDerivativeNonGMxBInsuranceProductsMember2021-12-310001333986us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2022-09-300001333986us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2021-12-310001333986eqh:DerivativeInstrumentsIncludingEmbeddedDerivativeMember2022-09-300001333986eqh:DerivativeInstrumentsIncludingEmbeddedDerivativeMember2021-12-310001333986us-gaap:CurrencySwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-07-012022-09-300001333986us-gaap:CurrencySwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300001333986us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-07-012022-09-300001333986us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300001333986us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-07-012022-09-300001333986us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300001333986eqh:EquityFuturesMemberus-gaap:NondesignatedMember2022-07-012022-09-300001333986eqh:EquityFuturesMemberus-gaap:NondesignatedMember2022-01-012022-09-300001333986us-gaap:EquitySwapMemberus-gaap:NondesignatedMember2022-07-012022-09-300001333986us-gaap:EquitySwapMemberus-gaap:NondesignatedMember2022-01-012022-09-300001333986us-gaap:NondesignatedMemberus-gaap:StockOptionMember2022-07-012022-09-300001333986us-gaap:NondesignatedMemberus-gaap:StockOptionMember2022-01-012022-09-300001333986us-gaap:NondesignatedMembereqh:InterestRateFuturesMember2022-07-012022-09-300001333986us-gaap:NondesignatedMembereqh:InterestRateFuturesMember2022-01-012022-09-300001333986us-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2022-07-012022-09-300001333986us-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2022-01-012022-09-300001333986us-gaap:NondesignatedMemberus-gaap:InterestRateSwaptionMember2022-07-012022-09-300001333986us-gaap:NondesignatedMemberus-gaap:InterestRateSwaptionMember2022-01-012022-09-300001333986us-gaap:NondesignatedMemberus-gaap:CreditDefaultSwapMember2022-07-012022-09-300001333986us-gaap:NondesignatedMemberus-gaap:CreditDefaultSwapMember2022-01-012022-09-300001333986us-gaap:CurrencySwapMemberus-gaap:NondesignatedMember2022-07-012022-09-300001333986us-gaap:CurrencySwapMemberus-gaap:NondesignatedMember2022-01-012022-09-300001333986us-gaap:NondesignatedMembereqh:CurrencyFowardMember2022-07-012022-09-300001333986us-gaap:NondesignatedMembereqh:CurrencyFowardMember2022-01-012022-09-300001333986us-gaap:NondesignatedMembereqh:MarginMember2022-07-012022-09-300001333986us-gaap:NondesignatedMembereqh:MarginMember2022-01-012022-09-300001333986us-gaap:CollateralizedSecuritiesMemberus-gaap:NondesignatedMember2022-07-012022-09-300001333986us-gaap:CollateralizedSecuritiesMemberus-gaap:NondesignatedMember2022-01-012022-09-300001333986us-gaap:NondesignatedMember2022-07-012022-09-300001333986us-gaap:NondesignatedMember2022-01-012022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMember2022-07-012022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMember2022-01-012022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMember2022-07-012022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMember2022-01-012022-09-300001333986us-gaap:GuaranteedMinimumWithdrawalBenefitMember2022-07-012022-09-300001333986us-gaap:GuaranteedMinimumWithdrawalBenefitMember2022-01-012022-09-300001333986eqh:EmbeddedDerivativeNonGMxBInsuranceProductsMember2022-07-012022-09-300001333986eqh:EmbeddedDerivativeNonGMxBInsuranceProductsMember2022-01-012022-09-300001333986us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2022-07-012022-09-300001333986us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2022-01-012022-09-300001333986eqh:DerivativeInstrumentsIncludingEmbeddedDerivativeMember2022-07-012022-09-300001333986eqh:DerivativeInstrumentsIncludingEmbeddedDerivativeMember2022-01-012022-09-300001333986us-gaap:CurrencySwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-07-012021-09-300001333986us-gaap:CurrencySwapMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300001333986us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-07-012021-09-300001333986us-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300001333986us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-07-012021-09-300001333986us-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-01-012021-09-300001333986eqh:EquityFuturesMemberus-gaap:NondesignatedMember2021-07-012021-09-300001333986eqh:EquityFuturesMemberus-gaap:NondesignatedMember2021-01-012021-09-300001333986us-gaap:EquitySwapMemberus-gaap:NondesignatedMember2021-07-012021-09-300001333986us-gaap:EquitySwapMemberus-gaap:NondesignatedMember2021-01-012021-09-300001333986us-gaap:NondesignatedMemberus-gaap:StockOptionMember2021-07-012021-09-300001333986us-gaap:NondesignatedMemberus-gaap:StockOptionMember2021-01-012021-09-300001333986us-gaap:NondesignatedMembereqh:InterestRateFuturesMember2021-07-012021-09-300001333986us-gaap:NondesignatedMembereqh:InterestRateFuturesMember2021-01-012021-09-300001333986us-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2021-07-012021-09-300001333986us-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2021-01-012021-09-300001333986us-gaap:NondesignatedMemberus-gaap:InterestRateSwaptionMember2021-07-012021-09-300001333986us-gaap:NondesignatedMemberus-gaap:InterestRateSwaptionMember2021-01-012021-09-300001333986us-gaap:NondesignatedMemberus-gaap:CreditDefaultSwapMember2021-07-012021-09-300001333986us-gaap:NondesignatedMemberus-gaap:CreditDefaultSwapMember2021-01-012021-09-300001333986us-gaap:CurrencySwapMemberus-gaap:NondesignatedMember2021-07-012021-09-300001333986us-gaap:CurrencySwapMemberus-gaap:NondesignatedMember2021-01-012021-09-300001333986us-gaap:NondesignatedMembereqh:CurrencyFowardMember2021-07-012021-09-300001333986us-gaap:NondesignatedMembereqh:CurrencyFowardMember2021-01-012021-09-300001333986us-gaap:NondesignatedMembereqh:MarginMember2021-07-012021-09-300001333986us-gaap:NondesignatedMembereqh:MarginMember2021-01-012021-09-300001333986us-gaap:CollateralizedSecuritiesMemberus-gaap:NondesignatedMember2021-07-012021-09-300001333986us-gaap:CollateralizedSecuritiesMemberus-gaap:NondesignatedMember2021-01-012021-09-300001333986us-gaap:NondesignatedMember2021-07-012021-09-300001333986us-gaap:NondesignatedMember2021-01-012021-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMember2021-07-012021-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMember2021-01-012021-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMember2021-07-012021-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMember2021-01-012021-09-300001333986us-gaap:GuaranteedMinimumWithdrawalBenefitMember2021-07-012021-09-300001333986us-gaap:GuaranteedMinimumWithdrawalBenefitMember2021-01-012021-09-300001333986eqh:EmbeddedDerivativeNonGMxBInsuranceProductsMember2021-07-012021-09-300001333986eqh:EmbeddedDerivativeNonGMxBInsuranceProductsMember2021-01-012021-09-300001333986us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2021-07-012021-09-300001333986us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2021-01-012021-09-300001333986eqh:DerivativeInstrumentsIncludingEmbeddedDerivativeMember2021-07-012021-09-300001333986eqh:DerivativeInstrumentsIncludingEmbeddedDerivativeMember2021-01-012021-09-300001333986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-06-300001333986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-06-300001333986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310001333986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-12-310001333986us-gaap:CurrencySwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-012022-09-300001333986us-gaap:CurrencySwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-07-012021-09-300001333986us-gaap:CurrencySwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-09-300001333986us-gaap:CurrencySwapMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-09-300001333986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:InterestRateSwapMember2022-07-012022-09-300001333986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:InterestRateSwapMember2021-07-012021-09-300001333986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:InterestRateSwapMember2022-01-012022-09-300001333986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMemberus-gaap:InterestRateSwapMember2021-01-012021-09-300001333986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-012022-09-300001333986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-07-012021-09-300001333986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-09-300001333986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-09-300001333986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-09-300001333986us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-09-300001333986eqh:Sp500Russell1000Nasdaq100AndEmergingMarketIndicesMember2022-09-300001333986eqh:Sp500Russell1000Nasdaq100AndEmergingMarketIndicesMember2021-12-310001333986eqh:UsTreasuryNotesUltraLongBondsAndEuroDollarMember2022-09-300001333986eqh:UsTreasuryNotesUltraLongBondsAndEuroDollarMember2021-12-310001333986eqh:EuroStoxxFTSE100TopixASX200AndEAFEIndicesMember2022-09-300001333986eqh:EuroStoxxFTSE100TopixASX200AndEAFEIndicesMember2021-12-310001333986us-gaap:DerivativeMember2022-09-300001333986eqh:OtherFinancialAssetsMember2022-09-300001333986eqh:OtherInvestedAssetsMember2022-09-300001333986eqh:OtherFinancialLiabilitiesMember2022-09-300001333986us-gaap:OtherLiabilitiesMember2022-09-300001333986us-gaap:DerivativeMember2021-12-310001333986eqh:OtherFinancialAssetsMember2021-12-310001333986eqh:OtherInvestedAssetsMember2021-12-310001333986eqh:OtherFinancialLiabilitiesMember2021-12-310001333986us-gaap:OtherLiabilitiesMember2021-12-310001333986eqh:GMDBDirectMember2022-06-300001333986eqh:GMDBAssumedMember2022-06-300001333986eqh:GMDBCededMember2022-06-300001333986eqh:GMIBDirectMember2022-06-300001333986eqh:GMIBAssumedMember2022-06-300001333986eqh:GMIBCededMember2022-06-300001333986eqh:GMDBDirectMember2022-07-012022-09-300001333986eqh:GMDBAssumedMember2022-07-012022-09-300001333986eqh:GMDBCededMember2022-07-012022-09-300001333986eqh:GMIBDirectMember2022-07-012022-09-300001333986eqh:GMIBAssumedMember2022-07-012022-09-300001333986eqh:GMIBCededMember2022-07-012022-09-300001333986eqh:GMDBDirectMember2022-09-300001333986eqh:GMDBAssumedMember2022-09-300001333986eqh:GMDBCededMember2022-09-300001333986eqh:GMIBDirectMember2022-09-300001333986eqh:GMIBAssumedMember2022-09-300001333986eqh:GMIBCededMember2022-09-300001333986eqh:GMDBDirectMember2021-06-300001333986eqh:GMDBAssumedMember2021-06-300001333986eqh:GMDBCededMember2021-06-300001333986eqh:GMIBDirectMember2021-06-300001333986eqh:GMIBAssumedMember2021-06-300001333986eqh:GMIBCededMember2021-06-300001333986eqh:GMDBDirectMember2021-07-012021-09-300001333986eqh:GMDBAssumedMember2021-07-012021-09-300001333986eqh:GMDBCededMember2021-07-012021-09-300001333986eqh:GMIBDirectMember2021-07-012021-09-300001333986eqh:GMIBAssumedMember2021-07-012021-09-300001333986eqh:GMIBCededMember2021-07-012021-09-300001333986eqh:GMDBDirectMember2021-09-300001333986eqh:GMDBAssumedMember2021-09-300001333986eqh:GMDBCededMember2021-09-300001333986eqh:GMIBDirectMember2021-09-300001333986eqh:GMIBAssumedMember2021-09-300001333986eqh:GMIBCededMember2021-09-300001333986eqh:GMDBDirectMember2021-12-310001333986eqh:GMDBAssumedMember2021-12-310001333986eqh:GMDBCededMember2021-12-310001333986eqh:GMIBDirectMember2021-12-310001333986eqh:GMIBAssumedMember2021-12-310001333986eqh:GMIBCededMember2021-12-310001333986eqh:GMDBDirectMember2022-01-012022-09-300001333986eqh:GMDBAssumedMember2022-01-012022-09-300001333986eqh:GMDBCededMember2022-01-012022-09-300001333986eqh:GMIBDirectMember2022-01-012022-09-300001333986eqh:GMIBAssumedMember2022-01-012022-09-300001333986eqh:GMIBCededMember2022-01-012022-09-300001333986eqh:GMDBDirectMember2020-12-310001333986eqh:GMDBAssumedMember2020-12-310001333986eqh:GMDBCededMember2020-12-310001333986eqh:GMIBDirectMember2020-12-310001333986eqh:GMIBAssumedMember2020-12-310001333986eqh:GMIBCededMember2020-12-310001333986eqh:GMDBDirectMember2021-01-012021-09-300001333986eqh:GMDBAssumedMember2021-01-012021-09-300001333986eqh:GMDBCededMember2021-01-012021-09-300001333986eqh:GMIBDirectMember2021-01-012021-09-300001333986eqh:GMIBAssumedMember2021-01-012021-09-300001333986eqh:GMIBCededMember2021-01-012021-09-300001333986eqh:ReturnOfPremiumMemberus-gaap:GuaranteedMinimumDeathBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-09-300001333986eqh:RatchetMemberus-gaap:GuaranteedMinimumDeathBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-09-300001333986eqh:RollUpMemberus-gaap:GuaranteedMinimumDeathBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-09-300001333986eqh:ComboMemberus-gaap:GuaranteedMinimumDeathBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-09-300001333986us-gaap:GuaranteedMinimumDeathBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-09-300001333986eqh:ReturnOfPremiumMemberus-gaap:GuaranteedMinimumDeathBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986eqh:RatchetMemberus-gaap:GuaranteedMinimumDeathBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986eqh:RollUpMemberus-gaap:GuaranteedMinimumDeathBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986eqh:ComboMemberus-gaap:GuaranteedMinimumDeathBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986us-gaap:GuaranteedMinimumDeathBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986eqh:ReturnOfPremiumMemberus-gaap:GuaranteedMinimumIncomeBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-09-300001333986us-gaap:GuaranteedMinimumIncomeBenefitMembereqh:RatchetMemberus-gaap:ImmediateVariableAnnuityMember2022-09-300001333986us-gaap:GuaranteedMinimumIncomeBenefitMembereqh:RollUpMemberus-gaap:ImmediateVariableAnnuityMember2022-09-300001333986eqh:ComboMemberus-gaap:GuaranteedMinimumIncomeBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-09-300001333986us-gaap:GuaranteedMinimumIncomeBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-09-300001333986us-gaap:CommonStockMemberus-gaap:GuaranteedMinimumDeathBenefitMember2022-09-300001333986us-gaap:GuaranteedMinimumIncomeBenefitMemberus-gaap:CommonStockMember2022-09-300001333986us-gaap:CommonStockMemberus-gaap:GuaranteedMinimumDeathBenefitMember2021-12-310001333986us-gaap:GuaranteedMinimumIncomeBenefitMemberus-gaap:CommonStockMember2021-12-310001333986us-gaap:GuaranteedMinimumDeathBenefitMemberus-gaap:FixedIncomeInvestmentsMember2022-09-300001333986us-gaap:GuaranteedMinimumIncomeBenefitMemberus-gaap:FixedIncomeInvestmentsMember2022-09-300001333986us-gaap:GuaranteedMinimumDeathBenefitMemberus-gaap:FixedIncomeInvestmentsMember2021-12-310001333986us-gaap:GuaranteedMinimumIncomeBenefitMemberus-gaap:FixedIncomeInvestmentsMember2021-12-310001333986us-gaap:BalancedFundsMemberus-gaap:GuaranteedMinimumDeathBenefitMember2022-09-300001333986us-gaap:BalancedFundsMemberus-gaap:GuaranteedMinimumIncomeBenefitMember2022-09-300001333986us-gaap:BalancedFundsMemberus-gaap:GuaranteedMinimumDeathBenefitMember2021-12-310001333986us-gaap:BalancedFundsMemberus-gaap:GuaranteedMinimumIncomeBenefitMember2021-12-310001333986us-gaap:OtherInvestmentsMemberus-gaap:GuaranteedMinimumDeathBenefitMember2022-09-300001333986us-gaap:OtherInvestmentsMemberus-gaap:GuaranteedMinimumIncomeBenefitMember2022-09-300001333986us-gaap:OtherInvestmentsMemberus-gaap:GuaranteedMinimumDeathBenefitMember2021-12-310001333986us-gaap:OtherInvestmentsMemberus-gaap:GuaranteedMinimumIncomeBenefitMember2021-12-310001333986us-gaap:GuaranteedMinimumDeathBenefitMember2022-09-300001333986us-gaap:GuaranteedMinimumIncomeBenefitMember2022-09-300001333986us-gaap:GuaranteedMinimumDeathBenefitMember2021-12-310001333986us-gaap:GuaranteedMinimumIncomeBenefitMember2021-12-310001333986eqh:DirectLiabilitiesForGuaranteesMember2022-06-300001333986eqh:DirectLiabilitiesForGuaranteesMember2021-06-300001333986eqh:DirectLiabilitiesForGuaranteesMember2021-12-310001333986eqh:DirectLiabilitiesForGuaranteesMember2020-12-310001333986eqh:DirectLiabilitiesForGuaranteesMember2022-07-012022-09-300001333986eqh:DirectLiabilitiesForGuaranteesMember2021-07-012021-09-300001333986eqh:DirectLiabilitiesForGuaranteesMember2022-01-012022-09-300001333986eqh:DirectLiabilitiesForGuaranteesMember2021-01-012021-09-300001333986eqh:DirectLiabilitiesForGuaranteesMember2022-09-300001333986eqh:DirectLiabilitiesForGuaranteesMember2021-09-300001333986eqh:RollUpMemberus-gaap:GuaranteedMinimumDeathBenefitMembersrt:MinimumMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986eqh:ComboMemberus-gaap:GuaranteedMinimumDeathBenefitMembersrt:MinimumMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986us-gaap:GuaranteedMinimumDeathBenefitMembersrt:MinimumMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986srt:MaximumMembereqh:RollUpMemberus-gaap:GuaranteedMinimumDeathBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986srt:MaximumMembereqh:ComboMemberus-gaap:GuaranteedMinimumDeathBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986srt:MaximumMemberus-gaap:GuaranteedMinimumDeathBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986us-gaap:GuaranteedMinimumIncomeBenefitMembereqh:RollUpMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986eqh:ComboMemberus-gaap:GuaranteedMinimumIncomeBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986us-gaap:GuaranteedMinimumIncomeBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986us-gaap:GuaranteedMinimumIncomeBenefitMembereqh:RollUpMembersrt:MinimumMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986eqh:ComboMemberus-gaap:GuaranteedMinimumIncomeBenefitMembersrt:MinimumMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986us-gaap:GuaranteedMinimumIncomeBenefitMembersrt:MinimumMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986srt:MaximumMemberus-gaap:GuaranteedMinimumIncomeBenefitMembereqh:RollUpMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986srt:MaximumMembereqh:ComboMemberus-gaap:GuaranteedMinimumIncomeBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986srt:MaximumMemberus-gaap:GuaranteedMinimumIncomeBenefitMemberus-gaap:ImmediateVariableAnnuityMember2022-01-012022-09-300001333986eqh:PublicCorporateMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986eqh:PublicCorporateMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-09-300001333986eqh:PublicCorporateMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986eqh:PublicCorporateMemberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommercialMortgageBackedSecuritiesMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CommercialMortgageBackedSecuritiesMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialMortgageBackedSecuritiesMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:RedeemablePreferredStockMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:RedeemablePreferredStockMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:RedeemablePreferredStockMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:RedeemablePreferredStockMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ShortTermInvestmentsMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ShortTermInvestmentsMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ShortTermInvestmentsMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMembereqh:AssetsofConsolidatedVIEsVOEsMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membereqh:AssetsofConsolidatedVIEsVOEsMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMembereqh:AssetsofConsolidatedVIEsVOEsMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMembereqh:AssetsofConsolidatedVIEsVOEsMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SwapMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:SwapMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SwapMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SwapMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CreditDefaultSwapMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CreditDefaultSwapMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CreditDefaultSwapMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CreditDefaultSwapMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FutureMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FutureMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FutureMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FutureMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:OptionMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OptionMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:GuaranteedMinimumWithdrawalBenefitMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:GuaranteedMinimumWithdrawalBenefitMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:GuaranteedMinimumWithdrawalBenefitMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:GuaranteedMinimumWithdrawalBenefitMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMembereqh:EmbeddedDerivativeNonGMxBInsuranceProductsMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membereqh:EmbeddedDerivativeNonGMxBInsuranceProductsMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMembereqh:EmbeddedDerivativeNonGMxBInsuranceProductsMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMembereqh:EmbeddedDerivativeNonGMxBInsuranceProductsMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-09-300001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-09-300001333986us-gaap:CollateralizedLoanObligationsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300001333986us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:OtherLiabilitiesMember2022-09-300001333986eqh:PublicCorporateMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986eqh:PublicCorporateMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001333986eqh:PublicCorporateMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986eqh:PublicCorporateMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ResidentialMortgageBackedSecuritiesMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ResidentialMortgageBackedSecuritiesMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CommercialMortgageBackedSecuritiesMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CommercialMortgageBackedSecuritiesMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialMortgageBackedSecuritiesMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:RedeemablePreferredStockMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:RedeemablePreferredStockMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:RedeemablePreferredStockMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:RedeemablePreferredStockMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ShortTermInvestmentsMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ShortTermInvestmentsMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ShortTermInvestmentsMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ShortTermInvestmentsMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMembereqh:AssetsofConsolidatedVIEsVOEsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membereqh:AssetsofConsolidatedVIEsVOEsMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMembereqh:AssetsofConsolidatedVIEsVOEsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMembereqh:AssetsofConsolidatedVIEsVOEsMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SwapMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:SwapMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SwapMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:SwapMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CreditDefaultSwapMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:CreditDefaultSwapMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CreditDefaultSwapMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CreditDefaultSwapMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FutureMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FutureMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FutureMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FutureMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:OptionMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OptionMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OptionMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwaptionMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwaptionMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwaptionMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwaptionMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:GuaranteedMinimumWithdrawalBenefitMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:GuaranteedMinimumWithdrawalBenefitMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:GuaranteedMinimumWithdrawalBenefitMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:GuaranteedMinimumWithdrawalBenefitMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMembereqh:EmbeddedDerivativeNonGMxBInsuranceProductsMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membereqh:EmbeddedDerivativeNonGMxBInsuranceProductsMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMembereqh:EmbeddedDerivativeNonGMxBInsuranceProductsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMembereqh:EmbeddedDerivativeNonGMxBInsuranceProductsMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2021-12-310001333986us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2021-12-310001333986us-gaap:CollateralizedLoanObligationsMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001333986us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2022-06-300001333986us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel3Member2022-06-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2022-06-300001333986us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-06-300001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-06-300001333986eqh:FixedMaturitiesAtFairValueUsingTheFairValueOptionMemberus-gaap:FairValueInputsLevel3Member2022-06-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2022-07-012022-09-300001333986us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel3Member2022-07-012022-09-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2022-07-012022-09-300001333986us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-07-012022-09-300001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-07-012022-09-300001333986eqh:FixedMaturitiesAtFairValueUsingTheFairValueOptionMemberus-gaap:FairValueInputsLevel3Member2022-07-012022-09-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2022-09-300001333986us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2022-09-300001333986us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986eqh:FixedMaturitiesAtFairValueUsingTheFairValueOptionMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2021-06-300001333986us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel3Member2021-06-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2021-06-300001333986us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-06-300001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-06-300001333986eqh:FixedMaturitiesAtFairValueUsingTheFairValueOptionMemberus-gaap:FairValueInputsLevel3Member2021-06-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2021-07-012021-09-300001333986us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel3Member2021-07-012021-09-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2021-07-012021-09-300001333986us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-07-012021-09-300001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-07-012021-09-300001333986eqh:FixedMaturitiesAtFairValueUsingTheFairValueOptionMemberus-gaap:FairValueInputsLevel3Member2021-07-012021-09-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2021-09-300001333986us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel3Member2021-09-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2021-09-300001333986us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-09-300001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-09-300001333986eqh:FixedMaturitiesAtFairValueUsingTheFairValueOptionMemberus-gaap:FairValueInputsLevel3Member2021-09-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2021-12-310001333986us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2021-12-310001333986us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986eqh:FixedMaturitiesAtFairValueUsingTheFairValueOptionMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2022-01-012022-09-300001333986us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-09-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2022-01-012022-09-300001333986us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-09-300001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-09-300001333986eqh:FixedMaturitiesAtFairValueUsingTheFairValueOptionMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-09-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2020-12-310001333986us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel3Member2020-12-310001333986us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2020-12-310001333986us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2020-12-310001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Member2020-12-310001333986eqh:FixedMaturitiesAtFairValueUsingTheFairValueOptionMemberus-gaap:FairValueInputsLevel3Member2020-12-310001333986us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2021-01-012021-09-300001333986us-gaap:USStatesAndPoliticalSubdivisionsMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-09-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:AssetBackedSecuritiesMember2021-01-012021-09-300001333986us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-09-300001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-09-300001333986eqh:FixedMaturitiesAtFairValueUsingTheFairValueOptionMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-09-300001333986us-gaap:EquityMethodInvestmentsMemberus-gaap:FairValueInputsLevel3Member2022-06-300001333986us-gaap:FairValueInputsLevel3Membereqh:EmbeddedDerivativeGMIBReinsuranceMember2022-06-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Member2022-06-300001333986eqh:SeparateAccountsMemberus-gaap:FairValueInputsLevel3Member2022-06-300001333986eqh:GuaranteedIncomeBenefitGuaranteedWithdrawalBenefitAndOtherFeaturesLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-06-300001333986us-gaap:FairValueInputsLevel3Membereqh:ContingentPaymentArrangementsMember2022-06-300001333986us-gaap:EquityMethodInvestmentsMemberus-gaap:FairValueInputsLevel3Member2022-07-012022-09-300001333986us-gaap:FairValueInputsLevel3Membereqh:EmbeddedDerivativeGMIBReinsuranceMember2022-07-012022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Member2022-07-012022-09-300001333986eqh:SeparateAccountsMemberus-gaap:FairValueInputsLevel3Member2022-07-012022-09-300001333986eqh:GuaranteedIncomeBenefitGuaranteedWithdrawalBenefitAndOtherFeaturesLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-07-012022-09-300001333986us-gaap:FairValueInputsLevel3Membereqh:ContingentPaymentArrangementsMember2022-07-012022-09-300001333986us-gaap:EquityMethodInvestmentsMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueInputsLevel3Membereqh:EmbeddedDerivativeGMIBReinsuranceMember2022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986eqh:SeparateAccountsMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986eqh:GuaranteedIncomeBenefitGuaranteedWithdrawalBenefitAndOtherFeaturesLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:FairValueInputsLevel3Membereqh:ContingentPaymentArrangementsMember2022-09-300001333986us-gaap:EquityMethodInvestmentsMemberus-gaap:FairValueInputsLevel3Member2021-06-300001333986us-gaap:FairValueInputsLevel3Membereqh:EmbeddedDerivativeGMIBReinsuranceMember2021-06-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Member2021-06-300001333986eqh:SeparateAccountsMemberus-gaap:FairValueInputsLevel3Member2021-06-300001333986eqh:GuaranteedIncomeBenefitGuaranteedWithdrawalBenefitAndOtherFeaturesLiabilityMemberus-gaap:FairValueInputsLevel3Member2021-06-300001333986us-gaap:FairValueInputsLevel3Membereqh:ContingentPaymentArrangementsMember2021-06-300001333986us-gaap:EquityMethodInvestmentsMemberus-gaap:FairValueInputsLevel3Member2021-07-012021-09-300001333986us-gaap:FairValueInputsLevel3Membereqh:EmbeddedDerivativeGMIBReinsuranceMember2021-07-012021-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Member2021-07-012021-09-300001333986eqh:SeparateAccountsMemberus-gaap:FairValueInputsLevel3Member2021-07-012021-09-300001333986eqh:GuaranteedIncomeBenefitGuaranteedWithdrawalBenefitAndOtherFeaturesLiabilityMemberus-gaap:FairValueInputsLevel3Member2021-07-012021-09-300001333986us-gaap:FairValueInputsLevel3Membereqh:ContingentPaymentArrangementsMember2021-07-012021-09-300001333986us-gaap:EquityMethodInvestmentsMemberus-gaap:FairValueInputsLevel3Member2021-09-300001333986us-gaap:FairValueInputsLevel3Membereqh:EmbeddedDerivativeGMIBReinsuranceMember2021-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Member2021-09-300001333986eqh:SeparateAccountsMemberus-gaap:FairValueInputsLevel3Member2021-09-300001333986eqh:GuaranteedIncomeBenefitGuaranteedWithdrawalBenefitAndOtherFeaturesLiabilityMemberus-gaap:FairValueInputsLevel3Member2021-09-300001333986us-gaap:FairValueInputsLevel3Membereqh:ContingentPaymentArrangementsMember2021-09-300001333986us-gaap:EquityMethodInvestmentsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueInputsLevel3Membereqh:EmbeddedDerivativeGMIBReinsuranceMember2021-12-310001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986eqh:SeparateAccountsMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986eqh:GuaranteedIncomeBenefitGuaranteedWithdrawalBenefitAndOtherFeaturesLiabilityMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:FairValueInputsLevel3Membereqh:ContingentPaymentArrangementsMember2021-12-310001333986us-gaap:EquityMethodInvestmentsMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-09-300001333986us-gaap:FairValueInputsLevel3Membereqh:EmbeddedDerivativeGMIBReinsuranceMember2022-01-012022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-09-300001333986eqh:SeparateAccountsMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-09-300001333986eqh:GuaranteedIncomeBenefitGuaranteedWithdrawalBenefitAndOtherFeaturesLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-09-300001333986us-gaap:FairValueInputsLevel3Membereqh:ContingentPaymentArrangementsMember2022-01-012022-09-300001333986us-gaap:EquityMethodInvestmentsMemberus-gaap:FairValueInputsLevel3Member2020-12-310001333986us-gaap:FairValueInputsLevel3Membereqh:EmbeddedDerivativeGMIBReinsuranceMember2020-12-310001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Member2020-12-310001333986eqh:SeparateAccountsMemberus-gaap:FairValueInputsLevel3Member2020-12-310001333986eqh:GuaranteedIncomeBenefitGuaranteedWithdrawalBenefitAndOtherFeaturesLiabilityMemberus-gaap:FairValueInputsLevel3Member2020-12-310001333986us-gaap:FairValueInputsLevel3Membereqh:ContingentPaymentArrangementsMember2020-12-310001333986us-gaap:EquityMethodInvestmentsMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-09-300001333986us-gaap:FairValueInputsLevel3Membereqh:EmbeddedDerivativeGMIBReinsuranceMember2021-01-012021-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-09-300001333986eqh:SeparateAccountsMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-09-300001333986eqh:GuaranteedIncomeBenefitGuaranteedWithdrawalBenefitAndOtherFeaturesLiabilityMemberus-gaap:FairValueInputsLevel3Member2021-01-012021-09-300001333986us-gaap:FairValueInputsLevel3Membereqh:ContingentPaymentArrangementsMember2021-01-012021-09-300001333986eqh:GuaranteedIncomeBenefitGuaranteedWithdrawalBenefitAndOtherFeaturesLiabilityMember2022-07-012022-09-300001333986eqh:GuaranteedIncomeBenefitGuaranteedWithdrawalBenefitAndOtherFeaturesLiabilityMember2021-07-012021-09-300001333986eqh:GuaranteedIncomeBenefitGuaranteedWithdrawalBenefitAndOtherFeaturesLiabilityMember2022-01-012022-09-300001333986eqh:GuaranteedIncomeBenefitGuaranteedWithdrawalBenefitAndOtherFeaturesLiabilityMember2021-01-012021-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMember2022-07-012022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMember2021-07-012021-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMember2022-01-012022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMember2021-01-012021-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMember2022-07-012022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMember2021-07-012021-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMember2022-01-012022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMember2021-01-012021-09-300001333986us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Membereqh:MatrixPricingModelValuationTechniqueMember2022-09-300001333986eqh:MeasurementInputSpreadOverBenchmarkMemberus-gaap:CorporateDebtSecuritiesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:MatrixPricingModelValuationTechniqueMember2022-09-300001333986srt:MaximumMembereqh:MeasurementInputSpreadOverBenchmarkMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Membereqh:MatrixPricingModelValuationTechniqueMember2022-09-300001333986eqh:MeasurementInputSpreadOverBenchmarkMemberus-gaap:CorporateDebtSecuritiesMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:MatrixPricingModelValuationTechniqueMember2022-09-300001333986eqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:MeasurementInputEbitdaMultipleMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986srt:MaximumMemberus-gaap:MeasurementInputEbitdaMultipleMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986eqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:CorporateDebtSecuritiesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986srt:MaximumMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986eqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMembersrt:MinimumMembereqh:MeasurementInputCashFlowMultiplesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986srt:MaximumMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMembereqh:MeasurementInputCashFlowMultiplesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986eqh:MeasurementInputLoanToValueMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986eqh:MeasurementInputLoanToValueMembersrt:MaximumMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:MeasurementInputEbitdaMultipleMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986eqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:CorporateDebtSecuritiesMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986eqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMembersrt:WeightedAverageMembereqh:MeasurementInputCashFlowMultiplesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986eqh:MeasurementInputLoanToValueMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:TradingSecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputsDiscountFactorMember2022-09-300001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-01-012022-09-300001333986us-gaap:EquityMethodInvestmentsMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:EquityMethodInvestmentsMembereqh:MarketComparableCompaniesValuationTechniqueMembersrt:MinimumMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:EquityMethodInvestmentsMembersrt:MaximumMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:EquityMethodInvestmentsMembereqh:MarketComparableCompaniesValuationTechniqueMembersrt:WeightedAverageMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputLapseRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMemberus-gaap:MeasurementInputLapseRateMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputUtilizationRateMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputUtilizationRateMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembereqh:MeasurementInputNonperformanceRiskMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMembereqh:MeasurementInputNonperformanceRiskMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputMortalityRateMembereqh:RangeOneMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:RangeOneMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputMortalityRateMembersrt:MinimumMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputMortalityRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMemberus-gaap:MeasurementInputMortalityRateMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputLapseRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputUtilizationRateMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembereqh:MeasurementInputNonperformanceRiskMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputMortalityRateMembersrt:WeightedAverageMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputMortalityRateMembereqh:RangeOneMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputMortalityRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:MeasurementInputLapseRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986srt:MaximumMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:MeasurementInputLapseRateMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2022-09-300001333986srt:MaximumMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputUtilizationRateMember2022-09-300001333986srt:MaximumMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputUtilizationRateMember2022-09-300001333986eqh:MeasurementInputNonperformanceRiskMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2022-09-300001333986srt:MaximumMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2022-09-300001333986us-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembereqh:RangeOneMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986srt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembereqh:RangeOneMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986us-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:MinimumMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986srt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986us-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2022-09-300001333986srt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:MeasurementInputLapseRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputUtilizationRateMember2022-09-300001333986eqh:MeasurementInputNonperformanceRiskMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2022-09-300001333986us-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembereqh:RangeOneMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986us-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:WeightedAverageMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986us-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2022-09-300001333986us-gaap:FairValueInputsLevel3Membereqh:AllianceBernsteinMembereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986srt:MinimumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputLongTermRevenueGrowthRateMembereqh:AllianceBernsteinMembereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986srt:MaximumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputLongTermRevenueGrowthRateMembereqh:AllianceBernsteinMembereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986us-gaap:MeasurementInputDiscountRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:AllianceBernsteinMembereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986srt:MaximumMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueInputsLevel3Membereqh:AllianceBernsteinMembereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputLongTermRevenueGrowthRateMembereqh:AllianceBernsteinMembereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986us-gaap:MeasurementInputDiscountRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:AllianceBernsteinMembereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:MeasurementInputNonperformanceRiskMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMemberus-gaap:MeasurementInputLapseRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986srt:MaximumMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMemberus-gaap:MeasurementInputLapseRateMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2022-09-300001333986srt:MaximumMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2022-09-300001333986eqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembereqh:MeasurementInputAnnuitizationRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986srt:MaximumMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembereqh:MeasurementInputAnnuitizationRateMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986us-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembereqh:RangeOneMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986srt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembereqh:RangeOneMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986us-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembersrt:MinimumMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986srt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986us-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2022-09-300001333986srt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2022-09-300001333986eqh:MeasurementInputNonperformanceRiskMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMemberus-gaap:MeasurementInputLapseRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2022-09-300001333986eqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembereqh:MeasurementInputAnnuitizationRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986us-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembereqh:RangeOneMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986us-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembersrt:WeightedAverageMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986us-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2022-09-300001333986eqh:GmwbGwblMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:GmwbGwblMemberus-gaap:MeasurementInputLapseRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:GmwbGwblMembersrt:MaximumMemberus-gaap:MeasurementInputLapseRateMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:GmwbGwblMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2022-09-300001333986eqh:GmwbGwblMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2022-09-300001333986eqh:GmwbGwblMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputUtilizationRateMember2022-09-300001333986eqh:GmwbGwblMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2022-09-300001333986eqh:GmwbGwblMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2022-09-300001333986eqh:GmwbGwblMembereqh:MeasurementInputNonperformanceRiskMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:GmwbGwblMemberus-gaap:MeasurementInputLapseRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:GmwbGwblMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2022-09-300001333986eqh:GmwbGwblMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2022-09-300001333986us-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMember2022-09-300001333986us-gaap:MeasurementInputLapseRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMember2022-09-300001333986srt:MaximumMemberus-gaap:MeasurementInputLapseRateMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMember2022-09-300001333986srt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMembereqh:GuaranteedInsuranceBenefitsMember2022-09-300001333986srt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMembereqh:GuaranteedInsuranceBenefitsMember2022-09-300001333986srt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMemberus-gaap:MeasurementInputUtilizationRateMember2022-09-300001333986srt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMemberus-gaap:MeasurementInputUtilizationRateMember2022-09-300001333986srt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMembereqh:GuaranteedInsuranceBenefitsMember2022-09-300001333986srt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMembereqh:GuaranteedInsuranceBenefitsMember2022-09-300001333986eqh:MeasurementInputNonperformanceRiskMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMember2022-09-300001333986us-gaap:MeasurementInputLapseRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMember2022-09-300001333986srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMembereqh:GuaranteedInsuranceBenefitsMember2022-09-300001333986srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMemberus-gaap:MeasurementInputUtilizationRateMember2022-09-300001333986srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMembereqh:GuaranteedInsuranceBenefitsMember2022-09-300001333986eqh:GuaranteedMinimumAnnuityBenefitsMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986us-gaap:MeasurementInputLapseRateMembereqh:GuaranteedMinimumAnnuityBenefitsMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986srt:MaximumMemberus-gaap:MeasurementInputLapseRateMembereqh:GuaranteedMinimumAnnuityBenefitsMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:GuaranteedMinimumAnnuityBenefitsMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2022-09-300001333986srt:MaximumMembereqh:GuaranteedMinimumAnnuityBenefitsMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2022-09-300001333986eqh:MeasurementInputNonperformanceRiskMembereqh:GuaranteedMinimumAnnuityBenefitsMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986us-gaap:MeasurementInputLapseRateMembereqh:GuaranteedMinimumAnnuityBenefitsMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-09-300001333986eqh:GuaranteedMinimumAnnuityBenefitsMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2022-09-300001333986us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Membereqh:MatrixPricingModelValuationTechniqueMember2021-12-310001333986eqh:MeasurementInputSpreadOverBenchmarkMemberus-gaap:CorporateDebtSecuritiesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:MatrixPricingModelValuationTechniqueMember2021-12-310001333986srt:MaximumMembereqh:MeasurementInputSpreadOverBenchmarkMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Membereqh:MatrixPricingModelValuationTechniqueMember2021-12-310001333986eqh:MeasurementInputSpreadOverBenchmarkMemberus-gaap:CorporateDebtSecuritiesMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:MatrixPricingModelValuationTechniqueMember2021-12-310001333986eqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:MeasurementInputEbitdaMultipleMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986srt:MaximumMemberus-gaap:MeasurementInputEbitdaMultipleMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986eqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:CorporateDebtSecuritiesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986srt:MaximumMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986eqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMembersrt:MinimumMembereqh:MeasurementInputCashFlowMultiplesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986srt:MaximumMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMembereqh:MeasurementInputCashFlowMultiplesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986eqh:MeasurementInputLoanToValueMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986eqh:MeasurementInputLoanToValueMembersrt:MaximumMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:MeasurementInputEbitdaMultipleMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986eqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:CorporateDebtSecuritiesMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986eqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMembersrt:WeightedAverageMembereqh:MeasurementInputCashFlowMultiplesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986eqh:MeasurementInputLoanToValueMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:CorporateDebtSecuritiesMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:TradingSecuritiesMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputsDiscountFactorMember2021-12-310001333986eqh:TradingSecuritiesMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2022-01-012022-03-310001333986us-gaap:EquityMethodInvestmentsMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:EquityMethodInvestmentsMembereqh:MarketComparableCompaniesValuationTechniqueMembersrt:MinimumMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:EquityMethodInvestmentsMembersrt:MaximumMembereqh:MarketComparableCompaniesValuationTechniqueMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:EquityMethodInvestmentsMembereqh:MarketComparableCompaniesValuationTechniqueMembersrt:WeightedAverageMemberus-gaap:MeasurementInputRevenueMultipleMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembereqh:MeasurementInputNonperformanceRiskMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMembereqh:MeasurementInputNonperformanceRiskMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputLapseRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMemberus-gaap:MeasurementInputLapseRateMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputUtilizationRateMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputUtilizationRateMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputMortalityRateMembereqh:RangeOneMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:RangeOneMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputMortalityRateMembersrt:MinimumMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputMortalityRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:MaximumMemberus-gaap:MeasurementInputMortalityRateMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembereqh:MeasurementInputNonperformanceRiskMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputLapseRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputUtilizationRateMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputMortalityRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputMortalityRateMembereqh:RangeOneMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeGMIBReinsuranceMemberus-gaap:MeasurementInputMortalityRateMembersrt:WeightedAverageMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:MeasurementInputLapseRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986srt:MaximumMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:MeasurementInputLapseRateMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2021-12-310001333986srt:MaximumMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2021-12-310001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputUtilizationRateMember2021-12-310001333986srt:MaximumMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputUtilizationRateMember2021-12-310001333986eqh:MeasurementInputNonperformanceRiskMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2021-12-310001333986srt:MaximumMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2021-12-310001333986us-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembereqh:RangeOneMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986srt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembereqh:RangeOneMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986us-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:MinimumMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986srt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986us-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2021-12-310001333986srt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2021-12-310001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMemberus-gaap:MeasurementInputLapseRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2021-12-310001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputUtilizationRateMember2021-12-310001333986eqh:MeasurementInputNonperformanceRiskMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2021-12-310001333986us-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2021-12-310001333986us-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembersrt:WeightedAverageMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986us-gaap:MeasurementInputMortalityRateMembereqh:EmbeddedDerivativeDueFromReinsuranceReinsurersMembereqh:RangeOneMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986us-gaap:FairValueInputsLevel3Membereqh:AllianceBernsteinMembereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986srt:MinimumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputLongTermRevenueGrowthRateMembereqh:AllianceBernsteinMembereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986srt:MaximumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputLongTermRevenueGrowthRateMembereqh:AllianceBernsteinMembereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986us-gaap:MeasurementInputDiscountRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:AllianceBernsteinMembereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986srt:MaximumMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:FairValueInputsLevel3Membereqh:AllianceBernsteinMembereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputLongTermRevenueGrowthRateMembereqh:AllianceBernsteinMembereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986us-gaap:MeasurementInputDiscountRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:AllianceBernsteinMembereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:MeasurementInputNonperformanceRiskMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMemberus-gaap:MeasurementInputLapseRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986srt:MaximumMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMemberus-gaap:MeasurementInputLapseRateMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2021-12-310001333986srt:MaximumMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2021-12-310001333986eqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembereqh:MeasurementInputAnnuitizationRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986srt:MaximumMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembereqh:MeasurementInputAnnuitizationRateMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986us-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembereqh:RangeOneMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986srt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembereqh:RangeOneMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986us-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembersrt:MinimumMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986srt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986us-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2021-12-310001333986srt:MaximumMemberus-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2021-12-310001333986eqh:MeasurementInputNonperformanceRiskMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMemberus-gaap:MeasurementInputLapseRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2021-12-310001333986eqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembereqh:MeasurementInputAnnuitizationRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986us-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembereqh:RangeOneMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986us-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:RangeThreeMember2021-12-310001333986us-gaap:MeasurementInputMortalityRateMembereqh:GuaranteedMinimumInsuranceBenefitsnoLapseGuaranteeMembersrt:WeightedAverageMembereqh:RangeTwoMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:GmwbGwblMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:GmwbGwblMembereqh:MeasurementInputNonperformanceRiskMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:GmwbGwblMemberus-gaap:MeasurementInputLapseRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:GmwbGwblMembersrt:MaximumMemberus-gaap:MeasurementInputLapseRateMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:GmwbGwblMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2021-12-310001333986eqh:GmwbGwblMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2021-12-310001333986eqh:GmwbGwblMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputUtilizationRateMember2021-12-310001333986eqh:GmwbGwblMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2021-12-310001333986eqh:GmwbGwblMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2021-12-310001333986eqh:GmwbGwblMemberus-gaap:MeasurementInputLapseRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:GmwbGwblMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMember2021-12-310001333986eqh:GmwbGwblMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2021-12-310001333986us-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMember2021-12-310001333986eqh:MeasurementInputNonperformanceRiskMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMember2021-12-310001333986us-gaap:MeasurementInputLapseRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMember2021-12-310001333986srt:MaximumMemberus-gaap:MeasurementInputLapseRateMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMember2021-12-310001333986srt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMembereqh:GuaranteedInsuranceBenefitsMember2021-12-310001333986srt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMembereqh:GuaranteedInsuranceBenefitsMember2021-12-310001333986srt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMemberus-gaap:MeasurementInputUtilizationRateMember2021-12-310001333986srt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMemberus-gaap:MeasurementInputUtilizationRateMember2021-12-310001333986srt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMembereqh:GuaranteedInsuranceBenefitsMember2021-12-310001333986srt:MaximumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMembereqh:GuaranteedInsuranceBenefitsMember2021-12-310001333986us-gaap:MeasurementInputLapseRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMember2021-12-310001333986srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMemberus-gaap:MeasurementInputWithdrawalRateMembereqh:GuaranteedInsuranceBenefitsMember2021-12-310001333986srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:GuaranteedInsuranceBenefitsMemberus-gaap:MeasurementInputUtilizationRateMember2021-12-310001333986srt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMembereqh:GuaranteedInsuranceBenefitsMember2021-12-310001333986eqh:GuaranteedMinimumAnnuityBenefitsMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:MeasurementInputNonperformanceRiskMembereqh:GuaranteedMinimumAnnuityBenefitsMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986us-gaap:MeasurementInputLapseRateMembereqh:GuaranteedMinimumAnnuityBenefitsMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986srt:MaximumMemberus-gaap:MeasurementInputLapseRateMembereqh:GuaranteedMinimumAnnuityBenefitsMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:GuaranteedMinimumAnnuityBenefitsMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2021-12-310001333986srt:MaximumMembereqh:GuaranteedMinimumAnnuityBenefitsMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2021-12-310001333986us-gaap:MeasurementInputLapseRateMembereqh:GuaranteedMinimumAnnuityBenefitsMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMember2021-12-310001333986eqh:GuaranteedMinimumAnnuityBenefitsMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Membereqh:DiscountedCashFlowValuationTechniqueMembereqh:MeasurementInputEquityVolatilityMember2021-12-310001333986us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2022-09-300001333986us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2021-12-310001333986us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-09-300001333986us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2022-09-300001333986us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-09-300001333986us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2022-09-300001333986us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-09-300001333986us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001333986us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel1Member2021-12-310001333986us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001333986us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2021-12-310001333986us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001333986us-gaap:SeriesAPreferredStockMember2022-09-300001333986us-gaap:SeriesAPreferredStockMember2021-12-310001333986us-gaap:SeriesBPreferredStockMember2022-09-300001333986us-gaap:SeriesBPreferredStockMember2021-12-310001333986us-gaap:SeriesCPreferredStockMember2022-09-300001333986us-gaap:SeriesCPreferredStockMember2021-12-310001333986us-gaap:SeriesAPreferredStockMember2022-07-012022-09-300001333986us-gaap:SeriesAPreferredStockMember2021-07-012021-09-300001333986us-gaap:SeriesAPreferredStockMember2021-01-012021-09-300001333986us-gaap:SeriesBPreferredStockMember2022-07-012022-09-300001333986us-gaap:SeriesBPreferredStockMember2021-07-012021-09-300001333986us-gaap:SeriesBPreferredStockMember2022-01-012022-09-300001333986us-gaap:SeriesBPreferredStockMember2021-01-012021-09-300001333986us-gaap:SeriesCPreferredStockMember2022-07-012022-09-300001333986us-gaap:SeriesCPreferredStockMember2021-07-012021-09-300001333986us-gaap:SeriesCPreferredStockMember2021-01-012021-09-3000013339862022-02-090001333986eqh:AcceleratedShareRepurchaseAgreementMember2022-07-012022-09-300001333986eqh:AcceleratedShareRepurchaseAgreementMember2021-07-012021-09-300001333986eqh:AcceleratedShareRepurchaseAgreementMember2022-01-012022-09-300001333986eqh:AcceleratedShareRepurchaseAgreementMember2021-01-012021-09-300001333986eqh:AcceleratedShareRepurchaseAgreementApril2022Member2022-04-300001333986eqh:AcceleratedShareRepurchaseAgreementApril2022Member2022-04-012022-04-300001333986eqh:AcceleratedShareRepurchaseAgreementMay2022Member2022-05-310001333986eqh:AcceleratedShareRepurchaseAgreementMay2022Member2022-05-012022-05-310001333986eqh:AcceleratedShareRepurchaseAgreementApril2022Member2022-05-310001333986eqh:AcceleratedShareRepurchaseAgreementApril2022Member2022-09-300001333986eqh:AcceleratedShareRepurchaseAgreementApril2022Member2022-09-012022-09-300001333986eqh:BrachFamilyFoundationLitigationMember2016-02-290001333986eqh:EquitableFinancialMember2016-02-29eqh:federalAction0001333986eqh:EquitableFinancialMemberstpr:NY2016-02-29eqh:legalAction00013339862022-07-012022-07-310001333986eqh:PreCapitalizedTrustSecuritiesTrancheOneMember2019-04-012019-04-300001333986eqh:PreCapitalizedTrustSecuritiesTrancheTwoMember2019-04-012019-04-300001333986eqh:ShortTermFundingAgreementsMaturingInLessThanOneYearMemberus-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember2021-12-310001333986eqh:ShortTermFundingAgreementsMaturingInLessThanOneYearMemberus-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember2022-01-012022-09-300001333986eqh:ShortTermFundingAgreementsMaturingInLessThanOneYearMemberus-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember2022-09-300001333986eqh:LongTermFundingAgreementsMaturingBetweenTwoAndFiveYearsMemberus-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember2021-12-310001333986eqh:LongTermFundingAgreementsMaturingBetweenTwoAndFiveYearsMemberus-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember2022-01-012022-09-300001333986eqh:LongTermFundingAgreementsMaturingBetweenTwoAndFiveYearsMemberus-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember2022-09-300001333986eqh:LongTermFundingAgreementsMaturingInGreaterThanFiveYearsMemberus-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember2021-12-310001333986eqh:LongTermFundingAgreementsMaturingInGreaterThanFiveYearsMemberus-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember2022-01-012022-09-300001333986eqh:LongTermFundingAgreementsMaturingInGreaterThanFiveYearsMemberus-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember2022-09-300001333986eqh:LongTermFundingAgreementsMemberus-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember2021-12-310001333986eqh:LongTermFundingAgreementsMemberus-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember2022-01-012022-09-300001333986eqh:LongTermFundingAgreementsMemberus-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember2022-09-300001333986us-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember2021-12-310001333986us-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember2022-01-012022-09-300001333986us-gaap:FederalHomeLoanBankCertificatesAndObligationsFHLBMember2022-09-300001333986eqh:TrustNotesMember2022-09-300001333986eqh:ShortTermFundingAgreementsMaturingInLessThanOneYearMembereqh:FundingAgreementBackedNotesProgramFABNMember2021-12-310001333986eqh:ShortTermFundingAgreementsMaturingInLessThanOneYearMembereqh:FundingAgreementBackedNotesProgramFABNMember2022-01-012022-09-300001333986eqh:ShortTermFundingAgreementsMaturingInLessThanOneYearMembereqh:FundingAgreementBackedNotesProgramFABNMember2022-09-300001333986eqh:FundingAgreementBackedNotesProgramFABNMembereqh:LongTermFundingAgreementsMaturingBetweenTwoAndFiveYearsMember2021-12-310001333986eqh:FundingAgreementBackedNotesProgramFABNMembereqh:LongTermFundingAgreementsMaturingBetweenTwoAndFiveYearsMember2022-01-012022-09-300001333986eqh:FundingAgreementBackedNotesProgramFABNMembereqh:LongTermFundingAgreementsMaturingBetweenTwoAndFiveYearsMember2022-09-300001333986eqh:FundingAgreementBackedNotesProgramFABNMembereqh:LongTermFundingAgreementsMaturingInGreaterThanFiveYearsMember2021-12-310001333986eqh:FundingAgreementBackedNotesProgramFABNMembereqh:LongTermFundingAgreementsMaturingInGreaterThanFiveYearsMember2022-01-012022-09-300001333986eqh:FundingAgreementBackedNotesProgramFABNMembereqh:LongTermFundingAgreementsMaturingInGreaterThanFiveYearsMember2022-09-300001333986eqh:FundingAgreementBackedNotesProgramFABNMembereqh:LongTermFundingAgreementsMember2021-12-310001333986eqh:FundingAgreementBackedNotesProgramFABNMembereqh:LongTermFundingAgreementsMember2022-01-012022-09-300001333986eqh:FundingAgreementBackedNotesProgramFABNMembereqh:LongTermFundingAgreementsMember2022-09-300001333986eqh:FundingAgreementBackedNotesProgramFABNMember2021-12-310001333986eqh:FundingAgreementBackedNotesProgramFABNMember2022-01-012022-09-300001333986eqh:FundingAgreementBackedNotesProgramFABNMember2022-09-300001333986us-gaap:RevolvingCreditFacilityMembereqh:HoldingsRevolvingCreditFacilityMember2018-02-280001333986us-gaap:RevolvingCreditFacilityMembereqh:HoldingsRevolvingCreditFacilityMember2018-02-012018-02-280001333986us-gaap:RevolvingCreditFacilityMembereqh:HoldingsRevolvingCreditFacilityMember2021-06-300001333986eqh:HoldingsRevolvingCreditFacilityMemberus-gaap:LetterOfCreditMember2018-02-280001333986eqh:HoldingsRevolvingCreditFacilityMember2022-09-300001333986eqh:HoldingsRevolvingCreditFacilityMemberus-gaap:LetterOfCreditMember2022-09-300001333986eqh:BilateralLetterOfCreditFacilitiesMemberus-gaap:LetterOfCreditMember2018-02-280001333986us-gaap:RevolvingCreditFacilityMember2022-09-30eqh:prescribedAndPermittedPractice0001333986eqh:StatementOfStatutoryAccountingPrinciples108Member2022-09-300001333986eqh:StatementOfStatutoryAccountingPrinciples108Member2022-07-012022-09-300001333986eqh:StatementOfStatutoryAccountingPrinciples108Member2022-01-012022-09-300001333986eqh:StatementOfStatutoryAccountingPrinciples108Member2021-06-300001333986eqh:RegulationNumber213Member2022-01-012022-09-300001333986eqh:RegulationNumber213Member2022-09-300001333986eqh:RegulationNumber213Member2022-07-012022-09-300001333986eqh:RegulationNumber213WithSeperateAccountsMember2022-01-012022-09-300001333986eqh:RegulationNumber213WithSeperateAccountsMember2022-07-012022-09-3000013339862020-01-012020-12-310001333986us-gaap:MaterialReconcilingItemsMember2022-07-012022-09-300001333986us-gaap:MaterialReconcilingItemsMember2021-07-012021-09-300001333986us-gaap:MaterialReconcilingItemsMember2022-01-012022-09-300001333986us-gaap:MaterialReconcilingItemsMember2021-01-012021-09-300001333986us-gaap:OperatingSegmentsMembereqh:IndividualRetirementMember2022-07-012022-09-300001333986us-gaap:OperatingSegmentsMembereqh:IndividualRetirementMember2021-07-012021-09-300001333986us-gaap:OperatingSegmentsMembereqh:IndividualRetirementMember2022-01-012022-09-300001333986us-gaap:OperatingSegmentsMembereqh:IndividualRetirementMember2021-01-012021-09-300001333986us-gaap:OperatingSegmentsMembereqh:GroupRetirementMember2022-07-012022-09-300001333986us-gaap:OperatingSegmentsMembereqh:GroupRetirementMember2021-07-012021-09-300001333986us-gaap:OperatingSegmentsMembereqh:GroupRetirementMember2022-01-012022-09-300001333986us-gaap:OperatingSegmentsMembereqh:GroupRetirementMember2021-01-012021-09-300001333986us-gaap:OperatingSegmentsMembereqh:InvestmentManagementAndResearchMember2022-07-012022-09-300001333986us-gaap:OperatingSegmentsMembereqh:InvestmentManagementAndResearchMember2021-07-012021-09-300001333986us-gaap:OperatingSegmentsMembereqh:InvestmentManagementAndResearchMember2022-01-012022-09-300001333986us-gaap:OperatingSegmentsMembereqh:InvestmentManagementAndResearchMember2021-01-012021-09-300001333986us-gaap:OperatingSegmentsMembereqh:ProtectionSolutionsMember2022-07-012022-09-300001333986us-gaap:OperatingSegmentsMembereqh:ProtectionSolutionsMember2021-07-012021-09-300001333986us-gaap:OperatingSegmentsMembereqh:ProtectionSolutionsMember2022-01-012022-09-300001333986us-gaap:OperatingSegmentsMembereqh:ProtectionSolutionsMember2021-01-012021-09-300001333986us-gaap:CorporateNonSegmentMember2022-07-012022-09-300001333986us-gaap:CorporateNonSegmentMember2021-07-012021-09-300001333986us-gaap:CorporateNonSegmentMember2022-01-012022-09-300001333986us-gaap:CorporateNonSegmentMember2021-01-012021-09-300001333986us-gaap:MaterialReconcilingItemsMembereqh:NonGuaranteedMinimumWithdrawalBenefitMember2022-07-012022-09-300001333986us-gaap:MaterialReconcilingItemsMembereqh:NonGuaranteedMinimumWithdrawalBenefitMember2021-07-012021-09-300001333986us-gaap:MaterialReconcilingItemsMembereqh:NonGuaranteedMinimumWithdrawalBenefitMember2022-01-012022-09-300001333986us-gaap:MaterialReconcilingItemsMembereqh:NonGuaranteedMinimumWithdrawalBenefitMember2021-01-012021-09-300001333986us-gaap:IntersegmentEliminationMember2022-07-012022-09-300001333986us-gaap:IntersegmentEliminationMember2021-07-012021-09-300001333986us-gaap:IntersegmentEliminationMember2022-01-012022-09-300001333986us-gaap:IntersegmentEliminationMember2021-01-012021-09-300001333986us-gaap:InvestmentAdviceMemberus-gaap:IntersegmentEliminationMember2022-07-012022-09-300001333986us-gaap:InvestmentAdviceMemberus-gaap:IntersegmentEliminationMember2021-07-012021-09-300001333986us-gaap:InvestmentAdviceMemberus-gaap:IntersegmentEliminationMember2022-01-012022-09-300001333986us-gaap:InvestmentAdviceMemberus-gaap:IntersegmentEliminationMember2021-01-012021-09-300001333986us-gaap:OperatingSegmentsMembereqh:IndividualRetirementMember2022-09-300001333986us-gaap:OperatingSegmentsMembereqh:IndividualRetirementMember2021-12-310001333986us-gaap:OperatingSegmentsMembereqh:GroupRetirementMember2022-09-300001333986us-gaap:OperatingSegmentsMembereqh:GroupRetirementMember2021-12-310001333986us-gaap:OperatingSegmentsMembereqh:InvestmentManagementAndResearchMember2022-09-300001333986us-gaap:OperatingSegmentsMembereqh:InvestmentManagementAndResearchMember2021-12-310001333986us-gaap:OperatingSegmentsMembereqh:ProtectionSolutionsMember2022-09-300001333986us-gaap:OperatingSegmentsMembereqh:ProtectionSolutionsMember2021-12-310001333986us-gaap:CorporateNonSegmentMember2022-09-300001333986us-gaap:CorporateNonSegmentMember2021-12-310001333986us-gaap:SubsequentEventMemberus-gaap:NumberOfEmployeesTotalMembereqh:ReinsuranceTransactionMember2022-10-032022-10-030001333986us-gaap:SubsequentEventMembereqh:MassachusettsDomiciledInsuranceCompanyMember2022-10-030001333986us-gaap:SubsequentEventMembereqh:MassachusettsDomiciledInsuranceCompanyMember2022-10-032022-10-03
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
———————————————
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2022 
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to
Commission File No. 001-38469
————————————————
eqh-20220930_g1.jpg
Equitable Holdings, Inc.
(Exact name of registrant as specified in its charter) 
Delaware 90-0226248
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)

1290 Avenue of the Americas, New York, New York                 10104
(Address of principal executive offices) (Zip Code)

(212) 554-1234
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbolName of each exchange on which registered
Common StockEQHNew York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series AEQH PR ANew York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of Fixed Rate Noncumulative Perpetual Preferred Stock, Series CEQH PR CNew York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes     No 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an “emerging growth company”. See definition of “accelerated filer,” “large accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No
As of November 1, 2022, 370,042,369 shares of the registrant’s Common Stock, $0.01 par value, were outstanding.


Table of Contents
TABLE OF CONTENTS
 Page
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.



Table of Contents
NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INFORMATION
Certain of the statements included or incorporated by reference in this Quarterly Report on Form 10-Q constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “expects,” “believes,” “anticipates,” “intends,” “seeks,” “aims,” “plans,” “assumes,” “estimates,” “projects,” “should,” “would,” “could,” “may,” “will,” “shall” or variations of such words are generally part of forward-looking statements. Forward-looking statements are made based on management’s current expectations and beliefs concerning future developments and their potential effects upon Equitable Holdings, Inc. (“Holdings”) and its consolidated subsidiaries. “We,” “us” and “our” refer to Holdings and its consolidated subsidiaries, unless the context refers only to Holdings as a corporate entity. There can be no assurance that future developments affecting Holdings will be those anticipated by management. Forward-looking statements include, without limitation, all matters that are not historical facts.
These forward-looking statements are not a guarantee of future performance and involve risks and uncertainties, and there are certain important factors that could cause actual results to differ, possibly materially, from expectations or estimates reflected in such forward-looking statements, including, among others: (i) conditions in the financial markets and economy, including the impact of COVID-19 and related economic conditions, equity market declines and volatility, interest rate fluctuations, impacts on our goodwill and changes in liquidity and access to and cost of capital; (ii) operational factors, including reliance on the payment of dividends to Holdings by its subsidiaries, protection of confidential customer information or proprietary business information, operational failures by us or our service providers, catastrophic events, such as the outbreak of pandemic diseases including COVID-19, potential strategic transactions, and changes in accounting standards; (iii) credit, counterparties and investments, including counterparty default on derivative contracts, failure of financial institutions, defaults by third parties and affiliates and economic downturns, defaults and other events adversely affecting our investments; (iv) our reinsurance and hedging programs; (v) our products, structure and product distribution, including variable annuity guaranteed benefits features within certain of our products, variations in statutory capital requirements, financial strength and claims-paying ratings, state insurance laws limiting the ability of our insurance subsidiaries to pay dividends and key product distribution relationships; (vi) estimates, assumptions and valuations, including risk management policies and procedures, potential inadequacy of reserves and experience differing from pricing expectations, amortization of deferred acquisition costs and financial models; (vii) our Investment Management and Research segment, including fluctuations in assets under management and the industry-wide shift from actively-managed investment services to passive services; (viii) legal and regulatory risks, including federal and state legislation affecting financial institutions, insurance regulation and tax reform; (ix) risks related to our common stock and (x) general risks, including strong industry competition, information systems failing or being compromised and protecting our intellectual property.
Forward-looking statements should be read in conjunction with the other cautionary statements, risks, uncertainties and other factors identified in Holdings’ Annual Report on Form 10-K for the year ended December 31, 2021, as amended or supplemented in our subsequently filed Quarterly Reports on Form 10-Q, including in the section entitled “Risk Factors,” and elsewhere in this Quarterly Report on Form 10-Q. You should read this Form 10-Q completely and with the understanding that actual future results may be materially different from expectations. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as otherwise may be required by law.
Other risks, uncertainties and factors, including those discussed under “Risk Factors”, in our Annual Report on Form 10-K could cause our actual results to differ materially from those projected in any forward-looking statements we make. Readers should read carefully the factors described in “Risk Factors” in our Annual Report on Form 10-K to better understand the risks and uncertainties inherent in our business and underlying any forward-looking statements.
Throughout this Quarterly Report on Form 10-Q we use certain defined terms and abbreviations, which are summarized in the “Glossary” and “Acronyms” sections.
2

Table of Contents
Part I FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements

3

EQUITABLE HOLDINGS, INC.
Consolidated Balance Sheets
September 30, 2022 (Unaudited) and December 31, 2021
September 30, 2022December 31, 2021
(in millions, except share data)
ASSETS
Investments:
Fixed maturities available-for-sale, at fair value (amortized cost of $75,320 and $73,429) (allowance for credit losses of $22 and $22)
$64,600 $78,216 
Fixed maturities, at fair value using the fair value option (1)
1,548 1,641 
Mortgage loans on real estate (net of allowance for credit losses of $83 and $62) (1)
15,688 14,033 
Policy loans4,018 4,024 
Other equity investments (1)3,183 2,975 
Trading securities, at fair value631 631 
Other invested assets (1)2,849 3,591 
Total investments92,517 105,111 
Cash and cash equivalents (1)4,139 5,188 
Cash and securities segregated, at fair value1,335 1,504 
Broker-dealer related receivables2,539 2,599 
Deferred policy acquisition costs8,244 5,491 
Goodwill and other intangible assets, net5,635 4,728 
Amounts due from reinsurers (allowance for credit losses of $7 and $5) (includes amounts accounted for at fair value of $4,312 and $5,813) (3)
13,378 14,679 
GMIB reinsurance contract asset, at fair value1,289 1,848 
Current and deferred income taxes2,222 195 
Other assets (1)4,680 3,613 
Separate Accounts assets109,622 147,306 
Total Assets$245,600 $292,262 
LIABILITIES
Policyholders’ account balances$79,999 $79,357 
Future policy benefits and other policyholders' liabilities34,225 36,717 
Broker-dealer related payables607 1,283 
Customer related payables3,361 3,600 
Amounts due to reinsurers1,348 1,381 
Short-term and long-term debt 4,088 3,931 
Notes issued by consolidated variable interest entities, at fair value using the fair value option (1)1,165 1,191 
Other liabilities (1)5,998 3,933 
Separate Accounts liabilities109,622 147,306 
Total Liabilities$240,413 $278,699 
Redeemable noncontrolling interest (1) (2)$354 $468 
Commitments and contingent liabilities (4)
EQUITY
Equity attributable to Holdings:
Preferred stock and additional paid-in capital, $1 par value and $25,000 liquidation preference
$1,562 $1,562 
Common stock, $0.01 par value, 2,000,000,000 shares authorized; 510,362,388 and 520,918,331 shares issued, respectively; 370,114,999 and 391,290,224 shares outstanding, respectively
4 
Additional paid-in capital2,027 1,919 
Treasury stock, at cost, 140,247,389 and 129,628,107 shares, respectively
(3,202)(2,850)
Retained earnings10,839 8,880 
Accumulated other comprehensive income (loss)(7,876)2,004 
Total equity attributable to Holdings3,354 11,519 
Noncontrolling interest1,479 1,576 
Total Equity4,833 13,095 
Total Liabilities, Redeemable Noncontrolling Interest and Equity$245,600 $292,262 
____________
(1) See Note 2 of the Notes to these Consolidated Financial Statements for details of balances with VIEs.
(2) See Note 11 of the Notes to these Consolidated Financial Statements for details of redeemable noncontrolling interest.
(3) Represents the fair value of the ceded reserves to Venerable. See Note 1 of the Notes to these Consolidated Financial Statements for details of the Venerable Transaction and Note 7 of the Notes to these Consolidated Financial Statements.
(4) See Note 12 of the Notes to these Consolidated Financial Statements for details of commitments and contingent liabilities.


See Notes to Consolidated Financial Statements (Unaudited).
4

EQUITABLE HOLDINGS, INC.
Consolidated Statements of Income (Loss)
Three and Nine Months Ended September 30, 2022 and 2021 (Unaudited)

Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions, except per share data)
REVENUES
Policy charges and fee income$796 $867 $2,449 $2,755 
Premiums259 230 744 729 
Net derivative gains (losses)68 (185)3,118 (3,930)
Net investment income (loss)842 997 2,357 2,914 
Investment gains (losses), net:
Credit and intent to sell losses on available for sale debt securities and loans(267)(2)(266)
Other investment gains (losses), net(65)165 (624)763 
Total investment gains (losses), net(332)163 (890)767 
Investment management and service fees1,179 1,323 3,731 3,898 
Other income197 220 612 585 
Total revenues3,009 3,615 12,121 7,718 
BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits625 751 2,599 2,518 
Interest credited to policyholders’ account balances378 305 1,002 905 
Compensation and benefits566 614 1,679 1,762 
Commissions and distribution-related payments368 436 1,184 1,215 
Interest expense51 59 148 184 
Amortization of deferred policy acquisition costs105 64 446 257 
Other operating costs and expenses497 456 1,617 1,511 
Total benefits and other deductions2,590 2,685 8,675 8,352 
Income (loss) from continuing operations, before income taxes419 930 3,446 (634)
Income tax (expense) benefit(92)(165)(707)222 
Net income (loss)327 765 2,739 (412)
Less: Net income (loss) attributable to the noncontrolling interest54 93 165 281 
Net income (loss) attributable to Holdings$273 $672 $2,574 $(693)
Less: Preferred stock dividends14 14 54 53 
Net income (loss) available to Holdings’ common shareholders$259 $658 $2,520 $(746)
EARNINGS PER COMMON SHARE
Net income (loss) applicable to Holdings’ common shareholders per common share:
Basic$0.69 $1.60 $6.62 $(1.76)
Diluted$0.69 $1.59 $6.58 $(1.76)
Weighted average common shares outstanding (in millions):
Basic374.5 411.3 380.6 423.2 
Diluted376.8 414.6 382.9 423.2 


See Notes to Consolidated Financial Statements (Unaudited).
5


EQUITABLE HOLDINGS, INC.
Consolidated Statements of Comprehensive Income (Loss)
Three and Nine Months Ended September 30, 2022 and 2021 (Unaudited)
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
COMPREHENSIVE INCOME (LOSS)
Net income (loss)$327 $765 $2,739 $(412)
Other comprehensive income (loss) net of income taxes:
Change in unrealized gains (losses), net of reclassification adjustment(2,326)(123)(9,894)(2,056)
Changes in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment16 22 61 77 
Foreign currency translation adjustment(30)(9)(75)(13)
Total other comprehensive income (loss), net of income taxes(2,340)(110)(9,908)(1,992)
Comprehensive income (loss)(2,013)655 (7,169)(2,404)
Less: Comprehensive income (loss) attributable to the noncontrolling interest42 90 137 276 
Comprehensive income (loss) attributable to Holdings$(2,055)$565 $(7,306)$(2,680)

See Notes to Consolidated Financial Statements (Unaudited).
6


EQUITABLE HOLDINGS, INC.
Consolidated Statements of Equity
For the Three and Nine Months Ended September 30, 2022 and 2021 (Unaudited)

Three Months Ended September 30,
Equity Attributable to Holdings
Preferred Stock and Additional Paid-In CapitalCommon StockAdditional Paid-in CapitalTreasury StockRetained EarningsAccumulated Other Comprehensive Income (Loss)Total Holdings EquityNon-controlling InterestTotal Equity
(in millions)
July 1, 2022$1,562 $4 $1,918 $(3,065)$10,718 $(5,548)$5,589 $1,410 $6,999 
Stock compensation  33 3   36 9 45 
Purchase of treasury stock  (1)(200)  (201) (201)
Reissuance of treasury stock    (3) (3) (3)
Retirement of common stock   60 (60)    
Repurchase of AB Holding units       (1)(1)
Dividends paid to noncontrolling interest       (79)(79)
Issuance of AB Units for CarVal acquisition  55    55 78 133 
Dividends on common stock (cash dividends declared per common share of $0.20)
    (75) (75) (75)
Issuance of preferred stock         
Dividends on preferred stock    (14) (14) (14)
Net income (loss)    273  273 62 335 
Other comprehensive income (loss)     (2,328)(2,328)(12)(2,340)
Other  22    22 12 34 
September 30, 2022$1,562 $4 $2,027 $(3,202)$10,839 $(7,876)$3,354 $1,479 $4,833 

July 1, 2021$1,562 $$1,980 $(2,537)$8,739 $1,983 $11,732 $1,572 $13,304 
Stock compensation— — (26)(1)— — (27)27 — 
Purchase of treasury stock— — (462)— — (459)— (459)
Retirement of common stock— — — 463 (463)— — — — 
Repurchase of AB Holding units— — — — — — — (95)(95)
Dividends paid to noncontrolling interest— — — — — — — (101)(101)
Stockholder dividends (cash dividends declared per common share of $0.18)
— — — — (74)— (74)— (74)
Dividends on preferred stock— — — — (14)— (14)— (14)
Net income (loss)— — — — 672 — 672 93 765 
Other comprehensive income (loss)— — — — — (107)(107)(3)(110)
Other— — (40)— (3)— (43)(1)(44)
September 30, 2021$1,562 $$1,917 $(2,537)$8,857 $1,876 $11,680 $1,492 $13,172 

See Notes to Consolidated Financial Statements (Unaudited).
7


EQUITABLE HOLDINGS, INC.
Consolidated Statements of Equity
For the Three and Nine Months Ended September 30, 2022 and 2021 (Unaudited)
Nine Months Ended September 30,
Equity Attributable to Holdings
Preferred Stock and Additional Paid-In CapitalCommon StockAdditional Paid-in CapitalTreasury StockRetained EarningsAccumulated Other Comprehensive Income (Loss)Total Holdings EquityNon-controlling InterestTotal Equity
(in millions)
January 1, 2022$1,562 $4 $1,919 $(2,850)$8,880 $2,004 $11,519 $1,576 $13,095 
Stock compensation  68 39   107 36 143 
Purchase of treasury stock  (6)(693)  (699) (699)
Reissuance of treasury stock    (39) (39) (39)
Retirement of common stock   302 (302)    
Repurchase of AB Holding units       (108)(108)
Dividends paid to noncontrolling interest       (318)(318)
Issuance of AB Units for CarVal acquisition  55    55 78 133 
Dividends on common stock (cash dividends declared per common share of $0.58)
    (220) (220) (220)
Dividends on preferred stock    (54) (54) (54)
Issuance of preferred stock         
Net income (loss)    2,574  2,574 229 2,803 
Other comprehensive income (loss)     (9,880)(9,880)(28)(9,908)
Other  (9)   (9)14 5 
September 30, 2022$1,562 $4 $2,027 $(3,202)$10,839 $(7,876)$3,354 $1,479 $4,833 
January 1, 2021$1,269 $$1,985 $(2,245)$10,699 $3,863 $15,576 $1,601 $17,177 
Stock compensation— — 46 — — 51 38 89 
Purchase of treasury stock— — (8)(1,160)— — (1,168)— (1,168)
Reissuance of treasury stock— — — — (47)— (47)— (47)
Retirement of common stock— — — 822 (822)— — — — 
Repurchase of AB Holding units— — — — — — — (122)(122)
Dividends paid to noncontrolling interest— — — — — — — (296)(296)
Dividends on common stock (cash dividends declared per common share of $0.53)
— — — — (224)— (224)— (224)
Dividends on preferred stock— — — — (53)— (53)— (53)
Issuance of preferred stock293 — — — — — 293 — 293 
Net income (loss)— — — — (693)— (693)277 (416)
Other comprehensive income (loss)— — — — (1,987)(1,987)(5)(1,992)
Other— — (65)— (3)— (68)(1)(69)
September 30, 2021$1,562 $$1,917 $(2,537)$8,857 $1,876 $11,680 $1,492 $13,172 



See Notes to Consolidated Financial Statements (Unaudited).
8

EQUITABLE HOLDINGS, INC.
Consolidated Statements of Cash Flows
Nine Months Ended September 30, 2022 and 2021 (Unaudited)





Nine Months Ended September 30,
20222021
(in millions)
Cash flows from operating activities:
Net income (loss)$2,739 $(412)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances1,002 905 
Policy charges and fee income(2,449)(2,755)
Net derivative (gains) losses(3,118)3,930 
Credit and intent to sell losses on available for sale debt securities and loans266 (4)
Investment (gains) losses, net624 (761)
(Gains) losses on businesses HFS (2)
Realized and unrealized (gains) losses on trading securities239 48 
Non-cash long-term incentive compensation expense104 34 
Amortization and depreciation587 336 
Equity (income) loss from limited partnerships(128)(431)
Changes in:
Net broker-dealer and customer related receivables/payables(195)(625)
Reinsurance recoverable (1)(846)(758)
Segregated cash and securities, net169 845 
Capitalization of deferred policy acquisition costs(645)(620)
Future policy benefits122 (107)
Current and deferred income taxes589 (516)
Other, net195 539 
Net cash provided by (used in) operating activities$(745)$(354)
Cash flows from investing activities:
Proceeds from the sale/maturity/prepayment of:
Fixed maturities, available-for-sale$14,413 $25,911 
Fixed maturities, at fair value using the fair value option 433 610 
Mortgage loans on real estate901 1,417 
Trading account securities205 5,115 
Short term investments313 84 
Other454 1,447 
Payment for the purchase/origination of:
Fixed maturities, available-for-sale(17,022)(33,276)
Fixed maturities, at fair value using the fair value option(416)(1,564)
Mortgage loans on real estate(2,604)(1,680)
Trading account securities(185)(178)
Short term investments(676)(14)
Other(992)(2,259)
Purchase of business, net of cash acquired 40 — 
Cash from the sale of business, net of cash sold 215 
Cash settlements related to derivative instruments, net799 (6,502)
Repayments of loans to affiliates — 
Investment in capitalized software, leasehold improvements and EDP equipment(102)(93)



See Notes to Consolidated Financial Statements (Unaudited).
9

EQUITABLE HOLDINGS, INC.
Consolidated Statements of Cash Flows
Nine Months Ended September 30, 2022 and 2021 (Unaudited)





Nine Months Ended September 30,
20222021
(in millions)
Other, net167 (8)
Net cash provided by (used in) investing activities$(4,272)$(10,775)
Cash flows from financing activities:
Policyholders’ account balances:
Deposits$11,680 $12,760 
Withdrawals(5,011)(4,617)
Transfers (to) from Separate Accounts1,148 1,455 
Change in short-term financings155 
Change in collateralized pledged assets37 55 
Change in collateralized pledged liabilities(2,472)1,494 
(Decrease) increase in overdrafts payable(20)25 
Repayment of long-term debt (280)
Repayment of acquisition-related debt obligation(43)— 
Proceeds from notes issued by consolidated VIEs(34)874 
Dividends paid on common stock(220)(224)
Dividends paid on preferred stock(54)(53)
Issuance of preferred stock 293 
Purchases of AB Holding Units to fund long-term incentive compensation plan awards(108)(122)
Purchase of treasury shares(699)(1,169)
Purchases (redemptions) of noncontrolling interests of consolidated
company-sponsored investment funds
(49)23 
Distribution to noncontrolling interest of consolidated subsidiaries(318)(296)
Other, net65 (38)
Net cash provided by (used in) financing activities$4,058 $10,181 
Effect of exchange rate changes on cash and cash equivalents$(90)$(15)
Change in cash and cash equivalents(1,049)(963)
Cash and cash equivalents, beginning of year5,188 6,179 
Change in cash of businesses held-for-sale 39 
Cash and cash equivalents, end of year$4,139 $5,255 
Non-cash transactions from investing and financing activities:
Right-of-use assets obtained in exchange for lease obligations$54 $93 
Transfer of assets to reinsurer$ $(9,023)
_______________
(1) Amount includes cash paid for Venerable Transaction of $494 million. See the Note 1 of the Notes to these Consolidated Financial Statements.




See Notes to Consolidated Financial Statements (Unaudited).
10

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited)

1)    ORGANIZATION
Equitable Holdings, Inc. is the holding company for a diversified financial services organization. The Company conducts operations in four segments: Individual Retirement, Group Retirement, Investment Management and Research, and Protection Solutions. The Company’s management evaluates the performance of each of these segments independently.
The Individual Retirement segment offers a diverse suite of variable annuity products which are primarily sold to affluent and high net worth individuals saving for retirement or seeking retirement income.
The Group Retirement segment offers tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities and not-for-profit entities, as well as small and medium-sized businesses.
The Investment Management and Research segment provides diversified investment management, research and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail and Private Wealth - and distributes its institutional research products and solutions through Bernstein Research Services. The Investment Management and Research segment reflects the business of AB Holding and ABLP and their subsidiaries (collectively, AB).
The Protection Solutions segment includes the Company’s life insurance and group employee benefits businesses. The life insurance business offers a variety of VUL, IUL and term life products to help affluent and high net worth individuals, as well as small and medium-sized business owners, with their wealth protection, wealth transfer and corporate needs. Our group employee benefits business offers a suite of life, short- and long-term disability, dental and vision insurance products to small and medium-size businesses across the United States.
The Company reports certain activities and items that are not included in our segments in Corporate and Other. Corporate and Other includes certain of our financing and investment expenses. It also includes: Equitable Advisors broker-dealer business, closed block of life insurance (the “Closed Block”), run-off variable annuity reinsurance business, run-off group pension business, run-off health business, benefit plans for our employees, certain strategic investments and certain unallocated items, including capital and related investments, interest expense and corporate expense. AB’s results of operations are reflected in the Investment Management and Research segment. Accordingly, Corporate and Other does not include any items applicable to AB.
As of September 30, 2022 and December 31, 2021, the Company’s economic interest in AB was approximately 64% and 65%, respectively. The slight decrease was due to the issuance of AB Units relating to AB’s 100% acquisition of CarVal Investments L.P. (“CarVal”). On July 1, 2022, AB issued 3.2 million AB Units (with a fair value of $133 million) and recorded a $419 million liability for the issuance of additional AB Units on November 1, 2022. AB also recorded a contingent consideration payable of $227 million (to be paid predominantly in AB Units) based on CarVal achieving certain performance objectives over a six-year period ending December 31, 2027. The General Partner of AB is a wholly-owned subsidiary of the Company. Because the General Partner has the authority to manage and control the business of AB, AB is consolidated in the Company’s financial statements for all periods presented.
On June 1, 2021, Holdings completed the sale (the “Venerable Transaction”) of CS Life, to Venerable Insurance and Annuity Company, an insurance company domiciled in Iowa (“VIAC”), pursuant to the Master Transaction Agreement, dated October 27, 2020 (the “Master Transaction Agreement”), among the Company, VIAC and, solely with respect to Article XIV thereof, Venerable Holdings, Inc., a Delaware corporation (“Venerable”).
Pursuant to the Master Transaction Agreement, immediately prior to the closing of the Venerable Transaction, CS Life effected the recapture of all of the business that was ceded to CS Life Re Company, a wholly owned subsidiary of CS Life (“Reinsurance Subsidiary”), and sold 100% of the equity of the Reinsurance Subsidiary to another wholly owned subsidiary of the Company.
VIAC paid the Company a cash purchase price of $215 million for CS Life at closing. The post-closing true-up adjustment was immaterial. VIAC also issued a surplus note in aggregate principal amount of $60 million, to Equitable Financial Life Insurance Company, a New York-domiciled life insurance company and a wholly owned subsidiary of Holdings, for cash consideration.
11

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Immediately following the closing of the Venerable Transaction, CS Life and Equitable Financial entered into a coinsurance and modified coinsurance agreement (the “Reinsurance Agreement”), pursuant to which Equitable Financial ceded to CS Life, on a combined coinsurance and modified coinsurance basis, legacy variable annuity policies sold by Equitable Financial between 2006-2008 (the “Block”), comprised of non-New York “Accumulator” policies containing fixed rate Guaranteed Minimum Income Benefit and/or Guaranteed Minimum Death Benefit guarantees. At the closing of the Transaction, CS Life deposited assets supporting the general account liabilities relating to the Block into a trust account for the benefit of Equitable Financial, which assets will secure its obligations to Equitable Financial under the Reinsurance Agreement. At the closing of the Transaction, ABLP, entered into an investment advisory agreement with CS Life pursuant to which ABLP will serve as the preferred investment manager of the general account assets transferred to the trust account. The Company transferred assets of $9.5 billion, including primarily available for sale securities and cash, to a collateral trust account as the consideration for the reinsurance transaction. In addition, the Company recorded $9.6 billion of direct insurance liabilities ceded under the reinsurance contract, of which $5.3 billion is accounted at fair value, as the reinsurance of GMxB with no lapse guarantee riders are embedded derivatives. Additionally, $16.9 billion of Separate Account liabilities were ceded under a modified coinsurance portion of the agreement.
In addition, upon the completion of the Venerable Transaction, EIMG acquired an approximate 9.09% equity interest in Venerable’s parent holding company, VA Capital Company LLC. In connection with such investment, EIMG designated a member to the Board of Managers of VA Capital Company LLC.

2)     SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Principles of Consolidation
The unaudited interim consolidated financial statements (the “consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP” or “GAAP”) on a basis consistent with reporting interim financial information in accordance with instructions to the Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”).
In the opinion of management, all adjustments necessary for a fair statement of the financial position and results of operations have been made. All such adjustments are of a normal, recurring nature. Interim results are not necessarily indicative of the results that may be expected for the full year. These financial statements should be read in conjunction with the Company’s consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.
The accompanying unaudited consolidated financial statements present the consolidated results of operations, financial condition, and cash flows of the Company and its subsidiaries and those investment companies, partnerships and joint ventures in which the Company has control and a majority economic interest as well as those variable interest entities (“VIEs”) that meet the requirements for consolidation.
All significant intercompany transactions and balances have been eliminated in consolidation. The terms “third quarter 2022” and “third quarter 2021” refer to the three months ended September 30, 2022 and 2021, respectively. The terms “first nine months of 2022” and “first nine months of 2021” refer to the nine months ended September 30, 2022 and 2021, respectively.
Certain prior year amounts have been reclassified to conform to the current year’s presentation.

Recent Accounting Pronouncements
Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates (“ASUs”) to the FASB Accounting Standards Codification (“ASC”). The Company considers the applicability and impact of all ASUs. ASUs listed below include those that have been adopted during the current fiscal year and/or those that have been issued but not yet adopted as of September 30, 2022, and as of the date of this filing. ASUs not listed below were assessed and determined to be either not applicable or not material.

12

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Future Adoption of New Accounting Pronouncements
Description
Effective Date and Method of Adoption
Effect on the Financial Statement or Other Significant Matters
ASU 2018-12: Financial Services - Insurance (Topic 944); ASU 2020-11: Financial Services - Insurance (Topic 944): Effective Date and Early Application
This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including:
1. Measurement of the liability for future policy benefits for traditional and limited payment contracts. The ASU requires companies to review, and if necessary, update cash flow assumptions at least annually for non-participating traditional and limited-payment insurance contracts. The ASU also prescribes the discount rate to be used in measuring the liability for future policy benefits for traditional and limited payment long-duration contracts.

2. Measurement of MRBs. MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk.

3. Amortization of deferred acquisition costs. The ASU simplifies the amortization of deferred acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts.

4. Expanded footnote disclosures. The ASU requires additional disclosures including information about significant inputs, judgements, assumptions and methods used in measurement.
In November 2020, the FASB issued ASU 2020-11 which deferred the effective date of the amendments in ASU 2018-12 for all insurance entities. ASU 2018-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Early adoption is allowed.

For the liability for future policyholder benefits for traditional and limited payment contracts, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for deferred policy acquisition costs.

For MRBs, the ASU should be applied retrospectively as of the beginning of the earliest period presented.
The Company continues to progress with implementation efforts and the evaluation of the impact that adoption of this guidance will have on the Company’s consolidated financial statements. Due to its extensive nature, the adoption of the ASU is expected to have a significant impact on the Company’s consolidated financial statements, as well as systems, processes and controls. Effective January 1, 2023, the new guidance will be adopted using the modified retrospective approach, except for MRBs which will use the full retrospective approach.

The Company has created a governance framework and implementation plan to ensure timely adoption of the guidance. In preparation for implementation, the Company continues to refine key accounting policy decisions, modernize processes and update internal controls. These changes include modifications of actuarial valuation systems, data sourcing, analytical procedures and reporting processes.

The impact on total equity of applying this ASU is estimated to be neutral to the current amount of reported total equity as of September 30, 2022. As of September 30, 2022, a positive impact to AOCI is expected due to increases in the Company’s estimate of its non-performance risk on variable annuity guarantees accounted for as MRBs for the first time under the guidance. The estimated impact to the retained earnings element of total equity as of September 30, 2022, due to accounting for variable annuity guarantees as MRBs that are not currently measured at fair value, is mitigated by the Company’s present use of a near industry low interest rate assumption of 2.25% on GMIB business. Because movements in equity markets, interest rates and credit spreads are unpredictable and at times volatile, it is possible that the estimated effects of adoption could change materially between September 30, 2022 and January 1, 2023.

Securities Sold under Agreements to Repurchase

Securities sold under agreements to repurchase involve the temporary exchange of securities for cash or
other collateral of equivalent value, with agreement to redeliver a like quantity of the same or similar securities at a
13

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

future date prior to maturity at a fixed and determinable price. Securities sold under agreements to repurchase
transactions are conducted by the Company under a standardized securities industry master agreement, amended to suit
the requirements of each respective counterparty. Transfers of securities under these agreements to repurchase
are evaluated by the Company to determine whether they satisfy the criteria for accounting treatment as secured
borrowing arrangements. Agreements not meeting the criteria would require recognition of the transferred
securities as sales with related forward repurchase commitments. All of the Company’s securities repurchase transactions are accounted for as secured borrowings with the related obligations distinctly captioned in the consolidated balance sheets on a gross basis. As of September 30, 2022 and December 31, 2021, the Company had no Securities sold under agreements to repurchase outstanding. During the year ended December 31, 2021 there was no activity on Securities sold under agreements to repurchase.
Accounting and Consolidation of VIEs
For all new investment products and entities developed by the Company, the Company first determines whether the entity is a VIE, which involves determining an entity’s variability and variable interests, identifying the holders of the equity investment at risk and assessing the five characteristics of a VIE. Once an entity has been determined to be a VIE, the Company then determines whether it is the primary beneficiary of the VIE based on its beneficial interests. If the Company is deemed to be the primary beneficiary of the VIE, then the Company consolidates the entity.
Management of the Company reviews quarterly its investment management agreements and its investments in, and other financial arrangements with, certain entities that hold client AUM to determine the entities that the Company is required to consolidate under this guidance. These entities include certain mutual fund products, hedge funds, structured products, group trusts, collective investment trusts and limited partnerships.
The analysis performed to identify variable interests held, determine whether entities are VIEs or VOEs, and evaluate whether the Company has a controlling financial interest in such entities requires the exercise of judgment and is updated on a continuous basis as circumstances change or new entities are developed. The primary beneficiary evaluation generally is performed qualitatively based on all facts and circumstances, including consideration of economic interests in the VIE held directly and indirectly through related parties and entities under common control, as well as quantitatively, as appropriate.
Consolidated VIEs
Consolidated CLOs
The Company is the investment manager of certain asset-backed investment vehicles, commonly referred to as CLOs, and certain other vehicles for which the Company earns fee income for investment management services. The Company may sell or syndicate investments through these vehicles, principally as part of the strategic investing activity as part of its investment management businesses. Additionally, the Company may invest in securities issued by these vehicles which are eliminated in consolidation of the CLOs.
As of September 30, 2022 and December 31, 2021, respectively, Equitable Financial holds $93 million and $109 million of equity interests in the CLOs. The Company consolidated the CLOs as of September 30, 2022 and December 31, 2021 as it is the primary beneficiary due to the combination of both its equity interest held by Equitable Financial and the majority ownership of AB, which functions as the CLOs loan manager. The assets of the CLOs are legally isolated from the Company’s creditors and can only be used to settle obligations of the CLOs. The liabilities of the CLOs are non-recourse to the Company and the Company has no obligation to satisfy the liabilities of the CLOs. As of September 30, 2022, Equitable Financial holds $67 million of equity interests in a SPE established to purchase loans from the market in anticipation of a new CLO transaction. The Company consolidated the SPE as of September 30, 2022 as it is the primary beneficiary due to the combination of both its equity interest held by Equitable Financial and the majority ownership of AB, which functions as the SPE loan manager.
Resulting from this consolidation in the Company’s consolidated balance sheets are fixed maturities, at fair value using the fair value option with total assets of $1.5 billion and $1.6 billion notes issued by consolidated variable interest entities, at fair value using the fair value option with total liabilities of $1.2 billion and $1.2 billion at September 30, 2022 and December 31, 2021, respectively. The unpaid outstanding principal balance of the notes and short-term borrowing is $1.4 billion and $1.3 billion at September 30, 2022 and December 31, 2021.
Consolidated Limited Partnerships and LLCs
14

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

As of September 30, 2022 and December 31, 2021 the Company consolidated limited partnerships and LLCs for which it was identified as the primary beneficiary under the VIE model. Included in Other invested assets, Mortgage loans on real estate, Other equity investments, Trading securities, cash and other liabilities in the Company’s consolidated balance sheets at September 30, 2022 and December 31, 2021 are total net assets of $562 million and $219 million, respectively related to these VIEs.
Consolidated AB-Sponsored Investment Funds
Included in the Company’s consolidated balance sheet as of September 30, 2022 and December 31, 2021 are assets of $477 million and $734 million, liabilities of $26 million and $87 million, and redeemable noncontrolling interests of $310 million and $421 million, respectively, associated with the consolidation of AB-sponsored investment funds under the VIE model. Also included in the Company’s consolidated balance sheets as of September 30, 2022 and December 31, 2021 are assets of $28 million and $0 million, liabilities of $2 million and $0 million, and redeemable noncontrolling interests of $2 million and $0 million, respectively, from consolidation of AB-sponsored investment funds under the VOE model. The assets of these consolidated funds are presented within other invested assets and cash and cash equivalents, and liabilities of these consolidated funds are presented with other liabilities in the Company’s consolidated balance sheets; ownership interests not held by the Company relating to consolidated VIEs and VOEs are presented either as redeemable or non-redeemable noncontrolling interests, as appropriate. Redeemable noncontrolling interests are presented in mezzanine equity and non-redeemable noncontrolling interests are presented within permanent equity. The Company is not required to provide financial support to these AB-sponsored investment funds, and only the assets of such funds are available to settle each fund’s own liabilities.
Non-Consolidated VIEs
As of September 30, 2022 and December 31, 2021 respectively, the Company held approximately $2.3 billion and $2.1 billion of investment assets in the form of equity interests issued by non-corporate legal entities determined under the guidance to be VIEs, such as limited partnerships and limited liability companies, including CLOs, hedge funds, private equity funds and real estate-related funds. As an equity investor, the Company is considered to have a variable interest in each of these VIEs as a result of its participation in the risks and/or rewards these funds were designed to create by their defined portfolio objectives and strategies. Primarily through qualitative assessment, including consideration of related party interests or other financial arrangements, if any, the Company was not identified as primary beneficiary of any of these VIEs, largely due to its inability to direct the activities that most significantly impact their economic performance. Consequently, the Company continues to reflect these equity interests in the consolidated balance sheets as other equity investments and applies the equity method of accounting for these positions. The net assets of these non-consolidated VIEs are approximately $278.9 billion and $245.6 billion as of September 30, 2022 and December 31, 2021 respectively. The Company’s maximum exposure to loss from its direct involvement with these VIEs is the carrying value of its investment of $2.3 billion and $2.1 billion and approximately $1.3 billion and $1.2 billion of unfunded commitments as of September 30, 2022 and December 31, 2021, respectively. The Company has no further economic interest in these VIEs in the form of guarantees, derivatives, credit enhancements or similar instruments and obligations.
Non-Consolidated AB-Sponsored Investment Products
As of September 30, 2022 and December 31, 2021, the net assets of investment products sponsored by AB that are non-consolidated VIEs are approximately $39.9 billion and $68.9 billion, respectively. The Company’s maximum exposure to loss from its direct involvement with these VIEs is its investment of $5 million and $9 million as of September 30, 2022 and December 31, 2021. The Company has no further commitments to or economic interest in these VIEs.
Assumption Updates
The Company conducts its annual review of its assumptions during the third quarter of each year. The annual review encompasses assumptions underlying the valuation of unearned revenue liabilities, embedded derivatives for our insurance business, liabilities for future policyholder benefits, DAC and DSI assets.
However, the Company updates its assumptions as needed in the event it becomes aware of economic conditions or events that could require a change in assumptions that it believes may have a significant impact to the carrying value of product liabilities and assets and consequently materially impact its earnings in the period of the change.
The net impact of assumption changes in the three and nine months ended September 30, 2022 decreased policy charges and fee income by $23 million, decreased policyholders’ benefits by $243 million, increased interest credited
15

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

to policyholder account balances by $1 million, increased net derivative losses by $80 million and decreased amortization of DAC by $43 million. This resulted in an increase in income (loss) from operations, before income taxes of $182 million and increased net income (loss) by $144 million.
The net impact of assumption changes in the three and nine months ended September 30, 2021 decreased policy charges and fee income by $28 million, decreased policyholders’ benefits by $62 million, increased net derivative gains by $200 million and decreased amortization of DAC by $58 million. This resulted in a decrease in income (loss) from operations, before income taxes of $108 million and decreased net income (loss) by $85 million. As part of this annual assumption update the reference interest rate utilized in our GAAP fair value calculations was updated from the LIBOR swap curve to the US Treasury curve due to the impending cessation of LIBOR and our GAAP fair value liability risk margins were increased, resulting in little impact to overall valuation as our view regarding market participant pricing of our guarantees has not changed at this time.
Model Changes
There were no material model changes in the first nine months of 2021 and 2022.

3)    INVESTMENTS
Fixed Maturities AFS
The components of fair value and amortized cost for fixed maturities classified as AFS on the consolidated balance sheets excludes accrued interest receivable because the Company elected to present accrued interest receivable within other assets. Accrued interest receivable on AFS fixed maturities as of September 30, 2022 and December 31, 2021 was $604 million and $506 million, respectively. There was no accrued interest written off for AFS fixed maturities for the three and nine months ended September 30, 2022 and 2021.
The following tables provide information relating to the Company’s fixed maturities classified as AFS.
AFS Fixed Maturities by Classification
 
Amortized CostAllowance for Credit Losses Gross Unrealized GainsGross Unrealized LossesFair Value
 
 (in millions)
September 30, 2022
Fixed Maturities:
Corporate (1)$52,643 $22 $69 $8,144 $44,546 
U.S. Treasury, government and agency
7,241  4 1,215 6,030 
States and political subdivisions668  8 92 584 
Foreign governments
1,114  2 190 926 
Residential mortgage-backed (2)500  1 25 476 
Asset-backed (3)9,289  1 545 8,745 
Commercial mortgage-backed3,824   574 3,250 
Redeemable preferred stock41  2  43 
Total at September 30, 2022$75,320 $22 $87 $10,785 $64,600 
December 31, 2021:
Fixed Maturities:
Corporate (1)
$50,172 $22 $2,601 $240 $52,511 
U.S. Treasury, government and agency
13,056 — 2,344 15 15,385 
States and political subdivisions
586 — 78 662 
Foreign governments
1,124 — 42 14 1,152 
Residential mortgage-backed (2)90 — — 98 
Asset-backed (3)5,933 — 21 20 5,934 
Commercial mortgage-backed2,427 — 19 25 2,421 
16

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

 
Amortized CostAllowance for Credit Losses Gross Unrealized GainsGross Unrealized LossesFair Value
 
 (in millions)
Redeemable preferred stock 41 — 12 — 53 
Total at December 31, 2021$73,429 $22 $5,125 $316 $78,216 
______________
(1)Corporate fixed maturities include both public and private issues.
(2)Includes publicly traded agency pass-through securities and collateralized obligations.
(3)Includes credit-tranched securities collateralized by sub-prime mortgages, credit risk transfer securities and other asset types.
The contractual maturities of AFS fixed maturities as of September 30, 2022 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
Contractual Maturities of AFS Fixed Maturities
 Amortized Cost (Less Allowance for Credit Losses)Fair Value
 (in millions)
September 30, 2022
Contractual maturities:
Due in one year or less$1,419 $1,397 
Due in years two through five14,893 14,033 
Due in years six through ten18,743 16,531 
Due after ten years26,589 20,125 
Subtotal61,644 52,086 
Residential mortgage-backed500 476 
Asset-backed9,289 8,745 
Commercial mortgage-backed3,824 3,250 
Redeemable preferred stock 41 43 
Total at September 30, 2022$75,298 $64,600 

The following table shows proceeds from sales, gross gains (losses) from sales and allowance for credit losses for AFS fixed maturities for the three and nine months ended September 30, 2022 and 2021:
Proceeds from Sales, Gross Gains (Losses) from Sales and Allowance for Credit and Intent to Sell Losses for AFS Fixed Maturities

 
Three Months Ended September 30,Nine Months Ended September 30,
 
2022202120222021
 
(in millions)
Proceeds from sales$905 $3,701 $11,640 $20,776 
Gross gains on sales$ $171 $44 $1,019 
Gross losses on sales$(62)$(8)$(653)$(162)
Net change in Allowance for Credit and Intent to Sell losses$(243)$(2)$(246)$(14)

The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts.

17

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

AFS Fixed Maturities - Credit and Intent to Sell Loss Impairments

Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Balance, beginning of period$32 $42 $44 $32 
Previously recognized impairments on securities that matured, paid, prepaid or sold(2)(1)(17)(4)
Recognized impairments on securities impaired to fair value this period (1) (2)246 — 246 — 
Credit losses recognized this period on securities for which credit losses were not previously recognized(1)— — 
Additional credit losses this period on securities previously impaired
Increases due to passage of time on previously recorded credit losses— — — — 
Accretion of previously recognized impairments due to increases in expected cash flows (for OTTI securities 2019 and prior)— — — — 
Balance at September 30,$280 $42 $280 $42 
______________
(1)Represents circumstances where the Company determined in the current period that it intends to sell the security, or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost.
(2)Amounts reflected as of three and nine months ended September 30, 2022 represent AFS fixed maturities in an unrealized loss position, which the Company intends to sell in anticipation of the EQUI-VEST Transaction. For additional details on the EQUI-VEST Transaction, see Note 16 of the Notes to the Consolidated Financial Statements.

The tables that follow below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI.

18

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Net Unrealized Gains (Losses) on AFS Fixed Maturities

Net Unrealized Gains (Losses) on InvestmentsDACPolicyholders’ LiabilitiesDeferred Income Tax Asset (Liability)AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
(in millions)
Balance, July 1, 2022$(6,965)$1,180 $(333)$1,285 $(4,833)
Net investment gains (losses) arising during the period(4,045)   (4,045)
Reclassification adjustment:
Included in net income (loss)311    311 
Excluded from net income (loss)     
Other      
Impact of net unrealized investment gains (losses) 593 3 659 1,255 
Net unrealized investment gains (losses) excluding credit losses(10,699)1,773 (330)1,944 (7,312)
Net unrealized investment gains (losses) with credit losses1    1 
Balance, September 30, 2022$(10,698)$1,773 $(330)$1,944 $(7,311)
Balance, July 1, 2021$5,361 $(1,165)$(414)$(794)$2,988 
Net investment gains (losses) arising during the period(395)   (395)
Reclassification adjustment:
Included in net income (loss)(165)   (165)
Other (1)     
Impact of net unrealized investment gains (losses) 377 33 31 441 
Net unrealized investment gains (losses) excluding credit losses4,801 (788)(381)(763)2,869 
Net unrealized investment gains (losses) with credit losses(1)   (1)
Balance, Balance, September 30, 2021$4,800 $(788)$(381)$(763)$2,868 

Net Unrealized Gains (Losses) on InvestmentsDACPolicyholders’ LiabilitiesDeferred Income Tax Asset (Liability)AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses)
(in millions)
Balance, January 1, 2022$4,809 $(782)$(418)$(757)$2,852 
Net investment gains (losses) arising during the period(16,359)   (16,359)
Reclassification adjustment:
Included in net income (loss)859    859 
Other      
Impact of net unrealized investment gains (losses) 2,554 88 2,699 5,341 
Net unrealized investment gains (losses) excluding credit losses(10,691)1,772 (330)1,942 (7,307)

19

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Net unrealized investment gains (losses) with credit losses(7)1  2 (4)
Balance, September 30, 2022$(10,698)$1,773 $(330)$1,944 $(7,311)
Balance, January 1, 2021$8,811 $(1,548)$(1,065)$(1,302)$4,896 
Net investment gains (losses) arising during the period(3,231)— — — (3,231)
Reclassification adjustment:
Included in net income (loss)(747)— — — (747)
Other (1)(33)— — — (33)
Impact of net unrealized investment gains (losses)— 761 685 539 1,985 
Net unrealized investment gains (losses) excluding credit losses4,800 (787)(380)(763)2,870 
Net unrealized investment gains (losses) with credit losses— (1)(1)— (2)
Balance, September 30, 2021$4,800 $(788)$(381)$(763)$2,868 
_____________
(1) Effective January 1, 2021, certain preferred stock have been reclassified to other equity investments.

The following tables disclose the fair values and gross unrealized losses of the 5,220 issues as of September 30, 2022 and the 2,060 issues as of December 31, 2021 that are not deemed to have credit losses, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated.
AFS Fixed Maturities in an Unrealized Loss Position for Which No Allowance Is Recorded
Less Than 12 Months
12 Months or Longer
Total
Fair Value
Gross Unrealized Losses
Fair Value
Gross Unrealized Losses
Fair Value
Gross Unrealized Losses
(in millions)
September 30, 2022
Fixed Maturities:
Corporate$33,987 $6,565 $6,312 $1,577 $40,299 $8,142 
U.S. Treasury, government and agency5,536 1,196 201 19 5,737 1,215 
States and political subdivisions339 84 14 8 353 92 
Foreign governments605 138 167 52 772 190 
Residential mortgage-backed438 25 1  439 25 
Asset-backed8,072 503 440 42 8,512 545 
Commercial mortgage-backed2,435 382 813 192 3,248 574 
Total at September 30, 2022$51,412 $8,893 $7,948 $1,890 $59,360 $10,783 
December 31, 2021:
Fixed Maturities:
Corporate$10,571 $163 $1,633 $75 $12,204 $238 
U.S. Treasury, government and agency993 11 105 1,098 15 
States and political subdivisions120 11 — 131 
Foreign governments349 92 441 14 
Residential mortgage-backed— — — — — — 
Asset-backed3,865 20 38 — 3,903 20 
Commercial mortgage-backed1,527 21 96 1,623 25 
Total at December 31, 2021$17,425 $223 $1,975 $91 $19,400 $314 


20

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued


The Company’s investments in fixed maturities do not include concentrations of credit risk of any single issuer greater than 10% of the consolidated equity of the Company, other than securities of the U.S. government, U.S. government agencies, and certain securities guaranteed by the U.S. government. The Company maintains a diversified portfolio of corporate securities across industries and issuers and does not have exposure to any single issuer in excess of 0.6% of total corporate securities. The largest exposures to a single issuer of corporate securities held as of September 30, 2022 and December 31, 2021 were $275 million and $322 million, respectively, representing 5.7% and 2.5% of the consolidated equity of the Company.
Corporate high yield securities, consisting primarily of public high yield bonds, are classified as other than investment grade by the various rating agencies, i.e., a rating below Baa3/BBB- or the NAIC designation of 3 (medium investment grade), 4 or 5 (below investment grade) or 6 (in or near default). As of September 30, 2022 and December 31, 2021, respectively, approximately $2.9 billion and $2.9 billion, or 3.9% and 3.9%, of the $75.3 billion and $73.4 billion aggregate amortized cost of fixed maturities held by the Company were considered to be other than investment grade. These securities had gross unrealized losses of $242 million and $18 million as of September 30, 2022 and December 31, 2021, respectively.
As of September 30, 2022 and December 31, 2021, respectively, the $1,890 million and $91 million of gross unrealized losses of twelve months or more were primarily concentrated in corporate securities. In accordance with the policy described in Note 2 of the Notes to these Consolidated Financial Statements, the Company concluded that an adjustment to allowance for credit losses for these securities was not warranted at either September 30, 2022 or December 31, 2021. As of September 30, 2022 and December 31, 2021, the Company did not intend to sell the securities nor will it likely be required to dispose of the securities before the anticipated recovery of their remaining amortized cost basis.
Based on the Company’s evaluation both qualitatively and quantitatively of the drivers of the decline in fair value of fixed maturity securities as of September 30, 2022, the Company determined that the unrealized loss was primarily due to increases in interest rates, credit spreads and changes in credit ratings.
Mortgage Loans on Real Estate
Accrued interest receivable on commercial and agricultural mortgage loans as of September 30, 2022 and December 31, 2021 was $63 million and $57 million, respectively. There was no accrued interest written off for commercial and agricultural mortgage loans for the nine months ended September 30, 2022 and 2021.
As of September 30, 2022, the Company had no loans for which foreclosure was probable included within the individually assessed mortgage loans, and accordingly had no associated allowance for credit losses.
Allowance for Credit Losses on Mortgage Loans
The change in the allowance for credit losses for commercial mortgage loans and agricultural mortgage loans during the nine months ended September 30, 2022 and 2021 were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Allowance for credit losses on mortgage loans:
Commercial mortgages:
Balance, beginning of period $58 $59 $57 $77 
Current-period provision for expected credit losses19 20 (17)
Write-offs charged against the allowance —  — 
Recoveries of amounts previously written off —  — 
Net change in allowance19 20 (17)
Balance, end of period$77 $60 $77 $60 

21

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Agricultural mortgages:
Balance, beginning of period$6 $$5 $
Current-period provision for expected credit losses — 1 — 
Write-offs charged against the allowance —  — 
Recoveries of amounts previously written off —  — 
Net change in allowance — 1 — 
Balance, end of period$6 $$6 $
Total allowance for credit losses$83 $64 $83 $64 

The change in the allowance for credit losses is attributable to:
increases/decreases in the loan balance due to new originations, maturing mortgages, and loan amortization; and
changes in credit quality.
Credit Quality Information
The following tables summarize the Company’s mortgage loans segregated by risk rating exposure as of September 30, 2022 and December 31, 2021.

Loan to Value (“LTV”) Ratios (1)
September 30, 2022
Amortized Cost Basis by Origination Year
20222021202020192018PriorRevolving Loans Amortized Cost BasisRevolving Loans Converted to Term Loans Amortized Cost BasisTotal
(in millions)
Mortgage loans:
Commercial:
0% - 50%$488 $130 $ $ $119 $1,469 $ $ $2,206 
50% - 70%1,780 1,857 1,255 275 733 2,597 273  8,770 
70% - 90%136 124 115 368 315 898  33 1,989 
90% plus    35 174   209 
Total commercial$2,404 $2,111 $1,370 $643 $1,202 $5,138 $273 $33 $13,174 
Agricultural:
0% - 50%$121 $190 $214 $123 $135 $754 $ $ $1,537 
50% - 70%182 179 238 86 82 277   1,044 
70% - 90%1     15   16 
90% plus         
Total agricultural$304 $369 $452 $209 $217 $1,046 $ $ $2,597 
Total mortgage loans:

22

EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

September 30, 2022
Amortized Cost Basis by Origination Year
20222021202020192018PriorRevolving Loans Amortized Cost BasisRevolving Loans Converted to Term Loans Amortized Cost BasisTotal
(in millions)
0% - 50%$609 $320 $214 $123 $254 $2,223 $ $ $3,743 
50% - 70%1,962 2,036 1,493 361 815 2,874 273  9,814 
70% - 90%137 124 115 368 315 913  33 2,005 
90% plus    35 174   209 
Total mortgage loans$2,708 $2,480 $1,822 $852 $1,419 $6,184 $273 $33 $15,771 


Debt Service Coverage Ratios (“DSC”) (2)
September 30, 2022
Amortized Cost Basis by Origination Year
20222021202020192018PriorRevolving Loans Amortized Cost BasisRevolving Loans Converted to Term Loans Amortized Cost BasisTotal
(in millions)
Mortgage loans:
Commercial:
Greater than 2.0x$605 $1,143 $1,078 $103 $571 $1,863 $ $ $5,363 
1.8x to 2.0x135 187 165 216 186 421 161  1,471 
1.5x to 1.8x413 274 32 177 250 1,173 75  2,394 
1.2x to 1.5x614 259 60 92 47 1,376   2,448 
1.0x to 1.2x222 248 35 55 148 234 37 33 1,012 
Less than 1.0x415     71   486 
Total commercial$2,404 $2,111 $1,370 $643 $1,202 $5,138 $273 $33 $13,174 
Agricultural:
Greater than 2.0x$48 $40 $62 $22 $12 $195 $ $ $379 
1.8x to 2.0x17 58 35 24 14 63   211 
1.5x to 1.8x48 42 112 28 19 202   451 
1.2x to 1.5x89 154 174 99 100 313   929 
1.0x to 1.2x86 74 65 30 66 260   581 
Less than 1.0x16 1 4 6 6 13   46 
Total agricultural$304 $369 $452 $209 $217 $1,046 $ $ $2,597 
Total mortgage loans:
Greater than 2.0x$653 $1,183 $1,140 $125 $583 $2,058 $ $ $5,742 
1.8x to 2.0x152 245 200 240 200 484 161  1,682 
1.5x to 1.8x461 316 144 205 269 1,375 75  2,845 
1.2x to 1.5x703 413 234 191 147 1,689   3,377 
1.0x to 1.2x308 322 100 85 214 494 37 33 1,593 

23

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Less than 1.0x431 1 4 6 6 84   532 
Total mortgage loans$2,708 $2,480 $1,822 $852 $1,419 $6,184 $273 $33 $15,771 
______________
(1)The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually for each mortgage loan.
(2)The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service.
LTV Ratios (1)
December 31, 2021
Amortized Cost Basis by Origination Year
20212020201920182017PriorRevolving Loans Amortized Cost BasisRevolving Loans Converted to Term Loans Amortized Cost BasisTotal
(in millions)
Mortgage loans:
Commercial:
0% - 50%$— $— $— $184 $293 $1,009 $— $— $1,486 
50% - 70%1,944 1,286 339 619 491 2,533 139 — 7,351 
70% - 90%190 236 412 415 276 972 — — 2,501 
90% plus— — — 35 73 — — 113 
Total commercial$2,134 $1,522 $751 $1,253 $1,065 $4,587 $139 $— $11,451 
Agricultural:
0% - 50%$180 $212 $128 $129 $119 $738 $— $— $1,506 
50% - 70%200 268 102 126 87 338 — — 1,121 
70% - 90%— — — — — 17 — — 17 
90% plus— — — — — — — — — 
Total agricultural$380 $480 $230 $255 $206 $1,093 $— $— $2,644 
Total mortgage loans:
0% - 50%$180 $212 $128 $313 $412 $1,747 $— $— $2,992 
50% - 70%2,144 1,554 441 745 578 2,871 139 — 8,472 
70% - 90%190 236 412 415 276 989 — — 2,518 
90% plus— — — 35 73 — — 113 
Total mortgage loans$2,514 $2,002 $981 $1,508 $1,271 $5,680 $139 $— $14,095 

DSC Ratios (2)
December 31, 2021
Amortized Cost Basis by Origination Year
20212020201920182017PriorRevolving Loans Amortized Cost BasisRevolving Loans Converted to Term Loans Amortized Cost BasisTotal
(in millions)
Mortgage loans:
Commercial:

24

EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Greater than 2.0x$1,143 $1,243 $210 $772 $485 $2,235 $— $— $6,088 
1.8x to 2.0x185 135 182 46 161 372 68 — 1,149 
1.5x to 1.8x275 49 284 211 166 919 48 — 1,952 
1.2x to 1.5x264 95 75 101 253 701 — — 1,489 
1.0x to 1.2x267 — — 88 — 287 23 — 665 
Less than 1.0x— — — 35 — 73 — — 108 
Total commercial$2,134 $1,522 $751 $1,253 $1,065 $4,587 $139 $— $11,451 
Agricultural:
Greater than 2.0x$49 $64 $25 $22 $24 $210 $— $— $394 
1.8x to 2.0x52 37 25 14 14 70 — — 212 
1.5x to 1.8x43 113 28 22 41 193 — — 440 
1.2x to 1.5x161 179 112 116 72 355 — — 995 
1.0x to 1.2x75 83 31 77 54 226 — — 546 
Less than 1.0x— 39 — — 57 
Total agricultural$380 $480 $230 $255 $206 $1,093 $— $— $2,644 
Total mortgage loans:
Greater than 2.0x$1,192 $1,307 $235 $794 $509 $2,445 $— $— $6,482 
1.8x to 2.0x237 172 207 60 175 442 68 — 1,361 
1.5x to 1.8x318 162 312 233 207 1,112 48 — 2,392 
1.2x to 1.5x425 274 187 217 325 1,056 — — 2,484 
1.0x to 1.2x342 83 31 165 54 513 23 — 1,211 
Less than 1.0x— 39 112 — — 165 
Total mortgage loans$2,514 $2,002 $981 $1,508 $1,271 $5,680 $139 $— $14,095 
______________
(1)The LTV ratio is derived from current loan balance divided by the fair value of the property. The fair value of the underlying commercial properties is updated annually for each mortgage loan.
(2)The DSC ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service.
Past-Due and Nonaccrual Mortgage Loan Status
The following table provides information relating to the aging analysis of past-due mortgage loans as of September 30, 2022 and December 31, 2021, respectively.
Age Analysis of Past Due Mortgage Loans (1)
Accruing Loans
Non-accruing Loans
Total Loans
Non-accruing Loans with No AllowanceInterest Income on Non-accruing Loans
Past Due
Current
Total
30-59 Days
60-89 Days
90 Days or More
Total
(in millions)
September 30, 2022:
Mortgage loans:
Commercial$ $ $ $ $13,174 $13,174 $ $13,174 $ $ 
Agricultural12 7 19 38 2,543 2,581 16 2,597   
Total$12 $7 $19 $38 $15,717 $15,755 $16 $15,771 $ $ 

25

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

December 31, 2021:
Mortgage loans:
Commercial$— $— $— $— $11,451 $11,451 $— $11,451 $— $— 
Agricultural25 27 2,601 2,628 16 2,644 — — 
Total$$$25 $27 $14,052 $14,079 $16 $14,095 $— $— 
_______________
(1)Amounts presented at amortized cost basis.
As of September 30, 2022 and December 31, 2021, the carrying values of problem mortgage loans that had been classified as non-accrual loans were $13 million and $14 million, respectively.
Troubled Debt Restructuring
During the three and nine months ended September 30, 2022 and 2021, the Company identified an immaterial amount of TDRs.
Equity Securities
The table below presents a breakdown of unrealized and realized gains and (losses) on equity securities during the three and nine months ended September 30, 2022 and 2021.
Unrealized and Realized Gains (Losses) from Equity Securities
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period$(33)$(48)$(143)$(8)
Net investment gains (losses) recognized on securities sold during the period 43 (11)47 
Unrealized and realized gains (losses) on equity securities $(33)$(5)$(154)$39 
Trading Securities
As of September 30, 2022 and December 31, 2021, respectively, the fair value of the Company’s trading securities was $631 million and $631 million. As of September 30, 2022 and December 31, 2021, respectively, trading securities included the General Account’s investment in Separate Accounts had carrying values of $34 million and $45 million.
The table below shows a breakdown of net investment income (loss) from trading securities during the three and nine months ended September 30, 2022 and 2021.
Net Investment Income (Loss) from Trading Securities
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period$(44)$(57)$(246)$(303)
Net investment gains (losses) recognized on securities sold during the period 42 6 255 
Unrealized and realized gains (losses) on trading securities(44)(15)(240)(48)
Interest and dividend income from trading securities2 20 85 
Net investment income (loss) from trading securities$(42)$(11)$(220)$37 
Fixed maturities, at fair value using the fair value option
The table below shows a breakdown of net investment income (loss) from fixed maturities, at fair value using the fair value option during the three and nine months ended September 30, 2022 and 2021.

26



Net Investment Income (Loss) from Fixed Maturities, at Fair Value using the Fair Value Option
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period$(7)$$(20)$
Net investment gains (losses) recognized on securities sold during the period(1)5 
Unrealized and realized gains (losses) from fixed maturities(8)10 (15)10 
Interest and dividend income from fixed maturities1 12  22 
Net investment income (loss) from fixed maturities$(7)$22 $(15)$32 

4)     DERIVATIVES
The Company uses derivatives as part of its overall asset/liability risk management primarily to reduce exposures to equity market and interest rate risks. Derivative hedging strategies are designed to reduce these risks from an economic perspective and are all executed within the framework of a “Derivative Use Plan” approved by applicable states’ insurance law. Derivatives are generally not accounted for using hedge accounting, with the exception of TIPS and cash flow hedges, which are discussed further below. Operation of these hedging programs is based on models involving numerous estimates and assumptions, including, among others, mortality, lapse, surrender and withdrawal rates, election rates, fund performance, market volatility and interest rates. A wide range of derivative contracts are used in these hedging programs, including exchange traded equity, currency and interest rate futures contracts, total return and/or other equity swaps, interest rate swap and floor contracts, bond and bond-index total return swaps, swaptions, variance swaps and equity options, credit and foreign exchange derivatives, as well as bond and repo transactions to support the hedging. The derivative contracts are collectively managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in capital markets. In addition, as part of its hedging strategy, the Company targets an asset level for all variable annuity products at or above a CTE98 level under most economic scenarios (CTE is a statistical measure of tail risk which quantifies the total asset requirement to sustain a loss if an event outside a given probability level has occurred. CTE98 denotes the financial resources a company would need to cover the average of the worst 2% of scenarios.)
Derivatives Utilized to Hedge Exposure to Variable Annuities with Guarantee Features
The Company has issued and continues to offer variable annuity products with GMxB features. The risk associated with the GMDB feature is that under-performance of the financial markets could result in GMDB benefits, in the event of death, being higher than what accumulated policyholders’ account balances would support. The risk associated with the GMIB feature is that under-performance of the financial markets could result in the present value of GMIB, in the event of annuitization, being higher than what accumulated policyholders’ account balances would support, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. The risk associated with products that have a GMxB derivative features liability is that under-performance of the financial markets could result in the GMxB derivative features’ benefits being higher than what accumulated policyholders’ account balances would support.
For GMxB features, the Company retains certain risks including basis, credit spread and some volatility risk and risk associated with actual experience versus expected actuarial assumptions for mortality, lapse and surrender, withdrawal and policyholder election rates, among other things. The derivative contracts are managed to correlate with changes in the value of the GMxB features that result from financial markets movements. A portion of exposure to realized equity volatility is hedged using equity options and variance swaps and a portion of exposure to credit risk is hedged using total return swaps on fixed income indices. Additionally, the Company is party to total return swaps for which the reference U.S. Treasury securities are contemporaneously purchased from the market and sold to the swap counterparty. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. The Company has also purchased reinsurance contracts to mitigate the risks associated with GMDB features and the impact of potential market fluctuations on future policyholder elections of GMIB features contained in certain annuity contracts issued by the Company. The reinsurance of the GMIB features is accounted for as a derivative. In addition, on June 1, 2021, we

27

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

ceded legacy variable annuity policies sold by Equitable Financial between 2006-2008 (the “Block”), comprised of non-New York “Accumulator” policies containing fixed rate GMIB and/or GMDB guarantees to CS Life. As this contract provides full risk transfer and thus has the same risk attributes as the underlying direct contracts, the benefits of this treaty are accounted for in the same manner as the underlying gross reserves and therefore the Amounts Due from Reinsurers related to the GMIB with NLG are accounted for as an embedded derivative.
The Company has in place an economic hedge program using U.S. Treasury futures to partially protect the overall profitability of future variable annuity sales against declining interest rates.
Derivatives Utilized to Hedge Crediting Rate Exposure on SCS, SIO, MSO and IUL Products/Investment Options
The Company hedges crediting rates in the SCS variable annuity, SIO in the EQUI-VEST variable annuity series, MSO in the variable life insurance products and IUL insurance products. These products permit the contract owner to participate in the performance of an index, ETF or commodity price movement up to a cap for a set period of time. They also contain a protection feature, in which the Company will absorb, up to a certain percentage, the loss of value in an index, ETF or commodity price, which varies by product segment.
In order to support the returns associated with these features, the Company enters into derivative contracts whose payouts, in combination with fixed income investments, emulate those of the index, ETF or commodity price, subject to caps and buffers, thereby substantially reducing any exposure to market-related earnings volatility.
Derivatives Used to Hedge Equity Market Risks Associated with the General Account’s Seed Money Investments in Retail Mutual Funds
The Company’s General Account seed money investments in retail mutual funds expose us to market risk, including equity market risk which is partially hedged through equity-index futures contracts to minimize such risk.
Derivatives Used for General Account Investment Portfolio
The Company maintains a strategy in its General Account investment portfolio to replicate the credit exposure of fixed maturity securities otherwise permissible for investment under its investment guidelines through the sale of CDS. Under the terms of these swaps, the Company receives quarterly fixed premiums that, together with any initial amount paid or received at trade inception, replicate the credit spread otherwise currently obtainable by purchasing the referenced entity’s bonds of similar maturity. These credit derivatives generally have remaining terms of five years or less and are recorded at fair value with changes in fair value, including the yield component that emerges from initial amounts paid or received, reported in net derivative gains (losses).
The Company manages its credit exposure taking into consideration both cash and derivatives based positions and selects the reference entities in its replicated credit exposures in a manner consistent with its selection of fixed maturities. In addition, the Company generally transacts the sale of CDS in single name reference entities of investment grade credit quality and with counterparties subject to collateral posting requirements. If there is an event of default by the reference entity or other such credit event as defined under the terms of the swap contract, the Company is obligated to perform under the credit derivative and, at its option, either pay the referenced amount of the contract less an auction-determined recovery amount or pay the referenced amount of the contract and receive in return the defaulted or similar security of the reference entity for recovery by sale at the contract settlement auction. The Company purchased CDS to mitigate its exposure to a reference entity through cash positions. These positions do not replicate credit spreads.
To date, there have been no events of default or circumstances indicative of a deterioration in the credit quality of the named referenced entities to require or suggest that the Company will have to perform under the CDS that it sold. The maximum potential amount of future payments the Company could be required to make under the credit derivatives sold is limited to the par value of the referenced securities which is the dollar or euro-equivalent of the derivative’s notional amount. The Standard North American CDS Contract or Standard European Corporate Contract under which the Company executes these CDS sales transactions does not contain recourse provisions for recovery of amounts paid under the credit derivative.
The Company purchased 30-year TIPS and other sovereign bonds, both inflation linked and non-inflation linked, as General Account investments and enters into asset or cross-currency basis swaps, to result in payment of the given bond’s coupons and principal at maturity in the bond’s specified currency to the swap counterparty in return for fixed dollar amounts. These swaps, when considered in combination with the bonds, together result in a net position that is

28

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

intended to replicate a dollar-denominated fixed-coupon cash bond with a yield higher than a term-equivalent U.S. Treasury bond.
Derivatives Utilized to Hedge Exposure to Foreign Currency Denominated Cash Flows
The Company purchases private placement debt securities and issues funding agreements in the FABN program in currencies other than its functional U.S. dollar currency. The Company enters into cross currency swaps with external counterparties to hedge the exposure of the foreign currency denominated cash flows of these instruments. The foreign currency received from or paid to the cross currency swap counterparty is exchanged for fixed U.S. dollar amounts with improved net investment yields or net product costs over equivalent U.S. dollar denominated instruments issued at that time. The transactions are accounted for as cash flow hedges when they are designated in hedging relationships and qualify for hedge accounting. The first cross currency swap hedges were designated and applied hedge accounting during the quarter ended June 30, 2021.
These cross currency swaps are for the period the foreign currency denominated private placement debt securities and funding agreement are outstanding, with the longest cross currency swap expiring in 2033. Since designation and qualification as cash flow hedges, cross currency swap interest accruals are recognized in Net investment income and in Interest credited to policyholders’ account balances.
The tables below present quantitative disclosures about the Company’s derivative instruments designated in hedging relationships and derivative instruments which have not been designated in hedging relationships, including those embedded in other contracts required to be accounted for as derivative instruments.
The following table presents the gross notional amount and estimated fair value of the Company’s derivatives:


29

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Derivative Instruments by Category
September 30, 2022December 31, 2021
  Fair ValueFair Value
  Notional Amount Derivative Assets Derivative LiabilitiesNotional AmountDerivative AssetsDerivative Liabilities
(in millions)
Derivatives: designated for hedge accounting (1)
 Cash flow hedges:
 Currency swaps $1,267 $178 $118 $921 $$42 
 Interest swaps955 1 252 955 — 395 
 Total: designated for hedge accounting 2,222 179 370 1,876 437 
Derivatives: not designated for hedge accounting (1)
Equity contracts:
Futures 4,022 8  2,640 — 
Swaps 9,814 28 13 13,378 
Options36,788 6,209 3,899 48,489 12,024 5,065 
Interest rate contracts:
Futures5,612   12,575 — — 
Swaps1,134  134 1,889 — 46 
Swaptions   — — — 
Credit contracts:
Credit default swaps315 20 8 774 10 
Currency contracts
Currency swaps326 24  541  
Currency forwards60 20 20 79 
Other freestanding contracts:
Margin 116  — 125 — 
Collateral 140 3,323 — 178 6,160 
Total: not designated for hedge accounting58,071 6,565 7,397 80,365 12,351 11,293 
Embedded derivatives:
Amounts due from reinsurers (5) 4,312  — 5,813 — 
GMIB reinsurance contracts (2) 1,289  — 1,848 — 
GMxB derivative features liability (3)  5,825 — — 8,525 
SCS, SIO, MSO and IUL indexed features (4)  2,086 — — 6,773 
Total embedded derivatives 5,601 7,911 — 7,661 15,298 
Total derivative instruments$60,293 $12,345 $15,678 $82,241 $20,019 $27,028 
___________
(1)Reported in other invested assets in the consolidated balance sheets.
(2)Reported in GMIB reinsurance contract asset in the consolidated balance sheets.
(3)Reported in future policy benefits and other policyholders’ liabilities in the consolidated balance sheets.
(4)Reported in policyholders’ account balances in the consolidated balance sheets.
(5)Represents GMIB NLG ceded related to the Venerable Transaction.


The following table presents the effects of derivative instruments on the consolidated statements of income and comprehensive income (loss).

Derivative Instruments by Category

30

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued


31

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Three Months Ended September 30, 2022Nine Months Ended September 30, 2022
(in millions)
Net Derivatives Gain(Losses) (1)Net Investment IncomeInterest Credited To Policyholders Account BalancesAOCINet Derivatives Gain(Losses) (1)Net Investment IncomeInterest Credited To Policyholders Account BalancesAOCI
Derivatives: designated for hedge accounting
Cash flow hedges:
Currency swaps$7 $5 $(36)$111 $21 $7 $(46)$116 
Interest swaps(38)  94 (79)  242 
Total: designated for hedge accounting(31)5 (36)205 (58)7 (46)358 
Derivatives: not Designated for hedge accounting
Equity contracts
Futures31    486    
Swaps596    3,374    
Options(649)   (4,379)   
Interest rate contracts
Futures(428)   (1,486)   
Swaps(125)   (428)   
Swaptions        
Credit contracts
Credit default swaps(1)   13    
Currency contracts
Currency swaps23    41    
Currency forwards2    5    
Other freestanding contracts
Margin        
Collateral        
Total: not designated for hedge accounting(551)   (2,374)   
Embedded derivatives
Amounts due from reinsurers(364)   (1,506)   
GMIB reinsurance contracts(196)   (535)   
GMxB derivative features liability (2)429    2,943    
SCS, SIO,MSO and IUL indexed features781    4,648    
Total embedded derivatives$650 $ $ $ $5,550 $ $ $ 
Total derivative instruments$68 $5 $(36)$205 $3,118 $7 $(46)$358 


32

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued




Three Months Ended September 30, 2021Nine Months Ended September 30, 2021
(in millions)
Net Derivatives Gain(Losses) (1)Net Investment IncomeInterest Credited To Policyholders Account BalancesAOCINet Derivatives Gain(Losses) (1)Net Investment IncomeInterest Credited To Policyholders Account BalancesAOCI
Derivatives: designated for hedge accounting
Cash flow hedges:
Currency/interest rate
Currency swaps$— $— $(15)$$— $— $(32)$
Interest swaps$(26)$— $(9)$(54)$— $— $(42)
Total: designated for hedge accounting(26)— (15)(1)(54)— (32)(34)
Derivatives: not designated for hedge accounting
Equity contracts
Futures(2)— — — (451)— — — 
Swaps(3)— — — (2,613)— — — 
Options(169)— — — 2,177 — — — 
Interest rate contracts
Futures(93)— — — (891)— — — 
Swaps67 — — — (2,375)— — — 
Swaptions— — — — — — — — 
Credit contracts
Credit default swaps— — — — — — — — 
Currency contracts
Currency swaps— — — — — — 
Currency forwards— — — — — — 
Other freestanding contracts
Margin— — — — — — — — 
Collateral— — — — — — — — 
Total: not designated for hedge accounting(196)— — — (4,148)— — — 
Embedded derivatives
Amounts due from reinsurers344 — — — 586 — — — 
GMIB reinsurance contracts(84)— — — (542)— — — 
GMxB derivative features liability (2)(395)— — — 2,340 — — — 
SCS, SIO,MSO and IUL indexed features172 — — — (2,157)— — — 
Total embedded derivatives$37 $— $— $— $227 $— $— $— 
Total derivative instruments$(185)$— $(15)$(1)$(3,975)$— $(32)$(34)
______________
(1)Reported in net derivative gains (losses) in the consolidated statements of income (loss).
(2)Excludes settlement fees of $45 million on CS Life reinsurance contract for the nine months ended September 30, 2021.

33


The following table presents a roll-forward of cash flow hedges recognized in AOCI.
Roll-forward of Cash flow hedges in AOCI

Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Balance, beginning of period $(55)$(158)$(208)$(126)
Amount recorded in AOCI
Currency swaps77 77 
Interest swaps51 (40)149 (118)
Total amount recorded in AOCI128 (33)226 (111)
Amount reclassified from AOCI to income
Currency swaps34 — 39 — 
Interest swaps43 31 93 77 
Total amount reclassified from AOCI to income77 31 132 77 
Balance, end of period (1)$150 $(160)$150 $(160)
_______________
(1) The Company does not estimate the amount of the deferred losses in AOCI at three and nine months ended September 30, 2022 and 2021 which will be released and reclassified into Net income (loss) over the next 12 months as the amounts cannot be reasonably estimated.
Equity-Based and Treasury Futures Contracts Margin
All outstanding equity-based and treasury futures contracts as of September 30, 2022 and December 31, 2021 are exchange-traded and net settled daily in cash. As of September 30, 2022 and December 31, 2021, respectively, the Company had open exchange-traded futures positions on: (i) the S&P 500, Nasdaq, Russell 2000 and Emerging Market indices, having initial margin requirements of $187 million and $109 million, (ii) the 2-year, 5-year and 10-year U.S. Treasury Notes on U.S. Treasury bonds and ultra-long bonds, having initial margin requirements of $63 million and $200 million, and (iii) the Euro Stoxx, FTSE 100, Topix, ASX 200 and EAFE indices as well as corresponding currency futures on the Euro/U.S. dollar, Pound/U.S. dollar, Australian dollar/U.S. dollar, and Yen/U.S. dollar, having initial margin requirements of $14 million and $16 million.
Collateral Arrangements
The Company generally has executed a CSA under the ISDA Master Agreement it maintains with each of its OTC derivative counterparties that requires both posting and accepting collateral either in the form of cash or high-quality securities, such as U.S. Treasury securities, U.S. government and government agency securities and investment grade corporate bonds. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related CSA have been executed. As of September 30, 2022 and December 31, 2021, respectively, the Company held $3.3 billion and $6.2 billion in cash and securities collateral delivered by trade counterparties, representing the fair value of the related derivative agreements. The unrestricted cash collateral is reported in other invested assets. The Company posted collateral of $140 million and $178 million as of September 30, 2022 and December 31, 2021, respectively, in the normal operation of its collateral arrangements. The Company is exposed to losses in the event of non-performance by counterparties to financial derivative transactions with a positive fair value. The Company manages credit risk by: (i) entering into derivative transactions with highly rated major international financial institutions and other creditworthy counterparties governed by master netting agreements, as applicable; (ii) trading through central clearing and OTC parties; (iii) obtaining collateral, such as cash and securities, when appropriate; and (iv) setting limits on single party credit exposures which are subject to periodic management review.
Substantially all of the Company’s derivative agreements have zero thresholds which require daily full collateralization by the party in a liability position. In addition, certain of the Company’s derivative agreements contain credit-risk related contingent features; if the credit rating of one of the parties to the derivative agreement is to fall below a certain level, the party with positive fair value could request termination at the then fair value or demand immediate full collateralization from the party whose credit rating fell and is in a net liability position.

34

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

As of September 30, 2022 and December 31, 2021, there were no net liability derivative positions with counterparties with credit risk-related contingent features whose credit rating has fallen. All derivatives have been appropriately collateralized by the Company or the counterparty in accordance with the terms of the derivative agreements.


The following tables presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments as of September 30, 2022 and December 31, 2021:

Offsetting of Financial Assets and Liabilities and Derivative Instruments
As of September 30, 2022

Gross Amount RecognizedGross Amount Offset in the Balance SheetsNet Amount Presented in the Balance SheetsGross Amount not Offset in the Balance Sheets (3)Net Amount
(in millions)
Assets:
Derivative assets (1)$6,745 $6,012 $733 $(596)$137 
Other financial assets2,116  2,116  2,116 
Other invested assets$8,861 $6,012 $2,849 $(596)$2,253 
Liabilities:
Derivative liabilities (2)$7,172 $6,012 $1,160 $ $1,160 
Other financial liabilities4,838  4,838  4,838 
Other liabilities$12,010 $6,012 $5,998 $ $5,998 
______________
(1)Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs.
(2)Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs.
(3)Financial instruments/Collateral sent (held).


As of December 31, 2021

Gross Amount RecognizedGross Amount Offset in the Balance SheetsNet Amount Presented in the Balance SheetsGross Amount not Offset in the Balance Sheets (3)Net Amount
(in millions)
Assets:
Derivative assets (1)$12,358 $10,756 $1,602 $(961)$641 
Other financial assets1,989 — 1,989 — 1,989 
Other invested assets$14,347 $10,756 $3,591 $(961)$2,630 
Liabilities:
Derivative liabilities (2)$10,770 $10,756 $14 $— $14 
Other financial liabilities3,919 — 3,919 — 3,919 
Other liabilities$14,689 $10,756 $3,933 $— $3,933 
______________
(1)Excludes Investment Management and Research segment’s derivative assets of consolidated VIEs/VOEs.
(2)Excludes Investment Management and Research segment’s derivative liabilities of consolidated VIEs/VOEs.
(3)Financial instruments sent (held).
5)    CLOSED BLOCK

35

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

As a result of demutualization, the Company’s Closed Block was established in 1992 for the benefit of certain individual participating policies that were in force on that date. Assets, liabilities and earnings of the Closed Block are specifically identified to support its participating policyholders.
Assets allocated to the Closed Block inure solely to the benefit of the Closed Block policyholders and will not revert to the benefit of the Company. No reallocation, transfer, borrowing or lending of assets can be made between the Closed Block and other portions of the Company’s General Account, any of its Separate Accounts or any affiliate of the Company without the approval of the New York State Department of Financial Services (the “NYDFS”). Closed Block assets and liabilities are carried on the same basis as similar assets and liabilities held in the General Account. For more information on the Closed Block, see Note 6 to the Company’s consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2021.
Summarized financial information for the Company’s Closed Block is as follows:
 September 30, 2022December 31, 2021
(in millions)
Closed Block Liabilities:
Future policy benefits, policyholders’ account balances and other$5,750 $5,928 
Policyholder dividend obligation — 
Other liabilities74 39 
Total Closed Block liabilities5,824 5,967 
Assets Designated to the Closed Block:
Fixed maturities AFS, at fair value (amortized cost of $3,190 and $3,185) (allowance for credit losses of $0 and $0)
2,932 3,390 
Mortgage loans on real estate (net of allowance for credit losses of $4 and $4)
1,687 1,771 
Policy loans575 602 
Cash and other invested assets 63 
Other assets154 90 
Total assets designated to the Closed Block5,348 5,916 
Excess of Closed Block liabilities over assets designated to the Closed Block476 51 
Amounts included in AOCI:
Net unrealized investment gains (losses), net of policyholders’ dividend obligation: $0 and $0; and net of income tax: $54 and $(43)
(193)172 
Maximum future earnings to be recognized from Closed Block assets and liabilities$283 $223 


36

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

The Company’s Closed Block revenues and expenses were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Revenues:
Premiums and other income$29 $33 $93 $109 
Net investment income (loss)52 59 164 179 
Investment gains (losses), net(1)— (2)
Total revenues80 92 255 290 
Benefits and Other Deductions:
Policyholders’ benefits and dividends92 108 248 304 
Other operating costs and expenses  
Total benefits and other deductions92 110 248 307 
Net income (loss), before income taxes(12)(18)7 (17)
Income tax (expense) benefit(5)(2)(1)(3)
Net income (loss)$(17)$(20)$6 $(20)

A reconciliation of the Company’s policyholder dividend obligation follows:

Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Beginning balance$ $72 $ $160 
Unrealized investment gains (losses) (47) (135)
Ending balance$ $25 $ $25 

6)    INSURANCE LIABILITIES
Variable Annuity Contracts – GMDB, GMIB, GIB and GWBL and Other Features
The Company has certain variable annuity contracts with GMDB, GMIB, GIB and GWBL and other features in-force that guarantee one of the following:
Return of Premium: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals);
Ratchet: the benefit is the greatest of current account value, premiums paid (adjusted for withdrawals), or the highest account value on any anniversary up to contractually specified ages (adjusted for withdrawals);
Roll-Up: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals) accumulated at contractually specified interest rates up to specified ages;
Combo: the benefit is the greater of the ratchet benefit or the roll-up benefit, which may include either a five year or an annual reset; or
Withdrawal: the withdrawal is guaranteed up to a maximum amount per year for life.
Liabilities for Variable Annuity Contracts with GMDB and GMIB Features without NLG Rider Feature
The change in the liabilities for variable annuity contracts with GMDB and GMIB features and without a NLG feature are summarized in the tables below. The amounts for the direct contracts (before reinsurance ceded) and assumed contracts are reflected in the consolidated balance sheets in future policy benefits and other policyholders’ liabilities.

37

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

The amounts for the ceded contracts are reflected in the consolidated balance sheets in amounts due from reinsurers. The amounts for the ceded GMIB that are reflected in the consolidated balance sheets in GMIB reinsurance contract asset are at fair value.

Change in Liability for Variable Annuity Contracts with GMDB and GMIB Features and No NLG Feature
Three and Nine Months Ended September 30, 2022 and 2021

GMDBGMIB
DirectAssumed
(1) (2)
CededDirectAssumed
(1) (2)
Ceded
(in millions)
Balance, July 1, 2022$5,096 $ $(2,276)$6,165 $ $(3,707)
Paid guarantee benefits(152) 63 (171) 46 
Other changes in reserve379  (147)(312) 341 
Balance, September 30, 2022$5,323 $ $(2,360)$5,682 $ $(3,320)
Balance, July 1, 2021$5,091 $— $(2,262)$5,905 $— $(4,168)
Paid guarantee benefits(103)— 41 (87)— 16 
Other changes in reserve(6)— 131 — 89 
Impact of the Venerable Transaction— — — — — — 
Balance, September 30, 2021$4,982 $— $(2,219)$5,949 $— $(4,063)

GMDBGMIB
DirectAssumed
(1) (2)
CededDirectAssumed
(1) (2)
Ceded
(in millions)
Balance, January 1, 2022$4,951 $ $(2,216)$5,892 $ $(3,968)
Paid guarantee benefits(433) 180 (437) 53 
Other changes in reserve805  (324)227  595 
Balance, September 30, 2022$5,323 $ $(2,360)$5,682 $ $(3,320)
Balance, January 1, 2021$5,097 $72 $(88)$6,026 $196 $(2,488)
Paid guarantee benefits(350)(12)64 (271)(49)41 
Other changes in reserve235 14 (19)194 (7)525 
Impact of the Venerable Transaction— (74)(2,176)— (140)(2,141)
Balance, September 30, 2021$4,982 $— $(2,219)$5,949 $— $(4,063)
______________
(1)Change in Assumed is driven by the sale of CSLRC to Venerable.
(2)Includes the impact as of June 1, 2021 on the ceded reserves to Venerable. See Note 1 of the Notes to these Consolidated Financial Statements for details of the Venerable Transaction.
Liabilities for Embedded and Freestanding Insurance Related Derivatives
The liability for the GMxB derivative features, the liability for SCS, SIO, MSO and IUL indexed features and the asset and liability for the GMIB reinsurance contracts and amounts due from reinsurers related to GMIB NLG product features (GMIB NLG Reinsurance) are considered embedded or freestanding insurance derivatives and are reported at fair value. For the fair value of the assets and liabilities associated with these embedded or freestanding insurance derivatives, see Note 7 of the Notes to these Consolidated Financial Statements.
Account Values and Net Amount at Risk
Account Values and NAR for direct variable annuity contracts in force with GMDB and GMIB features as of September 30, 2022 are presented in the following tables by guarantee type. For contracts with the GMDB feature, the NAR in the event of death is the amount by which the GMDB feature exceeds the related Account Values. For

38

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

contracts with the GMIB feature, the NAR in the event of annuitization is the amount by which the present value of the GMIB benefits exceed the related Account Values, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. Since variable annuity contracts with GMDB features may also offer GMIB guarantees in the same contract, the GMDB and GMIB amounts listed are not mutually exclusive.
Direct Variable Annuity Contracts with GMDB and GMIB Features
as of September 30, 2022
Guarantee Type
Return of PremiumRatchetRoll-UpComboTotal
(in millions, except age and interest rate)
Variable annuity contracts with GMDB features
Account Values invested in:
General Account$16,657$94$48$148$16,947
Separate Accounts44,8797,2132,38424,54779,023
Total Account Values$61,536$7,307$2,432$24,695$95,970
NAR, gross$1,176 $1,802 $1,975$24,164$29,117
NAR, net of amounts reinsured$1,164 $1,630 $1,439$13,074$17,307
Average attained age of policyholders (in years)51.6 69.6 76.0 71.6 55.4 
Percentage of policyholders over age 7012.1 %52.1 %74.2 %60.0 %21.1 %
Range of contractually specified interest ratesN/AN/A3% - 6%3% - 6.5%3% - 6.5%
Variable annuity contracts with GMIB features
Account Values invested in:
General Account$ $ $14$193$207
Separate Accounts  20,23525,77146,006
Total Account Values$ $ $20,249$25,964$46,213
NAR, gross$$$546$8,237$8,783
NAR, net of amounts reinsured$$$176$3,377$3,553
Average attained age of policyholders (in years)N/AN/A65.6 71.3 69.1 
Weighted average years remaining until annuitizationN/AN/A5.6 0.5 2.4 
Range of contractually specified interest ratesN/AN/A3% - 6%3% - 6.5%3% - 6.5%

For more information about the reinsurance programs of the Company’s GMDB and GMIB exposure, see “Reinsurance” in Note 11 of the Notes to the Consolidated Financial Statements 2021 Form 10-K.
Separate Accounts Investments by Investment Category Underlying Variable Annuity Contracts with GMDB and GMIB Features
The total Account Values of variable annuity contracts with GMDB and GMIB features include amounts allocated to the guaranteed interest option, which is part of the General Account and variable investment options that invest through Separate Accounts in variable insurance trusts. The following table presents the aggregate fair value of assets, by major investment category, held by Separate Accounts that support variable annuity contracts with GMDB and GMIB features. The investment performance of the assets impacts the related Account Values and, consequently, the NAR associated with the GMDB and GMIB benefits and guarantees. Because the Company’s variable annuity contracts offer both GMDB and GMIB features, GMDB and GMIB amounts are not mutually exclusive.

39

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Investment in Variable Insurance Trust Mutual Funds

 
September 30, 2022December 31, 2021
Mutual Fund Type
GMDB
GMIB
GMDB
GMIB
(in millions)
Equity$37,285 $13,460 $52,771 $20,015 
Fixed income4,474 2,028 5,391 2,507 
Balanced36,134 30,264 48,390 40,491 
Other1,130 254 1,025 263 
Total$79,023 $46,006 $107,577 $63,276 
Hedging Programs for GMDB, GMIB, GIB and Other Features
The Company has a program intended to hedge certain risks associated first with the GMDB feature and with the GMIB feature of the Accumulator series of variable annuity products. The program has also been extended to cover other guaranteed benefits as they have been made available. This program utilizes derivative contracts, such as exchange-traded equity, currency and interest rate futures contracts, total return and/or equity swaps, interest rate swap and floor contracts, swaptions, variance swaps as well as equity options, that collectively are managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in the capital markets. At the present time, this program hedges certain economic risks on products sold from 2001 forward, to the extent such risks are not externally reinsured.
These programs do not qualify for hedge accounting treatment. Therefore, gains (losses) on the derivatives contracts used in these programs, including current period changes in fair value, are recognized in net derivative gains (losses) in the period in which they occur, and may contribute to income (loss) volatility.
Variable and Interest-Sensitive Life Insurance Policies – NLG
The NLG feature contained in variable and interest-sensitive life insurance policies keeps them in force in situations where the policy value is not sufficient to cover monthly charges then due. The NLG remains in effect so long as the policy meets a contractually specified premium funding test and certain other requirements.
The change in the NLG liabilities, reflected in future policy benefits and other policyholders’ liabilities in the consolidated balance sheets, is summarized in the table below.
Direct Liability (1)
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Beginning balance$1,134 $1,070 $1,096 $1,022 
Paid guarantee benefits(46)(24)(62)(52)
Other changes in reserves74 38 128 114 
Ending balance$1,162 $1,084 $1,162 $1,084 
_____________
(1)There were no amounts of reinsurance ceded in any period presented.
7)    FAIR VALUE DISCLOSURES
U.S. GAAP establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value:
Level 1    Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

40

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Level 2    Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data.
Level 3    Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity’s own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability.
The Company uses unadjusted quoted market prices to measure fair value for those instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value cannot be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument.
Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued also are considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness.
Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis
Fair value measurements are required on a non-recurring basis for certain assets only when an impairment or other events occur. As of September 30, 2022 and December 31, 2021, no assets or liabilities were required to be measured at fair value on a non-recurring basis.
Assets and Liabilities Measured at Fair Value on a Recurring Basis
Assets and liabilities measured at fair value on a recurring basis are summarized below.

41

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Fair Value Measurements as of September 30, 2022

Level 1
Level 2
Level 3
Total
 
(in millions)
Assets
Investments
Fixed maturities, AFS:
Corporate (1)
$ $42,635 $1,911 $44,546 
U.S. Treasury, government and agency 6,030  6,030 
States and political subdivisions 555 29 584 
Foreign governments 926  926 
Residential mortgage-backed (2)
 476  476 
Asset-backed (3)
 8,735 10 8,745 
Commercial mortgage-backed 3,218 32 3,250 
Redeemable preferred stock 43  43 
Total fixed maturities, AFS 62,618 1,982 64,600 
Fixed maturities, at fair value using the fair value option  1,174 374 1,548 
Other equity investments (7)270 487 12 769 
Trading securities276 303 52 631 
Other invested assets:
Short-term investments 374  374 
Assets of consolidated VIEs/VOEs86 390 5 481 
Swaps (286) (286)
Credit default swaps
 12  12 
Futures8   8 
Options 2,310  2,310 
Total other invested assets94 2,800 5 2,899 
Cash equivalents2,199 561  2,760 
Segregated securities 1,335  1,335 
Amounts due from reinsurer (6)  4,312 4,312 
GMIB reinsurance contracts asset  1,289 1,289 
Separate Accounts assets (4)106,565 2,374 1 108,940 
Total Assets$109,404 $71,652 $8,027 $189,083 
Liabilities
Notes issued by consolidated VIE’s, at fair value using the fair value option (5)
$ $1,398 $ $1,398 
GMxB derivative features’ liability  5,825 5,825 
SCS, SIO, MSO and IUL indexed features’ liability 2,086  2,086 
Liabilities of consolidated VIEs and VOEs17 5  22 
Contingent payment arrangements  273 273 
Total Liabilities$17 $3,489 $6,098 $9,604 
______________
(1)Corporate fixed maturities includes both public and private issues.
(2)Includes publicly traded agency pass-through securities and collateralized obligations.
(3)Includes credit-tranched securities collateralized by sub-prime mortgages, credit risk transfer securities and other asset types.
(4)Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate. As of September 30, 2022, the fair value of such investments was $452 million.

42

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

(5)Includes CLO short-term debt of $248 million, which is inclusive as fair valued within Notes issued by consolidated VIE’s, at fair value using the fair value option. Accrued interest payable of $15 million is reported in Notes issued by consolidated VIE’s, at fair value using the fair value option in the consolidated balance sheets, which is not required to be measured at fair value on a recurring basis.
(6)This represents GMIB NLG ceded reserves related to the Venerable Transaction. See Note 1 of the Notes to these Consolidated Financial Statements for details of the Venerable Transaction.
(7)Includes short position equity securities of $23 million that are reported in other liabilities.
Fair Value Measurements as of December 31, 2021

Level 1
Level 2
Level 3
Total
 
(in millions)
Assets
Investments
Fixed maturities, AFS:
Corporate (1)
$— $51,007 $1,504 $52,511 
U.S. Treasury, government and agency— 15,385 — 15,385 
States and political subdivisions— 627 35 662 
Foreign governments— 1,152 — 1,152 
Residential mortgage-backed (2)
— 98 — 98 
Asset-backed (3)
— 5,926 5,934 
Commercial mortgage-backed (2)
— 2,401 20 2,421 
Redeemable preferred stock— 53 — 53 
Total fixed maturities, AFS— 76,649 1,567 78,216 
Fixed maturities, at fair value using the fair value option1,440 201 1,641 
Other equity investments322 457 784 
Trading securities340 226 65 631 
Other invested assets:

Short-term investments— 30 — 30 
Assets of consolidated VIEs/VOEs166 450 11 627 
Swaps— (473)— (473)
Credit default swaps
— (1)— (1)
Futures(1)— — (1)
Options— 6,959 — 6,959 
Swaptions— — — — 
Total other invested assets165 6,965 11 7,141 
Cash equivalents3,275 293 — 3,568 
Segregated securities— 1,504 — 1,504 
Amounts due from reinsurer— — 5,813 5,813 
GMIB reinsurance contracts asset— — 1,848 1,848 
Separate Accounts assets (4)
144,124 2,572 146,697 
Total Assets$148,226 $90,106 $9,511 $247,843 
Liabilities
Notes issued by consolidated VIE’s, at fair value using the fair value option (5)
$— $1,277 $— $1,277 
GMxB derivative features’ liability— — 8,525 8,525 
SCS, SIO, MSO and IUL indexed features’ liability— 6,773 — 6,773 
Liabilities of consolidated VIEs and VOEs16 — 18 
Contingent payment arrangements— — 38 38 
Total Liabilities$16 $8,052 $8,563 $16,631 
______________

43

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

(1)Corporate fixed maturities includes both public and private issues.
(2)Includes publicly traded agency pass-through securities and collateralized obligations.
(3)Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.
(4)Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate and commercial mortgages. As of December 31, 2021, the fair value of such investments was $404 million.
(5)Includes CLO short-term debt of $92 million, which is inclusive as fair valued within Notes issued by consolidated VIE’s, at fair value using the fair value option Accrued interest payable of $6 million is reported in Notes issued by consolidated VIE’s, at fair value using the fair value option in the consolidated balance sheets, which is not required to be measured at fair value on a recurring basis.
Public Fixed Maturities
The fair values of the Company’s public fixed maturities, including those accounted for using the fair value option are generally based on prices obtained from independent valuation service providers and for which the Company maintains a vendor hierarchy by asset type based on historical pricing experience and vendor expertise. Although each security generally is priced by multiple independent valuation service providers, the Company ultimately uses the price received from the independent valuation service provider highest in the vendor hierarchy based on the respective asset type, with limited exception. To validate reasonableness, prices also are internally reviewed by those with relevant expertise through comparison with directly observed recent market trades. Consistent with the fair value hierarchy, public fixed maturities validated in this manner generally are reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs.
Private Fixed Maturities
The fair values of the Company’s private fixed maturities, including those accounted for using the fair value option are determined from prices obtained from independent valuation service providers. Prices not obtained from an independent valuation service provider are determined by using a discounted cash flow model or a market comparable company valuation technique. In certain cases, these models use observable inputs with a discount rate based upon the average of spread surveys collected from private market intermediaries who are active in both primary and secondary transactions, taking into account, among other factors, the credit quality and industry sector of the issuer and the reduced liquidity associated with private placements. Generally, these securities have been reflected within Level 2. For certain private fixed maturities, the discounted cash flow model or a market comparable company valuation technique may also incorporate unobservable inputs, which reflect the Company’s own assumptions about the inputs market participants would use in pricing the asset. To the extent management determines that such unobservable inputs are significant to the fair value measurement of a security, a Level 3 classification generally is made.
Notes issued by consolidated VIE’s, at fair value using the fair value option
These notes are based on the fair values of corresponding fixed maturity collateral. The CLO liabilities are also reduced by the fair value of the beneficial interests the Company retains in the CLO and the carrying value of any beneficial interests that represent compensation for services. As the notes are valued based on the reference collateral, they are classified as Level 2 or 3. See “Fair Value Option” below for additional information.
Freestanding Derivative Positions
The net fair value of the Company’s freestanding derivative positions as disclosed in Note 4 of the Notes to these Consolidated Financial Statements are generally based on prices obtained either from independent valuation service providers or derived by applying market inputs from recognized vendors into industry standard pricing models. The majority of these derivative contracts are traded in the OTC derivative market and are classified in Level 2. The fair values of derivative assets and liabilities traded in the OTC market are determined using quantitative models that require use of the contractual terms of the derivative instruments and multiple market inputs, including interest rates, prices, and indices to generate continuous yield or pricing curves, including overnight index swap curves, and volatility factors, which then are applied to value the positions. The predominance of market inputs is actively quoted and can be validated through external sources or reliably interpolated if less observable.
Level Classifications of the Company’s Financial Instruments
Financial Instruments Classified as Level 1
Investments classified as Level 1 primarily include redeemable preferred stock, trading securities, cash equivalents and Separate Accounts assets. Fair value measurements classified as Level 1 include exchange-traded prices of fixed maturities, equity securities and derivative contracts, and net asset values for transacting subscriptions and redemptions

44

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

of mutual fund shares held by Separate Accounts. Cash equivalents classified as Level 1 include money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less and are carried at cost as a proxy for fair value measurement due to their short-term nature.
Financial Instruments Classified as Level 2
Investments classified as Level 2 are measured at fair value on a recurring basis and primarily include U.S. government and agency securities, certain corporate debt securities and financial assets and liabilities accounted for using the fair value option, such as public and private fixed maturities. As market quotes generally are not readily available or accessible for these securities, their fair value measures are determined utilizing relevant information generated by market transactions involving comparable securities and often are based on model pricing techniques that effectively discount prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security’s duration, also taking into consideration issuer-specific credit quality and liquidity. Segregated securities classified as Level 2 are U.S. Treasury bills segregated by AB in a special reserve bank custody account for the exclusive benefit of brokerage customers, as required by Rule 15c3-3 of the Exchange Act and for which fair values are based on quoted yields in secondary markets.
Observable inputs generally used to measure the fair value of securities classified as Level 2 include benchmark yields, reported secondary trades, issuer spreads, benchmark securities and other reference data. Additional observable inputs are used when available, and as may be appropriate, for certain security types, such as prepayment, default, and collateral information for the purpose of measuring the fair value of mortgage- and asset-backed securities. The Company’s AAA-rated mortgage- and asset-backed securities are classified as Level 2 for which the observability of market inputs to their pricing models is supported by sufficient, albeit more recently contracted, market activity in these sectors.
Certain Company products, such as the SCS, EQUI-VEST variable annuity products, IUL and the MSO fund available in some life contracts, offer investment options which permit the contract owner to participate in the performance of an index, ETF or commodity price. These investment options, which depending on the product and on the index selected, can currently have one, three, five or six year terms, provide for participation in the performance of specified indices, ETF or commodity price movement up to a segment-specific declared maximum rate. Under certain conditions that vary by product, e.g., holding these segments for the full term, these segments also shield policyholders from some or all negative investment performance associated with these indices, ETF or commodity prices. These investment options have defined formulaic liability amounts, and the current values of the option component of these segment reserves are classified as Level 2 embedded derivatives. The fair values of these embedded derivatives are based on data obtained from independent valuation service providers.
Financial Instruments Classified as Level 3
The Company’s investments classified as Level 3 primarily include corporate debt securities and financial assets and liabilities accounted for using the fair value option, such as private fixed maturities and asset-backed securities. Determinations to classify fair value measures within Level 3 of the valuation hierarchy generally are based upon the significance of the unobservable factors to the overall fair value measurement. Included in the Level 3 classification are fixed maturities with indicative pricing obtained from brokers that otherwise could not be corroborated to market observable data.
The Company also issues certain benefits on its variable annuity products that are accounted for as derivatives and are also considered Level 3. The GMIB NLG feature allows the policyholder to receive guaranteed minimum lifetime annuity payments based on predetermined annuity purchase rates applied to the contract’s benefit base if and when the contract account value is depleted and the NLG feature is activated. The GMWB feature allows the policyholder to withdraw at minimum, over the life of the contract, an amount based on the contract’s benefit base. The GWBL feature allows the policyholder to withdraw, each year for the life of the contract, a specified annual percentage of an amount based on the contract’s benefit base. The GMAB feature increases the contract account value at the end of a specified period to a GMAB base. The GIB feature provides a lifetime annuity based on predetermined annuity purchase rates if and when the contract account value is depleted. This lifetime annuity is based on predetermined annuity purchase rates applied to a GIB base.
Level 3 also includes the GMIB reinsurance contract assets, which are accounted for as derivative contracts. The GMIB reinsurance contract asset and liabilities’ fair value reflects the present value of reinsurance premiums, net of recoveries, and risk margins over a range of market consistent economic scenarios while GMxB derivative features liability reflects the present value of expected future payments (benefits) less fees, adjusted for risk margins and

45

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

nonperformance risk, attributable to GMxB derivative features’ liability over a range of market-consistent economic scenarios. 
Also included are the Amounts due from Reinsurers related to the GMIB NLG product features (GMIB NLG Reinsurance). The fair value reflects the present value of reinsurance premiums, net of recoveries, adjusted for risk margins and nonperformance risk over a range of market consistent economic scenarios.
The valuations of the GMIB reinsurance contract asset, GMIB NLG Reinsurance and GMxB derivative features liability incorporate significant non-observable assumptions related to policyholder behavior, risk margins and equity projections of Separate Account funds. The credit risks of the counterparty and of the Company are considered in determining the fair values of its GMIB reinsurance contract asset, GMIB NLG Reinsurance and GMxB derivative features liability positions, respectively, after taking into account the effects of collateral arrangements. Incremental adjustment to the U.S. Treasury curve for non-performance risk is made to the fair values of the GMIB reinsurance contract asset, GMIB NLG Reinsurance and GMIB NLG feature to reflect the claims-paying ratings of counterparties and the Company. Due to the unique, long duration of the GMIB NLG feature and GMIB NLG Reinsurance, risk margins were applied to the non-capital markets inputs to the GMIB NLG valuations.
After giving consideration to collateral arrangements, the impact to the fair value of its GMIB reinsurance contract asset was a decrease of $112 million and $107 million as of September 30, 2022 and December 31, 2021, respectively, to recognize incremental counterparty non-performance risk.
After giving consideration to collateral arrangements, the impact to the fair value of its Amounts due from Reinsurers was a decrease of $199 million and $210 million at September 30, 2022 and December 31, 2021 to recognize incremental counterparty non-performance risk.
Lapse rates are adjusted at the contract level based on a comparison of the actuarial calculated guaranteed values and the current policyholder account value, which include other factors such as considering surrender charges. Generally, lapse rates are assumed to be lower in periods when a surrender charge applies. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in-the-money contracts are less likely to lapse. For valuing the embedded derivative, lapse rates vary throughout the period over which cash flows are projected.
The Company’s Level 3 liabilities include contingent payment arrangements associated with acquisitions in 2016 and 2019 by AB. At each reporting date, AB estimates the fair values of the contingent consideration expected to be paid based upon revenue and discount rate projections, using unobservable market data inputs, which are included in Level 3 of the valuation hierarchy. The Company’s consolidated VIEs/VOEs hold investments that are classified as Level 3, primarily corporate bonds that are vendor priced with no ratings available, bank loans, non-agency collateralized mortgage obligations and asset-backed securities.
Transfers of Financial Instruments Between Levels 2 and 3
During the nine months ended September 30, 2022, fixed maturities with fair values of $150 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, fixed maturities with fair value of $191 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 7.1% of total equity as of September 30, 2022.
During the nine months ended September 30, 2021, fixed maturities with fair values of $782 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, fixed maturities with fair value of $1 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 5.9% of total equity as of September 30, 2021.

46

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

The tables below present reconciliations for all Level 3 assets and liabilities and changes in unrealized gains (losses) for the three and nine months ended September 30, 2022 and 2021, respectively.

CorporateState and Political SubdivisionsAsset-backedCMBSTrading Securities, at Fair ValueFixed maturities, at FVO
Balance, July 1, 2022$1,767 $30 $18 $25 $52 $423 
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss)1     (20)
Investment gains (losses), net(3)     
Subtotal(2)    (20)
Other comprehensive income (loss)(71)(1)1    
Purchases218 — (3)7  6 
Sales(34)—    17 
Activity related to consolidated VIEs/VOEs— —     
Transfers into Level 3 (1)25 —    (84)
Transfers out of Level 3 (1)8 — (6)  32 
Balance, September 30, 2022$1,911 $29 $10 $32 $52 $374 
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2)$ $ $ $ $ $(20)
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2)$(70)$(1)$ $ $ $ 
Balance, July 1, 2021$1,261 $37 $128 $10 $39 $148 
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss)— — — — (7)
Investment gains (losses), net(2)— — — — — 
Subtotal(1)— — — — (7)
Other comprehensive income (loss)(1)— — — — 
Purchases262 — (121)— — 62 
Sales(71)— (2)— — (17)
Activity related to consolidated VIEs/VOEs— — — — — — 
Transfers into Level 3 (1)(2)— — — — (14)
Transfers out of Level 3 (1)— — — — — 10 
Balance, September 30, 2021$1,453 $36 $$10 $39 $182 
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2)$— $— $— $— $— $
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2)$$(1)$— $— $— $— 

47

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

_____
CorporateState and Political SubdivisionsAsset-backedCMBSTrading Securities, at Fair ValueFixed maturities, at FVO
Balance, January 1, 2022$1,504 $35 $8 $20 $65 $201 
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss)3     (20)
Investment gains (losses), net(3)   (13) 
Subtotal    (13)(20)
Other comprehensive income (loss)(152)(5) (2)  
Purchases777 — 9 14  159 
Sales(195)(1)(1)  (36)
Activity related to consolidated VIEs/VOEs— —     
Transfers into Level 3 (1)90 —    101 
Transfers out of Level 3 (1)(113)— (6)  (31)
Balance, September 30, 2022$1,911 $29 $10 $32 $52 $374 
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2)$ $ $ $ $(13)$(9)
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2)$(149)$(5)$ $(2)$ $ 
Balance, January 1, 2021$1,702 $39 $20 $— $39 $80 
Total gains and (losses), realized and unrealized, included in:
Net income (loss) as:
Net investment income (loss)— — — — 
Investment gains (losses), net(14)— — — — — 
Subtotal(10)— — — — 
Other comprehensive income (loss)30 (2)— — — — 
Purchases721 — 10 — 192 
Sales(277)(1)(18)— — (26)
Activity related to consolidated VIEs/VOEs— — — — — — 
Transfers into Level 3 (1)— — — — — 
Transfers out of Level 3 (1)(713)— — — — (69)
Balance, September 30, 2021$1,453 $36 $$10 $39 $182 
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (2)$— $— $— $— $— $
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (2)$30 $(2)$— $— $— $— 
________
(1)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(2)For instruments held as of September 30, 2022 or September 30, 2021, amounts are included in net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.


48

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Other Equity Investments (7)GMIB Reinsurance Contract AssetAmounts Due from ReinsurersSeparate Accounts AssetsGMxB Derivative Features LiabilityContingent Payment Arrangement
Balance, July 1, 2022$67 $1,498 $4,681 $1 $(6,180)$(42)
Realized and unrealized gains (losses), included in Net income (loss) as:
Investment gains (losses), reported in net investment income(1)     
Net derivative gains (losses) (1) (196)(364) 429  
Total realized and unrealized gains (losses)(1)(196)(364) 429  
Other comprehensive income (loss)      
Purchases (2)(49)10 28  (111)(228)
Sales (3) (23)(33) 37  
Activity related to consolidated VIEs/VOEs     (3)
Transfers into Level 3 (4)      
Transfers out of Level 3 (4)      
Balance, September 30, 2022$17 $1,289 $4,312 $1 $(5,825)$(273)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (6)$(1)$(196)$(364)$ $428 $ 
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (6)$ $ $ $ $ $ 
Balance, July 1, 2021$103 $2,026 $5,510 $$(8,455)$(38)
Realized and unrealized gains (losses), included in Net income (loss) as:
Investment gains (losses), reported in net investment income— — — — — 
Net derivative gains (losses) (1) (5)— (84)344 — (395)— 
Total realized and unrealized gains (losses)(84)344 — (395)— 
Other comprehensive income (loss)— — — — — — 
Purchases (2)11 31 (1)(108)
Sales (3)(91)(16)(16)— 20 — 
Activity related to consolidated VIEs/VOEs— — — — (1)
Transfers into Level 3 (4)— — — — — — 
Transfers out of Level 3 (4)— — — — — — 
Balance, September 30, 2021$15 $1,937 $5,869 $— $(8,938)$(38)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (6)$$(84)$344 $— $(395)$— 
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (6)$— $— $— $— $— $— 



49

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Other Equity Investments (7)GMIB Reinsurance Contract AssetAmounts Due from ReinsurersSeparate Accounts AssetsGMxB Derivative Features LiabilityContingent Payment Arrangement
Balance, January 1, 2022$16 $1,848 $5,815 $1 $(8,525)$(38)
Realized and unrealized gains (losses), included in Net income (loss) as:
Investment gains (losses), reported in net investment income(1)     
Net derivative gains (losses) (1) (535)(1,506) 2,943  
Total realized and unrealized gains (losses)(1)(535)(1,506) 2,943  
Other comprehensive income (loss)      
Purchases (2)8 31 89  (347)(230)
Sales (3) (55)(86) 104  
Activity related to consolidated VIEs/VOEs(3)    (5)
Transfers into Level 3 (4)      
Transfers out of Level 3 (4)(3)     
Balance, September 30, 2022$17 $1,289 $4,312 $1 $(5,825)$(273)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (6)$(1)$(535)$(1,506)$ $2,943 $ 
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (6)$ $ $ $ $ $ 
Balance, January 1, 2021$84 $2,488 $— $$(11,131)$(28)
Realized and unrealized gains (losses), included in Net income (loss) as:
Investment gains (losses), reported in net investment income20 — — — — — 
Net derivative gains (losses) (1) (5)— (542)586 — 2,340 — 
Total realized and unrealized gains (losses)20 (542)586 — 2,340 — 
Other comprehensive income (loss)— — — — — — 
Purchases (2)32 41 — (348)(7)
Sales (3)(92)(41)(17)— 61 — 
Other— — 5,259 — — — 
Activity related to consolidated VIEs/VOEs(1)— — — — (3)
Transfers into Level 3 (4)— — — — — — 
Transfers out of Level 3 (4)— — — (1)140 — 
Balance, September 30, 2021$15 $1,937 $5,869 $— $(8,938)$(38)
Change in unrealized gains or losses for the period included in earnings for instruments held at the end of the reporting period (6)$$(542)$586 $— $2,340 $— 
Change in unrealized gains or losses for the period included in other comprehensive income for instruments held at the end of the reporting period (6)$— $— $— $— $— $— 
______________
(1)For the three and nine months ended September 30, 2022 and 2021, the Company’s non-performance risk impact of $(41) million , $(92) million, $837 million and $(72) million for the GMxB Derivative Features Liability, $8 million ,$5 million, $(66) million and $6 million for the GMIB Reinsurance Contract Asset, and $(16) million, $(19) million, $(93) million and $(7) million for the Amounts due from Reinsurers is recorded through Net derivative gains (losses), respectively.

50

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

(2)For the GMIB reinsurance contract asset, Amounts Due from Reinsurers and GMxB derivative features liability, represents attributed fee.
(3)For the GMIB reinsurance contract asset and Amounts Due from Reinsurers, represents recoveries from reinsurers and for GMxB derivative features liability represents benefits paid.
(4)Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
(5)For the nine months ended September 30, 2021, GMxB Derivative Features Liability excludes settlement fees on CS Life reinsurance contract of $45 million.
(6)For instruments held as of September 30, 2022 or September 30, 2021, amounts are included in net investment income or net derivative gains (losses) in the consolidated statements of income (loss) or unrealized gains (losses) on investments in the consolidated statements of comprehensive income.
(7)Other Equity Investments include other invested assets.

51

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Quantitative and Qualitative Information about Level 3 Fair Value Measurements
The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities as of September 30, 2022 and December 31, 2021, respectively.
Quantitative Information about Level 3 Fair Value Measurements as of September 30, 2022

Fair
Value
Valuation
Technique
Significant
Unobservable Input
Range
Weighted Average (2)
 
(in millions)
Assets:
Investments:
Fixed maturities, AFS:
Corporate$241 Matrix pricing model
Spread over Benchmark
20 bps - 797 bps
174 bps
917 Market comparable 
companies
EBITDA multiples
Discount rate
Cash flow multiples
Loan to value
5.7x - 38.5x
5.5% - 41.5%
0.5x - 12.0x
0.0% - 46.7%
14.1x
8.3%
6.4x
26.3%
Trading Securities, at Fair Value52 Discounted Cash Flow
Earnings multiple
Discount factor
Discount years
7.3x
10.0%
11
Other equity investments4 Market comparable companies
Revenue multiple
0.5x - 9.9x
2.8x
GMIB reinsurance contract asset1,289 Discounted cash flow
Lapse rates
Withdrawal Rates
GMIB Utilization Rates
Non-performance risk
Volatility rates - Equity
Mortality: Ages 0-40
Ages 41-60
Ages 61-115

0.38%-22.66%
0.14%-10.02%
0.04%-60.54%
101 bps - 167 bps
14%-35%
0.01%-0.17%
0.06%-0.52%
0.32%-40.00%
2.92%
1.02%
5.61%
103 bps
25%
3.09%
(same for all ages)
(same for all ages)
Amount Due from Reinsurers4,312 Discounted Cash Flow
Lapse rates
Withdrawal Rates
GMIB Utilization Rates
Non-performance risk (bps)
Volatility rates - Equity
Mortality: Ages 0-40
Ages 41-60
Ages 61-115
0.38%-22.66%
0.14%-10.02%
0.04%-60.54%
63 bps
14%-35%
0.01%-0.17%
0.06%-0.52%
0.32%-40.00%


1.93%
1.38%
8.27%
63 bps
25%
2.28%
(same for all ages)
(same for all ages)
Liabilities:

52

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Fair
Value
Valuation
Technique
Significant
Unobservable Input
Range
Weighted Average (2)
AB Contingent Consideration Payable273 Discounted cash flow
Expected revenue growth rates
Discount rate
2.0% - 83.9%
1.9% - 10.4%
11.5%
4.5%
GMIB NLG5,817 Discounted cash flow
Non-performance risk
Lapse rates
Withdrawal rates
Annuitization rates
Mortality rates (1):
Ages 0 - 40
Ages 41-60
Ages 61-115
186 bps
0.38%-28.79%
0.14%-10.02%
0.04%-100.00%

0.01%-0.18%
0.07%-0.56%
0.44%-43.60%
186 bps
4.23%
1.27%
6.10%

1.71%
(same for all ages)
(same for all ages)
GWBL/GMWB73 Discounted cash flow
Lapse rates
Withdrawal Rates
Utilization Rates

Volatility rates - Equity
Non-performance risk(bps)
0.50%-22.66%
0.00%-8.00%
100% once starting
14%-35%
186 bps
2.92%
1.02%


25%
GIB(64)Discounted cash flow
Lapse rates
Withdrawal Rates
Utilization Rates
Volatility rates - Equity
Non-performance risk(bps)
0.50%-22.66%
0.26%-2.10%
0.04%-100.00%
14% - 35%
186 bps
2.92%
1.02%
5.61%
25%
GMAB(1)Discounted cash flow
Lapse rates
Volatility rates - Equity
Non-performance risk(bps)
0.50%-22.66%
14%-35%
186 bps
2.92%
25%
______________
(1)Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.
(2)For lapses, withdrawals, and utilizations the rates were weighted by counts; for mortality weighted average rates are shown for all ages combined; and for withdrawals the weighted averages were based on an estimated split of partial withdrawal and dollar-for-dollar withdrawals.
Quantitative Information about Level 3 Fair Value Measurements as of December 31, 2021

Fair
Value
Valuation
Technique
Significant
Unobservable Input
Range
Weighted Average (2)
 
(in millions)
Assets:
Investments:
Fixed maturities, AFS:
Corporate$258 Matrix pricing model
Spread over benchmark
20 bps - 270 bps
144 bps
888 Market comparable companies
EBITDA multiples
 Discount rate
 Cash flow multiples
Loan to value
4.9x - 62.3x
6.2% - 21.5%
0.5x-10.0x
3.1%-63.4%
13.0x
9.1%
5.5x
30.8%
Trading Securities, at Fair Value65 Discounted cash flow
Earnings multiple
Discounts factor
Discount years
7.3x
10.00%
11
Other equity investmentsMarket comparable companies
Revenue multiple
7.8x - 10.3x
9.5x

53

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Fair
Value
Valuation
Technique
Significant
Unobservable Input
Range
Weighted Average (2)
 
(in millions)
GMIB reinsurance contract asset1,848 Discounted cash flow
Non-performance risk
Lapse rates
Withdrawal rates
Utilization rates
Volatility rates - Equity
Mortality rates (1):
Ages 0 - 40
Ages 41 - 60
Ages 60 - 115
57 bps - 93 bps
0.45% - 20.86%
0.27% - 8.66%
0.04% - 60.44%
11% - 31%

0.01% - 0.17%
0.06% - 0.53%
0.31% - 40.00%
60 bps
2.65%
0.93%
5.27%
24%

2.79%
(same for all ages)
(same for all ages)
Amount Due from Reinsurers5,813 Discounted Cash Flow
Lapse rates
Withdrawal Rates
GMIB Utilization Rates
Non-performance risk (bps)
Volatility rates - Equity
Mortality: Ages 0-40
Ages 41-60
Ages 61-115

0.45%-20.86%
0.27%-8.66%
0.04%-60.44%
37 bps
11%-31%
0.01%-0.17%
0.06%-0.53%
0.31%-40.00%



1.70%
1.18%
7.20%
37 bps
24%
2.17%
(same for all ages)
(same for all ages)
Liabilities:
AB Contingent Consideration Payable38 Discounted cash flow
Expected revenue growth rates
Discount rate
2.0% - 83.9%
1.9% - 10.4%
11.9%
7.0%
GMIB NLG8,503 Discounted cash flow
Non-performance risk
Lapse rates
Withdrawal rates
Annuitization rates
Mortality rates (1):
Ages 0 - 40
Ages 41 - 60
Ages 60 - 115
111 bps
1.04% - 23.57%
0.27% - 8.66%
0.03% -100.00%

0.01% - 0.19%
0.07% - 0.57%
0.44% - 43.60%
111 bps
3.55%
1.04%
5.24%

1.62%
(same for all ages)
(same for all ages)
GWBL/GMWB99 Discounted cash flow
Non-performance risk
Lapse rates
Withdrawal rates
Utilization rates

Volatility rates - Equity
111 bps
0.60%-20.86%
0.00%-8.00%
100% once starting
11%-31%

2.65%
0.93%


24%
GIB(75)Discounted cash flow
Non-performance risk
Lapse rates
Withdrawal rates
Utilization rates
Volatility rates - Equity
111 bps
0.60%-20.86%
0.13%-8.66%
0.04%-100.00%
11%-31%

2.65%
0.93%
5.27%
24%
GMAB(3)Discounted cash flow
Non-performance risk
Lapse rates
Volatility rates - Equity
111 bps
0.60%-20.86%
11%-31%

2.65%
24%
______________
(1)Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.
(2)For lapses, withdrawals, and utilizations the rates were weighted by counts; for mortality weighted average rates are shown for all ages combined; and for withdrawals the weighted averages were based on an estimated split of partial withdrawal and dollar-for-dollar withdrawals.

54

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Level 3 Financial Instruments for which Quantitative Inputs are Not Available
Certain Privately Placed Debt Securities with Limited Trading Activity
Excluded from the tables above as of September 30, 2022 and December 31, 2021, respectively, are approximately $1.2 billion and $635 million of Level 3 fair value measurements of investments for which the underlying quantitative inputs are not developed by the Company and are not readily available. These investments primarily consist of certain privately placed debt securities with limited trading activity, including residential mortgage- and asset-backed instruments, and their fair values generally reflect unadjusted prices obtained from independent valuation service providers and indicative, non-binding quotes obtained from third-party broker-dealers recognized as market participants. Significant increases or decreases in the fair value amounts received from these pricing sources may result in the Company’s reporting significantly higher or lower fair value measurements for these Level 3 investments.
The fair value of private placement securities is determined by application of a matrix pricing model or a market comparable company value technique. The significant unobservable input to the matrix pricing model valuation technique is the spread over the industry-specific benchmark yield curve. Generally, an increase or decrease in spreads would lead to directionally inverse movement in the fair value measurements of these securities. The significant unobservable input to the market comparable company valuation technique is the discount rate. Generally, a significant increase (decrease) in the discount rate would result in significantly lower (higher) fair value measurements of these securities.
Residential mortgage-backed securities classified as Level 3 primarily consist of non-agency paper with low trading activity. Included in the tables above as of September 30, 2022 and December 31, 2021, there were no Level 3 securities that were determined by application of a matrix pricing model and for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Generally, a change in spreads would lead to directionally inverse movement in the fair value measurements of these securities.
Asset-backed securities classified as Level 3 primarily consist of non-agency mortgage loan trust certificates, including subprime and Alt-A paper, credit risk transfer securities, and equipment financings. Included in the tables above as of September 30, 2022 and December 31, 2021, there were no securities that were determined by the application of matrix-pricing for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Significant increases (decreases) in spreads would have resulted in significantly lower (higher) fair value measurements.
Other Equity Investments
Included in other equity investments classified as Level 3 are venture capital securities in the Technology, Media and Telecommunications industries. The fair value measurements of these securities include significant unobservable inputs including an enterprise value to revenue multiples and a discount rate to account for liquidity and various risk factors. Significant increases (decreases) in the enterprise value to revenue multiple inputs in isolation would have resulted in a significantly higher (lower) fair value measurement. Significant increases (decreases) in the discount rate would have resulted in a significantly lower (higher) fair value measurement.
GMIB Reinsurance Contract Asset, Amounts Due from Reinsurers and GMxB Derivative Features
Significant unobservable inputs with respect to the fair value measurement of the Level 3 GMIB reinsurance contract asset and the Level 3 liabilities identified in the table above are developed using Company data.
The significant unobservable inputs used in the fair value measurement of the Company’s GMIB reinsurance contract asset are lapse rates, withdrawal rates, and GMIB utilization rates. Significant increases in GMIB utilization rates or decreases in lapse or withdrawal rates in isolation would tend to increase the GMIB reinsurance contract asset.
Fair value measurement of the GMIB reinsurance contract asset, GMIB NLG Reinsurance and liabilities includes dynamic lapse and GMIB utilization assumptions whereby projected contractual lapses and GMIB utilization reflect the projected net amount of risks of the contract. As the net amount of risk of a contract increases, the assumed lapse rate decreases and the GMIB utilization increases. Increases in volatility would increase the asset and liabilities.
The significant unobservable inputs used in the fair value measurement of the Company’s GMIB NLG liability and GMIB NLG Reinsurance are lapse rates, withdrawal rates, GMIB utilization rates, adjustment for non-performance risk and NLG forfeiture rates. NLG forfeiture rates are caused by excess withdrawals above the annual GMIB accrual rate that cause the NLG to expire. Significant decreases in lapse rates, NLG forfeiture rates, adjustment for non-

55

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

performance risk and GMIB utilization rates would tend to increase the GMIB NLG liability and GMIB NLG Reinsurance, while decreases in withdrawal rates and volatility rates would tend to decrease the GMIB NLG liability and GMIB NLG Reinsurance.
The significant unobservable inputs used in the fair value measurement of the Company’s GMWB and GWBL liability are lapse rates and withdrawal rates. Significant increases in withdrawal rates or decreases in lapse rates in isolation would tend to increase these liabilities. Increases in volatility would increase these liabilities.
Carrying Value of Financial Instruments Not Otherwise Disclosed in Note 3 and Note 4 of the Notes to these Consolidated Financial Statements
The carrying values and fair values as of September 30, 2022 and December 31, 2021 for financial instruments not otherwise disclosed in Note 3 and Note 4 of the Notes to these Consolidated Financial Statements are presented in the table below.
Carrying Values and Fair Values for Financial Instruments Not Otherwise Disclosed

 
Carrying
Value
Fair Value
 
Level 1
Level 2
Level 3
Total
(in millions)
September 30, 2022:
Mortgage loans on real estate $15,688 $ $ $13,946 $13,946 
Policy loans$4,018 $ $ $4,963 $4,963 
Policyholders’ liabilities: Investment contracts$2,023 $ $ $1,838 $1,838 
FHLB funding agreements $7,830 $ $7,709 $ $7,709 
FABN funding agreements$6,613 $ $5,914 $ $5,914 
Short-term and long-term debt (1)$3,840 $ $3,559 $ $3,559 
Separate Accounts liabilities$9,806 $ $ $9,806 $9,806 
December 31, 2021:
Mortgage loans on real estate$14,033 $— $— $14,308 $14,308 
Policy loans$4,024 $— $— $5,050 $5,050 
Policyholders’ liabilities: Investment contracts$2,035 $— $— $2,103 $2,103 
FHLB funding agreements $6,647 $— $6,679 $— $6,679 
FABN funding agreements$6,689 $— $6,626 $— $6,626 
Short-term and long-term debt (1)$3,839 $— $4,544 $— $4,544 
Separate Accounts liabilities$11,620 $— $— $11,620 $11,620 
_____________
(1)As of September 30, 2022 and December 31, 2021 excludes CLO short-term debt of $248 million and $92 million, which is inclusive as fair valued within Notes issued by consolidated VIE’s, at fair value using the fair value option.

Mortgage Loans on Real Estate
Fair values for commercial and agricultural mortgage loans on real estate are measured by discounting future contractual cash flows to be received on the mortgage loan using interest rates at which loans with similar characteristics and credit quality would be made. The discount rate is derived based on the appropriate U.S. Treasury rate with a like term to the remaining term of the loan to which a spread reflective of the risk premium associated with the specific loan is added. Fair values for mortgage loans anticipated to be foreclosed and problem mortgage loans are limited to the fair value of the underlying collateral, if lower.

56

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Policy Loans
The fair value of policy loans is calculated by discounting expected cash flows based upon the U.S. Treasury yield curve and historical loan repayment patterns.
Short-term and Long-term Debt
The Company’s short-term debt primarily includes commercial paper with short-term maturities and carrying value approximates fair value. The fair values for the Company’s long-term debt are determined by Bloomberg’s evaluated pricing service, which uses direct observations or observed comparables.
FHLB Funding Agreements
The fair values of the Company’s FHLB funding agreements are determined by discounted cash flow analysis based on the indicative funding agreement rates published by the FHLB.
FABN Funding Agreements
The fair values of Equitable Financial’s FABN funding agreements are determined by Bloomberg’s evaluated pricing service, which uses direct observations or observed comparables.
Policyholder Liabilities - Investment Contracts and Separate Accounts Liabilities
The fair values for deferred annuities and certain annuities, which are included in Policyholders’ account balances, and liabilities for investment contracts with fund investments in Separate Accounts, are estimated using projected cash flows discounted at rates reflecting current market rates. Significant unobservable inputs reflected in the cash flows include lapse rates and withdrawal rates. Incremental adjustments may be made to the fair value to reflect non-performance risk. Certain other products such as the Company’s association plans contracts, supplementary contracts not involving life contingencies, Access Accounts and Escrow Shield Plus product reserves are held at book value.
Financial Instruments Exempt from Fair Value Disclosure or Otherwise Not Required to be Disclosed
Exempt from Fair Value Disclosure Requirements
Certain financial instruments are exempt from the requirements for fair value disclosure, such as insurance liabilities other than financial guarantees and investment contracts, limited partnerships accounted for under the equity method and pension and other postretirement obligations.
Otherwise Not Required to be Included in the Table Above
The Company’s investment in COLI policies are recorded at their cash surrender value and are therefore not required to be included in the table above. See Note 2 of the Notes to these Consolidated Financial Statements for further description of the Company’s accounting policy related to its investment in COLI policies.
8)    EMPLOYEE BENEFIT PLANS
Pension Plans
Holdings and Equitable Financial Retirement Plans
Holdings sponsors the MONY Life Retirement Income Security Plan for Employees and Equitable Financial sponsors the Equitable Retirement Plan (the “Equitable Financial QP”), both of which are frozen qualified defined benefit plans covering eligible employees and financial professionals. These pension plans are non-contributory, and their benefits are generally based on a cash balance formula and/or, for certain participants, years of service and average earnings over a specified period. Holdings and Equitable Financial also sponsor certain nonqualified defined benefit plans, including the Equitable Excess Retirement Plan, that provide retirement benefits in excess of the amount permitted under the tax law for the qualified plans. Holdings has assumed primary liability for both plans. Equitable Financial remains secondarily liable for its obligations under the Equitable Financial QP and would recognize such liability in the event Holdings does not perform.

57

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

AB Retirement Plans
AB maintains a qualified, non-contributory, defined benefit retirement plan covering current and former employees who were employed by AB in the United States prior to October 2, 2000 (the “AB Plan”). Benefits under the AB Plan are based on years of credited service, average final base salary, and primary Social Security benefits. Service and compensation after December 31, 2008 are not taken into account in determining participants’ retirement benefits.
Net Periodic Pension Expense
Components of net periodic pension expense for the Company’s plans were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
 (in millions)
Service cost$2 $$6 $
Interest cost21 13 49 40 
Expected return on assets(40)(40)(119)(116)
Prior Period Svc Cost Amortization(1)(2)— 
Actuarial (gain) loss — 1 
Net amortization15 23 55 81 
Impact of settlement  
Net Periodic Pension Expense$(3)$$(10)$15 
9)    INCOME TAXES
Income tax expense for the three and nine months ended September 30, 2022 and 2021 was computed using an estimated annual effective tax rate (“ETR”), with discrete items recognized in the period in which they occur. The estimated ETR is revised, as necessary, at the end of successive interim reporting periods.
10)    EQUITY
Preferred Stock
Preferred stock authorized, issued and outstanding was as follows:
September 30, 2022December 31, 2021
SeriesShares AuthorizedShares
 Issued
Shares OutstandingShares AuthorizedShares
 Issued
Shares Outstanding
Series A 32,000 32,000 32,000 32,000 32,000 32,000 
Series B 20,000 20,000 20,000 20,000 20,000 20,000 
Series C12,000 12,000 12,000 12,000 12,000 12,000 
Total64,000 64,000 64,000 64,000 64,000 64,000 

Dividends declared per share were as follows for the periods indicated:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Series A dividends declared $328 $328 $984 $984 
Series B dividends declared$ $— $619 $619 
Series C dividends declared$269 $269 $806 $738 
Common Stock
Dividends declared per share of common stock were as follows for the periods indicated:

58

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Dividends declared$0.20 $0.18 $0.58 $0.53 

Share Repurchase

On February 9, 2022, the Company’s Board of Directors authorized a new $1.2 billion share repurchase program. Under this program, the Company may, from time to time purchase shares of its common stock through various means. The Company may choose to suspend or discontinue the repurchase program at any time. The repurchase program does not obligate the Company to purchase any particular number of shares. As of September 30, 2022, Holdings had authorized capacity of approximately $578 million remaining in its share repurchase program.
Holdings repurchased a total of 7.0 million, 15.6 million, 23.2 million and 38.2 million shares of its common stock at an average price of $28.67, $29.50, $30.17, and $30.56 per share, respectively through open market repurchases, ASRs and privately negotiated transactions during the three and nine months ended September 30, 2022 and 2021.
Holdings purchased 4.7 million and 0 shares of its common stock through open market purchases in the three months ended September 30, 2022 and 2021. During the nine months ended September 30, 2022 and 2021, Holdings repurchased 12.6 million and 3.2 million shares of its common stock through open market repurchases.
In April 2022, Holdings entered into an ASR with a third-party financial institution to repurchase an aggregate of $100 million of Holdings’ common stock. Pursuant to the ASR, Holdings made a prepayment of $100 million and initially received 2.6 million shares. The ASR terminated during April 2022, at which time 684,700 additional shares of common stock were received.
In May 2022, Holdings entered into an ASR with a third-party financial institution to repurchase an aggregate of $150 million of Holdings’ common stock. Pursuant to the ASR, Holdings made a prepayment of $150 million and initially received 4.3 million shares. The ASR terminated during July 2022, at which time 1.2 million additional shares of common stock were received.
In September 2022, Holdings entered into an ASR contract with a third-party financial institution to repurchase an aggregate of $37.5 million of Holdings’ common stock. Pursuant to the ASR, Holdings made a prepayment of $37.5 million and received initial delivery of 1.1 million shares. The ASR is scheduled to terminate on November 4, 2022, at which time additional shares may be delivered or returned depending on the daily volume weighted average price of Holdings’ common stock.
Accumulated Other Comprehensive Income (Loss)
AOCI represents cumulative gains (losses) on items that are not reflected in net income (loss). The balances as of September 30, 2022 and December 31, 2021 follow:
 September 30,December 31,
 20222021
 
(in millions)
Unrealized gains (losses) on investments$(7,210)$2,684 
Defined benefit pension plans(608)(669)
Foreign currency translation adjustments(120)(45)
Total accumulated other comprehensive income (loss)(7,938)1,970 
Less: Accumulated other comprehensive income (loss) attributable to noncontrolling interest(62)(34)
Accumulated other comprehensive income (loss) attributable to Holdings$(7,876)$2,004 


59

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

The components of OCI, net of taxes for the three and nine months ended September 30, 2022 and 2021 follow:

Three Months Ended September 30,

Nine Months Ended September 30,
 2022202120222021
 (in millions)
Change in net unrealized gains (losses) on investments:
Net unrealized gains (losses) arising during the period$(3,195)$(310)$(12,929)$(2,547)
(Gains) losses reclassified into net income (loss) during the period (1)245 (131)678 (617)
Net unrealized gains (losses) on investments(2,950)(441)(12,251)(3,164)
Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other624 318 2,357 1,108 
Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $(619), $(32), $(2,630) and $(546))
(2,326)(123)(9,894)(2,056)
Change in defined benefit plans:
Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost16 22 61 77 
Change in defined benefit plans (net of deferred income tax expense (benefit) of $(4), $6, $(13), and $20)
16 22 61 77 
Foreign currency translation adjustments:
Foreign currency translation gains (losses) arising during the period(30)(9)(75)(13)
Foreign currency translation adjustment(30)(9)(75)(13)
Total other comprehensive income (loss), net of income taxes(2,340)(110)(9,908)(1,992)
Less: Other comprehensive income (loss) attributable to noncontrolling interest(12)(3)(28)(5)
Other comprehensive income (loss) attributable to Holdings$(2,328)$(107)$(9,880)$(1,987)
_______________
(1)See “Reclassification adjustment” in Note 3 of the Notes to these Consolidated Financial Statements. Reclassification amounts presented net of income tax expense (benefit) of $(65) million, $35 million, $(180) million, and $164 million for the three and nine months ended September 30, 2022 and 2021, respectively.
Investment gains and losses reclassified from AOCI to net income (loss) primarily consist of realized gains (losses) on sales and credit losses of AFS securities and are included in total investment gains (losses), net on the consolidated statements of income (loss). Amounts reclassified from AOCI to net income (loss) as related to defined benefit plans primarily consist of amortization of net (gains) losses and net prior service cost (credit) recognized as a component of net periodic cost and reported in compensation and benefits in the consolidated statements of income (loss). Amounts presented in the table above are net of tax.
11)    REDEEMABLE NONCONTROLLING INTEREST
The changes in the components of redeemable noncontrolling interests are presented in the table that follows:
Three Months Ended September 30,Nine Months Ended September 30,
 2022202120222021
(in millions)
Balance, beginning of period$348 $42 $468 $143 
Net earnings (loss) attributable to redeemable noncontrolling interests(9)— (65)
Purchase/change of redeemable noncontrolling interests15 101 (49)(4)
Balance, end of period$354 $143 $354 $143 

60

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

12)    COMMITMENTS AND CONTINGENT LIABILITIES
Litigation and Regulatory Matters
Litigation, regulatory and other loss contingencies arise in the ordinary course of the Company’s activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters arising from the conduct of its business. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. Modern pleading practice permits considerable variation in the assertion of monetary damages and other relief. Claimants are not always required to specify the monetary damages they seek, or they may be required only to state an amount sufficient to meet a court’s jurisdictional requirements. Moreover, some jurisdictions allow claimants to allege monetary damages that far exceed any reasonably possible verdict. The variability in pleading requirements and past experience demonstrates that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. Litigation against the Company includes a variety of claims including, among other things, insurers’ sales practices, alleged agent misconduct, alleged failure to properly supervise agents, contract administration, product design, features and accompanying disclosure, cost of insurance increases, payments of death benefits and the reporting and escheatment of unclaimed property, alleged breach of fiduciary duties, alleged mismanagement of client funds and other matters.
The outcome of a litigation or regulatory matter is difficult to predict, and the amount or range of potential losses associated with these or other loss contingencies requires significant management judgment. It is not possible to predict the ultimate outcome or to provide reasonably possible losses or ranges of losses for all pending regulatory matters, litigation and other loss contingencies. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company’s financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters, nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company’s litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company’s results of operations or cash flows in a particular quarterly or annual period.
For some matters, the Company is able to estimate a range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of September 30, 2022, the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date, to be up to approximately $250 million.
For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company’s accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews.
In August 2015, a lawsuit was filed in Connecticut Superior Court entitled Richard T. O’Donnell, on behalf of himself and all others similarly situated v. AXA Equitable Life Insurance Company. This lawsuit was a putative class action on behalf of all persons who purchased variable annuities from Equitable Financial, in which the volatility management tool was subsequently implemented and who claimed to have suffered injury as a result thereof. Plaintiff asserted a claim for breach of contract alleging that Equitable Financial implemented the volatility management strategy in violation of applicable law. In September 2022, this lawsuit was withdrawn with prejudice.
In February 2016, a lawsuit was filed in the Southern District of New York entitled Brach Family Foundation, Inc. v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action brought on behalf of all owners of UL policies subject to Equitable Financial’s COI rate increase. In early 2016, Equitable Financial raised COI rates for certain UL policies issued between 2004 and 2008, which had both issue ages 70 and above and a current face value amount of $1 million and above. A second putative class action was filed in the District of Arizona in 2017 and consolidated with the Brach matter in federal court in New York. The consolidated amended class action complaint
61

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

alleges the following claims: breach of contract; misrepresentations in violation of Section 4226 of the New York Insurance Law; violations of New York General Business Law Section 349; and violations of the California Unfair Competition Law, and the California Elder Abuse Statute. Plaintiffs seek: (a) compensatory damages, costs, and, pre- and post-judgment interest; (b) with respect to their claim concerning Section 4226, a penalty in the amount of premiums paid by the plaintiffs and the putative class; and (c) injunctive relief and attorneys’ fees in connection with their statutory claims. In August 2020, the federal district court issued a decision certifying nationwide breach of contract and Section 4226 classes, and a New York State Section 349 class. Owners of a substantial number of policies opted out of the Brach class action. Most opt-out policies are not yet the subject of litigation. Others filed suit previously including three federal actions that have been coordinated with the Brach action and contain similar allegations along with additional allegations for violations of state consumer protection statutes and common law fraud. In March 2022, the federal district court issued a summary judgment decision, denying in significant part but granting in part Equitable Financial’s motion and denying the motion filed by plaintiffs in the coordinated actions. In July 2022, the federal district court granted Equitable Financial’s motion to reconsider its summary judgment decision in part and granted summary judgment as to a portion of the Section 4226 class. The federal district court also agreed to consider whether it should decertify the Section 4226 class and set a briefing schedule. Equitable Financial has commenced settlement discussions with the Brach class action plaintiffs and plaintiffs in the coordinated actions. No assurances can be given about the outcome of those settlement discussions. Equitable Financial has settled actual and threatened litigations challenging the COI increase by individual policyowners and one entity that invested in numerous policies purchased in the life settlement market. Two actions are also pending against Equitable Financial in New York state court. In July 2022, the trial court in one of the New York state court actions, Hobish v. AXA Equitable Life Insurance Company, granted in significant part Equitable Financial’s motion for summary judgment and denied plaintiff’s cross motion. That plaintiff filed a notice of appeal and Equitable filed a notice of cross-appeal. Equitable Financial is vigorously defending each of these matters.
As with other financial services companies, Equitable Financial periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. It is the practice of the Company to cooperate fully in these matters. In July 2022, the SEC issued an order with findings that daily separate account and portfolio operating expenses disclosed in customer prospectuses for the EQUI-VEST variable annuity product and incorporated in the calculation of net investment portfolio results in EQUI-VEST quarterly account statements were not properly presented or referenced in those account statements. The Company neither admitted nor denied the findings but agreed to prospectively modify the relevant account statements and cross-reference the relevant prospectus disclosures, and pay a civil monetary penalty of $50 million, to be distributed to plan participants. The Company has fully accrued for the cost of the settlement and its implementation.
Obligations under Funding Agreements
Pre-Capitalized Trust Securities (“P-Caps”)
In April 2019, pursuant to separate Purchase Agreements among Holdings, Credit Suisse Securities (USA) LLC, as representative of the several initial purchasers, and the Trusts (as defined below), Pine Street Trust I, a Delaware statutory trust (the “2029 Trust”), completed the issuance and sale of 600,000 of its Pre-Capitalized Trust Securities redeemable February 15, 2029 (the “2029 P-Caps”) for an aggregate purchase price of $600 million and Pine Street Trust II, a Delaware statutory trust (the “2049 Trust” and, together with the 2029 Trust, the “Trusts”), completed the issuance and sale of 400,000 of its Pre-Capitalized Trust Securities redeemable February 15, 2049 (the “2049 P-Caps” and, together with the 2029 P-Caps, the “P-Caps”) for an aggregate purchase price of $400 million in each case to qualified institutional buyers in reliance on Rule 144A that are also “qualified purchasers” for purposes of Section 3(c)(7) of the Investment Company Act of 1940, as amended.
The P-Caps are an off-balance sheet contingent funding arrangement that, upon Holdings’ election, gives Holdings the right over a ten-year period (in the case of the 2029 Trust) or over a thirty-year period (in the case of the 2049 Trust) to issue senior notes to these Trusts. The Trusts each invested the proceeds from the sale of their P-Caps in separate portfolios of principal and/or interest strips of U.S. Treasury securities. In return, Holdings will pay a semi-annual facility fee to the 2029 Trust and 2049 Trust calculated at a rate of 2.125% and 2.715% per annum, respectively, which will be applied to the unexercised portion of the contingent funding arrangement and Holdings will reimburse the Trusts for certain expenses. The facility fees are recorded in Other operating costs and expenses in the Consolidated Statements of Income (Loss).
62

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Federal Home Loan Bank (“FHLB”)
As a member of the FHLB, Equitable Financial has access to collateralized borrowings. It also may issue funding agreements to the FHLB. Both the collateralized borrowings and funding agreements would require Equitable Financial to pledge qualified mortgage-backed assets and/or government securities as collateral. Equitable Financial issues short-term funding agreements to the FHLB and uses the funds for asset, liability, and cash management purposes. Equitable Financial issues long-term funding agreements to the FHLB and uses the funds for spread lending purposes.
Entering into FHLB membership, borrowings and funding agreements requires the ownership of FHLB stock and the pledge of assets as collateral. Equitable Financial has purchased FHLB stock of $364 million and pledged collateral with a carrying value of $11.0 billion as of September 30, 2022.
Funding agreements are reported in policyholders’ account balances in the consolidated balance sheets. For other instruments used for asset/liability and cash management purposes, see “Derivative and offsetting assets and liabilities” included in Note 4 of the Notes to these Consolidated Financial Statements. The table below summarizes the Company’s activity of funding agreements with the FHLB.
Change in FHLB Funding Agreements during the Nine Months Ended September 30, 2022
Outstanding Balance at December 31, 2021Issued During the PeriodRepaid During the PeriodLong-term Agreements Maturing Within One YearLong-term Agreements Maturing Within Five YearsOutstanding Balance at September 30, 2022
(in millions)
Short-term funding agreements:
Due in one year or less$5,353 $40,964 $(41,132)$153 $ $5,338 
Long-term funding agreements:
Due in years two through five1,290 647  (153) 1,784 
Due in more than five years— 705    705 
Total long-term funding agreements1,290 1,352  (153) 2,489 
Total funding agreements (1)$6,643 $42,316 $(41,132)$ $ $7,827 
_____________
(1)The $4 million and $4 million difference between the funding agreements carrying value shown in fair value table for September 30, 2022 and December 31, 2021, respectively, reflects the remaining amortization of a hedge implemented and closed, which locked in the funding agreements borrowing rates.
Funding Agreement-Backed Notes Program (“FABN”)
Under the FABN program, Equitable Financial may issue funding agreements in U.S. dollar or other foreign currencies to a Delaware special purpose statutory trust (the “Trust”) in exchange for the proceeds from issuances of fixed and floating rate medium-term marketable notes issued by the Trust from time to time (the “Trust Notes”). The funding agreements have matching interest, maturity and currency payment terms to the applicable Trust Notes. The Company hedges the foreign currency exposure of foreign currency denominated funding agreements using cross currency swaps as discussed in Note 4 of the Notes to these Consolidated Financial Statements. As of September 30, 2022, the maximum aggregate principal amount of Trust Notes permitted to be outstanding at any one time is $10 billion. Funding agreements issued to the Trust, including any foreign currency transaction adjustments, are reported in policyholders’ account balances in the consolidated balance sheets. Foreign currency transaction adjustments to policyholder’s account balances are recognized in net income (loss) as an adjustment to interest credited to policyholders’ account balances and are offset in interest credited to policyholders’ account balances by a release of AOCI from deferred changes in fair value of designated and qualifying cross currency swap cash flow hedges. The table below summarizes Equitable Financial’s activity of funding agreements under the FABN program.
63

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

Change in FABN Funding Agreements during the Nine Months Ended September 30, 2022
Outstanding Balance at December 31, 2021Issued During the PeriodRepaid During the PeriodLong-term Agreements Maturing Within One YearLong-term Agreements Maturing Within Five YearsForeign Currency Transaction AdjustmentOutstanding Balance at September 30,
2022
(in millions)
Short-term funding agreements:
Due in one year or less$ $ $ $1,000 $ $ $1,000 
Long-term funding agreements:
Due in years two through five4,600   (1,000)500  4,100 
Due in more than five years2,119    (500)(79)1,540 
Total long-term funding agreements6,719   (1,000) (79)5,640 
Total funding agreements (1)$6,719 $ $ $ $ $(79)$6,640 
_____________
(1)The $28 million and $70 million difference between the funding agreements notional value shown and carrying value table as of September 30, 2022 and December 31, 2021, respectively, reflects the remaining amortization of the issuance cost of the funding agreements and the foreign currency transaction adjustment.
Holdings Revolving Credit Facility
In February 2018, Holdings entered into a $2.5 billion five-year senior unsecured revolving credit facility with a syndicate of banks. In June 2021, Holdings entered into an amended and restated revolving credit agreement, which lowered the facility amount to $1.5 billion and extended the maturity date to June 24, 2026, among other changes. The revolving credit facility has a sub-limit of $1.5 billion for the issuance of letters of credit to support the life insurance business reinsured by EQ AZ Life Re. As of September 30, 2022, the Company had $210 million undrawn letters of credit issued out of the $1.5 billion sub-limit for Equitable Financial as beneficiary.
Bilateral Letter of Credit Facilities
In February 2018, the Company entered into bilateral letter of credit facilities, each guaranteed by Holdings, with an aggregate principal amount of approximately $1.9 billion, with multiple counterparties. In June 2021, Holdings entered into amendments with each of the issuers of its bilateral letter of credit facilities to effect changes similar to those effected in the amended and restated revolving credit agreement. The respective facility limits of the bilateral letter of credit facilities remained unchanged. These facilities support the life insurance business reinsured by EQ AZ Life Re. The HSBC facility matures on February 16, 2024 and the rest of the facilities mature on February 16, 2026.
Guarantees and Other Commitments
The Company provides certain guarantees or commitments to affiliates and others. As of September 30, 2022, these arrangements include commitments by the Company to provide equity financing of $1.3 billion to certain limited partnerships and real estate joint ventures under certain conditions. Management believes the Company will not incur material losses as a result of these commitments.
The Company had $17 million of undrawn letters of credit related to reinsurance as of September 30, 2022. The Company had $880 million of commitments under existing mortgage loan agreements as of September 30, 2022.
The Company is the obligor under certain structured settlement agreements it had entered into with unaffiliated insurance companies and beneficiaries. To satisfy its obligations under these agreements, the Company owns single premium annuities issued by previously wholly-owned life insurance subsidiaries. The Company has directed payment under these annuities to be made directly to the beneficiaries under the structured settlement agreements. A contingent liability exists with respect to these agreements should the previously wholly-owned subsidiaries be unable to meet their obligations. Management believes the need for the Company to satisfy those obligations is remote.
13)    INSURANCE GROUP STATUTORY FINANCIAL INFORMATION
Prescribed and Permitted Accounting Practices
64

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

As of September 30, 2022, the following three prescribed and permitted practices resulted in net income (loss) and capital and surplus that is different from the statutory surplus that would have been reported had NAIC statutory accounting practices been applied.
Equitable Financial was granted a permitted practice by the NYDFS to apply SSAP 108, Derivatives Hedging Variable Annuity Guarantees on a retroactive basis from January 1, 2021 through June 30, 2021, after reflecting the impacts of our reinsurance transaction with Venerable. The permitted practice was amended to also permit Equitable Financial to adopt SSAP 108 prospectively as of July 1, 2021 and to consider the impact of both the interest rate derivatives and the general account assets used to fully hedge the interest rate risk inherent in its variable annuity guarantees when determining the amount of the deferred asset or liability under SSAP 108. Application of the permitted practice partially mitigates the New York Insurance Regulation 213 (“Reg 213”) impact of the Venerable Transaction on Equitable Financial’s statutory capital and surplus and enables Equitable Financial to more effectively neutralize the impact of interest rates on its statutory surplus and to better align with our economic hedging program. The impact of applying this permitted practice relative to SSAP 108 as written was an increase of approximately $128 million in statutory special surplus funds and a decrease of $332 million and $1.2 billion in statutory net income as of and for the three and nine months ended September 30, 2022, respectively, which will be amortized over five years for each of the retrospective and prospective components. The permitted practice also reset Equitable Financial’s unassigned surplus to zero as of June 30, 2021 to reflect the transformative nature of the Venerable Transaction.
The NAIC Accounting Practices and Procedures manual (“NAIC SAP”) has been adopted as a component of prescribed or permitted practices by the State of New York. However, Reg 213 adopted in May of 2019 and as amended in February 2020 and March 2021, differs from the NAIC variable annuity reserve and capital framework. Reg 213 requires Equitable Financial to carry statutory basis reserves for its variable annuity contract obligations equal to the greater of those required under (i) the NAIC standard or (ii) a revised version of the NYDFS requirement in effect prior to the adoption of the first amendment for contracts issued prior to January 1, 2020, and for policies issued after that date a new standard that in current market conditions imposes more conservative reserving requirements for variable annuity contracts than the NAIC standard.
The impact of the application of Reg 213 was a decrease of approximately $2.2 billion in statutory surplus as of September 30, 2022 compared to statutory surplus under the NAIC variable annuity framework. Our hedging program is designed to hedge the economics of our insurance liabilities and largely offsets Reg 213 and NAIC framework reserve movements due to interest rates and equities. The NYDFS allows domestic insurance companies a five year phase-in provision for Reg 213 reserves. As of September 30, 2022, Equitable Financial’s Reg 213 reserves are 100% phased-in. As of September 30, 2022, given the prevailing market conditions and business mix, there are no Reg 213 redundant reserves over the US RBC CTE 98 total asset requirement (“TAR”). Finally, the continued application of Reg 213 resulted in a corresponding increase of $0.8 billion and a decrease of $0.9 billion in statutory net income for the three and nine months ended September 30, 2022, which was largely offset by net income gains on our hedging program during the same period as noted.
During the fourth quarter 2020, Equitable Financial received approval from NYDFS for its proposed amended Plan of Operation for Separate Account No. 68 (“SA 68”) for our Structured Capital Strategies product and Separate Account No. 69 (“SA 69”) for our Equi-Vest product Structured Investment Option, to change the accounting basis of these two non-insulated Separate Accounts from fair value to book value in accordance with Section 1414 of the Insurance Law to align with how we manage and measure our overall general account asset portfolio. In order to facilitate this change and comply with Section 4240(a)(10), the Company also sought approval to amend the Plans to remove the requirement to comply with Section 4240(a)(5)(iii) and substitute it with a commitment to comply with Section 4240(a)(5)(i). Similarly, the Company updated the reserves section of each Plan to reflect the fact that Regulation 128 would no longer be applicable upon the change in accounting basis. We applied this change effective January 1, 2021. The impact of the application is an increase of approximately $2.3 billion in statutory surplus and an increase in statutory net income as of and for the three and nine months ended September 30, 2022 of $426 million and $2.4 billion, respectively.
65

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

14)    BUSINESS SEGMENT INFORMATION
The Company has four reportable segments: Individual Retirement, Group Retirement, Investment Management and Research and Protection Solutions.
These segments reflect the manner by which the Company’s chief operating decision maker views and manages the business. A brief description of these segments follows:
The Individual Retirement segment offers a diverse suite of variable annuity products which are primarily sold to affluent and high net worth individuals saving for retirement or seeking retirement income.
The Group Retirement segment offers tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities and not-for-profit entities, as well as small and medium-sized businesses.
The Investment Management and Research segment provides diversified investment management, research and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail and Private Wealth - and distributes its institutional research products and solutions through Bernstein Research Services.
The Protection Solutions segment includes our life insurance and group employee benefits businesses. Our life insurance business offers a variety of VUL, UL and term life products to help affluent and high net worth individuals, as well as small and medium-sized business owners, with their wealth protection, wealth transfer and corporate needs. Our group employee benefits business offers a suite of dental, vision, life, and short- and long-term disability and other insurance products to small and medium-size businesses across the United States.
Measurement
Operating earnings (loss) is the financial measure which primarily focuses on the Company’s segments’ results of operations as well as the underlying profitability of the Company’s core business. By excluding items that can be distortive and unpredictable such as investment gains (losses) and investment income (loss) from derivative instruments, the Company believes operating earnings (loss) by segment enhances the understanding of the Company’s underlying drivers of profitability and trends in the Company’s segments.
Operating earnings is calculated by adjusting each segment’s net income (loss) attributable to Holdings for the following items:
Items related to variable annuity product features, which include: (i) certain changes in the fair value of the derivatives and other securities we use to hedge these features; (ii) the effect of benefit ratio unlock adjustments, including extraordinary economic conditions or events such as COVID-19; (iii) changes in the fair value of the embedded derivatives reflected within variable annuity products’ net derivative results and the impact of these items on DAC amortization on our SCS product; and (iv) DAC amortization for the SCS variable annuity product arising from near-term fluctuations in index segment returns;
Investment (gains) losses, which includes credit loss impairments of securities/investments, sales or disposals of securities/investments, realized capital gains/losses and valuation allowances;
Net actuarial (gains) losses, which includes actuarial gains and losses as a result of differences between actual and expected experience on pension plan assets or projected benefit obligation during a given period related to pension, other postretirement benefit obligations, and the one-time impact of the settlement of the defined benefit obligation;
Other adjustments, which primarily include restructuring costs related to severance and separation, COVID-19 related impacts, net derivative gains (losses) on certain Non-GMxB derivatives, net investment income from certain items including consolidated VIE investments, seed capital mark-to-market adjustments, unrealized gain/losses associated with equity securities, certain legal accruals; and a bespoke deal to repurchase UL policies from one entity that had invested in numerous policies purchased in the life settlement market, which disposed of the risk of additional COI litigation by that entity related to those UL policies; and
Income tax expense (benefit) related to the above items and non-recurring tax items, which includes the effect of uncertain tax positions for a given audit period.
66

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

In the first quarter 2022, the Company updated its Operating earnings measure to exclude the DAC amortization impact of near-term fluctuations in indexed segment returns on the SCS variable annuity product to reflect the impact of market fluctuations consistently with the long term duration of the product. Operating earnings was favorably impacted by this change in the amount of $24 million and $94 million for the three and nine months ended September 30, 2022, respectively. The presentation of Operating earnings in prior periods was not revised to reflect this modification, however, the Company estimated that had the treatment in the Company’s Operating earnings measure of the Amortization of DAC for SCS been modified in 2020, the pre-tax impact on Operating earnings of excluding the SCS-related DAC amortization from Operating earnings would have been an increase of $7 million for the three months ended September 30, 2021, and a decrease of $7 million, $16 million and $34 million for the nine months ended September 30, 2021, and years ended December 31, 2021 and 2020, respectively.
The General Account investment portfolio is used to support the insurance and annuity liabilities of our Individual Retirement, Group Retirement and Protection Solutions businesses segments. In the first quarter 2022, the Company changed its methodology for allocating its General Account investment portfolio, which resulted in a change in the asset and net investment income allocation amongst the Company’s business segments. Following this change the segmentation of the general account investments is now more closely aligned with the liability characteristics of the product groups. Management determined that the change in the allocation methodology allows for improved flexibility and infuses an active asset liability management practice into the segmentation process. Additionally, the Company also changed its basis for allocating the spread earned from our FHLB investment borrowing and FABN programs. The spread earned from our FHLB investment borrowing and FABN programs includes the investment income on the assets less interest credited on the funding agreements. The net spread as reflected in net investment income is allocated to the segments based on the percentage of the individual segment insurance liabilities over the combined segments insurance liabilities.
This change in measurement only impacts our segment disclosures, and thus it has no impact on our overall consolidated financial statements. Historical segment operating income (loss), revenues and assets have not been recast in the tables as the impact was immaterial.
Revenues derived from any customer did not exceed 10% of revenues for the three and nine months ended September 30, 2022 and 2021.
The table below presents operating earnings (loss) by segment and Corporate and Other and a reconciliation to net income (loss) attributable to Holdings for the three and nine months ended September 30, 2022 and 2021, respectively:
 Three Months Ended September 30,Nine Months Ended September 30,
 2022202120222021
(in millions)
Net income (loss) attributable to Holdings$273 $672 $2,574 $(693)
Adjustments related to:
Variable annuity product features(114)172 (2,639)3,632 
Investment (gains) losses333 (164)890 (767)
Net actuarial (gains) losses related to pension and other postretirement benefit obligations19 27 57 87 
Other adjustments (1) (2) (3)39 141 407 672 
Income tax expense (benefit) related to above adjustments(59)(35)270 (761)
Non-recurring tax items7 13 
Non-GAAP Operating Earnings$498 $818 $1,572 $2,176 
Operating earnings (loss) by segment:
Individual Retirement$270 $316 $837 $1,093 
Group Retirement$134 $192 $415 $514 
Investment Management and Research$94 $134 $330 $381 
Protection Solutions$72 $160 $208 $264 
Corporate and Other (4)$(72)$16 $(218)$(76)
______________
67

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

(1)Includes separation costs of $25 million and $62 million for the three and nine months ended September 30, 2021, respectively. Separation costs were completed during 2021.
(2)Includes certain gross legal expenses related to the COI litigation of $2 million, $0 million, $168 million and $180 million for the three and nine months ended September 30, 2022 and 2021, respectively. Includes policyholder benefit costs of $0 million and $75 million for the three and nine months ended September 30, 2022 stemming from a deal to repurchase UL policies from one entity that had invested in numerous policies purchased in the life settlement market.
(3)Includes Non-GMxB related derivative hedge gains and losses of ($28) million, ($4) million, ($68) million and $140 million for the three and nine months ended September 30, 2022 and 2021, respectively.
(4)Includes interest expense and financing fees of $51 million, $65 million, $156 million and $180 million for the three and nine months ended September 30, 2022 and 2021, respectively.

Segment revenues is a measure of the Company’s revenue by segment as adjusted to exclude certain items. The following table reconciles segment revenues to total revenues by excluding the following items:
Items related to variable annuity product features, which include certain changes in the fair value of the derivatives and other securities we use to hedge these features and changes in the fair value of the embedded derivatives reflected within the net derivative results of variable annuity product features;
Investment (gains) losses, which includes credit loss impairments of securities/investments, sales or disposals of securities/investments, realized capital gains/losses and valuation allowances;
Other adjustments, which primarily includes net derivative gains (losses) on certain Non-GMxB derivatives and net investment income from certain items including consolidated VIE investments, seed capital mark-to-market adjustments and unrealized gain/losses associated with equity securities.
The table below presents segment revenues for the three and nine months ended September 30, 2022 and 2021.
 
Three Months Ended September 30,Nine Months Ended September 30,
 
2022202120222021
(in millions)
Segment revenues:
Individual Retirement (1)$1,017 $998 $3,061 $2,957 
Group Retirement (1)289 343 924 1,018 
Investment Management and Research (2)996 1,093 3,134 3,169 
Protection Solutions (1)791 838 2,478 2,496 
Corporate and Other (1)363 479 1,087 1,199 
Adjustments related to:
Variable annuity product features(107)(256)2,468 (3,750)
Investment gains (losses), net(333)164 (890)767 
Other adjustments to segment revenues(7)(44)(141)(138)
Total revenues$3,009 $3,615 $12,121 $7,718 
______________
(1)Includes investment expenses charged by AB of $33 million, $20 million, $77 million and $59 million for the three and nine months ended September 30, 2022 and 2021, respectively, for services provided to the Company.
(2)Inter-segment investment management and other fees of $41 million $32 million, $101 million and $94 million for the three and nine months ended September 30, 2022 and 2021, respectively, are included in segment revenues of the Investment Management and Research segment.

The table below presents total assets by segment as of September 30, 2022 and 2021:
68

Table of Contents
EQUITABLE HOLDINGS, INC.
Notes to Consolidated Financial Statements (Unaudited), Continued

 
September 30, 2022December 31, 2021
(in millions)
Total assets by segment:
Individual Retirement$119,883 $143,663 
Group Retirement38,908 55,368 
Investment Management and Research12,370 11,602 
Protection Solutions36,998 50,686 
Corporate and Other37,441 30,943 
Total assets$245,600 $292,262 

15)    EARNINGS PER COMMON SHARE
The following table presents a reconciliation of Net income (loss) and Weighted-average common shares used in calculating basic and diluted Earnings per common share for the periods indicated:
 
Three Months Ended September 30,Nine Months Ended September 30,
 
2022202120222021
(in millions)
Weighted-average common shares outstanding:
Weighted-average common shares outstanding basic
374.5 411.3 380.6 423.2 
Effect of dilutive potential common shares:
Employee share awards (1)2.3 3.3 2.3 — 
Weighted-average common shares outstanding — diluted (2)
376.8 414.6 382.9 423.2 
Net income (loss):
Net income (loss)$327 $765 $2,739 $(412)
Less: Net income (loss) attributable to the noncontrolling interest54 93 165 281 
Net income (loss) attributable to Holdings273 672 2,574 (693)
Less: Preferred stock dividends14 14 54 53 
Net income (loss) available to Holdings’ common shareholders$259 $658 $2,520 $(746)
Earnings per common share:
Basic$0.69 $1.60 $6.62 $(1.76)
Diluted$0.69 $1.59 $6.58 $(1.76)
_____________
(1)Calculated using the treasury stock method.
(2)Due to net loss for the nine months ended September 30, 2021 approximately 3.7 million share awards were excluded from the diluted EPS calculation.
For the three and nine months ended September 30, 2022 and 2021, 2.9 million, 4.5 million, 3.5 million and 8.3 million of outstanding stock awards, respectively, were not included in the computation of diluted earnings per share because their effect was anti-dilutive.
16)     SUBSEQUENT EVENTS
EQUI-VEST Reinsurance Transaction

69

Table of Contents
On October 3, 2022, Equitable Financial completed the transactions (the “EQUI-VEST Transaction”) contemplated by the previously announced Master Transaction Agreement, dated August 16, 2022, by and between Equitable Financial and First Allmerica Financial Life Insurance Company, a Massachusetts-domiciled insurance company (the “Reinsurer”), a wholly owned subsidiary of Global Atlantic Financial Group.
At the closing of the EQUI-VEST Transaction, Equitable Financial and the Reinsurer entered into a Coinsurance and Modified Coinsurance Agreement (the “EQUI-VEST Reinsurance Agreement”), pursuant to which Equitable Financial ceded to the Reinsurer, on a combined coinsurance and modified coinsurance basis, a 50% quota share of approximately 360,000 legacy Group EQUI-VEST deferred variable annuity contracts issued by Equitable Financial between 1980 and 2008, which predominately include Equitable Financial’s highest guaranteed general account crediting rates of 3%, supported by general account assets of approximately $4 billion and $5 billion of separate account value (the “Reinsured Contracts”).
70

Table of Contents
Item 2.     Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in its entirety and in conjunction with the consolidated financial statements and related notes contained in Part I, Item 1 of this Quarterly Report on Form 10-Q, as well as “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section contained in our Annual Report on Form 10-K for the year ended December 31, 2021 (“2021 Form 10-K”).
In addition to historical data, this discussion contains forward-looking statements about our business, operations and financial performance based on current expectations that involve risks, uncertainties and assumptions. Actual results may differ materially from those discussed in the forward-looking statements as a result of various factors. See the Note Regarding Forward-Looking Statements and Information. Investors are directed to consider the risks and uncertainties discussed in Part II, Item 1A of this Quarterly Report on Form 10-Q, as well as in other documents we have filed with the SEC.
Executive Summary
Overview
We are one of America’s leading financial services companies, providing: (i) advice and solutions for helping Americans set and meet their retirement goals and protect and transfer their wealth across generations; and (ii) a wide range of investment management insights, expertise and innovations to drive better investment decisions and outcomes for clients worldwide.
We manage our business through four segments: Individual Retirement, Group Retirement, Investment Management and Research, and Protection Solutions. We report certain activities and items that are not included in these segments in Corporate and Other. See Note 14 of the Notes to the Consolidated Financial Statements for further information on our segments.
We benefit from our complementary mix of businesses. This business mix provides diversity in our earnings sources, which helps offset fluctuations in market conditions and variability in business results, while offering growth opportunities.
EQUI-VEST Reinsurance Transaction
On October 3, 2022, Equitable Financial completed the transactions (the “EQUI-VEST Transaction”) contemplated by the previously announced Master Transaction Agreement, dated August 16, 2022, by and between Equitable Financial and First Allmerica Financial Life Insurance Company, a Massachusetts-domiciled insurance company (the “Reinsurer”), a wholly owned subsidiary of Global Atlantic Financial Group.
At the closing of the EQUI-VEST Transaction, Equitable Financial and the Reinsurer entered into a Coinsurance and Modified Coinsurance Agreement (the “EQUI-VEST Reinsurance Agreement”), pursuant to which Equitable Financial ceded to the Reinsurer, on a combined coinsurance and modified coinsurance basis, a 50% quota share of approximately 360,000 legacy Group EQUI-VEST deferred variable annuity contracts issued by Equitable Financial between 1980 and 2008 supported by general account assets of approximately $4 billion and $5 billion of separate account value (the “Reinsured Contracts”). The Reinsured Contracts predominately include certain of Equitable Financial’s contracts that offer the highest guaranteed general account crediting rates of 3%. At the closing of the EQUI-VEST Transaction, Reinsurer deposited assets supporting the general account liabilities relating to the Reinsured Contracts into a trust account for the benefit of Equitable Financial, which assets will secure its obligations to Equitable Financial under the EQUI-VEST Reinsurance Agreement. Equitable Financial reinsured the separate accounts relating to the Reinsured Contracts on a modified coinsurance basis. Commonwealth Annuity and Life Insurance Company, an insurance company domiciled in the Commonwealth of Massachusetts and affiliate of Reinsurer (“Commonwealth”), provided a guarantee of Reinsurer’s payment obligation to Equitable Financial under the EQUI-VEST Reinsurance Agreement. In addition, the investment of assets in the trust account is subject to investment guidelines, and the EQUI-VEST Reinsurance Agreement requires enhanced funding upon certain capital adequacy related triggers. The EQUI-VEST Reinsurance Agreement also contains additional counterparty risk management and mitigation provisions. At the closing of the EQUI-VEST Transaction, ABLP entered into an investment advisory agreement with Reinsurer pursuant to which ABLP will serve as the preferred investment manager of certain general account assets transferred to the trust account. Equitable Financial will continue to administer the Reinsured Contracts.
Revenues
Our revenues come from three principal sources:
71

Table of Contents
fee income derived from our retirement and protection products and our investment management and research services;
premiums from our traditional life insurance and annuity products; and
investment income from our General Account investment portfolio.
Our fee income varies directly in relation to the amount of the underlying AV or benefit base of our retirement and protection products and the amount of AUM of our Investment Management and Research business. AV and AUM, each as defined in “Key Operating Measures,” are influenced by changes in economic conditions, primarily equity market returns, as well as net flows. Our premium income is driven by the growth in new policies written and the persistency of our in-force policies, both of which are influenced by a combination of factors, including our efforts to attract and retain customers and market conditions that influence demand for our products. Our investment income is driven by the yield on our General Account investment portfolio and is impacted by the prevailing level of interest rates as we reinvest cash associated with maturing investments and net flows to the portfolio.
Benefits and Other Deductions
Our primary expenses are:
•    policyholders’ benefits and interest credited to policyholders’ account balances;
•    sales commissions and compensation paid to intermediaries and advisors that distribute our products and services; and
•    compensation and benefits provided to our employees and other operating expenses.
Policyholders’ benefits are driven primarily by mortality, customer withdrawals, and benefits which change in response to changes in capital market conditions. In addition, some of our policyholders’ benefits are directly tied to the AV and benefit base of our variable annuity products. Interest credited to policyholders varies in relation to the amount of the underlying AV or benefit base. Sales commissions and compensation paid to intermediaries and advisors vary in relation to premium and fee income generated from these sources, whereas compensation and benefits to our employees are more constant and impacted by market wages and decline with increases in efficiency. Our ability to manage these expenses across various economic cycles and products is critical to the profitability of our company.
Net Income Volatility
We have offered and continue to offer variable annuity products with GMxB features. The future claims exposure on these features is sensitive to movements in the equity markets and interest rates. Accordingly, we have implemented hedging and reinsurance programs designed to mitigate the economic exposure to us from these features due to equity market and interest rate movements. Changes in the values of the derivatives associated with these programs due to equity market and interest rate movements are recognized in the periods in which they occur while corresponding changes in offsetting liabilities not measured at fair value are recognized over time. This results in net income volatility as further described below. See “—Significant Factors Impacting Our Results—Impact of Hedging and GMxB Reinsurance on Results.”
In addition to our dynamic hedging strategy, we have static hedge positions designed to mitigate the adverse impact of changing market conditions on our statutory capital. We believe this program will continue to preserve the economic value of our variable annuity contracts and better protect our target variable annuity asset level. However, these static hedge positions increase the size of our derivative positions and may result in higher net income volatility on a period-over-period basis.
Due to the impacts on our net income of equity market and interest rate movements and other items that are not part of the underlying profitability drivers of our business, we evaluate and manage our business performance using Non-GAAP Operating Earnings, a non-GAAP financial measure that is intended to remove these impacts from our results. See “—Key Operating Measures—Non-GAAP Operating Earnings. ”
COVID-19 Impact
COVID-19 continues to evolve. We continue to closely monitor COVID-19 developments and the impact on our business, operations and investment portfolio. Any future impact of COVID-19 depends on many unknown factors and is highly uncertain, including as to the emergence and spread of COVID-19 variants, the availability, adoption and efficacy of COVID-19 treatments and vaccines, and future actions taken by governmental authorities, central banks and other parties in
72

Table of Contents
response to COVID-19. Further, as COVID-19 has not yet subsided, it is not possible to predict or estimate the longer-term effects of COVID-19 on the broad economy or on our business, results of operations and financial condition, including the impact on our investment portfolio and the possible need for us revisit or revise targets and/or aspects of our business model previously provided to the markets. For additional information regarding the actual and potential impacts of COVID-19 and action we have taken to mitigate certain impacts, see “Risk Factors—Risks Relating to Conditions in the Financial Markets and Economy—The coronavirus (COVID-19) pandemic”, “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Summary—COVID-19 Impact” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations—General Account Investment Portfolio” in the 2021 Form 10-K.
Significant Factors Impacting Our Results
The following significant factors have impacted, and may in the future impact, our financial condition, results of operations or cash flows.
Impact of Hedging and GMxB Reinsurance on Results
We have offered and continue to offer variable annuity products with GMxB features. The future claims exposure on these features is sensitive to movements in the equity markets and interest rates. Accordingly, we have implemented hedging and reinsurance programs designed to mitigate the economic exposure to us from these features due to equity market and interest rate movements. These programs include:
Variable annuity hedging programs. We use a dynamic hedging program (within this program, generally, we reevaluate our economic exposure at least daily and rebalance our hedge positions accordingly) to mitigate certain risks associated with the GMxB features that are embedded in our liabilities for our variable annuity products. This program utilizes various derivative instruments that are managed in an effort to reduce the economic impact of unfavorable changes in GMxB features’ exposures attributable to movements in the equity markets and interest rates. Although this program is designed to provide a measure of economic protection against the impact of adverse market conditions, it does not qualify for hedge accounting treatment. Accordingly, changes in value of the derivatives will be recognized in the period in which they occur with offsetting changes in reserves partially recognized in the current period, resulting in net income volatility. In addition to our dynamic hedging program, we have a hedging program using static hedge positions (derivative positions intended to be HTM with less frequent re-balancing) to protect our statutory capital against stress scenarios. This program in addition to our dynamic hedge program has increased the size of our derivative positions, resulting in an increase in net income volatility. The impacts are most pronounced for variable annuity products in our Individual Retirement segment.
GMxB reinsurance contracts. Historically, GMIB reinsurance contracts were used to cede to non-affiliated reinsurers a portion of our exposure to variable annuity products that offer a GMIB feature. We account for the GMIB reinsurance contracts as derivatives and report them at fair value. Gross GMIB reserves are calculated on the basis of assumptions related to projected benefits and related contract charges over the lives of the contracts. Accordingly, our gross reserves will not immediately reflect the offsetting impact on future claims exposure resulting from the same capital market or interest rate fluctuations that cause gains or losses on the fair value of the GMIB reinsurance contracts. Because changes in the fair value of the GMIB reinsurance contracts are recorded in the period in which they occur and a majority of the changes in gross reserves for GMIB are recognized over time, net income will be more volatile. In addition, on June 1, 2021, we ceded legacy variable annuity policies sold by Equitable Financial between 2006-2008 (the “Block”), comprised of non-New York “Accumulator” policies containing fixed rate GMIB and/or GMDB guarantees. As this contract provides full risk transfer and thus has the same risk attributes as the underlying direct contracts, the benefits of this treaty are accounted for in the same manner as the underlying gross reserves.
Effect of Assumption Updates on Operating Results
During the third quarter of each year, we conduct our annual review of the assumptions underlying the valuation of DAC, deferred sales inducement assets, unearned revenue liabilities, liabilities for future policyholder benefits and embedded derivatives for our Individual Retirement, Group Retirement, and Protection Solution segments (assumption reviews are not relevant for the Investment Management and Research segment). Assumptions are based on a combination of Company experience, industry experience, management actions and expert judgment and reflect our best estimate as of the date of the applicable financial statements.
Most of the variable annuity products, variable universal life insurance and universal life insurance products we offer maintain policyholder deposits that are reported as liabilities and classified within either Separate Accounts liabilities or policyholder account balances. Our products and riders also impact liabilities for future policyholder benefits and unearned
73

Table of Contents
revenues and assets for DAC and DSI. The valuation of these assets and liabilities (other than deposits) is based on differing accounting methods depending on the product, each of which requires numerous assumptions and considerable judgment. The accounting guidance applied in the valuation of these assets and liabilities includes, but is not limited to, the following: (i) traditional life insurance products for which assumptions are locked in at inception; (ii) universal life insurance and variable life insurance secondary guarantees for which benefit liabilities are determined by estimating the expected value of death benefits payable when the account balance is projected to be zero and recognizing those benefits ratably over the accumulation period based on total expected assessments; (iii) certain product guarantees for which benefit liabilities are accrued over the life of the contract in proportion to actual and future expected policy assessments; and (iv) certain product guarantees reported as embedded derivatives at fair value.
For further details of our accounting policies and related judgments pertaining to assumption updates, see Note 2 of the Notes to the Consolidated Financial Statements and “—Summary of Critical Accounting Estimates—Liability for Future Policy Benefits” included in the 2021 Form 10-K.
Assumption Updates
We conduct our annual review of our assumptions during the third quarter of each year. We also update our assumptions as needed in the event we become aware of economic conditions or events that could require a change in our assumptions that we believe may have a significant impact to the carrying value of product liabilities and assets and consequently materially impact our earnings in the period of the change.
Impact of Assumption Updates on Income from Continuing Operations before income taxes and Net income (loss)
The table below presents the impact of our actuarial assumption update during the three months ended September 30, 2022 and 2021 to our income (loss) from continuing operations, before income taxes and net income (loss).
Three Months Ended September 30, (1)
20222021
(in millions)
Impact of assumption update on Net income (loss):
Variable annuity product features related assumption update
$175 $(91)
Assumption updates for other business
7 (17)
Impact of assumption updates on Income (loss) from continuing operations, before income tax182 (108)
Income tax benefit on assumption update(38)23 
Net income (loss) impact of assumption update
$144 $(85)
_____________
(1)The amounts for the three months and the nine months ended September 30 of each year represented the same amounts.
2022 Assumption Updates
The impact of the assumption update in the third quarter 2022 was an increase of $182 million to income (loss) from continuing operations, before income taxes and an increase to net income (loss) of $144 million.
The net impact of this assumption update on income (loss) from continuing operations, before income taxes of $182 million consisted of a decrease in policy charges and fee income of $23 million, a decrease in policyholders’ benefits of $243 million, an increase in interest credited to policyholder account balances of $1 million, an increase in net derivative losses of $80 million and a decrease in the amortization of DAC of $43 million.
2021 Assumption Updates
The impact of the economic assumption update in the third quarter 2021 was a decrease of $108 million to income (loss) from continuing operations, before income taxes and a decrease to net income (loss) of $85 million. As part of this annual update the reference interest rate utilized in our GAAP fair value calculations was updated from the LIBOR swap curve to the US Treasury curve to the US Treasury curve due to the impending cessation of LIBOR and our GAAP fair value liability risk margins were increased, resulting in little impact to overall valuation as our view regarding market participant pricing of our guarantees has not changed at this time.
74

Table of Contents
The net impact of this assumption update on income (loss) from operations, before income taxes of $108 million consisted of a decrease in policy charges and fee income of $28 million, a decrease in policyholders’ benefits of $62 million, an increase in net derivative gains (losses) of $200 million and a decrease in amortization of DAC of $58 million.
Impact of Assumption Updates on Pre-tax Non-GAAP Operating Earnings
The table below presents the impact on pre-tax Non-GAAP Operating Earnings of our actuarial assumption updates during the three months ended September 30, 2022 and 2021 by segment and Corporate and Other.
Three Months Ended September 30, (1)
20222021
(in million)
Impact of assumption updates by segment:
Individual Retirement$(13)$(47)
Group Retirement34 35 
Protection Solutions7 20 
Impact of assumption updates on Corporate and Other — 
Total impact on pre-tax Non-GAAP Operating Earnings$28 $
______________
(1)The amounts for the three months and the nine months ended September 30 of each year represented the same amounts.
2022 Assumption Updates
The impact of our 2022 annual review on Non-GAAP Operating Earnings was favorable by $28 million before taking into consideration the tax impacts or $22 million after tax. For Individual Retirement segment, the impacts primarily reflect updated mortality on our older payout business. For Group Retirement segment, the impacts reflect updated economic assumptions. The annual update for Protection Solutions segment reflects favorable economic conditions and surrenders primarily on the VUL line. This, in turn, creates future profits and lowers the accrual on our PFBL reserve.
The net impact of assumption changes on Non-GAAP Operating Earnings in the third quarter 2022 decreased policy charges and fee income by $23 million, decreased policyholders’ benefits by $9 million, increased interest credited to policyholder account balances by $1 million and decreased amortization of DAC by $43 million. Non-GAAP Operating Earnings excludes items related to Variable annuity product features, such as changes in the fair value of the embedded derivatives associated with the GMIBNLG liability and the effect of benefit ratio unlock adjustments.
2021 Assumption Updates
The impact of our 2021 annual review on Non-GAAP Operating Earnings was favorable by $8 million before taking into consideration the tax impacts or $6 million after tax. For the Individual Retirement segment, the impacts primarily reflect updated mortality on our older payout business. For Group Retirement segment, the impacts reflect updated economic assumptions. The annual update for Protection Solutions segment reflects favorable economic conditions and surrenders primarily on the VUL line. This, in turn, creates future profits and lowers the accrual on our PFBL reserve.
The net impact of assumption changes on Non-GAAP Operating Earnings in the third quarter 2021 decreased Policy charges and fee income by $28 million, increased Policyholders’ benefits by $22 million and decreased Amortization of DAC by $58 million. Non-GAAP Operating Earnings excludes items related to Variable annuity product features, such as changes in the fair value of the embedded derivatives associated with the GMIBNLG liability and the effect of benefit ratio unlock adjustments.
Macroeconomic and Industry Trends
Our business and consolidated results of operations are significantly affected by economic conditions and consumer confidence, conditions in the global capital markets and the interest rate environment.
Financial and Economic Environment
A wide variety of factors continue to impact financial and economic conditions. These factors include, among others, increased volatility in the capital markets, equity market declines, rising interest rates, inflationary pressures, plateauing or decreasing economic growth, high fuel and energy costs, changes in fiscal or monetary policy and geopolitical tensions. The
75

Table of Contents
invasion of Ukraine by Russia and the sanctions and other measures imposed in response to this conflict significantly increased the level of volatility in the financial markets and have increased the level of economic and political uncertainty.
Stressed conditions, volatility and disruptions in the capital markets, particular markets, or financial asset classes can have an adverse effect on us, in part because we have a large investment portfolio. In addition, our insurance liabilities and derivatives are sensitive to changing market factors, including equity market performance and interest rates. During the third quarter 2022, equity markets continued their decline, while interest rates continued to rise, and are anticipated to continue to rise throughout the year based on statements of members of the Board of Governors of the Federal Reserve System. An increase in market volatility could continue to affect our business, including through effects on the yields we earn on invested assets, changes in required reserves and capital and fluctuations in the value of our AUM, AV or AUA from which we derive our fee income. These effects could be exacerbated by uncertainty about future fiscal policy, changes in tax policy, the scope of potential deregulation and levels of global trade.
The potential for increased volatility, coupled with prevailing interest rates remaining below historical averages despite recent increases, could pressure sales and reduce demand for our products as consumers consider purchasing alternative products to meet their objectives. In addition, this environment could make it difficult to consistently develop products that are attractive to customers. Financial performance can be adversely affected by market volatility and equity market declines as fees driven by AV and AUM fluctuate, hedging costs increase and revenues decline due to reduced sales and increased outflows.
We monitor the behavior of our customers and other factors, including mortality rates, morbidity rates, annuitization rates and lapse and surrender rates, which change in response to changes in capital market conditions, to ensure that our products and solutions remain attractive and profitable. For additional information on our sensitivity to interest rates and capital market prices, see “Quantitative and Qualitative Disclosures About Market Risk.”
Interest Rate Environment
We believe the interest rate environment will continue to impact our business and financial performance in the future for several reasons, including the following:
Certain of our variable annuity and life insurance products pay guaranteed minimum interest crediting rates. We are required to pay these guaranteed minimum rates even if earnings on our investment portfolio decline, with the resulting investment margin compression negatively impacting earnings. In addition, we expect more policyholders to hold policies with comparatively high guaranteed rates longer (lower lapse rates) in a low interest rate environment. Conversely, a rise in average yield on our investment portfolio should positively impact earnings. Similarly, we expect policyholders would be less likely to hold policies with existing guaranteed rates (higher lapse rates) as interest rates rise.
A prolonged low interest rate environment also may subject us to increased hedging costs or an increase in the amount of statutory reserves that our insurance subsidiaries are required to hold for GMxB features, lowering their statutory surplus, which would adversely affect their ability to pay dividends to us. In addition, it may also increase the perceived value of GMxB features to our policyholders, which in turn may lead to a higher rate of annuitization and higher persistency of those products over time. Finally, low interest rates may continue to cause an acceleration of DAC amortization or reserve increase due to loss recognition for interest sensitive products, primarily for our Protection Solutions segment.
For a discussion on derivatives we used to hedge interest rates, see Note 4 of the Notes to the Consolidated Financial Statements in this Form 10-Q.
Regulatory Developments
Our life insurance subsidiaries are regulated primarily at the state level, with some policies and products also subject to federal regulation. In addition, Holdings and its insurance subsidiaries are subject to regulation under the insurance holding company laws of various U.S. jurisdictions. Furthermore, on an ongoing basis, regulators refine capital requirements and introduce new reserving standards. Regulations recently adopted or currently under review can potentially impact our statutory reserve, capital requirements and profitability of the industry and result in increased regulation and oversight for the industry. For additional information on regulatory developments and the risks we face, see “Business—Regulation” and “Risk Factors—Legal and Regulatory Risks.” in the 2021 Form 10-K.
76

Table of Contents
Inflation Reduction Act. On August 16, 2022, President Biden signed the Inflation Reduction Act into law which introduces a 15% minimum tax based on financial statement income as well as a 1% excise tax on share buybacks, effective for tax years beginning in 2023. While neither the minimum tax nor the excise tax on share buybacks are currently expected to have a significant impact on the Company, we continue to monitor developments and regulations associated with the Inflation Reduction Act for any potential future impacts on our business, results of operations and financial condition.
Climate Risks. In March 2022, the SEC released proposed rule changes on climate-related disclosure. The proposed rule changes would require companies to include certain climate-related disclosures including information about climate-related risks that have had or reasonably likely to have a material impact on their business, results of operations, or financial condition, and certain climate-related financial statement metrics in a note to the audited financial statements. Among other things, the required information about climate-related risks also would include disclosure of a company’s greenhouse gas emissions, information about climate-related targets and goals, and if a transition plan, has been adopted as part of climate-related risk management strategy, and requires extensive attestation requirements. If adopted as proposed, the rule changes are expected to result in additional compliance and reporting costs.
Privacy and Security of Customer Information and Cybersecurity Regulation. In March 2022, the SEC released proposed rules enhancing cybersecurity risk and management disclosure requirements for companies. If enacted, the proposed rules would, among other things, require disclosure of any material cybersecurity incident on its Form 8-K within four business days of determining that the incident it has experienced is material. They would also require periodic disclosures of, among other things, (i) details on the company’s cybersecurity policies and procedures, (ii) cybersecurity governance, oversight policies and risk management policies, including the board of directors’ oversight of cybersecurity risks, (iii) the relevant expertise of members of the board of directors with respect to cybersecurity issues and (iv) details of any cybersecurity incident that was previously disclosed on Form 8-K, as well as any undisclosed incidents that were non-material, but have become material in the aggregate.
In July 2022, the NYDFS proposed amendments to the New York Cybersecurity Requirements for Financial Services Companies promulgated by the NYDFS in March 2017. The amendments, if adopted, would require new reporting, governance and oversight measures be implemented, enhance certain cybersecurity safeguards (e.g., annual audits, vulnerability assessments, and password controls and monitoring), and mandate notifications in the event that a covered entity makes a cyber-ransom payment. The pre-proposal comment period on these draft amendments ended in August 2022, and an additional comment period is expected in the future.
Fiduciary Rules / “Best Interest” Standards of Conduct. The NYDFS’ amendments to Regulation 187 - Suitability and Best Interests in Life Insurance and Annuity Transactions (“Regulation 187”) incorporate the “best interest” standard for annuity transactions and they expand the scope of the regulation to include sales of life insurance policies to consumers. In April 2021, the Appellate Division of the New York Supreme Court overturned Regulation 187 for being unconstitutionally vague, although the New York State Court of Appeals reversed this ruling on October 20, 2022. We cannot predict whether any rules or rule amendments will be adopted by either the SEC or NYDFS, what form any such final rules may take, or what effect adoption of such rules or amendments would have on our business or compliance costs.
Productivity Strategies
Retirement and Protection Businesses
As part of our continuing efforts to drive productivity improvements, in January 2021, we began a new program expected to achieve $80 million of targeted run-rate expense savings by 2023, of which $43 million has been achieved as of September 30, 2022. We expect to achieve these savings by shifting our workforce into an agile working model, leveraging technology-enabled capabilities, optimizing our real estate footprint, and continuing to realize a portion of COVID-19 related savings.
77

Table of Contents
Key Operating Measures
In addition to our results presented in accordance with U.S. GAAP, we report Non-GAAP Operating Earnings, Non-GAAP Operating ROE, and Non-GAAP operating common EPS, each of which is a measure that is not determined in accordance with U.S. GAAP. Management principally uses these non-GAAP financial measures in evaluating performance because they present a clearer picture of our operating performance and they allow management to allocate resources. Similarly, management believes that the use of these Non-GAAP financial measures, together with relevant U.S. GAAP measures, provide investors with a better understanding of our results of operations and the underlying profitability drivers and trends of our business. These non-GAAP financial measures are intended to remove from our results of operations the impact of market changes (where there is mismatch in the valuation of assets and liabilities) as well as certain other expenses which are not part of our underlying profitability drivers or likely to re-occur in the foreseeable future, as such items fluctuate from period-to-period in a manner inconsistent with these drivers. These measures should be considered supplementary to our results that are presented in accordance with U.S. GAAP and should not be viewed as a substitute for the U.S. GAAP measures. Other companies may use similarly titled non-GAAP financial measures that are calculated differently from the way we calculate such measures. Consequently, our non-GAAP financial measures may not be comparable to similar measures used by other companies.
We also discuss certain operating measures, including AUM, AUA, AV, Protection Solutions Reserves and certain other operating measures, which management believes provide useful information about our businesses and the operational factors underlying our financial performance.
Non-GAAP Operating Earnings
Non-GAAP Operating Earnings is an after-tax non-GAAP financial measure used to evaluate our financial performance on a consolidated basis that is determined by making certain adjustments to our consolidated after-tax net income attributable to Holdings. The most significant of such adjustments relates to our derivative positions, which protect economic value and statutory capital, and are more sensitive to changes in market conditions than the variable annuity product liabilities as valued under U.S. GAAP. This is a large source of volatility in net income.
Non-GAAP Operating Earnings equals our consolidated after-tax net income attributable to Holdings adjusted to eliminate the impact of the following items:
Items related to variable annuity product features, which include: (i) certain changes in the fair value of the derivatives and other securities we use to hedge these features; (ii) the effect of benefit ratio unlock adjustments, including extraordinary economic conditions or events such as COVID-19; (iii) changes in the fair value of the embedded derivatives reflected within variable annuity products’ net derivative results and the impact of these items on DAC amortization on our SCS product; and (iv) DAC amortization for the SCS variable annuity product arising from near-term fluctuations in index segment returns;
Investment (gains) losses, which includes credit loss impairments of securities/investments, sales or disposals of securities/investments, realized capital gains/losses and valuation allowances;
Net actuarial (gains) losses, which includes actuarial gains and losses as a result of differences between actual and expected experience on pension plan assets or projected benefit obligation during a given period related to pension, other postretirement benefit obligations, and the one-time impact of the settlement of the defined benefit obligation;
Other adjustments, which primarily include restructuring costs related to severance and separation, COVID-19 related impacts, net derivative gains (losses) on certain Non-GMxB derivatives, net investment income from certain items including consolidated VIE investments, seed capital mark-to-market adjustments, unrealized gain/losses associated with equity securities, certain legal accruals; and a bespoke deal to repurchase UL policies from one entity that had invested in numerous policies purchased in the life settlement market, which disposed of the risk of additional COI litigation by that entity related to those UL policies; and
Income tax expense (benefit) related to the above items and non-recurring tax items, which includes the effect of uncertain tax positions for a given audit period.
In the first quarter 2022, the Company updated its Non-GAAP Operating Earnings measure to exclude the DAC amortization impact of near-term fluctuations in indexed segment returns on the SCS variable annuity product to reflect the impact of market fluctuations consistently with the long term duration of the product. For the three and nine months ended September 30, 2022, Non-GAAP Operating Earnings was favorably impacted by this change in the amount of $24 million and $94 million for the three and nine months ended September 30, 2022, respectively. The presentation of Non-GAAP Operating Earnings in prior periods was not revised to reflect this modification, however, the Company estimated that had the treatment in
78

Table of Contents
the Company’s Non-GAAP Operating Earnings measure of the Amortization of DAC for SCS been modified in 2020, the pre-tax impact on Non-GAAP Operating Earnings of excluding the SCS-related DAC amortization from Non-GAAP Operating Earnings would have been an increase of $7 million for the three months ended September 30, 2021, and a decrease of $7 million, $16 million and $34 million for the nine months ended September 30, 2021, and years ended December 31, 2021 and 2020, respectively.
Because Non-GAAP Operating Earnings excludes the foregoing items that can be distortive or unpredictable, management believes that this measure enhances the understanding of the Company’s underlying drivers of profitability and trends in our business, thereby allowing management to make decisions that will positively impact our business.
We use the prevailing corporate federal income tax rate of 21% while taking into account any non-recurring differences for events recognized differently in our financial statements and federal income tax returns as well as partnership income taxed at lower rates when reconciling Net income (loss) attributable to Holdings to Non-GAAP Operating Earnings.
The table below presents a reconciliation of net income (loss) attributable to Holdings to Non-GAAP Operating Earnings for the three and nine months ended September 30, 2022 and 2021:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Net income (loss) attributable to Holdings$273 $672 $2,574 $(693)
Adjustments related to:
Variable annuity product features(114)172 (2,639)3,632 
Investment (gains) losses333 (164)890 (767)
Net actuarial (gains) losses related to pension and other postretirement benefit obligations19 27 57 87 
Other adjustments (1) (2) (3)39 141 407 672 
Income tax expense (benefit) related to above adjustments(59)(35)270 (761)
Non-recurring tax items7 13 
Non-GAAP Operating Earnings$498 $818 $1,572 $2,176 
______________
(1)Includes Separation Costs of $25 million and $62 million for the three months and nine months ended September 30, 2021, respectively. Separation costs were completed during 2021.
(2)Includes certain gross legal expenses related to the cost of insurance litigation of $2 million and $0 million, $168 million and $180 million for the three and nine months ended September 30, 2022 and 2021, respectively. Includes policyholder benefit costs of $0 million and $75 million for the three and nine months ended September 30, 2022 stemming from a deal to repurchase UL policies from one entity that had invested in numerous policies purchased in the life settlement market.
(3)Includes Non-GMxB related derivative hedge losses of ($28) million, ($4) million, ($68) million and $140 million for the three and nine months ended September 30, 2022 and 2021, respectively.

Non-GAAP Operating ROE
We calculate Non-GAAP Operating ROE by dividing Non-GAAP Operating Earnings for the previous twelve calendar months by consolidated average equity attributable to Holdings’ common shareholders, excluding AOCI. AOCI fluctuates period-to-period in a manner inconsistent with our underlying profitability drivers as the majority of such fluctuation is related to the market volatility of the unrealized gains and losses associated with our AFS securities. Therefore, we believe excluding AOCI is more effective for analyzing the trends of our operations.
The following table presents return on average equity attributable to Holdings’ common shareholders, excluding AOCI and Non-GAAP Operating ROE for the trailing twelve months ended September 30, 2022.
Trailing Twelve Months Ended September 30, 2022
(in millions)
Net income (loss) available to Holdings’ common shareholders$2,748 
Average equity attributable to Holdings’ common shareholders, excluding AOCI$8,844 
79

Table of Contents
Trailing Twelve Months Ended September 30, 2022
(in millions)
Return on average equity attributable to Holdings’ common shareholders, excluding AOCI31.1 %
Non-GAAP Operating Earnings available to Holdings’ common shareholders$2,141 
Average equity attributable to Holdings’ common shareholders, excluding AOCI$8,844 
Non-GAAP Operating ROE24.2 %
Non-GAAP Operating Common EPS
Non-GAAP operating common EPS is calculated by dividing Non-GAAP Operating Earnings by diluted common shares outstanding. The following table sets forth Non-GAAP operating common EPS for the three and nine months ended September 30, 2022 and 2021.
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(per share amounts)
Net income (loss) attributable to Holdings (1)$0.72 $1.62 $6.72 $(1.64)
Less: Preferred stock dividends0.03 0.03 0.14 0.12 
Net income (loss) available to Holdings’ common shareholders0.69 1.59 6.58 (1.76)
Adjustments related to:
Variable annuity product features (0.31)0.41 (6.89)8.58 
Investment (gains) losses0.87 (0.41)2.32 (1.81)
Net actuarial (gains) losses related to pension and other postretirement benefit obligations0.05 0.07 0.15 0.21 
Other adjustments (2) (3) (4)0.12 0.35 1.06 1.59 
Income tax expense (benefit) related to above adjustments(0.16)(0.08)0.71 (1.80)
Non-recurring tax items0.02 0.01 0.03 0.01 
Non-GAAP operating common EPS$1.28 $1.94 $3.96 $5.02 
______________
(1)For periods presented with a net loss, basic shares are used for EPS .
(2)Includes separation costs of $0.06 and $0.15 for the three months and nine months ended September 30, 2021, respectively.
(3)Includes certain gross legal expenses related to the cost of insurance litigation of $0.01, $0.00, $0.44 and $0.43 for the three and nine months ended September 30, 2022 and2021, respectively. Includes policyholder benefit costs of $0.00 and $0.20 for the three and nine months ended September 30, 2022 stemming from a deal to repurchase UL policies from one entity that had invested in numerous policies purchased in the life settlement market.
(4)Includes Non-GMxB related derivative hedge losses of ($0.07), ($0.01), ($0.18) and $0.31 for the three and nine months ended September 30, 2022 and 2021, respectively.
Assets Under Management
AUM means investment assets that are managed by one of our subsidiaries and includes: (i) assets managed by AB; (ii) the assets in our General Account investment portfolio; and (iii) the Separate Accounts assets of our Individual Retirement, Group Retirement and Protection Solutions businesses. Total AUM reflects exclusions between segments to avoid double counting.
Assets Under Administration
AUA includes non-insurance client assets that are invested in our savings and investment products or serviced by our Equitable Advisors platform. We provide administrative services for these assets and generally record the revenues received as distribution fees.
Account Value
AV generally equals the aggregate policy account value of our retirement products. General Account AV refers to account balances in investment options that are backed by the General Account while Separate Accounts AV refers to Separate Accounts investment assets.
80

Table of Contents
Protection Solutions Reserves
Protection Solutions Reserves equals the aggregate value of policyholders’ account balances and future policy benefits for policies in our Protection Solutions segment.
Consolidated Results of Operations
Our consolidated results of operations are significantly affected by conditions in the capital markets and the economy because we offer market sensitive products. These products have been a significant driver of our results of operations. Because the future claims exposure on these products is sensitive to movements in the equity markets and interest rates, we have in place various hedging and reinsurance programs that are designed to mitigate the economic risk of movements in the equity markets and interest rates. The volatility in net income attributable to Holdings for the periods presented below results from the mismatch between: (i) the change in carrying value of the reserves for GMDB and certain GMIB features that do not fully and immediately reflect the impact of equity and interest market fluctuations; (ii) the change in fair value of products with the GMIB feature that have a no-lapse guarantee; and (iii) our hedging and reinsurance programs.
Ownership and Consolidation of AllianceBernstein
Our indirect, wholly-owned subsidiary, AllianceBernstein Corporation, is the General Partner of AB. Accordingly, AB’s results are fully reflected in our consolidated financial statements.
Our economic interest in AB was approximately 64% and 65% during the three months ended September 30, 2022 and 2021, and approximately 65% during the nine months ended September 30, 2022 and 2021. The slight decrease in economic interest was due to the issuance of AB Units relating to AB’s 100% acquisition of CarVal. On July 1, 2022, AB issued 3.2 million AB Units (with a fair value of $133 million) and recorded a $419 million liability for the issuance of additional AB Units on November 1, 2022. AB also recorded a contingent consideration payable of $227 million (to be paid predominantly in AB Units) based on CarVal achieving certain performance objectives over a six-year period ending December 31, 2027. The issuance of the AB Units is not expected to have a significant impact on Non-GAAP Operating Earnings and Net Income.
Consolidated Results of Operations
The following table summarizes our consolidated statements of income (loss) for the three and nine months ended September 30, 2022 and 2021:
Consolidated Statement of Income (Loss)
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions, except per share data)
REVENUES
Policy charges and fee income$796 $867 $2,449 $2,755 
Premiums259 230 744 729 
Net derivative gains (losses)68 (185)3,118 (3,930)
Net investment income (loss)842 997 2,357 2,914 
Investment gains (losses), net:
Credit losses on available-for-sale debt securities and loans(267)(2)(266)
Other investment gains (losses), net(65)165 (624)763 
Total investment gains (losses), net(332)163 (890)767 
Investment management and service fees1,179 1,323 3,731 3,898 
Other income197 220 612 585 
Total revenues3,009 3,615 12,121 7,718 
81

Table of Contents
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions, except per share data)
BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits625 751 2,599 2,518 
Interest credited to policyholders’ account balances378 305 1,002 905 
Compensation and benefits566 614 1,679 1,762 
Commissions and distribution-related payments368 436 1,184 1,215 
Interest expense51 59 148 184 
Amortization of deferred policy acquisition costs105 64 446 257 
Other operating costs and expenses497 456 1,617 1,511 
Total benefits and other deductions2,590 2,685 8,675 8,352 
Income (loss) from continuing operations, before income taxes419 930 3,446 (634)
Income tax (expense) benefit(92)(165)(707)222 
Net income (loss)327 765 2,739 (412)
Less: Net income (loss) attributable to the noncontrolling interest54 93 165 281 
Net income (loss) attributable to Holdings273 672 2,574 (693)
Less: Preferred stock dividends14 14 54 53 
Net income (loss) available to Holdings’ common shareholders$259 $658 $2,520 $(746)
EARNINGS PER COMMON SHARE
Net income (loss) applicable to Holdings’ common shareholders per common share:
Basic$0.69 $1.60 $6.62 $(1.76)
Diluted$0.69 $1.59 $6.58 $(1.76)
Weighted average common shares outstanding (in millions):
Basic374.5 411.3 380.6 423.2 
Diluted376.8 414.6 382.9 423.2 
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Non-GAAP Operating Earnings$498 $818 $1,572 $2,176 

The following table summarizes our Non-GAAP Operating Earnings per common share for the three and nine months ended September 30, 2022 and 2021:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Non-GAAP operating earnings per common share:
Basic $1.29 $1.95 $3.99 $5.02 
Diluted$1.28 $1.94 $3.96 $5.02 

Three Months Ended September 30, 2022 Compared to the Three Months Ended September 30, 2021
Net Income Attributable to Holdings
Net income attributable to Holdings decreased by $399 million, to a net income of $273 million for the three months ended September 30, 2022 from a net income of $672 million in the three months ended September 30, 2021. The following notable items were the primary drivers for the change in net income (loss):
82

Table of Contents
Unfavorable items included:
Investment gains decreased by $495 million mainly due to AFS fixed maturities in an unrealized loss position in anticipation of the EQUI-VEST Transaction and rebalancing program to reduce duration during 2022.
Fee-type revenue decreased by $209 million mainly driven by lower average Separate Accounts AV within our Individual and Group Retirement segments as a result of lower equity markets, and lower advisory base fees, Bernstein Research Services revenues and distribution revenues in our Investment Management and Research segment primarily resulting from lower average AUM due to market depreciation.
Net investment income decreased by $155 million mainly due to lower alternative investment income, lower prepayments, and lower income from seed capital investments (offset by hedging gains in derivatives), partially offset by higher income from floating rate securities, higher asset balances and GA optimization.
Interest credited to policyholders’ account balances increased by $73 million mainly due to growth of SCS AV and increase in interest rates and average outstanding amounts of funding agreements during third quarter of 2022 compared to the third quarter 2021.
Amortization of DAC increased by $41 million mainly due to equity market depreciation and less favorable assumption updates during the third quarter 2022 compared to the third quarter 2021.
These were partially offset by the following favorable items:
Net derivative gains increased by $253 million from a $185 million loss from prior period due to equity market depreciation and more favorable assumption updates in the third quarter 2022 versus the prior period quarter partially offset by impacts from rising interest rate increases.
Policyholders’ benefits decreased by $126 million mainly due to more favorable assumption updates in third quarter 2022 compared to third quarter 2021 partially offset by equity market depreciation during the third quarter 2022 compared to equity market appreciation during the third quarter 2021 (offset in Net Derivative gains) and higher benefits due to strong growth in Employee Benefits.
Commissions and distribution-related payments decreased by $68 million mainly due to lower payments to financial intermediaries for the distribution of AB mutual funds in our Investment Management and Research segment and lower AV in our Individual Retirement segment related to equity market depreciation.
Net income attributable to noncontrolling interest decreased by $39 million mainly due to lower AB pre-tax income and consolidated VIE losses during the third quarter 2022.
Income tax expense decreased by $73 million mainly due to a decrease in pre-tax income in the third quarter 2022, partially offset by a higher effective tax rate.
Non-GAAP Operating Earnings
Non-GAAP Operating Earnings decreased by $319 million to $498 million for the three months ended September 30, 2022 from $818 million in the three months ended September 30, 2021. The following notable items were the primary drivers for the change in Non-GAAP Operating Earnings:
Unfavorable items included:
Fee-type revenue decreased by $214 million mainly due to lower average Separate Accounts AV within our Individual and Group Retirement segments as a result of lower equity markets, and lower advisory base fees, Bernstein Research Services revenues and distribution revenues in our Investment Management and Research segment primarily resulting from lower average AUM due to market depreciation.
Net investment income decreased by $163 million mainly due to lower alternative investment income, lower prepayments and lower income from seed capital investments (offset by hedging gains in derivatives), partially offset by higher income from floating rate securities and higher income from new investment yields.
Interest credited to policyholders’ account balances increased by $73 million mainly due to growth of SCS AV and increase in interest rates and average outstanding amounts of funding agreements during third quarter 2022 compared to the third quarter 2021.
83

Table of Contents
Policyholders’ benefits increased by $46 million mainly due to equity market depreciation during the third quarter 2022 compared to equity market appreciation during the third quarter 2021 (offset in Net Derivative gains), higher benefits due to strong growth in Employee Benefits partially offset by more favorable assumption updates in third quarter 2022 compared to third quarter 2021.
Amortization of DAC increased by $30 million mainly due to equity market depreciation and less favorable assumption updates during the third quarter 2022 compared to the third quarter 2021.
Compensation, benefits and other operating costs and expenses increased by $24 million mainly due to unfavorable COLI impacts.
These were partially offset by the following favorable items:
Net derivative gains increased by $82 million from a $64 million gain in the prior period mainly due to equity market depreciation (offset in Policyholder’s benefits) during third quarter 2022 partially offset by inflation related hedging losses on TIPS.
Commissions and distribution-related payments decreased by $68 million mainly due to lower AV in our Individual Retirement segment related to equity market depreciation and lower payments to financial intermediaries for the distribution of AB mutual funds within our Investment Management and Research segment,
Earnings attributable to the noncontrolling interest decreased by $24 million mainly due to lower Operating earnings in our Investment Management and Research segment.
Income tax expense decreased by $48 million driven by lower pre-tax earnings,

Nine Months Ended September 30, 2022 Compared to the Nine Months Ended September 30, 2021
Net Income Attributable to Holdings
Net loss attributable to Holdings increased by $3.3 billion to a net income of $2.6 billion for the nine months ended September 30, 2022 from a net loss of $693 million for the nine months ended September 30, 2021. The following notable items were the primary drivers for the change in net income (loss):
Favorable items included:
Net derivative gains increased $7.0 billion from a $3.9 billion loss in prior period driven by reduced interest rate derivative positions and equity market depreciation during 2022 as compared to 2021.
Commissions and distribution-related payments decreased by $31 million mainly due to lower AV in our Individual Retirement segment related to equity market depreciation and lower payments to financial intermediaries for the distribution of AB mutual funds within our Investment Management and Research segment, partially offset by growth in broker dealer sales and higher sales of Employee Benefits products in our Protection Solutions segment.
Net income attributable to noncontrolling interest decreased by $116 million mainly due to losses from AB’s consolidated VIEs and lower AB pre-tax income.
These were partially offset by the following unfavorable items:
Investment gains decreased by $1.7 billion mainly due to AFS fixed maturities in an unrealized loss position in anticipation of the EQUI-VEST Transaction and prior year rebalancing in the General Account portfolio associated with the Venerable Transaction and the rebalancing program to reduce duration during 2022.
Net investment income decreased by $557 million mainly due to lower alternative investment income, lower prepayments, lower assets due to the prior year Venerable Transaction, and lower income from seed capital investments (offset by hedging gains in derivatives), partially offset by higher income from floating rate securities, higher income from TIPS (offset in inflation related hedging losses) and GA optimization.
Fee-type revenue decreased by $431 million mainly driven by lower fees in our Individual Retirement segment as a result of lower equity markets and fee-income ceded to Venerable partially offset by higher premiums due to growth in Employee Benefits (offset in Policyholder’s benefits).
84

Table of Contents
Amortization of DAC increased by $189 million mainly due to equity market depreciation and less favorable assumption updates during 2022 compared to 2021.
Interest credited to policyholders’ account balances increased by $97 million mainly due to growth of SCS AV and increase in interest rates and average outstanding amounts of funding agreements during 2022.
Policyholders’ benefits increased by $81 million mainly due to the equity market depreciation during 2022 compared to equity market appreciation during 2021 (offset in Net Derivative gains), higher claims in Individual Retirement segment partially offset by more favorable assumption updates during 2022 and impact of the Venerable Transaction on GMxB reserve accrual.
Compensation, benefits and other operating expenses increased by $23 million mainly due to higher general and administrative expenses in our Investment Management and Research segment, unfavorable COLI impacts related to 2022 equity markets and higher consulting expenses partially offset by lower fund expenses from lower average assets due to the Venerable Transactions and lower separation expenses and legal reserve accruals.
Income tax expense increased by $929 million primarily due to pre-tax income in the nine months ended 2022 compared to a pre-tax loss in the nine months ended 2021, partially offset by higher effective tax rate.
See “—Significant Factors Impacting Our Results—Effect of Assumption Updates on Operating Results” for more information regarding assumption updates.
Non-GAAP Operating Earnings
Non-GAAP Operating Earnings decreased by $604 million to $1.6 billion for the nine months ended September 30, 2022 from $2.2 billion in the nine months ended September 30, 2021. The following notable items were the primary drivers for the change in Non-GAAP Operating Earnings.
Unfavorable items included:
Fee-type revenue decreased by $432 million mainly due to lower fees in our Individual Retirement segment as a result of lower equity markets and fee-income ceded to Venerable partially offset by higher premiums due to growth in Employee Benefits (offset in Policyholder’s benefits).
Net investment income decreased by $415 million mainly due to lower alternative investment income, lower prepayments, lower assets due to the prior year Venerable Transaction, and lower income from seed capital investments (offset by hedging gains in derivatives) partially offset by higher income from floating rate securities and TIPS (offset in inflation related hedging losses) and GA optimization.
Policyholders’ benefits increased by $318 million mainly due to the equity market depreciation during 2022 compared to equity market appreciation during 2021 (offset in Net Derivative gains) and higher claims in Individual Retirement segment partially offset by the impact of the Venerable Transaction on GMxB reserve accrual and lower mortality and lower accrual of PFBL reserves in our Protection Solutions segment.
Compensation, benefits and other operating costs and expenses increased by $127 million mainly due to higher general and administrative expenses in our Investment Management and Research segment, unfavorable COLI impacts related to 2022 equity market depreciation and higher consulting expenses partially offset by lower fund expenses from lower average assets due to the Venerable Transaction.
Interest credited to policyholders’ account balances increased by $97 million mainly due to an increase in interest rates and average outstanding amounts of funding agreements and the growth of SCS AV during 2022.
Amortization of DAC increased by $99 million mainly due to equity market depreciation and less favorable assumption updates during 2022 compared to 2021.
These were partially offset by the following favorable items:
Net derivative gains increased $692 million from a $114 million loss in the prior period mainly due to equity markets depreciation (offset in Policyholders’ benefits) during 2022.
Earnings attributable to the noncontrolling interest decreased by $43 million mainly due to lower Operating earnings in our Investment Management and Research segment.
Commissions and distribution-related payments decreased by $31 million mainly due to lower AV in our Individual Retirement segment related to equity market depreciation and lower payments to financial intermediaries for the
85

Table of Contents
distribution of AB mutual funds within our Investment Management and Research segment, partially offset by growth in broker dealer sales and higher sales of Employee Benefits products in our Protection Solutions segment.
Income tax expense decreased by $103 million mainly driven by lower pre-tax earnings, partially offset by higher effective tax rate.
Results of Operations by Segment
We manage our business through the following four segments: Individual Retirement, Group Retirement, Investment Management and Research, and Protection Solutions. We report certain activities and items that are not included in our four segments in Corporate and Other. The following section presents our discussion of operating earnings (loss) by segment and AUM, AV and Protection Solutions Reserves by segment, as applicable. Consistent with U.S. GAAP guidance for segment reporting, operating earnings (loss) is our U.S. GAAP measure of segment performance. See Note 14 of the Notes to the Consolidated Financial Statements for further information on our segments.
The following table summarizes operating earnings (loss) on our segments and Corporate and Other for the three and nine months ended September 30, 2022 and 2021:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Operating earnings (loss) by segment:
Individual Retirement$270 $316 $837 $1,093 
Group Retirement134 192 415 514 
Investment Management and Research94 134 330 381 
Protection Solutions72 160 208 264 
Corporate and Other(72)16 (218)(76)
Non-GAAP Operating Earnings$498 $818 $1,572 $2,176 
Effective Tax Rates by Segment
Income tax expense is calculated using the ETR and then allocated to our business segments using an 19% ETR for our retirement and protection businesses (Individual Retirement, Group Retirement, and Protection Solutions) and a 27% ETR for Investment Management and Research.
Individual Retirement
The Individual Retirement segment includes our variable annuity products which primarily meet the needs of individuals saving for retirement or seeking retirement income.
The following table summarizes operating earnings of our Individual Retirement segment for the periods presented:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Operating earnings$270 $316 $837 $1,093 


Key components of operating earnings are:
86

Table of Contents
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
REVENUES
Policy charges, fee income and premiums$385 $439 $1,152 $1,457 
Net investment income348 296 933 972 
Net derivative gains (losses)140 77 514 (51)
Investment management, service fees and other income144 186 462 579 
Segment revenues$1,017 $998 $3,061 $2,957 
BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits$300 $272 $998 $641 
Interest credited to policyholders’ account balances101 70 255 205 
Commissions and distribution-related payments61 89 208 245 
Amortization of deferred policy acquisition costs109 88 292 239 
Compensation, benefits and other operating costs and expenses105 96 272 307 
Interest expense —  — 
Segment benefits and other deductions$676 $615 $2,025 $1,637 

The following table summarizes AV for our Individual Retirement segment as of the dates indicated:
September 30, 2022December 31, 2021
(in millions)
AV (1)
General Account$35,509 $37,698 
Separate Accounts55,013 74,206 
Total AV$90,522 $111,904 
(1)AV presented are net of reinsurance.
The following table summarizes a roll-forward of AV for our Individual Retirement segment for the periods presented:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Balance as of beginning of period$94,263 $108,435 $111,904 $117,390 
Gross premiums3,083 2,848 9,065 8,138 
Surrenders, withdrawals and benefits(2,318)(2,835)(7,614)(8,819)
Net flows (1)765 13 1,451 (681)
Investment performance, interest credited and policy charges(4,506)(697)(22,833)7,912 
Ceded to Venerable (2) —  (16,927)
Other (3) (4) (38) 19 
Balance as of end of period$90,522 $107,713 $90,522 $107,713 
______________
(1)For the three and nine months ended September 30, 2022 and 2021, net flows of $(258) million, $(322) million, $(840) million and $(442) million and investment performance, interest credited and policy charges of $(721) million, $(273) million, $(4,108) million and $(125) million, respectively, are excluded as these amounts are related to ceded AV to Venerable.
(2)Effective June 1, 2021, AV excludes activity related to ceded AV to Venerable. In addition, roll-forward reflects the AV ceded to Venerable as of the transaction date. For additional information on the Venerable Transaction see Note 1 of the Notes to Consolidated Financial Statements.
87

Table of Contents
(3)For the three months and nine months ended September 30, 2021 amounts reflect $(38) million transfer of policyholders account balances to future policyholder benefits and other policyholders liabilities related to structured settlement contracts.
(4)For the nine months ended September 30, 2021, amounts reflect $57 million of AV transfer of a closed block of GMxB business from GR to IR.
Three Months Ended September 30, 2022 Compared to the Three Months Ended September 30, 2021 for the Individual Retirement Segment
Operating earnings
Operating earnings decreased $46 million to $270 million during the three months ended September 30, 2022 from $316 million in the three months ended September 30, 2021. The following notable items were the primary drivers of the change in operating earnings:
Unfavorable items included:
Fee-type revenue decreased by $90 million due to lower average Separate Accounts AV as result of equity market depreciation.
Interest credited to policyholders’ account balances increased by $31 million mainly due to the growth of SCS AV during third quarter 2022.
Amortization of DAC increased by $21 million mainly driven by equity market depreciation during the third quarter 2022.
Compensation, benefits and other operating costs and expenses increased by $9 million primarily due to higher performance shares driven by higher equity and restricted stock expense.

Income tax expense increased by $4 million mainly driven by a higher effective tax rate.

These were partially offset by the following favorable items:
Net investment income increased by $52 million mainly due to higher income primarily from floating rate securities, higher SCS asset balances and GA optimization, partially offset by lower income from alternative investments and lower prepayments.
Non-GMxB related Policyholders’ benefits decreased by $39 million due to the non-repeat of Q3 2021 payout assumption update.
Commissions and distribution-related payments decreased by $28 million mainly due to lower average asset balances as result of equity market performance.
Net Flows and AV
Total AV as of September 30, 2022 was $90.5 billion, down $3.7 billion, compared to June 30, 2022. The decline in AV was primarily due to a $4.5 billion decrease in equity markets, partially offset by $765 million in net inflows.
Net inflows of $765 million were $752 million higher than in the three months ended September 30, 2021, mainly driven by $1.3 billion of inflows on our newer, less capital-intensive products, partially offset by $498 million of outflows on our older fixed-rate GMxB block.
88

Table of Contents
Nine Months Ended September 30, 2022 Compared to the Nine Months Ended September 30, 2021 for the Individual Retirement Segment
Operating earnings
Operating earnings decreased $256 million to $837 million during the nine months ended September 30, 2022 from $1.1 billion in the nine months ended September 30, 2021. The following notable items were the primary drivers of the change in operating earnings:

Unfavorable items included:
Fee-type revenue decreased by $336 million mainly due to lower average Separate Accounts AV as result of lower equity markets and the impact of AV ceded to Venerable, partially offset by commission reimbursements in Other Income.
Amortization of DAC increased by $53 million mainly due to equity market depreciation during 2022 compared to 2021.
Interest credited to policyholders’ account balances increased by $50 million mainly due to the growth of SCS AV during 2022.
Net investment income decreased by $39 million mainly due to lower alternative investment income, lower prepayments and lower assets due to the Venerable transaction partially offset by higher income from floating rate securities, TIPS, higher SCS asset balances and GA optimization.
These were partially offset by the following favorable items:
Net GMxB results increased $89 million primarily due to improved GMxB margin from the Venerable Transaction, which mitigated the higher claims in 2022. GMxB results are included in policy charges and fee income, net derivative gains (losses), and policyholders’ benefits.
Commissions and distribution-related payments decreased by $37 million mainly due to lower AV due to equity market depreciation during 2022.
Compensation, benefits and other operating costs and expenses decreased by $35 million primarily due to lower allocated compensation related expenses, primarily associated with lower headcount, and lower subadvisory fees.

Income tax expense decreased by $28 million mainly driven by lower pre-tax earnings partially offset by a higher effective tax rate in 2022.
Net Flows and AV
The decline in AV of $21.4 billion in the nine months ended September 30, 2022 was driven by a decrease in investments performance and interest credited to account balances, net of policy charges of $22.8 billion as a result of equity market depreciation in 2022, partially offset by net inflows of $1.5 billion.
Net inflows of $1.5 billion were $2.1 billion higher than in the nine months ended September 30, 2021, mainly driven by $3.1 billion of inflows on our newer, less capital-intensive products, partially offset by $1.6 billion of outflows on our older fixed-rate GMxB block.
Group Retirement
The Group Retirement segment offers tax-deferred investment and retirement services or products to plans sponsored by educational entities, municipalities and not-for-profit entities, as well as small and medium-sized businesses.
The following table summarizes operating earnings of our Group Retirement segment for the periods presented:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Operating earnings$134 $192 $415 $514 
Key components of operating earnings are:
89

Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
REVENUES
Policy charges, fee income and premiums$80 $96 $257 $273 
Net investment income160 189 503 564 
Net derivative (losses) gains(11)(11)(23)(16)
Investment management, service fees and other income60 69 187 197 
Segment revenues$289 $343 $924 $1,018 
BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits$ $— $ $— 
Interest credited to policyholders’ account balances79 77 229 227 
Commissions and distribution-related payments12 12 43 41 
Amortization of deferred policy acquisition costs(20)(24)3 (11)
Compensation, benefits and other operating costs and expenses47 45 134 140 
Interest expense1 — 1 — 
Segment benefits and other deductions$119 $110 $410 $397 
The following table summarizes AV and AUA for our Group Retirement segment as of the dates indicated:
September 30, 2022December 31, 2021
(in millions)
AV and AUA
General Account$13,234 $13,046 
Separate Accounts and Mutual Funds (1)26,476 34,763 
Total AV and AUA$39,710 $47,809 
____________
(1) Prior period amounts related to Separate Account AV and Mutual Funds AUA were revised to include Mutual Fund AUA. The impact of the revision to December 31, 2021 total AV and AUA was $457 million.

The following table summarizes a roll-forward of AV and AUA for our Group Retirement segment for the periods indicated:
Three Months Ended September 30,Nine Months Ended September 30,
20222021 (1)20222021 (1)
(in millions)
Balance as of beginning of period$41,167 $46,299 $47,809 $42,756 
Gross premiums861 849 3,496 2,761 
Surrenders, withdrawals and benefits(918)(984)(2,886)(2,831)
Net flows(57)(135)610 (70)
Investment performance, interest credited and policy charges(1,400)(247)(8,709)3,288 
Other (2) —  (57)
Balance as of end of period$39,710 $45,917 $39,710 $45,917 
____________
(1)Prior period amounts related to the AV and AUA roll-forward were updated to include Mutual Fund AUA. The impact of the revision to the beginning balance of the three months and nine months ended September 30, 2021 were $376 million and $297 million, respectively. Net Flows revision impact for the three months and nine months ended September 30, 2021 were $0 million and $48 million. Investment performance, interest credited and policy charges revision impact for the three months and nine months ended September 30, 2021 were $3 million and $28 million, respectively.
90

Table of Contents
(2)For the three months and nine months ended September 30, 2021, amounts reflect AV transfer of GMxB closed block business from GR to IR.
Three Months Ended September 30, 2022 Compared to the Three Months Ended September 30, 2021 for the Group Retirement Segment
Operating earnings
Operating earnings decreased by $58 million to $134 million during the three months ended September 30, 2022 from $192 million in the three months ended September 30, 2021. The following notable items were the primary drivers of the change in operating earnings:
Unfavorable items included:
Net investment income decreased by $29 million due to lower alternative investment income and lower prepayments, partially offset by higher income primarily from floating rate securities, higher asset balances and General Account optimization.
Fee-type revenue decreased by $25 million due to lower average Separate Account AV from lower equity market performance.
These were partially offset by the following favorable items:
Amortization of DAC increased by $4 million mainly due to more favorable assumption updates in 2022 compared to 2021.
Income tax expense decreased by $5 million mainly driven by lower pre-tax earnings, partially offset by a higher effective tax rate in 2022.
See “—Significant Factors Impacting Our Results—Effect of Assumption Updates on Operating Results” for more information regarding assumption updates.
Net Flows and AV
The decrease in AV of $1.5 billion in the three months ended September 30, 2022 was driven by equity market performance and net outflows of $57 million.
Net outflows of $57 million improved by $78 million due to higher gross premiums and lower outflows.
91

Table of Contents

Nine Months Ended September 30, 2022 Compared to the Nine Months Ended September 30, 2021 for the Group Retirement Segment
Operating earnings
Operating earnings decreased by $99 million to $415 million during the nine months ended September 30, 2022 from $514 million during the nine months ended September 30, 2021. The following notable items were the primary drivers of the change in operating earnings:
Unfavorable items included:
Net investment income decreased by $61 million primarily due to lower alternative investment income and lower prepayments partially offset by higher income from floating rate securities, TIPS and General Account optimization.
Fee-type revenue decreased by $26 million due to lower average Separate Account AV from lower equity market performance.
Net derivative losses increased by $7 million due to inflation related hedging loss offset on TIPS in the General Account.
These were partially offset by the following favorable items:
Income tax expense decreased by $8 million primarily driven by lower pre-tax earnings partially offset by a higher effective tax rate in 2022.
Net Flows and AV
The decrease in AV of 6.2 billion in the nine months ended September 30, 2022 was primarily due to market depreciation, partially offset by net inflows of $610 million.
Net inflows of $610 million increased by $680 million compared to 2021, driven by strong gross premiums reflecting strong sales and client engagement, partially offset by higher outflows.
Investment Management and Research
The Investment Management and Research segment provides diversified investment management, research and related services to a broad range of clients around the world. Operating earnings (loss), net of tax, presented here represents our economic interest in AB of approximately 64% and 65% during the three months ended September 30, 2022 and 2021, and approximately 65% during the nine months ended September 30, 2022 and 2021.
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Operating earnings$94 $134 $330 $381 

Key components of operating earnings are:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
REVENUES
Net investment income$(9)$(2)$(58)$10 
Net derivative gains (losses)15 57 (7)
Investment management, service fees and other income990 1,093 3,135 3,166 
Segment revenues$996 $1,093 $3,134 $3,169 
92

Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
BENEFITS AND OTHER DEDUCTIONS
Commissions and distribution related payments$152 $187 $487 $517 
Compensation, benefits and other operating costs and expenses636 622 1,930 1,831 
Interest expense5 — 9 
Segment benefits and other deductions$793 $809 $2,426 $2,349 


Changes in AUM in the Investment Management and Research segment for the periods presented were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
 
(in billions)
Balance as of beginning of period$646.8 $738.4 $778.6 $685.9 
Long-term flows
Sales/new accounts19.8 32.3 84.6 110.6 
Redemptions/terminations(24.9)(21.5)(72.2)(78.1)
Cash flow/unreinvested dividends(5.4)(3.6)(14.2)(13.8)
Net long-term inflows (outflows) (2)(10.5)7.2 (1.8)18.7 
Adjustments (1) — (0.4)— 
Acquisition (3)12.2 — 12.2 — 
Market appreciation (depreciation)(35.8)(3.4)(175.9)37.6 
Net change(34.1)3.8 (165.9)56.3 
Balance as of end of period$612.7 $742.2 $612.7 $742.2 
__________
(1)Approximately $0.4 billion of Institutional AUM was removed from AB total assets under management during the second quarter 2022 due to a change in the fee structure.
(2)Institutional net flows include $3.9 billion and $4.5 billion of AXA's redemptions of certain low-fee fixed income mandates for the three and nine months ended September 30, 2022, respectively.
(3)The CarVal acquisition added approximately $12.2 billion of Institutional AUM in the third quarter 2022.
93

Average AUM in the Investment Management and Research segment for the periods presented by distribution channel and investment services were as follows:
 
Three Months Ended September 30,Nine Months Ended September 30,
 
2022202120222021
(in billions)
Distribution Channel:
Institutions$297.0 $331.1 $312.8 $323.3 
Retail250.9 299.5 274.9 284.1 
Private Wealth106.0 116.8 111.6 112.4 
Total$653.9 $747.4 $699.3 $719.8 
Investment Service:
Equity Actively Managed$222.8 $262.8 $245.7 $244.2 
Equity Passively Managed (1)56.7 70.4 61.8 67.8 
Fixed Income Actively Managed – Taxable198.9 252.5 216.4 254.8 
Fixed Income Actively Managed – Tax-exempt53.7 54.9 54.7 53.0 
Fixed Income Passively Managed (1)11.3 9.4 12.1 8.8 
Alternatives/Multi-Asset Solutions (2)110.5 97.4 108.6 91.2 
Total$653.9 $747.4 $699.3 $719.8 
____________
(1)Includes index and enhanced index services.
(2)Includes certain multi-asset solutions and services not included in equity of fixed income services.
Three Months Ended September 30, 2022 Compared to the Three Months Ended September 30, 2021 for the Investment Management and Research Segment
Operating earnings
Operating earnings decreased $40 million to $94 million during the three months ended September 30, 2022 from $134 million during the three months ended September 30, 2021. The following notable items were the primary drivers of the change in operating earnings:
Unfavorable items included:
Fee-type revenue decreased by $103 million primarily due to lower investment advisory base fees, distribution revenues, and Bernstein Research Services revenues. Lower investment advisory base fees and distribution revenues were driven by lower average AUM. Lower Bernstein Research Services revenues were primarily driven by significantly lower customer trading activity in Europe and Asia due to the prevailing macro-economic environment.
Compensation, benefits, interest expense and other operating costs increased by $19 million mainly due to higher general and administrative costs.
These were partially offset by the following favorable items:
Commissions and distribution-related payments decreased by $35 million mainly due to lower payments to financial intermediaries for the distribution of AB mutual funds.
Net derivative gains, net of net investment income, was favorable by $6 million. Net derivative gains increased $13 million mainly due to gains from economically hedging seed capital investments, partially offset by a decrease in Net investment income of $7 million mainly due to losses on the seed capital investments subject to market risk.
Earnings attributable to noncontrolling interest decreased by $26 million due to lower pre-tax earnings.
Income tax expense decreased by $14 million primarily due to lower pre-tax earnings.
Long-Term Net Flows and AUM
94

Table of Contents
Total AUM as of September 30, 2022 was $612.7 billion, down $34.1 billion, or 5.3%, compared to June 30, 2022. During the third quarter 2022, AUM decreased primarily as a result of market depreciation of $35.8 billion and net outflows of $10.5 billion, partially offset by the addition of $12.2 billion due to the acquisition of CarVal. Net outflows were due to Institution net outflows of $6.3 billion and Retail net outflows of $5.0 billion partially offset by Private Wealth net inflows of $0.8 billion. Excluding AXA redemptions of low-fee fixed income mandates of $3.9 billion, AB generated net outflows of $6.6 billion in the third quarter 2022.
Nine Months Ended September 30, 2022 Compared to the Nine Months Ended September 30, 2021 for the Investment Management and Research Segment
Operating earnings
Operating earnings decreased $51 million to $330 million during the nine months ended September 30, 2022 from $381 million in the nine months ended September 30, 2021. The following notable items were the primary drivers of the change in operating earnings:
Unfavorable items included:
Compensation, benefits, interest expense and other operating costs increased by $107 million mainly due to higher general and administrative costs, primarily relating to higher portfolio servicing fees, professional fees and technology fees.
Net investment income, net of derivative gains, was unfavorable by $4 million. Net investment income decreased by $68 million mainly due to higher losses on the seed capital investments subject to market risk, offset by an increase in Net derivative gains of $64 million mainly due to higher gains from economically hedging the seed capital investments.
Fee-type revenue decreased by $31 million primarily due to lower investment advisory base fees and Bernstein Research Services revenues, offset by higher performance based fees. The decrease in investment advisory base fees was primarily driven by lower average AUM. The decrease in Bernstein Research Services revenues were primarily driven by significantly lower customer trading activity in Europe and Asia due to the prevailing macro-economic environment. The increase in performance based fees was primarily due to higher performance fees earned on AB’s U.S. Real Estate Funds, partially offset by lower performance fees earned on AB’s U.S. Select Equity Long/Short and Private Credit Fund.
These were partially offset by the following favorable items:
Commissions and distribution-related payments decreased by $30 million mainly due to lower payments to financial intermediaries for the distribution of AB mutual funds.
Earnings attributable to noncontrolling interest decreased by $40 million due to lower pre-tax earnings.
Income tax expense decreased by $21 million due to lower pre-tax earnings.
Long-Term Net Flows and AUM
Total AUM as of September 30, 2022 was $612.7 billion, down $165.9 billion, or 21.3%, compared to December 31, 2021, and down $129.5 billion, or 17.5%, compared to September 30, 2021. During the nine months ended September 30, 2022, AUM decreased primarily as a result of market depreciation of $175.9 billion partially offset by the addition of $12.2 billion due to the acquisition of CarVal. During the twelve months ended September 30, 2022, AUM decreased primarily as a result of market depreciation of $147.0 billion partially offset by net inflows of $5.7 billion and the addition of $12.2 billion due to the acquisition of CarVal. Excluding AXA redemptions of low-fee fixed income mandates of $4.5 billion, AB generated net inflows of $2.7 billion and $10.2 billion during the nine and twelve month periods ended September 30, 2022.
During the nine months ended September 30, 2022, Retail net outflows of $8.2 billion were offset by Institutional and Private Wealth net inflows of $4.6 billion and $1.8 billion, respectively. During the twelve months ended September 30, 2022, Institutional and Private Wealth net inflows were $5.0 billion and $2.6 billion, respectively, offset by Retail net outflows of $1.9 billion.

95

Table of Contents
Protection Solutions
The Protection Solutions segment includes our life insurance and employee benefits businesses. We provide a targeted range of products aimed at serving the financial needs of our clients throughout their lives, including VUL, IUL and term life products. In 2015, we entered the employee benefits market and currently offer a suite of dental, vision, life, as well as short- and long-term disability insurance products to small and medium-size businesses.
In recent years, we have refocused our product offering and distribution towards less capital intensive, higher return accumulation and protection products. For example, in January 2021, we discontinued offering our most interest sensitive IUL product. We plan to improve our operating earnings over time through earnings generated from sales of our repositioned product portfolio and by proactively managing and optimizing our in-force book.
The following table summarizes operating earnings (loss) of our Protection Solutions segment for the periods presented:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Operating earnings (loss)$72 $160 $208 $264 
Key components of operating earnings (loss) are:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
REVENUES
Policy charges, fee income and premiums$505 $482 $1,544 $1,493 
Net investment income236 294 760 827 
Net derivative (losses) gains(13)(7)(18)(18)
Investment management, service fees and other income63 69 192 194 
Segment revenues$791 $838 $2,478 $2,496 
BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits$414 $392 $1,364 $1,370 
Interest credited to policyholders’ account balances130 126 380 383 
Commissions and distribution related payments46 44 132 120 
Amortization of deferred policy acquisition costs14 78 63 
Compensation, benefits and other operating costs and expenses96 78 266 241 
Interest expense —  — 
Segment benefits and other deductions$700 $644 $2,220 $2,177 
The following table summarizes Protection Solutions Reserves for our Protection Solutions segment as of the dates presented:
September 30, 2022December 31, 2021
(in millions)
Protection Solutions Reserves (1)
General Account$18,243 $18,625 
Separate Accounts12,783 17,012 
Total Protection Solutions Reserves$31,026 $35,637 
_______________
(1)Does not include Protection Solutions Reserves for our employee benefits business as it is a start-up business and therefore has immaterial in-force policies.
96

Table of Contents
The following table presents our in-force face amounts for the periods indicated, respectively, for our individual life insurance products:
September 30, 2022December 31, 2021
(in billions)
In-force face amount by product: (1)
Universal Life (2)
$43.7 $45.9 
Indexed Universal Life
27.6 27.9 
Variable Universal Life (3)
132.8 132.8 
Term
213.0 215.4 
Whole Life
1.2 1.2 
Total in-force face amount$418.3 $423.2 
_______________
(1)Includes individual life insurance and does not include employee benefits as it is a start-up business and therefore has immaterial in-force policies.
(2)UL includes GUL.
(3)VUL includes VL and COLI.
97

Table of Contents
Three Months Ended September 30, 2022 Compared to the Three Months Ended September 30, 2021 for the Protection Solutions Segment
Operating earnings (loss)
Operating earnings decreased by $88 million to $72 million during the three months ended September 30, 2022 from $160 million in the three months ended September 30, 2021. The following notable items were the primary drivers of the change in operating earnings:
Unfavorable items included:
Net investment income decreased by $58 million mainly due to lower alternative investment income and lower prepayments partially offset by higher income from floating rate securities, higher asset balances and GA optimization.
Policyholders’ benefits increased by $22 million mainly due to less favorable assumption updates in 2022 compared to 2021 and higher benefits due to strong growth in Employee Benefits, partially offset by lower Term mortality in 2022 compared to 2021 and lower accrual for PFBL reserves.
Compensation, benefits and other operating costs and expenses increased by $18 million mainly due to higher performance share expense due to equity returns, and restricted stock expense.
Amortization of DAC increased by $10 million mainly due to less favorable assumption update in 2022 compared to 2021.
These were partially offset by the following favorable items:
Fee-type revenue increased by $17 million mainly driven by higher premiums due to growth in Employee Benefits (offset in Policyholder’s benefits).
Income tax expense decreased by $15 million primarily due to lower pre-tax earnings, partially offset by a higher effective tax rate in 2022.
Nine Months Ended September 30, 2022 Compared to the Nine Months Ended September 30, 2021 for the Protection Solutions Segment
Operating earnings
Operating earnings decreased $56 million to $208 million during the nine months ended September 30, 2022 from $264 million in the nine months ended September 30, 2021. The following notable items were the primary drivers of the change in operating earnings:
Unfavorable items included:
Net investment income decreased by $67 million mainly due to lower alternative investment income and lower prepayments partially offset by higher income from floating rate securities, TIPS and GA optimization
Compensation, benefits and other operating costs and expenses increased by $25 million mainly due to higher performance share expense due to equity returns, and an increase in subadvisory fees and consulting expenses.
Amortization of DAC increased by $15 million mainly due to less favorable assumption updates in 2022 compared to 2021.
Commissions and distribution-related payments increased by $12 million mainly due to higher sales of Employee Benefits products.
These were partially offset by the following favorable items:
Fee-type revenue increased by $49 million mainly driven by higher premiums due to growth in Employee Benefits (offset in Policyholder’s benefits).
Policyholders’ benefits decreased by $6 million mainly due to lower mortality in 2022 compared to 2021 and lower PFBL reserves, partially offset by a higher increase in EB reserves.
Income tax expense decreased by $5 million primarily due to lower pre-tax earnings, partially offset by a higher effective tax rate in 2022.
98

Table of Contents
Corporate and Other
Corporate and Other includes some of our financing and investment expenses. It also includes: Equitable Advisors broker-dealer business, the Closed Block, run-off variable annuity reinsurance business, run-off group pension business, run-off health business, benefit plans for our employees, certain strategic investments and certain unallocated items, including capital and related investments, interest expense and financing fees and corporate expense. AB’s results of operations are reflected in the Investment Management and Research segment. Accordingly, Corporate and Other does not include any items applicable to AB.
The following table summarizes operating earnings (loss) of Corporate and Other for the periods presented:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(in millions)
Operating earnings (loss)$(72)$16 $(218)$(76)
General Account Investment Portfolio
The General Account investment portfolio is used to support the insurance and annuity liabilities of our Individual Retirement, Group Retirement and Protection Solutions businesses segments. In the first quarter 2022, the Company changed its methodology for allocating its General Account investment portfolio, which resulted in a change in the asset and net investment income allocation amongst the Company’s business segments. Following this change, the segmentation of the general account investments is now more closely aligned with the liability characteristics of the product groups. Management determined that the change in the allocation methodology allows for improved flexibility and infuses an active asset liability management practice into the segmentation process. Additionally, the Company also changed its basis for allocating the spread earned from our FHLB investment borrowing and FABN programs. The spread earned from our FHLB investment borrowing and FABN programs includes the investment income on the assets less interest credited on the funding agreements. The net spread as reflected in net investment income is allocated to the segments based on the percentage of the individual segment insurance liabilities over the combined segments insurance liabilities.
Our General Account investment portfolio investment strategy seeks to achieve sustainable risk-adjusted returns by focusing on principal preservation, investment return, duration and liquidity requirements by product class and the diversification of risks. Investment activities are undertaken according to investment policy statements that contain internally established guidelines and are required to comply with applicable laws and insurance regulations.
Risk tolerances are established for credit risk, market risk, liquidity risk and concentration risk across types of issuers and asset classes that seek to mitigate the impact of cash flow variability arising from these risks. Significant interest rate increases and market volatility in 2022 have reduced the fair value of fixed maturities from a net unrealized gain position to a net unrealized loss. These effects apply across the portfolio and are being assessed within the aggregate asset and liability management strategies. As a part of asset and liability management, we maintain a weighted average duration for our General Account investment portfolio that is within an acceptable range of the estimated duration of our liabilities given our risk appetite and hedging programs.
The General Account investment portfolio consists largely of investment grade fixed maturities, short-term investments, commercial and agricultural mortgage loans, alternative investments and other financial instruments. Fixed maturities include publicly issued corporate bonds, government bonds, privately placed notes and bonds, bonds issued by states and municipalities, mortgage-backed securities and asset-backed securities. The General Account investment portfolio also includes credit derivatives to replicate exposure to individual securities or pools of securities as a means of achieving credit exposure similar to bonds of the underlying issuer(s) more efficiently. In addition, from time to time we use derivatives for hedging purposes to reduce our exposure to equity markets, interest rates, foreign currency and credit spreads. As part of a yield enhancement strategy, the General Account has diversified into more asset and sub-asset classes including higher yielding commercial mortgage investments.
Investment portfolios are primarily managed by legal entity with dedicated portfolios for certain blocks of business. For portfolios that back multiple product groups, investment results are allocated to business segments.
Our investment philosophy is driven by our long-term commitments to clients, robust risk management and strategic asset allocation. In executing the activities of our General Account investment portfolio, we incorporate ESG factors into the investment processes for a significant portion of our portfolio. As investors with a long-term horizon, we believe that
99

Table of Contents
companies with sustainable practices are better positioned to deliver value to stakeholders over an extended period, thereby enhancing the quality of our portfolio. These companies are more likely to increase sales through sustainable products, reduce energy costs and attract and retain talent. This belief underpins our approach to sustainable investing, where we seek to enhance the sustainability of our investment portfolio by integrating ESG factors into our investment decision process.
The General Account investment portfolio reflects certain differences from the presentation of the U.S. GAAP Consolidated Financial Statements. This presentation is consistent with how we manage the General Account investment portfolio. For further investment information, please refer to Note 3 and Note 4 of the Notes to the Consolidated Financial Statements.
Investment Results of the General Account Investment Portfolio
The following table summarizes the General Account investment portfolio results with Non-GAAP Operating Earnings adjustments by asset category for the periods indicated. This presentation is consistent with how we measure investment performance for management purposes.
Three Months Ended September 30,
20222021
YieldAmount (2)YieldAmount (2)
(Dollars in millions)
Fixed Maturities: (5)
Income (loss)3.77 %$699 3.42 %$602 
Ending assets74,565 71,216 
Mortgages:
Income (loss)3.92 %148 3.99 %134 
Ending assets15,688 13,448 
Other Equity Investments: (1)
Income (loss)2.95 %26 31.06 %213 
Ending assets3,468 2,903 
Policy Loans:
Income (loss)4.90 %49 5.11 %52 
Ending assets4,018 4,027 
Cash and Short-term Investments:
Income (loss)(2.51)%(8)(0.05)%— 
Ending assets563 1,215 
Repurchase and funding agreements:
Interest expense and other(47)(13)
Ending assets (liabilities)(7,830)(6,807)
Total Invested Assets:
Income (loss)3.83 %867 4.68 %988 
Ending Assets90,472 86,002 
Short Duration Fixed Maturities:
Income (loss)3.41 %1 3.39 %
Ending assets117 142 
Total:
Investment income (loss)3.83 %868 4.67 %991 
Less: investment fees (3)(0.17)%(38)(0.13)%(28)
Investment Income, Net3.66 %830 4.54 %963 
Ending Net Assets$90,589 $86,144 
100

Table of Contents
Nine Months Ended September 30,Year Ended December 31
 202220212021
 YieldAmount (2)
Yield
Amount (2)
Yield
Amount (2)
(Dollars in millions)
Fixed Maturities:
Income (loss)3.52 %$1,935 3.41 %$1,822 3.40 %$2,429 
Ending assets74,565 71,216 72,545 
Mortgages:
Income (loss)3.87 %424 4.07 %407 4.08 %547 
Ending assets15,688 13,448 14,033 
Other Equity Investments: (1)
Income (loss)7.80 %188 22.97 %433 20.45 %534 
Ending assets3,468 2,903 2,901 
Policy Loans:
Income (loss)5.30 %160 5.28 %161 5.01 %203 
Ending assets4,018 4,027 4,024 
Cash and Short-term Investments:
Income (loss)(0.83)%(12)(0.05)%(1)(0.13)%(2)
Ending assets563 1,215 1,662 
Funding agreements:
Interest expense and other(82)(44)(56)
Ending assets (liabilities)(7,830)(6,807)(6,647)
Total Invested Assets:
Income (loss)3.86 %2,613 4.37 %2,778 4.28 %3,655 
Ending Assets90,472 86,002 88,518 
Short Duration Fixed Maturities:
Income (loss)3.53 %4 3.38 %77 4.48 %78 
Ending assets117 142 142 
Total:
Investment income (loss)3.86 %2,617 4.34 %2,855 4.28 %3,733 
Less: investment fees (3) (0.15)%(101)(0.13)%(82)(0.14)%(118)
Investment Income, Net3.71 %2,516 4.25 %2,773 4.15 %3,615 
Ending Net Assets$90,589 $86,144 $88,660 
_____________
(1)Includes, as of September 30, 2022, September 30, 2021 and December 31, 2021 respectively, $370 million, $328 million and $319 million of other invested assets.
(2)Amount for fixed maturities and mortgages represents original cost, reduced by repayments, write-downs, adjusted amortization of premiums, accretion of discount and allowances. Cost for equity securities represents original cost reduced by write-downs; cost for other limited partnership interests represents original cost adjusted for equity in earnings and reduced by distributions.
(3)Investment fees are inclusive of investment management fees paid to AB.

Fixed Maturities
The fixed maturity portfolio consists largely of investment grade corporate debt securities and includes significant amounts of U.S. government and agency obligations. The below investment grade securities in the General Account investment portfolio consist of loans to middle market companies, public high yield securities, bank loans, as well as “fallen angels,” originally purchased as investment grade investments.
Fixed Maturities by Industry
The following table sets forth these fixed maturities by industry category as of the dates indicated along with their associated gross unrealized gains and losses.
101

Table of Contents
Fixed Maturities by Industry (1)
Amortized Cost
Allowance for Credit Losses
Gross Unrealized Gains
Gross Unrealized Losses
Fair Value
Percentage of Total (%)
(in millions)
As of September 30, 2022
Corporate Securities:
Finance$14,195 $ $10 $1,909 $12,296 19 %
Manufacturing12,421 1 11 2,044 10,387 16 %
Utilities7,015  10 1,190 5,835 9 %
Services8,320 21 9 1,365 6,943 11 %
Energy3,901  9 652 3,258 5 %
Retail and wholesale3,508  12 487 3,033 5 %
Transportation2,409  8 430 1,987 3 %
Other119   17 102  %
Total corporate securities51,888 22 69 8,094 43,841 68 %
U.S. government7,241  4 1,215 6,030 10 %
Residential mortgage-backed (2)500  1 25 476 1 %
Preferred stock41  2  43  %
State & political668  8 92 584 1 %
Foreign governments1,114  2 190 926 1 %
Commercial mortgage-backed3,824   574 3,250 5 %
Asset-backed securities9,289  1 545 8,745 14 %
Total$74,565 $22 $87 $10,735 $63,895 100 %
As of December 31, 2021
Corporate Securities:
Finance$12,954 $— $545 $59 $13,440 17 %
Manufacturing12,212 775 39 12,947 17 %
Utilities6,446 — 351 36 6,761 %
Services8,191 21 380 50 8,500 11 %
Energy3,854 — 174 17 4,011 %
Retail and wholesale3,390 — 218 18 3,590 %
Transportation2,181 — 156 10 2,327 %
Other60 — — 62 — %
Total corporate securities49,288 22 2,601 229 51,638 67 %
U.S. government13,056 — 2,344 15 15,385 20 %
Residential mortgage-backed (2)90 — — 98 — %
Preferred stock41 — 12 — 53 — %
State & political586 — 78 661 %
Foreign governments1,124 — 42 14 1,152 %
Commercial mortgage-backed2,427 — 19 25 2,421 %
Asset-backed securities5,933 — 21 20 5,934 %
Total$72,545 $22 $5,125 $306 $77,342 100 %
______________
(1)Investment data has been classified based on standard industry categorizations for domestic public holdings and similar classifications by industry for all other holdings.
(2)Includes publicly traded agency pass-through securities and collateralized obligations.


102

Table of Contents
Fixed Maturities Credit Quality
The SVO of the NAIC evaluates the investments of insurers for regulatory reporting purposes and assigns fixed maturities to one of six categories (“NAIC Designations”). NAIC Designations of “1” or “2” include fixed maturities considered investment grade, which include securities rated Baa3 or higher by Moody’s or BBB- or higher by Standard & Poor’s. NAIC Designations of “3” through “6” are referred to as below investment grade, which include securities rated Ba1 or lower by Moody’s and BB+ or lower by Standard & Poor’s. As a result of time lags between the funding of investments and the completion of the SVO filing process, the fixed maturity portfolio typically includes securities that have not yet been rated by the SVO as of each balance sheet date. Pending receipt of SVO ratings, the categorization of these securities by NAIC designation is based on the expected ratings indicated by internal analysis.
The following table sets forth the General Account’s fixed maturities portfolio by NAIC rating at the dates indicated.
Fixed Maturities
NAIC Designation
Rating Agency Equivalent
Amortized
Cost
Allowance for Credit Losses
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
  
(in millions)
As of September 30, 2022
1................................Aaa, Aa, A$45,386 $ $52 $6,043 $39,395 
2................................Baa26,373  31 4,448 21,956 
Investment grade71,759  83 10,491 61,351 
3................................Ba1,648 1 2 172 1,477 
4................................B1,113 19 2 70 1,026 
5................................Caa45 2  2 41 
6................................Ca, C     
Below investment grade2,806 22 4 244 2,544 
Total Fixed Maturities$74,565 $22 $87 $10,735 $63,895 
As of December 31, 2021:
1................................Aaa, Aa, A$44,653 $— $3,734 $158 $48,229 
2................................Baa25,141 — 1,357 127 26,371 
Investment grade69,794 — 5,091 285 74,600 
3................................Ba1,601 22 14 1,608 
4................................B992 19 976 
5................................Caa130 131 
6................................Ca, C28 — — 27 
Below investment grade2,751 22 34 21 2,742 
Total Fixed Maturities$72,545 $22 $5,125 $306 $77,342 

Mortgage Loans
The mortgage portfolio primarily consists of commercial and agricultural mortgage loans. The investment strategy for the mortgage loan portfolio emphasizes diversification by property type and geographic location with a primary focus on asset quality. The tables below show the breakdown of the amortized cost of the General Account’s investments in mortgage loans by geographic region and property type as of the dates indicated.
103

Table of Contents
Mortgage Loans by Region and Property Type
 September 30, 2022December 31, 2021
 
Amortized
Cost
% of Total
Amortized
Cost
% of Total
(in millions)
By Region:
U.S. Regions:
Pacific$4,659 30 %$4,297 30 %
Middle Atlantic3,574 23 3,441 24 
South Atlantic2,038 13 1,982 14 
East North Central1,009 6 1,103 
Mountain1,374 9 978 
West North Central841 5 834 
West South Central968 6 609 
New England726 5 579 
East South Central249 2 146 
Total U.S.$15,438 98 %$13,969 99 %
Other Regions:
Europe$333 2 %$126 %
Total Other$333 2 $126 
Total Mortgage Loans$15,771 100 %$14,095 100 %
By Property Type:
Office$4,511 29 %$3,944 28 %
Multifamily5,417 34 4,694 33 
Agricultural loans2,597 16 2,644 19 
Retail328 2 728 
Industrial1,837 12 1,204 
Hospitality406 3 410 
Other675 4 471 
Total Mortgage Loans$15,771 100 %$14,095 100 %
Liquidity and Capital Resources
Liquidity refers to our ability to generate adequate amounts of cash from our operating, investment and financing activities to meet our cash requirements with a prudent margin of safety. Capital refers to our long-term financial resources available to support business operations and future growth. Our ability to generate and maintain sufficient liquidity and capital is dependent on the profitability of our businesses, timing of cash flows related to our investments and products, our ability to access the capital markets, general economic conditions and the alternative sources of liquidity and capital described herein. When considering our liquidity and cash flows, we distinguish between the needs of Holdings and the needs of our insurance and non-insurance subsidiaries. We also distinguish and separately manage the liquidity and capital resources of our retirement and protection businesses (our Individual Retirement, Group Retirement and Protection Solutions segments) and our Investment Management and Research segment.
Sources and Uses of Liquidity
The Company has sufficient cash flows from operations to satisfy liquidity requirements in 2022.
Cash Flows of Holdings
As a holding company with no business operations of its own, Holdings primarily derives cash flows from dividends from its subsidiaries and distributions related to its economic interest in AB, all of which is currently held outside our insurance company subsidiaries. These principal sources of liquidity are augmented by cash and short-term investments held by Holdings and access to bank lines of credit and the capital markets. The main uses of liquidity for Holdings are interest payments and debt repayment, payment of dividends and other distributions to stockholders (which may include stock repurchases) loans and
104

Table of Contents
capital contributions, if needed, to our insurance subsidiaries. Our principal sources of liquidity and our capital position are described in the following paragraphs.
Sources and Uses of Holding Company Highly Liquid Assets
The following table sets forth Holdings’ principal sources and uses of highly liquid assets for the periods indicated.
Nine Months Ended September 30,
20222021
(in millions)
Highly Liquid Assets, beginning of period$1,742 $3,088 
Dividends from subsidiaries1,574 545 
Capital contributions to subsidiaries(150)(760)
M&A Activity 215 
Total Business Capital Activity1,424 — 
Purchase of treasury shares(699)(1,169)
Shareholder dividends paid(220)(224)
Total Share Repurchases, Dividends and Acquisition Activity(919)(1,393)
Issuance of preferred stock 293 
Preferred stock dividend(54)(53)
Total Preferred Stock Activity(54)240 
Issuance of long-term debt — 
Repayment of long-term debt— (280)
Total External Debt Activity (280)
Proceeds from loans from affiliates 1,000 
Net decrease (increase) in existing facilities to affiliates (1)65 285 
Total Affiliated Debt Activity65 1,285 
Interest paid on external debt and P-Caps(116)(140)
Others, net89 (278)
Total Other Activity(27)(418)
Net increase (decrease) in highly liquid assets489 (566)
Highly Liquid Assets, end of period$2,231 $2,522 
(1) Represents net activity of draws and repayments of existing credit facilities between Holdings and affiliates.
105

Capital Contribution to Our Subsidiaries
During the nine months ended September 30, 2022, Holdings made cash capital contributions of $150 million.
Loans from Our Subsidiaries
There were no loans from our subsidiaries during the nine months ended September 30, 2022.
Cash Distributions from Our Subsidiaries
During the nine months ended September 30, 2022, Holdings and certain of its subsidiaries received pretax cash distributions from AB of $481 million and post-tax distributions from Equitable Financial of $930 million and EIM of $164 million.
Distributions from Insurance Subsidiaries
Our insurance companies are subject to limitations on the payment of dividends and other transfers of funds to Holdings and other affiliates under applicable insurance law and regulation. Also, more generally, the ability of our insurance subsidiaries to pay dividends can be affected by market conditions and other factors beyond our control.
Under New York insurance laws, which are applicable to Equitable Financial, a domestic stock life insurer may not, without prior approval of the NYDFS, pay an ordinary dividend to its stockholders exceeding an amount calculated based on a statutory formula (“Ordinary Dividend”). Dividends in excess of this amount require the insurer to file a notice of its intent to declare the dividends with the NYDFS and obtain prior approval or non-disapproval from the NYDFS with respect to such dividends (“Extraordinary Dividends”). Due to a permitted statutory accounting practice agreed to with the NYDFS, Equitable Financial will need the prior approval of the NYDFS to pay the portion, if any, of any Ordinary Dividend that exceeds the Ordinary Dividend that Equitable Financial would be permitted to pay under New York insurance law absent the application of such permitted practice (such excess, the “Permitted Practice Ordinary Dividend”). Applying the formula above, Equitable Financial could pay an Ordinary Dividend of up to approximately $0.9 billion in 2022 without the prior approval of the NYDFS. Holdings received a dividend distribution from Equitable Financial of $0.9 billion during July 2022.
Distributions from AllianceBernstein
ABLP is required to distribute all of its Available Cash Flow, as defined in the Amended and Restated Partnership Agreement of ABLP, to the holders of AB Units and to the General Partner. Available Cash Flow is defined as the cash flow received by ABLP from operations minus such amounts as the General Partner determines, in its sole discretion, should be retained by ABLP for use in its business, or plus such amounts as the General Partner determines, in its sole discretion, should be released from previously retained cash flow. Distributions by ABLP are made 1% to the General Partner and 99% among the limited partners.
Typically, Available Cash Flow has been the adjusted diluted net income per unit for the quarter multiplied by the number of general and limited partnership interests at the end of the quarter. In future periods, management of AB anticipates that Available Cash Flow will be based on adjusted diluted net income per unit, unless management of AB determines, with the concurrence of the Board of Directors of AB, that one or more adjustments that are made for adjusted net income should not be made with respect to the Available Cash Flow calculation.
AB Holding is required to distribute all of its Available Cash Flow, as defined in the Amended and Restated Agreement of Limited Partnership of AB Holding, to holders of AB Holding Units pro rata in accordance with their percentage interest in AB Holding. Available Cash Flow is defined as the cash distributions AB Holding receives from ABLP minus such amounts as the General Partner determines, in its sole discretion, should be retained by AB Holding for use in its business (such as the payment of taxes) or plus such amounts as the General Partner determines, in its sole discretion, should be released from previously retained cash flow. AB Holding is dependent on the quarterly cash distributions it receives from ABLP, which is subject to the performance of capital markets and other factors beyond our control. Distributions from AB Holding are made pro rata based on the holder’s percentage ownership interest in AB Holding.
As of September 30, 2022, Holdings and its non-insurance company subsidiaries hold approximately 170.1 million AB Units, 4.1 million AB Holding Units and the 1% General Partnership interest in ABLP.
As of September 30, 2022, the ownership structure of ABLP, including AB Units outstanding as well as the general partner’s 1% interest, was as follows:
106

OwnerPercentage Ownership
EQH and its subsidiaries62.8 %
AB Holding36.5 %
Unaffiliated holders0.7 %
Total100.0 %
Including both the general partnership and limited partnership interests in AB Holding and ABLP, Holdings and its subsidiaries had an approximate 64% economic interest in AB as of September 30, 2022. The issuance of AB Units relating to the CarVal acquisition is not expected to have a significant impact on the Company’s cash flows.
Holdings Credit Facilities
On June 24, 2021, Holdings entered into the Amended and Restated Revolving Credit Agreement with respect to a five-year senior unsecured revolving credit facility (the “Credit Facility”), which lowered the facility amount to $1.5 billion and extended the maturity date to June 24, 2026, among other changes. The Amended and Restated Revolving Credit Agreement amends the Revolving Credit Agreement entered into by Holdings on February 16, 2018, as amended on March 22, 2021.
The Credit Facility may provide significant support to our liquidity position when alternative sources of credit are limited. In addition to the Credit Facility, we have letter of credit facilities with an aggregate principal amount of approximately $1.9 billion (the “LOC Facilities”), primarily to be used to support our life insurance business reinsured to EQ AZ Life Re in April 2018. In June 2021, Holdings entered into amendments with each of the issuers of its bilateral letter of credit facilities to effect changes similar to those effected in the amended and restated revolving credit agreement. The respective facility limits of the bilateral letter of credit facilities remained unchanged.
The Credit Facility and LOC Facilities contain certain administrative, reporting, legal and financial covenants, including requirements to maintain a specified minimum consolidated net worth and to maintain a ratio of indebtedness to total capitalization not in excess of a specified percentage, and limitations on the dollar amount of indebtedness that may be incurred by our subsidiaries and the dollar amount of secured indebtedness that may be incurred by us, which could restrict our operations and use of funds. The right to borrow funds under the Credit Facility and LOC Facilities is subject to the fulfillment of certain conditions, including compliance with all covenants, and the ability to borrow thereunder is also subject to the continued ability of the lenders that are or will be parties to the facilities to provide funds. As of September 30, 2022, we were in compliance with these covenants.
Contingent Funding Arrangements
For information regarding activity pertaining to our contingent funding arrangements and other off-balance sheet commitments, see “Commitments and Contingent Liabilities” in Note 12 of the Notes to the Consolidated Financial Statements in this Form 10-Q.
Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock
For information pertaining to our Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock see Note 10 of the Notes to the Consolidated Financial Statements.
Capital Position of Holdings
We manage our capital position to maintain financial strength and credit ratings that facilitate the distribution of our products and provide our desired level of access to the bank and capital markets. Our capital position is supported by the ability of our subsidiaries to generate cash flows and distribute cash to us and our ability to effectively manage the risk of our businesses and to borrow funds and raise capital to meet our operating and growth needs.
Our Board and senior management are directly involved in the development of our capital management policies. Accordingly, capital actions, including proposed changes to the annual capital plan, capital targets and capital policies, are approved by the Board.
107

Dividends Declared and Paid
The declaration and payment of future dividends is subject to the discretion of our Board of Directors and depends on our financial condition, results of operations, cash requirements, future prospects, regulatory restrictions on the payment of dividends by Holdings’ insurance subsidiaries and other factors deemed relevant by the Board. 
The payment of dividends will be substantially restricted in the event that we do not declare and pay (or set aside) dividends on the Series A , Series B and Series C Preferred Stock for the last proceeding dividend period. For additional information on our preferred stock, see “—Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock”.
For information regarding activity pertaining to common and preferred dividends declared and paid, see Note 10 of the Notes to the Consolidated Financial Statements.
Share Repurchase Programs
For information regarding activity pertaining to share repurchase programs, see Note 10 of the Notes to the Consolidated Financial Statements.
Sources and Uses of Liquidity of Our Insurance Subsidiaries
The principal sources of liquidity for our insurance subsidiaries are premiums, investment and fee income, deposits associated with our insurance and annuity operations, cash and invested assets, as well as internal borrowings. The principal uses of that liquidity include benefits, claims and dividends paid to policyholders and payments to policyholders in connection with surrenders and withdrawals. Other uses of liquidity include commissions, general and administrative expenses, purchases of investments, the payment of dividends to Holdings and hedging activity. Certain of our insurance subsidiaries’ principal sources and uses of liquidity are described in the paragraphs that follow.
We manage the liquidity of our insurance subsidiaries with the objective of ensuring that they can meet payment obligations linked to our Individual Retirement, Group Retirement and Protection Solutions businesses and to their outstanding debt and derivative positions, including in our hedging programs, without support from Holdings. We employ an asset/liability management approach specific to the requirements of each of our insurance businesses. We measure liquidity against internally-developed benchmarks that consider the characteristics of our asset portfolio and the liabilities that it supports in both the short-term (the next 12 months) and long-term (beyond the next 12 months). We consider attributes of the various categories of our liquid assets (for example, type of asset and credit quality) in calculating internal liquidity indicators for our insurance and reinsurance operations. Our liquidity benchmarks are established for various stress scenarios and durations, including company-specific and market-wide events. The scenarios we use to evaluate the liquidity of our subsidiaries are defined to allow operating entities to operate without support from Holdings.
Liquid Assets
The investment portfolios of our insurance subsidiaries are a significant component of our overall liquidity. Liquid assets include cash and cash equivalents, short-term investments, U.S. Treasury fixed maturities, fixed maturities that are not designated as HTM and public equity securities. We believe that our business operations and the liquidity profile of our assets provide sufficient liquidity under reasonably foreseeable stress scenarios for each of our insurance subsidiaries.
See “—General Account Investment Portfolio” and Note 3 and Note 4 of the Notes to the Consolidated Financial Statements for a description of our retirement and protection businesses’ portfolio of liquid assets.
Hedging Activities
Because the future claims exposure on our insurance products, and in particular our variable annuity products with GMxB features, is sensitive to movements in the equity markets and interest rates, we have in place various hedging and reinsurance programs that are designed to mitigate the economic risks of movements in the equity markets and interest rates. We use derivatives as part of our overall asset/liability risk management program primarily to reduce exposures to equity market and interest rate risks. In addition, we use credit derivatives to replicate exposure to individual securities or pools of securities as a means of achieving credit exposure similar to bonds of the underlying issuer(s) more efficiently. The derivative contracts are an integral part of our risk management program, especially for the management of our variable annuities program, and are collectively managed to reduce the economic impact of unfavorable movements in capital markets. These derivative transactions require liquidity to meet payment obligations such as payments for periodic settlements, purchases, maturities and terminations as well as liquid assets pledged as collateral related to any decline in the net estimated fair value. Collateral calls
108

represent one of our biggest drivers for liquidity needs for our insurance subsidiaries. Our derivatives contracts reside primarily within Equitable Financial, which has a significantly large investment portfolio.
FHLB Membership
Equitable Financial and Equitable America are members of the FHLB, which provides access to collateralized borrowings and other FHLB products.
See Note 12 of the Notes to the Consolidated Financial Statements for further description of our FHLB program.
FABN
Under the FABN program, Equitable Financial may issue funding agreements in U.S. dollar or other foreign currencies.
See Note 12 of the Notes to the Consolidated Financial Statements for further description of our FABN program.
Sources and Uses of Liquidity of our Investment Management and Research Segment
The principal sources of liquidity for our Investment Management and Research business include investment management fees and borrowings under its credit facilities and commercial paper program. The principal uses of liquidity include general and administrative expenses, business financing and distributions to holders of AB Units and AB Holding Units plus interest and debt service. The primary liquidity risk for our fee-based Investment Management and Research business is its profitability, which is impacted by market conditions and our investment management performance.
AB Commercial Paper
As of September 30, 2022 and December 31, 2021, AB had no commercial paper outstanding. The commercial paper is short term in nature, and as such, recorded value is estimated to approximate fair value (and considered a Level 2 security in the fair value hierarchy). Average daily borrowings for the commercial paper outstanding during the first nine months of 2022 and full year 2021 were $202 million and $157 million, respectively, with weighted average interest rates of approximately 0.9% and 0.2%, respectively.
AB Revolver Credit Facility
AB had a $200 million committed, unsecured senior revolving credit facility (the "AB Revolver") with a leading international bank, which matured on November 16, 2021. Average daily borrowings for the full year 2021 were $13 million with a weighted average interest rate of 1.1%.
AB Credit Facility
AB has an $800 million committed, unsecured senior revolving credit facility (the “AB Credit Facility”) with a group of commercial banks and other lenders which matures on October 13, 2026. The credit facility provides for possible increases in the principal amount by up to an aggregate incremental amount of $200 million. Any such increase is subject to the consent of the affected lenders. The AB Credit Facility is available for AB and SCB LLC for business purposes, including the support of AB’s commercial paper program. Both AB and SCB LLC can draw directly under the AB Credit Facility and AB management expects to draw on the AB Credit Facility from time to time. AB has agreed to guarantee the obligations of SCB LLC under the AB Credit Facility.
The AB Credit Facility contains affirmative, negative and financial covenants, which are customary for facilities of this type, including, among other things, restrictions on dispositions of assets, restrictions on liens, a minimum interest coverage ratio and a maximum leverage ratio. As of September 30, 2022, AB was in compliance with these covenants. The AB Credit Facility also includes customary events of default (with customary grace periods, as applicable), including provisions under which, upon the occurrence of an event of default, all outstanding loans may be accelerated and/or lender’s commitments may be terminated. Also, under such provisions, upon the occurrence of certain insolvency- or bankruptcy-related events of default, all amounts payable under the AB Credit Facility would automatically become immediately due and payable, and the lender’s commitments would automatically terminate.
Amounts under the Credit Facility may be borrowed, repaid and re-borrowed by us from time to time until the maturity of the facility. Voluntary prepayments and commitment reductions requested by AB are permitted at any time without a fee (other than customary breakage costs relating to the prepayment of any drawn loans) upon proper notice and subject to a minimum dollar requirement. Borrowings under the AB Credit Facility bear interest at a rate per annum, which will be, at AB’s option, a
109

rate equal to an applicable margin, which is subject to adjustment based on the credit ratings of AB, plus one of the following indices: LIBOR; a floating base rate; or the Federal Funds rate.
As of September 30, 2022 and December 31, 2021, AB had no amounts outstanding under the AB Credit Facility. During the first nine months of 2022 and the full year 2021, AB and SCB LLC did not draw upon the AB Credit Facility.
In addition, SCB LLC currently has five uncommitted lines of credit with five financial institutions. Four of these lines of credit permit borrowing up to an aggregate of approximately $315 million, with AB named as an additional borrower, while the other line has no stated limit. As of September 30, 2022 and December 31, 2021, SCB LLC had no outstanding balance on these lines of credit. Average daily borrowings during the first nine months of 2022 and the full year 2021 were $1.2 million and $47 thousand with weighted average interest rates of approximately 1.9% and 0.9%, respectively.
EQH Facility
AB has a $900 million committed, unsecured senior credit facility (the “EQH Facility”). The EQH Facility matures on November 4, 2024 and is available for AB’s general business purposes. Borrowings under the EQH Facility generally bear interest at a rate per annum based on prevailing overnight commercial paper rates.
The EQH Facility contains affirmative, negative and financial covenants which are substantially similar to those in AB’s committed bank facilities. The EQH Facility also includes customary events of default substantially similar to those in AB’s committed bank facilities, including provisions under which, upon the occurrence of an event of default, all outstanding loans may be accelerated and/or the lender’s commitment may be terminated.
Amounts under the EQH Facility may be borrowed, repaid and re-borrowed by AB from time to time until the maturity of the facility. AB or Holdings may reduce or terminate the commitment at any time without penalty upon proper notice. Holdings also may terminate the facility immediately upon a change of control of AB’s general partner.
As of September 30, 2022 and December 31, 2021, AB had $690 million and $755 million outstanding under the EQH Facility, with interest rates of approximately 3.0% and 0.2%, respectively. Average daily borrowing of the EQH Facility during the first nine months of 2022 and the full year 2021 were $654 million and $405 million, respectively, with a weighted average interest rates of approximately 1.0% and 0.2%, respectively.
EQH Uncommitted Facility
In addition to the EQH Facility, AB entered into a $300 million uncommitted, unsecured senior credit facility (the “EQH Uncommitted Facility”) with EQH. The EQH Uncommitted Facility matures on September 1, 2024 and is available for AB’s general business purposes. Borrowings under the EQH Uncommitted Facility bear generally interest at a rate per annum based on prevailing overnight commercial paper rates. The EQH Uncommitted Facility contains affirmative, negative and financial covenants, which are substantially similar to those in the EQH Facility.
As of September 30, 2022 and December 31, 2021, AB had no outstanding balance on the EQH Uncommitted Facility and has not drawn upon the facility since its inception.
Statutory Capital of Our Insurance Subsidiaries
Our capital management framework for our insurance subsidiaries is primarily based on statutory RBC standards and the CTE asset standard for our variable annuity business.
RBC requirements are used as minimum capital requirements by the NAIC and the state insurance departments to evaluate the capital condition of regulated insurance companies. RBC is based on a formula calculated by applying factors to various asset, premium, claim, expense and statutory reserve items. The formula takes into account the risk characteristics of the insurer, including asset risk, insurance risk, interest rate risk, market risk and business risk and is calculated on a quarterly basis and made public on an annual basis. The formula is used as an early warning regulatory tool to identify possible inadequately capitalized insurers for purposes of initiating regulatory action, and not as a means to rank insurers generally. These rules apply to our insurance company subsidiaries and not to Holdings. State insurance laws provide insurance regulators the authority to require various actions by, or take various actions against, insurers whose total adjusted capital does not meet or exceed certain RBC levels. At the date of the most recent annual statutory financial statements filed with insurance regulators, the total adjusted capital of each of these insurance company subsidiaries subject to these requirements was in excess of each of those RBC levels.
110

See 13 of the Notes to the Consolidated Financial Statements for additional information relating to Prescribed and Permitted Statutory Accounting practices and its impact on our statutory surplus.
Captive Reinsurance Company
We use a captive reinsurance company to more effectively manage our reserves and capital on an economic basis and to enable the aggregation and transfer of risks. Our captive reinsurance company assumes business from affiliates only and is closed to new business. Our captive reinsurance company is a wholly-owned subsidiary located in the United States. In addition to state insurance regulation, our captive is subject to internal policies governing its activities. We continue to analyze the use of our existing captive reinsurance structure, as well as additional third-party reinsurance arrangements.
Borrowings
Our financial strategy going forward will remain subject to market conditions and other factors. For example, we may from time to time enter into additional bank or other financing arrangements, including public or private debt, structured facilities and contingent capital arrangements, under which we could incur additional indebtedness.
The following table sets forth the Company’s total consolidated borrowings. Short-term and long-term debt consists of the following:
September 30,December 31,
20222021
(in millions)
Short-term debt:
CLO Warehousing Debt$248 $92 
Senior Notes (3.9%, due 2023)
519 519 
Total short-term debt 767 611 
Long-term debt:
Senior Notes (5.0%, due 2048)
1,480 1,481 
Senior Notes (4.35%, due 2028)
1,491 1,490 
Senior Debentures, (7.0%, due 2028)
350 349 
Total long-term debt 3,321 3,320 
Total short-term and long-term debt $4,088 $3,931 

Notes and Debentures
The Senior Notes and Senior Debentures contain customary affirmative and negative covenants, including a limitation on certain liens and a limit on the Company’s ability to consolidate, merge or sell or otherwise dispose of all or substantially all of its assets. The Senior Notes and Senior Debentures also include customary events of default (with customary grace periods, as applicable), including provisions under which, upon the occurrence of an event of default, all outstanding Senior Notes and Senior Debentures may be accelerated. As of September 30, 2022, the Company is in compliance with all debt covenants.
Ratings
Financial strength ratings (which are sometimes referred to as “claims-paying” ratings) and credit ratings are important factors affecting public confidence in an insurer and its competitive position in marketing products. Our credit ratings are also important for our ability to raise capital through the issuance of debt and for the cost of such financing.
Financial strength ratings represent the opinions of rating agencies regarding the financial ability of an insurance company to meet its obligations under an insurance policy. Credit ratings represent the opinions of rating agencies regarding an entity’s ability to repay its indebtedness. The following table summarizes the ratings for Holdings and certain of its subsidiaries. AM Best, S&P and Moody’s have a stable outlook.
111

AM BestS&PMoody’s
Last review dateJan '22Jun '22Jul '22
Financial Strength Ratings:
Equitable Financial Life Insurance CompanyAA+A1
Equitable Financial Life Insurance Company of AmericaAA+A1
Credit Ratings:
Equitable Holdings, Inc.BBB+Baa1
Last review dateSep '22Jul '22
AllianceBernstein L.P.AA2

Material Cash Requirement
Our material cash requirements include policyholder obligations, long-term debt, commercial paper, employee benefits, operating leases and various funding commitments. See “Material Cash Requirement” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Annual Report on Form 10-K for the year ended December 31, 2021 for additional information.
Summary of Critical Accounting Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in our consolidated financial statements included elsewhere herein. For a discussion of our significant accounting policies, see Note 2 to the Company’s consolidated financial statements included in our 2021 Form 10-K. The most critical estimates include those used in determining:
liabilities for future policy benefits;
accounting for reinsurance;
capitalization and amortization of DAC;
estimated fair values of investments in the absence of quoted market values and investment impairments;
estimated fair values of freestanding derivatives and the recognition and estimated fair value of embedded derivatives requiring bifurcation;
goodwill and related impairment;
measurement of income taxes and the valuation of deferred tax assets; and
liabilities for litigation and regulatory matters.
In applying our accounting policies, we make subjective and complex judgments that frequently require estimates about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries while others are specific to our business and operations. Actual results could differ from these estimates.
Item 3.      Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes to the quantitative and qualitative disclosures about market risk described in the Annual Report on Form 10-K for the year ended December 31, 2021 in "Quantitative and Qualitative Disclosures About Market Risk".
112

Table of Contents
Item 4.     Controls and Procedures
Management, with the participation of the Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2022, the Company’s disclosure controls and procedures were effective.
During the first quarter 2022, we implemented a new accounting and financial reporting system, including the general ledger. We have modified our existing controls infrastructure, as well as added other processes and internal controls, to adapt to our new general ledger. There are no other changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) that occurred during the nine months ended September 30, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

113

Table of Contents
PART II. OTHER INFORMATION
Item 1.     Legal Proceedings
For information regarding certain legal proceedings pending against us, see Note 12 of the Notes to these Consolidated Financial Statements (unaudited) in this Form 10-Q. Also see “Risk Factors—Legal and Regulatory Risks—Legal and regulatory actions” included in our Annual Report on Form 10-K for the year ended December 31, 2021.
Item 1A. Risk Factors
You should carefully consider the risks described in the “Risk Factors” section included in our Annual Report on Form 10-K for the year ended December 31, 2021. Risks to which we are subject also include, but are not limited to, the factors mentioned under “Note Regarding Forward-Looking Statements and Information” above and the risks of our businesses described elsewhere in this Quarterly Report on Form 10-Q.
Item 2.     Unregistered Sales of Equity Securities and Use of Proceeds
The following table provides information about purchases by Holdings during the three months ended September 30, 2022, of its common stock:
Period
Total Number of Shares Purchased
Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsApproximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
7/1/22 through 7/31/221,167,227 $25.70 1,167,227 $674,529,426 
8/1/22 through 8/31/221,943,449 $30.60 1,943,449 $615,054,615 
9/1/22 through 9/30/223,869,178 $28.60 3,869,178 $577,554,615 
Total6,979,854 $28.67 6,979,854 $577,554,615 

See Note 10 to the Notes to Consolidated Financial Statements for ASR transaction detail during the three months ended September 30, 2022.
Item 3.     Defaults Upon Senior Securities
None.
Item 4.     Mine Safety Disclosures
Not applicable.
Item 5.      Other Information
None.
114

Table of Contents
Item 6.     Exhibits
Number
Description and Method of Filing
#Master Transaction Agreement, dated as of August 16, 2022 among Equitable Financial Life Insurance Company and First Allmerica Financial Life Insurance Company (redacted)
#Coinsurance and Modified Coinsurance Agreement, dated as of October 3, 2023, between Equitable Financial Life Insurance Company and First Allmerica Financial Life Insurance Company (redacted)
#Certification of the Registrant’s Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
#Certification of the Registrant’s Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
#Certification of the Registrant’s Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
#Certification of the Registrant’s Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
104Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibits 101).
______________
#    Filed herewith.
GLOSSARY
Selected Financial Terms
Account Value (“AV”)Generally equals the aggregate policy account value of our retirement and protection products. General Account AV refers to account balances in investment options that are backed by the General Account while Separate Accounts AV refers to Separate Accounts investment assets.
Alternative investmentsInvestments in real estate and real estate joint ventures and other limited partnerships.
Assets under administration (“AUA”)
Includes non-insurance client assets that are invested in our savings and investment products or serviced by our Equitable Advisors platform. We provide administrative services for these assets and generally record the revenues received as distribution fees.
Assets under management (“AUM”)Investment assets that are managed by one of our subsidiaries and includes: (i) assets managed by AB, (ii) the assets in our GAIA portfolio and (iii) the Separate Account assets of our retirement and protection businesses. Total AUM reflects exclusions between segments to avoid double counting.
Combined RBC RatioCalculated as the overall aggregate RBC ratio for the Company’s insurance subsidiaries including capital held for its life insurance and variable annuity liabilities and non-variable annuity insurance liabilities.
Conditional tail expectation (“CTE”)
Calculated as the average amount of total assets required to satisfy obligations over the life of the contract or policy in the worst x% of scenarios. Represented as CTE (100 less x). Example: CTE95 represents the worst five percent of scenarios.
Deferred policy acquisition cost (“DAC”)Represents the incremental costs related directly to the successful acquisition of new and certain renewal insurance policies and annuity contracts and which have been deferred on the balance sheet as an asset.
115

Table of Contents
Deferred sales inducements (“DSI”)Represent amounts that are credited to a policyholder’s account balance that are higher than the expected crediting rates on similar contracts without such an inducement and that are an incentive to purchase a contract and also meet the accounting criteria to be deferred as an asset that is amortized over the life of the contract.
Dividends Received Deduction (“DRD”)A tax deduction under U.S. federal income tax law received by a corporation on the dividends it receives from other corporations in which it has an ownership stake.
Fee-type revenueRevenue from fees and related items, including policy charges and fee income, premiums, investment management and service fees, and other income.
Gross PremiumsFYP and Renewal premium and deposits
Invested assetsIncludes fixed maturity securities, equity securities, mortgage loans, policy loans, alternative investments and short-term investments.
Protection Solutions ReservesEquals the aggregate value of Policyholders’ account balances and Future policy benefits for policies in our Protection Solutions segment.
ReinsuranceInsurance policies purchased by insurers to limit the total loss they would experience from an insurance claim.
Renewal premium and depositsPremiums and deposits after the first twelve months of the policy or contract.
Risk-based capital (“RBC”)Rules to determine insurance company statutory capital requirements. It is based on rules published by the National Association of Insurance Commissioners (“NAIC”).
Total adjusted capital (“TAC”)Primarily consists of capital and surplus, and the asset valuation reserve.
Product Terms 
401(k)A tax-deferred retirement savings plan sponsored by an employer. 401(k) refers to the section of the Internal Revenue Code of 1986, as amended (the “Code”) pursuant to which these plans are established.
403(b)A tax-deferred retirement savings plan available to certain employees of public schools and certain tax-exempt organizations. 403(b) refers to the section of the Code pursuant to which these plans are established.
AffluentRefers to individuals with $250,000 to $999,999 of investable assets.
AnnuitantThe person who receives annuity payments or the person whose life expectancy determines the amount of variable annuity payments upon annuitization of an annuity to be paid for life.
AnnuitizationThe process of converting an annuity investment into a series of periodic income payments, generally for life.
Benefit baseA notional amount (not actual cash value) used to calculate the owner’s guaranteed benefits within an annuity contract. The death benefit and living benefit within the same contract may not have the same benefit base.
Cash surrender valueThe amount an insurance company pays (minus any surrender charge) to the policyholder when the contract or policy is voluntarily terminated prematurely.
Dollar-for-dollar withdrawalA method of calculating the reduction of a variable annuity benefit base after a withdrawal in which the benefit is reduced by one dollar for every dollar withdrawn.
Future policy benefitsFuture policy benefits for the annuities business are comprised mainly of liabilities for life-contingent income annuities, and liabilities for the variable annuity guaranteed minimum benefits accounted for as insurance.

Future policy benefits for the life business are comprised mainly of liabilities for traditional life and certain liabilities for universal and variable life insurance contracts (other than the Policyholders’ account balance).
General Account Investment PortfolioThe invested assets held in the General Account.
116

Table of Contents
General AccountThe assets held in the general accounts of our insurance companies as well as assets held in our separate accounts on which we bear the investment risk.
GMxBA general reference to all forms of variable annuity guaranteed benefits, including guaranteed minimum living benefits, or GMLBs (such as GMIBs, GMWBs and GMABs), and guaranteed minimum death benefits, or GMDBs (inclusive of return of premium death benefit guarantees).
Guaranteed income benefit (“GIB”)An optional benefit which provides the policyholder with a guaranteed lifetime annuity based on predetermined annuity purchase rates applied to a GIB benefit base, with annuitization automatically triggered if and when the contract AV falls to zero.
Guaranteed minimum accumulation benefits (“GMAB”)An optional benefit (available for an additional cost) which entitles an annuitant to a minimum payment, typically in lump-sum, after a set period of time, typically referred to as the accumulation period. The minimum payment is based on the benefit base, which could be greater than the underlying AV.
Guaranteed minimum death
benefits (“GMDB”)
An optional benefit (available for an additional cost) that guarantees an annuitant’s beneficiaries are entitled to a minimum payment based on the benefit base, which could be greater than the underlying AV, upon the death of the annuitant.
Guaranteed minimum income benefits (“GMIB”)An optional benefit (available for an additional cost) where an annuitant is entitled to annuitize the policy and receive a minimum payment stream based on the benefit base, which could be greater than the underlying AV.
Guaranteed minimum living
benefits (“GMLB”)
A reference to all forms of guaranteed minimum living benefits, including GMIBs, GMWBs and GMABs (does not include GMDBs).
Guaranteed minimum withdrawal benefits (“GMWB”)An optional benefit (available for an additional cost) where an annuitant is entitled to withdraw a maximum amount of their benefit base each year, for which cumulative payments to the annuitant could be greater than the underlying AV.
Guaranteed Universal Life (“GUL”)A universal life insurance offering with a lifetime no lapse guarantee rider, otherwise known as a guaranteed UL policy. With a GUL policy, the premiums are guaranteed to last the life of the policy.
Guaranteed withdrawal benefit for life (“GWBL”)An optional benefit (available for an additional cost) where an annuitant is entitled to withdraw a maximum amount of their benefit base each year, for the duration of the policyholder’s life, regardless of account performance.
High net worthRefers to individuals with $1,000,000 or more of investable assets.
Indexed Universal Life (“IUL”)A permanent life insurance offering built on a universal life insurance framework that uses an equity-linked approach for generating policy investment returns.
Living benefitsOptional benefits (available at an additional cost) that guarantee that the policyholder will get back at least his original investment when the money is withdrawn.
Mortality and expense risk fee (“M&E fee”)A fee charged by insurance companies to compensate for the risk they take by issuing life insurance and variable annuity contracts.
Net flowsNet change in customer account balances in a period including, but not limited to, gross premiums, surrenders, withdrawals and benefits. It excludes investment performance, interest credited to customer accounts and policy charges.
Policyholder account balances
Annuities. Policyholder account balances are held for fixed deferred annuities, the fixed account portion of variable annuities and non-life contingent income annuities. Interest is credited to the policyholder’s account at interest rates we determine which are influenced by current market rates, subject to specified minimums.
 
Life Insurance Policies. Policyholder account balances are held for retained asset accounts, universal life policies and the fixed account of universal variable life insurance policies. Interest is credited to the policyholder’s account at interest rates we determine which are influenced by current market rates, subject to specified minimums.
117

Table of Contents
Return of premium (“ROP”) death benefitThis death benefit pays the greater of the account value at the time of a claim following the owner’s death or the total contributions to the contract (subject to adjustment for withdrawals). The charge for this benefit is usually included in the M&E fee that is deducted daily from the net assets in each variable investment option. We also refer to this death benefit as the Return of Principal death benefit.
RiderAn optional feature or benefit that a policyholder can purchase at an additional cost.
Separate AccountRefers to the separate account investment assets of our insurance subsidiaries excluding the assets held in those separate accounts on which we bear the investment risk.
Surrender chargeA fee paid by a contract owner for the early withdrawal of an amount that exceeds a specific percentage or for cancellation of the contract within a specified amount of time after purchase.
Surrender rateRepresents annualized surrenders and withdrawals as a percentage of average AV.
Universal life (“UL”) productsLife insurance products that provide a death benefit in return for payment of specified annual policy charges that are generally related to specific costs, which may change over time. To the extent that the policyholder chooses to pay more than the charges required in any given year to keep the policy in-force, the excess premium will be placed into the AV of the policy and credited with a stated interest rate on a monthly basis.
Variable annuityA type of annuity that offers guaranteed periodic payments for a defined period of time or for life and gives purchasers the ability to invest in various markets though the underlying investment options, which may result in potentially higher, but variable, returns.
Variable Universal Life (“VUL”)Universal life products where the excess amount paid over policy charges can be directed by the policyholder into a variety of Separate Account investment options. In the Separate Account investment options, the policyholder bears the entire risk and returns of the investment results.
Whole Life (“WL”)A life insurance policy that is guaranteed to remain in-force for the policyholder’s lifetime, provided the required premiums are paid.

118

Table of Contents
ACRONYMS
“AB” or “AllianceBernstein” means AB Holding and ABLP
“AB Holding” means AllianceBernstein Holding L.P., a Delaware limited partnership
“AB Holding Units” means units representing assignments of beneficial ownership of limited partnership interests in AB Holding
“AB Units” means units of limited partnership interests in ABLP
“ABLP” means AllianceBernstein L.P., a Delaware limited partnership and the operating partnership for the AB business
“AFS” means available-for-sale
“AOCI” means accumulated other comprehensive income
“ASC” means Accounting Standards Codification
“ASR” means accelerated share repurchase
“ASU” means Accounting Standards Update
“AUM” means assets under management
“AUA” means assets under administration
“AV” means Account Value
“AXA” means AXA S.A., a société anonyme organized under the laws of France, and formerly our controlling stockholder
“BPs” means basis points
“CDS” means credit default swaps
“CLO” means collateralized loan obligation
“COI” means cost of insurance
“COLI” means corporate owned life insurance
“Company” means Equitable Holdings, Inc. with its consolidated subsidiaries
“CS Life” means Corporate Solutions Life Reinsurance Company, a Delaware corporation and a wholly-owned direct subsidiary of Holdings
“CS Life RE” means CS Life RE Company, an Arizona corporation and a wholly-owned indirect subsidiary of Holdings
“CSA” means credit support annex
“CTE” means conditional tail expectation
“DAC” means deferred policy acquisition costs
“DI” means disability income
“DOL” means U.S. Department of Labor
“DSC” means debt service coverage
“DSI” means deferred sales inducement
“EAFE” means European, Australasia, and Far East
“EB” means Employee Benefits
“EFS” means Equitable Financial Services, LLC, a Delaware corporation and a wholly-owned direct subsidiary of Holdings
“EPS” means earnings per share
“EIMG” means Equitable Investment Management Group, LLC, a Delaware limited liability company and a wholly-owned indirect subsidiary of Holdings.
“EIM” means Equitable Investment Management, LLC, a Delaware limited liability company and wholly-owned indirect subsidiary of Holdings.
“Equitable Advisors” means Equitable Advisors, LLC, a Delaware limited liability company, our retail broker/dealer for our retirement and protection businesses and a wholly-owned indirect subsidiary of Holdings
“Equitable America” means Equitable Financial Life Insurance Company of America (f/k/a MONY Life Insurance Company of America), an Arizona corporation and a wholly-owned indirect subsidiary of Holdings
“Equitable Financial” means Equitable Financial Life Insurance Company, a New York corporation, a life insurance company and a wholly-owned subsidiary of EFS
“EQ AZ Life Re” means EQ AZ Life Re Company, an Arizona corporation and a wholly-owned indirect subsidiary of Holdings.
“ERISA” means Employee Retirement Income Security Act of 1974
“ESG” means environmental, social and governance
“ETF” means exchange traded funds
“ETR” means effective tax rate
“Exchange Act” means Securities Exchange Act of 1934, as amended
“FABN” means Funding Agreement Backed Notes Program
“FASB” means Financial Accounting Standards Board
“FHLB” means Federal Home Loan Bank
“FYP” means first year premium and deposits
“General Partner” means AllianceBernstein Corporation, a Delaware corporation and the general partner of AB Holding and ABLP
“GUL” means guaranteed universal life
“HFS” means held-for-sale
“Holdings” means Equitable Holdings, Inc.
“HTM” means held-to-maturity
“IPO” means initial public offering
119

Table of Contents
“ISDA Master Agreement” means International Swaps and Derivatives Association Master Agreement
“IUL” means indexed universal life
“IUS” means Investments Under Surveillance
“LIBOR” means London Interbank Offered Rate
“LTV” means loan-to-value
“MD&A” means Management’s Discussion and Analysis of Financial Condition and Results of Operations
“MRBs” means market risk benefits
“MSO” means Market Stabilizer Option
“MTA” means Master Transaction Agreement
“NAIC” means National Association of Insurance Commissioners
“NAR” means net amount at risk
“NAV” means net asset value
“NLG” means no-lapse guarantee
“NYDFS” means New York State Department of Financial Services
“OCI” means other comprehensive income
“OTC” means over-the-counter
“PFBL” means profits followed by losses
“REIT” means real estate investment trusts
“SCB LLC” means Sanford C. Bernstein & Co., LLC, a registered investment adviser and broker-dealer.
“SCS” means Structured Capital Strategies
“SEC” means U.S. Securities and Exchange Commission
“Series A Preferred Stock” means Holdings’ Series A Fixed Rate Noncumulative Perpetual Preferred Stock
“Series B Preferred Stock” means Holdings’ Series B Fixed Rate Reset Noncumulative Perpetual Preferred Stock
“Series C Preferred Stock” means Holdings’ Series C Fixed Rate Reset Noncumulative Perpetual Preferred Stock
“SIO” means structured investment option
“SPE” means special purpose entity
“SVO” means Securities Valuation Office
“TDRs” means troubled debt restructurings
“TIPS” means treasury inflation-protected securities
“U.S. GAAP” means accounting principles generally accepted in the United States of America
“UL” means universal life
“ULSG” means universal life products with secondary guarantee
“USFL” means U.S. Financial Life Insurance Company
“Venerable” means Venerable Holdings, Inc.
“VIAC” means Venerable Insurance and Annuity Company
“VIE” means variable interest entity
“VISL” means variable interest-sensitive life
“VOE” means voting interest entity
“VUL” means variable universal life
120

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, Equitable Holdings, Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: November 3, 2022EQUITABLE HOLDINGS, INC.
By:/s/ Robin M. Raju
 Name:Robin M. Raju
 Title:Chief Financial Officer
(Principal Financial Officer)
Date: November 3, 2022 /s/ William Eckert
 Name:William Eckert
 Title:Chief Accounting Officer
(Principal Accounting Officer)

Exhibit 10.1

Execution Version
MASTER TRANSACTION AGREEMENT
dated as of August 16, 2022
between
EQUITABLE FINANCIAL LIFE INSURANCE COMPANY
(referred to as the Ceding Company)
and
FIRST ALLMERICA FINANCIAL LIFE INSURANCE COMPANY
(referred to as the Reinsurer)



CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) PRIVATE OR CONFIDENTIAL. SUCH EXCLUDED INFORMATION IS IDENTIFIED HEREIN WITH “[***].” SCHEDULES AND EXHIBITS HAVE BEEN OMITTED PURSUANT TO ITEM 601(A)(5) OF REGULATION S-K.





TABLE OF CONTENTS
Article I DEFINITIONS
Section 1.01    Certain Defined Terms
Article II TRANSACTIONS TO BE EFFECTUATED AT CLOSING
Section 2.01    Closing
Section 2.02    Ceding Commission
Section 2.03    Estimated Closing Statement; Investment Asset Selection
Section 2.04    Final Closing Statement
Section 2.05    The Reinsurer’s Additional Closing Date Deliveries
Section 2.06    The Ceding Company’s Additional Closing Date Deliveries
Article III REPRESENTATIONS AND WARRANTIES REGARDING THE CEDING COMPANY
Section 3.01    Incorporation and Authority of the Ceding Company
Section 3.02    No Conflict
Section 3.03    Consents and Approvals
Section 3.04    Financial Statements
Section 3.05    Absence of Certain Changes
Section 3.06    Absence of Litigation
Section 3.07    Compliance with Laws
Section 3.08    Governmental Licenses and Permits
Section 3.09    Insurance Regulatory Matters
Section 3.10    Actuarial Appraisal
Section 3.11    Brokers
Section 3.12    Separate Accounts
Section 3.13    Reserves
Section 3.14    Product Tax Matters
Section 3.15    Specified Data
Section 3.16    Producers
Section 3.17    Investment Assets
Section 3.18    Data Protection and Privacy
Section 3.19    ERISA
Section 3.20    Assumed and Ceded Reinsurance Agreements
Section 3.21    Participating Policies
Section 3.22    NO OTHER REPRESENTATIONS OR WARRANTIES
Article IV REPRESENTATIONS AND WARRANTIES REGARDING THE REINSURER
Section 4.01    Incorporation and Authority of the Reinsurer
Section 4.02    No Conflict
Section 4.03    Consents and Approvals
Section 4.04    Absence of Litigation
Section 4.05    Solvency
i



Section 4.06    Regulatory Matters
Section 4.07    Financial Statements
Section 4.08    Financial Ability
Section 4.09    Brokers
Article V ACTIONS PRIOR TO THE CLOSING DATE
Section 5.01    Conduct of Business Prior to the Closing
Section 5.02    Access to Information
Section 5.03    Reasonable Best Efforts
Article VI ADDITIONAL AGREEMENTS
Section 6.01    Confidentiality
Section 6.02    Non-Solicitation
Section 6.03    Names and Marks
Section 6.04    Further Action
Section 6.05    Privilege Preservation
Article VII CONDITIONS TO CLOSING AND RELATED MATTERS
Section 7.01    Conditions to Obligations of the Ceding Company
Section 7.02    Conditions to Obligations of the Reinsurer
Section 7.03    Frustration of Closing Condition
Article VIII TERMINATION AND WAIVER
Section 8.01    Termination
Section 8.02    Notice of Termination
Section 8.03    Effect of Termination
Article IX SURVIVAL; INDEMNIFICATION
Section 9.01    Survival of Representations, Warranties and Covenants
Section 9.02    Indemnification
Section 9.03    Certain Limitations
Section 9.04    Definitions
Section 9.05    Procedures for Third Party Claims
Section 9.06    Direct Claims
Section 9.07    Sole Remedy
Section 9.08    Treatment of Indemnity Payment
Article X GENERAL PROVISIONS
Section 10.01    Expenses
Section 10.02    Notices
Section 10.03    Public Announcements
Section 10.04    Severability
Section 10.05    Entire Agreement
Section 10.06    Assignment
Section 10.07    No Third Party Beneficiaries
Section 10.08    Amendment
Section 10.09    Schedules
ii



Section 10.10    Submission to Jurisdiction
Section 10.11    Governing Law
Section 10.12    Waiver of Jury Trial
Section 10.13    Specific Performance
Section 10.14    Waivers
Section 10.15    Rules of Construction
Section 10.16    Reserves
Section 10.17    Counterparts
Section 10.18    Time of Essence
Section 10.19    Incontestability
iii



EXHIBITS
Exhibit A    Form of Reinsurance Agreement
Exhibit B    Form of Guarantee
Exhibit C    Investment Management Agreement Term Sheet

SCHEDULES
Schedule 1.01(a)    Agreed Accounting Principles
Schedule 1.01(b)    Ceding Company Knowledge Persons
Schedule 1.01(c)    Reinsurer Knowledge Persons
Schedule 1.01(d)    Ceding Commission Adjustment
Schedule 1.01(e)    Agreed Investment Assets
Schedule 1.01(f)    Potential Investment Assets
Schedule 1.01(g)    Asset List
Schedule 3.12(g)(i)    M&E Fees
Schedule 3.12(g)(ii)    12b-1 Fees
Schedule 3.12(g)(iii)    Revenue Sharing Fees
Schedule 3.12(h)    EIM Administrative Fee
Schedule 3.15        Specified Data
Schedule 4.01        Additional Reinsurer Representations and Warranties
Schedule 7.02(c)    Reinsurer Governmental Approvals

iv



This MASTER TRANSACTION AGREEMENT (including all schedules and exhibits hereto, this “Agreement”), dated as of August 16, 2022, is made by and between Equitable Financial Life Insurance Company, a New York-domiciled insurance company (the “Ceding Company”), and First Allmerica Financial Life Insurance Company, a Massachusetts-domiciled insurance company (the “Reinsurer”). Each of the Ceding Company and the Reinsurer shall be referred to herein as a “Party” and, together, the “Parties”.
PRELIMINARY STATEMENTS
A.    Upon the terms and subject to the conditions of this Agreement and the other Transaction Agreements, the Parties desire to enter into an indemnity coinsurance transaction for the Group EQUI-VEST® deferred variable annuity contracts issued by the Ceding Company between 1980 and 2008, pursuant to which the Ceding Company will cede a 50% quota share of all liabilities related to such business; and
B.    in order to effectuate the foregoing, upon consummation of the transactions contemplated by this Agreement, (i) the Ceding Company and the Reinsurer will enter into the Coinsurance and Modified Coinsurance Agreement, substantially in the form attached as Exhibit A hereto (the “Reinsurance Agreement”), pursuant to which, upon the terms and subject to the conditions set forth therein, the Reinsurer will reinsure, on a combined coinsurance and modified coinsurance basis, certain liabilities of the Ceding Company arising under the Business (as hereinafter defined); (ii) the Ceding Company, the Reinsurer and the Trustee (as defined in the Reinsurance Agreement) will enter into the Trust Agreement (as hereinafter defined), pursuant to which, upon the terms and subject to the conditions set forth therein, the Reinsurer will establish with the Trustee a trust account for the sole benefit of the Ceding Company (the “Trust Account”), (iii) Commonwealth Annuity and Life Insurance Company will enter into a Guarantee (as defined below) pursuant to which Commonwealth Annuity and Life Insurance Company and any other Guarantor (as defined below) under the Guarantee from time to time will guaranty the Reinsurer’s payment obligations and obligations to transfer amounts to the Trust Account pursuant to Section 5.7(c)(i) of the Reinsurance Agreement, (iv) the Reinsurer will enter into the Investment Management Agreement (as defined below) with AllianceBernstein L.P., (v) Equitable Holdings, Inc., the parent company of the Ceding Company, and the Reinsurer will enter into the IMA Letter Agreement (as defined below), and (vi) [***].
NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein, the Parties to this Agreement agree as follows:
Article I
DEFINITIONS
Section 1.01Certain Defined Terms. Capitalized terms used in this Agreement have the meanings specified or referred to in this Section 1.01.
12b-1 Fees” means all revenue sharing fees, service fees, distribution fees and other amounts from or in respect of any mutual fund organization’s mutual funds as funding vehicles to the extent attributable to the Reinsured Contracts received or receivable by the Ceding Company or any of its Affiliates, in each case solely to the extent constituting amounts pursuant to a plan adopted pursuant to Rule 12b-1 under the Investment Company Act of 1940, as amended.
Action” means any claim, action, suit, litigation, arbitration, investigation, inquiry, hearing, charge, complaint, demand or other proceeding by or before any Governmental Authority or arbitrator or arbitration panel or similar Person or body.
1



Actuarial Appraisal” shall have the meaning set forth in Section 3.10.
Additional Dispute Matters” shall have the meaning set forth in Section 2.04(e)(iii).
Adjusted Ceding Commission means the Ceding Commission, as adjusted as of the Closing by (i) adding the Ceding Commission Adjustment Amount, as set forth on Schedule 1.01(d) hereto, to the Ceding Commission, and (ii) thereafter reducing by $5.6 million for every month (pro rated for any incomplete month on the basis of the number of days actually elapsed in such month against the total number of days in such month) between January 1, 2022 and the date on which the Effective Time (as defined in the Reinsurance Agreement) occurs.
Adjustment Report” shall have the meaning set forth in Section 2.04(e)(iv).
Affiliate” means, with respect to any specified Person, any other Person that, at the time of determination, directly or indirectly through one or more intermediaries, Controls, is Controlled by or is under common Control with such specified Person.
Agreed Accounting Principles” means the accounting principles, procedures and methodologies set forth on Schedule 1.01(a).
Agreed Investment Assets” means the assets listed on Schedule 1.01(e).
Agreement” shall have the meaning set forth in the preamble hereto.
Applicable Privacy Laws” means any applicable Laws relating to the processing of Non-Public Personal Information gathered, collected or used by the Ceding Company or any of its Affiliates or their respective employees, agents or contractors in the course of the operations of the Reinsured Contracts.
Asset List” means a list of assets to be transferred to the Trust Account that will be determined in accordance with Schedule 1.01(g).
Binder” shall have the meaning set forth in Section 5.03(d).
Books and Records” means all originals or copies of all books and records and other information in the possession, custody or control of the Ceding Company or any of its Affiliates that relate to the Reinsured Liabilities, the Reinsured Contracts or the Separate Accounts, including administrative records, claim records, contract files, sales records, underwriting records, financial and accounting (including investment accounting) records, actuarial reports, analyses and memoranda, reinsurance records, compliance records, records relating to the underlying investment funds in which the assets supporting reserves related to the Reinsured Contracts in the Separate Accounts are invested and other records, in whatever form maintained, but excluding certificates of incorporation, bylaws, corporate seals, minute books and other corporate records relating to the corporate organization or capitalization of the Ceding Company or its Affiliates, Tax Returns or Tax records (other than with respect to transfer Taxes, premium Taxes and similar Taxes that relate to the Reinsured Contracts and the Separate Accounts), records of any employee of the Ceding Company or its Affiliates, benefit plan records with respect to any employee of the Ceding Company or its Affiliates, and books and records that are subject to the attorney-client, work product, or other similar privilege or doctrine, it being understood that the Ceding Company shall use commercially reasonable efforts to obtain waivers or make other arrangements (including redacting information) that would enable any such item to be provided to the Reinsurer without impinging on the ability to assert such privilege.
2



Burdensome Condition” means any condition, limitation or qualification imposed by a Governmental Authority on its grant of any consent, authorization, order, approval or exemption that a Party seeks to obtain in connection with the transactions contemplated by this Agreement that, individually or in the aggregate with all such conditions, limitations or qualifications, would or would reasonably be expected to (a) with respect to the Ceding Company, (i) have a material adverse effect on the business, results of operations or financial condition of the Ceding Company and its Affiliates, taken as a whole, or (ii) require or involve any modification of any Transaction Agreement that is or would reasonably be expected to be adverse to a material extent to any Ceding Company Party, and (b) with respect to the Reinsurer, (i) have a material adverse effect on the business, results of operations or financial condition of the Reinsurer and its Affiliates, taken as a whole, (ii) require or involve any modification of any Transaction Agreement that is or would reasonably be expected to be adverse to a material extent to any Reinsurer Party or (iii) require the Reinsurer or any of its Affiliates to make or obtain any consent, approval, waiver, authorization, notice or filing with the New York Department of Financial Services, other than de minimis information requests.
Business” means the marketing, underwriting, selling, distributing, delivering, issuing, insuring, cancelling and administering of the Reinsured Contracts (including General Account Liabilities and Separate Account Liabilities (each as defined under the Reinsurance Agreement)).
Business Day” means any day that is not a Saturday, Sunday or other day on which commercial banks in the City of New York, New York or Boston, Massachusetts are required or authorized by Law to be closed.
Business Material Adverse Effect” means (a) a material adverse effect on the business, assets, liabilities, condition (financial or otherwise), operations or results of operations of the Business, taken as a whole (after taking into account insurance recoveries and indemnification obligations by third parties, and tax benefits in respect thereof); provided that none of the following (or the results thereof) shall constitute or be deemed to contribute to a Business Material Adverse Effect, and otherwise shall not be taken into account in determining whether a Business Material Adverse Effect has occurred or would be reasonably likely to occur: any adverse fact, circumstance, change or effect arising out of, resulting from or attributable to (i) changes in the U.S. or global economy or capital or financial markets, including changes in interest or exchange rates or changes in equity markets (including the value of equities traded in equity markets) and corresponding changes in the value of the Investment Assets of the Ceding Company (including the Business), (ii) political conditions generally and any natural disasters, man-made disasters, pandemics, epidemics, outbreak of disease, hostilities, acts of war, sabotage, terrorism, military actions or other force majeure events, (iii) any occurrence or condition generally affecting participants in the U.S. life and annuity insurance or reinsurance industry, (iv) the execution and delivery of, or compliance with the terms of, or the taking of any action required by, this Agreement or the other Transaction Agreements, or the announcement of, or consummation of, any of the transactions contemplated hereby, and the identity or facts related to the Reinsurer or actions taken by the Reinsurer in breach of this Agreement, (v) any changes or prospective changes in Law, GAAP or SAP, or the enforcement or interpretation thereof, (vi) any action taken by the Ceding Company or its Affiliates at the express written request of the Reinsurer, (vii) any change (or threatened change) in the credit, financial strength or other ratings of the Ceding Company or any of its Affiliates (provided that this clause (vii) shall not by itself exclude the underlying cause of any such change or threatened change), (viii) changes in the value of any of the Investment Assets of the Ceding Company (provided that this clause (viii) shall not by itself exclude the underlying cause of any such change) or (ix) any failure by the Ceding Company to achieve any earnings, premiums written or other financial projections or forecasts (provided that this clause (ix) shall not by itself exclude the underlying cause of any such failure); provided that, notwithstanding the foregoing, with respect to clauses (i), (ii), (iii) and (v), such fact, circumstance, change or effect shall be taken into account in determining
3



whether a Business Material Adverse Effect has occurred or would be reasonably likely to occur solely to the extent such fact, circumstance, change or effect is disproportionately adverse with respect to the Ceding Company or the Business as compared to insurance companies operating in the United States engaged in business similar to the Business; or (b) a material impairment or delay of the ability of the Ceding Company or any of its Affiliates to perform any of their material obligations under this Agreement or the Transaction Agreements, including consummation of the transactions contemplated hereby or thereby.
Capital Stock” means any capital stock of, or other type of equity ownership interest in, as applicable, a Person.
Cash Surrender Value” shall have the meaning set forth in the Reinsurance Agreement.
Ceding Commission” means $1,238,500,000 (one billion two hundred thirty-eight million five hundred thousand dollars).
Ceding Commission Adjustment Amount” has the meaning set forth in Schedule 1.01(d).
Ceding Company” shall have the meaning set forth in the preamble hereto.
Ceding Company Disclosure Schedule” means the disclosure schedule dated as of the date hereof delivered by the Ceding Company to the Reinsurer in connection with the execution and delivery of this Agreement.
Ceding Company Fundamental Representations” means the representations and warranties set forth in Section 3.01 (Incorporation and Authority of the Ceding Company), the second sentence of Section 3.03 (Consents and Approvals), Section 3.11 (Brokers), and Section 3.17 (Investment Assets).
Ceding Company Indemnified Persons” shall have the meaning set forth in Section 9.02(b).
Ceding Company Names and Marks” shall have the meaning set forth in Section 6.03.
Ceding Company Party” means the Ceding Company or any Affiliate of the Ceding Company that is a party to any Transaction Agreement, if any.
Claim Notice” shall have the meaning set forth in Section 9.05(a).
Closing” shall have the meaning set forth in Section 2.01.
Closing Date” shall have the meaning set forth in Section 2.01.
Code” means the United States Internal Revenue Code of 1986, as amended.
Confidentiality Agreement” shall have the meaning set forth in Section 6.01(a).
Contract” means, with respect to any Person, any agreement, contract, lease, mortgage, indenture, note, bond, loan, license, instrument or other legally binding arrangement or agreement, whether written or oral, to which such Person is a party or is otherwise subject or bound.
4



Control” means, with respect to any Person, the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract or otherwise. The terms “Controlled,” “Controlled by,” “under common Control with” and “Controlling” shall have correlative meanings.
Customer” means the policyholders, contractholders, insureds and annuitants of Reinsured Contracts.
Data Breach” means any unauthorized processing or access to Non-Public Personal Information, or any failures, crashes, security breaches, use, or disclosure, or other adverse events or incidents related to Non-Public Personal Information, that would require notification to any Person or Governmental Authority under Applicable Privacy Laws.
Data Room” means the electronic data site titled “Project Explorer” established by the Ceding Company and maintained by Donnelley Financial Solutions Venue.
Deductible” shall have the meaning set forth in Section 9.03(a).
Dispute Notice” shall have the meaning set forth in Section 2.04(e)(i).
Effective Time” shall have the meaning set forth in Section 2.01.
EIM” shall have the meaning set forth in the Reinsurance Agreement.
EIM Administrative Fees” shall have the meaning set forth in the Reinsurance Agreement.
ERISA” means the Employee Retirement Income Security Act of 1974.
Estimated Adjusted Ceding Commission” shall have the meaning set forth in Section 2.03(a).
Estimated Closing Statement” shall have the meaning set forth in Section 2.03(a).
Estimated Initial Premium” shall have the meaning set forth in Section 2.03(a).
Estimated Initial Required Balanceshall have the meaning set forth in Section 2.03(a).
Estimated Transferred Asset Value” shall have the meaning set forth in Section 2.03(a).
Fair Market Value” shall have the meaning set forth in the Reinsurance Agreement.
Final Adjusted Ceding Commission” shall have the meaning set forth in Section 2.04(f).
Final Closing Statement” shall have the meaning set forth in Section 2.04(f).
Final Initial Premium” shall have the meaning set forth in Section 2.04(f).
Final Initial Required Balance” shall have the meaning set forth in Section 2.04(f).
Final Transferred Asset Value” shall have the meaning set forth in Section 2.04(f).
Financial Statements” shall have the meaning set forth in Section 3.04(a).
5



Fraud” means an actual fraud involving a knowing and intentional misrepresentation by a Person made with the express intent of inducing any other party to enter into this Agreement or any other Transaction Agreement and upon which such other party has relied to its detriment; provided, however, “Fraud” shall not include any fraud claim based on constructive knowledge, recklessness, negligent misrepresentation or a similar theory.
GAAP” means the accounting principles and practices generally accepted in the United States at the relevant time.
GA Re Financial Statements” shall have the meaning set forth in Schedule 4.01.
General Account Liabilities” shall have the meaning set forth in the Reinsurance Agreement.
Governmental Approval” means any consent, approval, license, permit, order, qualification, authorization of, or registration, waiver or other action by, or any filing with or notification to, any Governmental Authority.
Governmental Authority” means any United States or non-United States federal, state or local or any supra-national, political subdivision, governmental, legislative, tax, regulatory or administrative authority, instrumentality, agency, body, board or commission, self-regulatory organization or any court, tribunal, or judicial or arbitral body having jurisdiction over a Party.
Governmental Order” means any binding and enforceable order, writ, judgment, injunction, decree, stipulation, determination or award entered by or with any Governmental Authority.
Guarantee” means the Guarantee, to be entered into on the Closing Date, by the Guarantor in favor of the Ceding Company, substantially in the form attached as Exhibit B.
Guarantor” means Commonwealth Annuity and Life Insurance Company, a corporation organized under the laws of Massachusetts, and any other “Guarantor” under the Guarantee from time to time.

IMA Letter Agreement” means the termination letter agreement, to be entered into on the Closing Date, by and between Equitable Holdings, Inc., the parent company of the Ceding Company, and the Reinsurer, substantially consistent with the term sheet attached as Exhibit C hereto.
Indemnifiable Losses” shall have the meaning set forth in Section 9.04(a).
Indemnitee” shall have the meaning set forth in Section 9.04(b).
Indemnitor” shall have the meaning set forth in Section 9.04(c).
Indemnity Payment” shall have the meaning set forth in Section 9.04(d).
Independent Accounting Firm” shall have the meaning set forth in Section 2.04(e)(iii).
Interest Rate” means the sum of (a) [***] basis points (expressed as a rate per annum) plus (b) the annual yield rate, on the date to which the [***] Day Treasury Rate relates, of actively traded U.S. Treasury securities having a remaining duration to maturity of [***] months, as such rate is published under the “Treasury Constant Maturities” in Federal Reserve Statistical Release H.15(519).
6



Initial Premium” shall have the meaning set forth in the Reinsurance Agreement.
Initial Required Balance” shall have the meaning set forth in the Reinsurance Agreement.
Insurance Regulator” means, with respect to any jurisdiction, the Governmental Authority charged with the supervision of insurance companies in such jurisdiction.
Investment Assets” means those investment assets that are ultimately selected as Transferred Assets pursuant to the provisions of Section 2.03.
Investment Company Act” means the Investment Company Act of 1940, as amended.
Investment Management Agreement” means the Discretionary Investment Advisory Agreement, to be entered into on the Closing Date, by and between the Reinsurer and AllianceBernstein L.P., substantially consistent with the term sheet attached as Exhibit C hereto.
IRS” shall have the meaning set forth in Section 3.14(d).
Knowledge” means: (a) in the case of the Ceding Company, the actual knowledge, after reasonable inquiry, of those Persons listed on Schedule 1.01(b) and (b) in the case of the Reinsurer, the actual knowledge, after reasonable inquiry, of those Persons listed on Schedule 1.01(c).
Law” means any United States or non-United States federal, state or local statute, law, ordinance, rule, regulation, code, administrative interpretation or principle of common law or equity imposed by or on behalf of a Governmental Authority and any Governmental Order.
Lien” means any mortgage, deed of trust, pledge, hypothecation, attachment, security interest or other similar encumbrance or lien, except (a) such generally applicable restrictions as may be contained in any insurance applicable Law and (b) with respect to Investment Assets, any Lien created or imposed by the Trust Agreement and any other customary interests of nominees, custodians, brokers, clearinghouses or similar intermediaries in connection with investment assets or under applicable securities Laws.
Losses” means any and all damages, judgments, awards, liabilities, losses, obligations, claims of any kind or nature, fines and costs and expenses (including reasonable fees and expenses of attorneys, auditors, consultants and other agents).
M&E Fees” means all mortality and expense risk charges, administrative expense charges, rider charges, contract maintenance charges, back-end sales loads and other considerations billed separately for the Reinsured Contracts, and any other charges, fees, and similar amounts from the Separate Accounts received or receivable by the Ceding Company with respect to the Reinsured Contracts.
[***]
[***]
Non-Public Personal Information” means any non-public personally identifiable information concerning or relating to the Ceding Company’s past, current or prospective applicants, customers, clients, policy owners, contract holders, insureds, claimants, and beneficiaries of Reinsured Contracts or other contracts issued by the Ceding Company, and its representatives that is protected by Applicable Privacy Law, including (a) “non-public personal
7



information” as that term is defined in the Gramm-Leach-Bliley Act, as amended, and implementing regulations, 15 U.S.C. § 6809(4) or “protected health information” as defined in 45 C.F.R. § 160.103; and (b) “Personal Information” as defined in the California Consumer Privacy Act of 2018 (Cal. Civ. Code Division 3, Part 4, Title 1.81.5); provided, that information that is otherwise publicly available shall not be considered “Non-Public Personal Information”; and, provided, further, that “Non-Public Personal Information” does not include de-identified personal data, (i.e., information that does not identify, or could not reasonably be associated with, an individual).
Outside Date” shall have the meaning set forth in Section 8.01(b).
Party” or “Parties” shall have the meanings set forth in the preamble hereto.
Permit” means any license, permit, order, approval, consent, registration, membership, authorization or qualification under any applicable Law or with any Governmental Authority or under any industry or non-governmental self-regulatory organization.
Permitted Liens” means customary interests of nominees, custodians, brokers, clearinghouses or similar intermediaries in connection with investment assets or restrictions or limitations on transfer under applicable securities Laws.
Person” means any natural person, general or limited partnership, corporation, limited liability company, limited liability partnership, firm, joint-stock company, trust, governmental, judicial or regulatory body, business unit, division, association or organization or other entity.
Potential Investment Assets” shall have the meaning set forth in Schedule 1.01(f).
Producer” means any broker, insurance producer, agent, general agent, managing general agent, master broker agency, broker general agency, financial specialist or other Person, including any employee of the Ceding Company or its Affiliates, responsible for writing, marketing, producing, selling or soliciting Reinsured Contracts.
Quota Share” means fifty percent (50%).
Registered Separate Account” shall have the meaning set forth in Section 3.12(c).
Reinsurance Agreement” shall have the meaning set forth in the recitals hereto.
Reinsured Contracts” shall have the meaning set forth in the Reinsurance Agreement.
Reinsured Liabilities” shall have the meaning set forth in the Reinsurance Agreement.
Reinsurer” shall have the meaning set forth in the preamble hereto.
Reinsurer Business Material Adverse Effect” means a material adverse effect on the business, assets, liabilities, condition (financial or otherwise), operations or results of operations of the business of the Reinsurer, taken as a whole (after taking into account insurance recoveries and indemnification obligations by third parties, and tax benefits in respect thereof); provided that none of the following (or the results thereof) shall constitute or be deemed to contribute to a Reinsurer Business Material Adverse Effect, and otherwise shall not be taken into account in determining whether a Reinsurer Business Material Adverse Effect has occurred or would be reasonably likely to occur: any adverse fact, circumstance, change or effect arising out of,
8



resulting from or attributable to (a) changes in the U.S. or global economy or capital or financial markets, including changes in interest or exchange rates or changes in equity markets (including the value of equities traded in equity markets) and corresponding changes in the value of the investment assets of the Reinsurer, (b) political conditions generally and any natural disasters, man-made disasters, pandemics, epidemics, outbreak of disease, hostilities, acts of war, sabotage, terrorism, military actions or other force majeure events, (c) any occurrence or condition generally affecting participants in the U.S. life and annuity insurance or reinsurance industry, (d) the execution and delivery of, or compliance with the terms of, or the taking of any action required by, this Agreement or the other Transaction Agreements, or the announcement of, or consummation of, any of the transactions contemplated hereby, and the identity or facts related to the Ceding Company or actions taken by the Ceding Company in breach of this Agreement, (e) any changes or prospective changes in Law, GAAP or SAP, or the enforcement or interpretation thereof, (f) any action taken by the Reinsurer or its Affiliates at the express written request of the Ceding Company, (g) any change (or threatened change) in the credit, financial strength or other ratings of the Reinsurer or any of its Affiliates (provided that this clause (g) shall not by itself exclude the underlying cause of any such change or threatened change), (h) changes in the value of any of the investment assets of the Reinsurer (provided that this clause (h) shall not by itself exclude the underlying cause of any such change) or (i) any failure by the Reinsurer to achieve any earnings, premiums written or other financial projections or forecasts (provided that this clause (i) shall not by itself exclude the underlying cause of any such failure); provided that, notwithstanding the foregoing, with respect to clauses (a), (b), (c) and (e), such fact, circumstance, change or effect shall be taken into account in determining whether a Reinsurer Business Material Adverse Effect has occurred or would be reasonably likely to occur solely to the extent such fact, circumstance, change or effect is disproportionately adverse with respect to the Reinsurer or its business as compared to insurance companies operating in the United States engaged in business similar to the Reinsurer’s business.
Reinsurer Disclosure Schedule” means the disclosure schedule dated as of the date hereof delivered by the Reinsurer to the Ceding Company in connection with the execution and delivery of this Agreement.
Reinsurer Financial Statements” shall have the meaning set forth in Section 4.07.
Reinsurer Fundamental Representations” means the representations and warranties set forth in Section 4.01 (Incorporation and Authority of the Reinsurer), the second sentence of Section 4.03 (Consents and Approvals), Section 4.05 (Solvency) and Section 4.09 (Brokers).
Reinsurer Indemnified Persons” shall have the meaning set forth in Section 9.02(a).
Reinsurer Material Adverse Effect” means a material impairment or delay of the ability of the Reinsurer or any of its Affiliates to perform their respective material obligations under this Agreement or the Transaction Agreements, including consummation of the transactions contemplated hereby or thereby.
Reinsurer Names and Marks” shall have the meaning set forth in Section 6.03.
Reinsurer Party” means the Reinsurer or any Affiliate of the Reinsurer that is a party to any Transaction Agreement.
9



Related Plan” shall have the meaning set forth in Section 3.14(a).
Representative” of a Person means such Person’s Affiliates and the directors, officers, employees, advisors, agents, stockholders or other equity holders or investors, consultants, independent accountants, investment bankers, counsel, advisors or other representatives of such Person and of such Person’s Affiliates.
Resolution Period” shall have the meaning set forth in Section 2.04(e)(iii).
Resolution Process” means, with respect to any condition, limitation or qualification that if imposed by a Governmental Authority in connection with any Permit, order, consent, approval or authorization relating to the consummation of the transactions contemplated by the Transaction Agreements would result in a Burdensome Condition, a process by which the Ceding Company and the Reinsurer will meet in order to: (a) exchange and review their respective views as to such condition, limitation or qualification; (b) discuss in good faith potential approaches that would avoid such condition, limitation or qualification or mitigate its impact; and (c) negotiate in good faith with respect to any potential modification of the terms of this Agreement or the other Transaction Agreements, on mutually acceptable terms and on an equitable basis, in a way that would substantially eliminate any such condition, limitation or qualification or sufficiently mitigate its adverse effect so that it would no longer constitute a Burdensome Condition hereunder; provided that neither the Ceding Company nor the Reinsurer shall be required to enter into an amendment or modification of this Agreement or any other Transaction Agreement solely by virtue of engaging in such Resolution Process.
Retrocession Agreement” means that certain retrocession agreement between the Reinsurer and Global Atlantic Re Limited relating to the retrocession of a portion of the Business and to be entered into on the Closing Date.
Revenue Sharing Fees” means all revenue sharing fees, service fees, distribution fees and other amounts from or in respect of any mutual fund organization’s mutual funds as funding vehicles to the extent attributable to the Reinsured Contracts received or receivable by the Ceding Company or any of its Affiliates, in each case other than 12b-1 Fees.
Review Period” shall have the meaning set forth in Section 2.04(e).
SAP” means, with respect to either Party, the statutory accounting principles prescribed by the Insurance Regulator for the jurisdiction in which such insurance company is domiciled consistently applied.
Securities Act” means the Securities Act of 1933.
Separate Account Annual Statements” shall have the meaning set forth in Section 3.04(d).
Separate Account Liabilities” shall have the meaning set forth in the Reinsurance Agreement.
Separate Accounts” shall have the meaning set forth in Section 3.12(a).
Solvent” shall have the meaning set forth in Section 4.05.
Specified Data” shall mean the information listed in Schedule 3.15.
Subject Closing Statement” shall have the meaning set forth in Section 2.04(d).
10



Subsidiary” of any Person means any corporation, general or limited partnership, joint venture, limited liability company, limited liability partnership or other Person that is a legal entity, trust or estate of which (or in which) at the time of determination (a) the issued and outstanding Capital Stock having ordinary voting power to elect a majority of the board of directors (or a majority of another body performing similar functions) of such corporation or other Person (irrespective of whether at the time Capital Stock of any other class or classes of such corporation or other Person shall or might have voting power upon the occurrence of any contingency), (b) more than fifty percent (50%) of the interest in the capital or profits of such partnership, joint venture or limited liability company or (c) more than fifty percent (50%) of the beneficial interest in such trust or estate, is directly or indirectly owned by such Person.
Tax” or “Taxes” means all income, premium, excise, gross receipts, ad valorem, sales, use, employment, franchise, profits, gains, property, transfer, payroll, stamp taxes or other taxes, (whether payable directly or by withholding) imposed by any Tax Authority, together with any interest and any penalties thereon or additional amounts with respect thereto; provided that any guarantee fund assessment or escheatment obligation shall not be treated as a Tax.
Tax Authority” means any Governmental Authority having jurisdiction over the assessment, determination, collection or imposition of any Tax.
Tax Returns” means all returns, reports and claims for refunds (including elections, declarations, disclosures, schedules and information returns) required to be supplied to a Tax Authority relating to Taxes and, in each case, any amendments thereto.
Third Party Actuary” means Milliman, Inc.
Third Party Claim” shall have the meaning set forth in Section 9.04(e).
Threshold Amount” shall have the meaning set forth in Section 9.03(a).
Transaction Agreements” means, collectively, this Agreement, the Reinsurance Agreement, the Guarantee, the Investment Management Agreement, the IMA Letter Agreement, the Trust Agreement, [***] and the Retrocession Agreement.
Transferred Asset Value” means the aggregate Fair Market Value of the Transferred Assets determined in accordance with the definition of “Fair Market Value” as of the Closing Date.
Transferred Assets” shall have the meaning set forth in Section 2.03(a).
Trust Account” shall have the meaning set forth in the recitals hereto.
Trust Agreement” means that certain Trust Agreement by and among the Reinsurer, the Ceding Company and the Trustee, substantially in the form attached as Exhibit 2 to the Reinsurance Agreement.
Trustee” shall have the meaning set forth in the Reinsurance Agreement.
Willful Breach” means, with respect to any breaches or failures to perform any of the covenants or other agreements contained in this Agreement, a breach that is a consequence of an act or a failure to act undertaken by the breaching Person with actual or constructive knowledge (which shall be deemed to include knowledge of facts that a Person acting reasonably should have, based on reasonable due inquiry) that such Person’s act or failure to act would, or would reasonably be expected to, result in or constitute a breach of this Agreement.
11



Willkie” shall have the meaning set forth in Section 6.05.
Article II
TRANSACTIONS TO BE EFFECTUATED AT CLOSING
Section 1.02Closing. The closing of the transactions contemplated by this Agreement to be then completed, including entry into the Reinsurance Agreement and the Trust Agreement (the “Closing”) shall take place at 10:00 a.m., New York City time, at the offices of Willkie Farr & Gallagher LLP, 787 7th Avenue, New York, New York 10019 (or such other place as the Ceding Company and the Reinsurer may agree in writing), on such date that is the first Business Day of the month immediately following the month during which each of the conditions set forth in Section 7.01 and Section 7.02 are satisfied or waived (other than those conditions that by their terms are to be satisfied at the Closing, but subject to the satisfaction or waiver of such conditions at the Closing) and in any event following October 1, 2022 (and not earlier than such date). The date on which the Closing takes place shall be the “Closing Date.” The transactions contemplated hereby to be completed at the Closing shall be deemed to have been consummated and become effective for all purposes as of 12:01 a.m., New York City time, on the first day of month in which the Closing occurs (the “Effective Time”).
Section 1.03Ceding Commission. Subject to the satisfaction or waiver of all of the conditions to the Closing set forth in Section 7.01 and Section 7.02, and subject to the terms and conditions set forth in this Agreement and the Reinsurance Agreement, at the Closing, (i) the Ceding Company will cede to the Reinsurer, and the Reinsurer shall reinsure, the Quota Share of the Reinsured Liabilities, (ii) the Ceding Company shall pay to the Reinsurer the Initial Premium and (iii) the Reinsurer shall pay to the Ceding Company the Adjusted Ceding Commission, which will reduce the amount of the Initial Premium paid by the Ceding Company to the Reinsurer.
Section 1.04Estimated Closing Statement; Investment Asset Selection.
(a)No later than eight (8) calendar days prior to the anticipated Closing Date, the Ceding Company shall deliver to the Reinsurer a statement (the “Estimated Closing Statement”) setting forth: (i) the Ceding Company’s good faith estimate of the Initial Premium (as defined in the Reinsurance Agreement) as of the Effective Time (the “Estimated Initial Premium”) and the Adjusted Ceding Commission (the “Estimated Adjusted Ceding Commission”) applied as a reduction to the Initial Premium; (ii) the Asset List constituting the “Transferred Assets”; (iii) a statement setting forth the Ceding Company’s good faith estimate of the Initial Required Balance (as defined in the Reinsurance Agreement) as of the Closing Date (the “Estimated Initial Required Balance”), (iv) the Ceding Company’s good faith estimate of the Fair Market Value, determined in accordance with the definition of “Fair Market Value”, of each of the Investment Assets set forth on the Asset List as of the Closing Date, constituting, in the aggregate, the “Estimated Transferred Asset Value” and (v) a proposed, in good faith, amortization schedule for the Transaction IMR Amount (as defined in the Reinsurance Agreement), prepared in accordance with SAP applicable to the Ceding Company.
(b)Each component of the Estimated Closing Statement will be prepared in good faith as of the Effective Time on the Closing Date and in accordance with the Agreed Accounting Principles, as well as, in the case of the Estimated Adjusted Ceding Commission, Schedule 1.01(d). During the period between the delivery of the Estimated Closing Statement and the Closing, the Ceding Company and the Reinsurer shall cooperate and seek in good faith to correct any errors or mistakes in the preparation of, and any inaccuracies of any items reflected in, the Estimated Closing Statement and, if applicable, the Estimated Closing Statement as revised pursuant to such discussions between the Ceding Company and the Reinsurer shall thereafter be deemed the Estimated Closing Statement for all purposes hereunder; provided,
12



however, that if the Ceding Company and the Reinsurer do not reach agreement with respect to any such corrections during such period for any reason, then the Estimated Closing Statement delivered by the Ceding Company shall be the Estimated Closing Statement for all purposes hereunder.
Section 1.05Final Closing Statement.
(a)The Final Initial Premium (which shall be determined after reducing such amount by the Final Adjusted Ceding Commission), the Final Transferred Asset Value and the Final Initial Required Balance shall be determined as set forth in this Section 2.04 and in accordance with the Agreed Accounting Principles.
(b)Within five (5) Business Days after the determination of the Final Initial Premium, the Final Transferred Asset Value and the Final Initial Required Balance in accordance with this Section 2.04:
(i)If the Final Initial Premium exceeds the Estimated Initial Premium, the Ceding Company shall pay to the Reinsurer or its designee an amount equal to such excess;
(ii)If the Estimated Initial Premium exceeds the Final Initial Premium, the Reinsurer shall pay to the Ceding Company or its designee an amount equal to such excess;
(iii)If the Final Transferred Asset Value exceeds the Estimated Transferred Asset Value, the Reinsurer shall pay to the Ceding Company or its designee an amount equal to such excess; and
(iv)If the Estimated Transferred Asset Value exceeds the Final Transferred Asset Value, the Ceding Company shall pay to the Reinsurer or its designee an amount equal to such excess.
For the avoidance of doubt, the aggregate payments (if any) required by (x) the Ceding Company, pursuant to Section 2.04(b)(i) and/or Section 2.04(b)(iv), on the one hand and (y) the Reinsurer, pursuant to Section 2.04(b)(ii) and/or Section 2.04(b)(iii), on the other hand, may be net settled against one another, and interest will accrue on each payment at the Interest Rate for the period from and including the Closing Date to but not including the date of payment.
(c)Payments pursuant to Section 2.04(b) shall be made in cash or investment assets as mutually agreed between the applicable payee and the payor, and any investment assets shall be transferred with valid legal title free and clear of all Liens other than Permitted Liens. The payor shall estimate in good faith the Fair Market Value of any investment assets to be transferred in connection therewith, and each of the Parties shall use reasonable best efforts to agree to the actual Fair Market Value as promptly as possible thereafter in a manner consistent with, and based upon, the Fair Market Value Methodologies attached as Schedule G to the Reinsurance Agreement, and (x) if the Fair Market Value of any such investment assets is greater than the estimate made by the payor, the payee shall make any subsequent payments that may be required to address such difference within five (5) Business Days after such determination, and (y) if the Fair Market Value of any such investment assets is less than the estimate made by the payor, the payor shall, make any subsequent payments that may be required to address such difference within five (5) Business Days after such determination in each case with interest accruing on such amount at the Interest Rate for the period from and including the date of payment pursuant to Section 2.04(b) to but not including the date of payment.
13



(d)No later than sixty (60) calendar days after the Closing Date, the Ceding Company shall deliver to the Reinsurer a statement (the “Subject Closing Statement”) setting forth (i) the Ceding Company’s good faith calculation of the Initial Premium as of the Effective Time and the Adjusted Ceding Commission as of the Closing Date applied as a reduction to the Initial Premium, (ii) the Ceding Company’s good faith calculation of the Transferred Asset Value of each Transferred Asset and the aggregate Transferred Asset Value of all Transferred Assets as of the Closing Date, (iii) the Ceding Company’s good faith calculation of the Initial Required Balance as of the Closing Date, and (iv) the amortization schedule for the Transaction IMR Amount (as defined in the Reinsurance Agreement), prepared in accordance with SAP applicable to the Ceding Company. The Subject Closing Statement will be prepared in good faith in accordance with the Agreed Accounting Principles and will be in the same format as the Estimated Closing Statement, as well as, in the case of the Adjusted Ceding Commission, Schedule 1.01(d). During the period following Closing prior to the delivery of the Subject Closing Statement, the Ceding Company and the Reinsurer shall cooperate and the Ceding Company shall take into account in preparing the Subject Closing Statement any errors or mistakes in the preparation of, and any inaccuracies of any items reflected in, the Estimated Closing Statement or any corrections, adjustments, additional information and details, updated calculations or similar information, if any, brought to its attention by the Reinsurer.
(e)The Reinsurer shall have sixty (60) calendar days after the date on which the Subject Closing Statement is delivered to it to review the Subject Closing Statement and the calculations set forth therein (the “Review Period”). In furtherance of such review, the Ceding Company shall provide the Reinsurer and its Representatives with such access to the employees and Representatives of the Ceding Company and to such documentation, records and other information of the Ceding Company that the Reinsurer or any of its Representatives may reasonably request; provided that such access does not unreasonably interfere with the conduct of the business of the Ceding Company or its Affiliates; provided further that the independent accountants and actuaries of the Ceding Company will not be obligated to make any work papers available to the Reinsurer, unless and until the Reinsurer has signed a customary confidentiality/non-reliance agreement relating to such access to work papers in form and substance reasonably acceptable to such accountants and actuaries, as applicable.
(v)If the Reinsurer disagrees with the Subject Closing Statement (including any amount or computation set forth therein), the Reinsurer may, on or prior to the last day of the Review Period, deliver a notice to the Ceding Company setting forth, in reasonable detail, each disputed item or amount and the basis for the Reinsurer’s disagreement therewith (the “Dispute Notice”). The Dispute Notice shall set forth, with respect to each disputed item or amount, the Reinsurer’s position as to the correct amount or computation that should have been included in the Subject Closing Statement. The Parties will pay any undisputed amount upon receipt of the Dispute Notice in accordance with the requirements set forth in Section 2.04(b).
(vi)If no Dispute Notice is received by the Ceding Company with respect to any matter in the Subject Closing Statement on or prior to the last day of the Review Period, the amount or computation with respect to such matters as set forth in the Subject Closing Statement shall be deemed accepted by the Reinsurer, whereupon the amount or computation of such matter or matters shall be final and binding on the Parties.
(vii)For a period of thirty (30) calendar days (the “Resolution Period”) beginning on the date that the Ceding Company receives a Dispute Notice, if any, the Reinsurer and the Ceding Company shall endeavor in good faith to resolve by mutual agreement all matters identified in the Dispute Notice, as well as any matters related to the Subject Closing Statement raised by the Ceding Company that directly arise out of, or become applicable as a result of, matters identified in the Dispute Notice, to the extent
14



such matters would be applicable if the matters in the Dispute Notice were resolved in favor of the Reinsurer, even if such matters are not directly in dispute in the Dispute Notice (the “Additional Dispute Matters”). In the event that the Parties are unable to resolve by mutual agreement any matter in the Dispute Notice within such Resolution Period, the Reinsurer and the Ceding Company shall, within thirty (30) calendar days after the expiration of the Resolution Period, jointly engage (A) an accounting firm of national reputation as mutually agreed by the Parties (the “Independent Accounting Firm”), to make a determination with respect to all matters remaining in dispute, other than with respect to the calculation of the Cash Surrender Value, or (B) with respect to the calculation of the Cash Surrender Value, the Independent Accounting Firm; provided that if no firm is willing or able to serve, unless otherwise agreed by the Parties, such dispute shall be resolved in accordance with Section 10.10.
(viii)The Ceding Company and the Reinsurer will direct the Independent Accounting Firm to render a determination within thirty (30) calendar days after its retention, and the Ceding Company and the Reinsurer and their respective employees and Representatives will cooperate with the Independent Accounting Firm during its engagement. The Ceding Company, on the one hand, and the Reinsurer, on the other hand, shall promptly (and in any event within ten (10) Business Days) after the Independent Accounting Firm’s engagement, as applicable, each submit to the Independent Accounting Firm their respective computations of the disputed items or amounts identified in the Dispute Notice or as Additional Dispute Matters and information, arguments and support for their respective positions, and shall concurrently deliver a copy of such materials to the other Party. Each Party shall then be given an opportunity to supplement the information, arguments and support included in its initial submission with one additional submission to respond to any arguments or positions taken by the other Party in such other Party’s initial submission, which supplemental information shall be submitted to the Independent Accounting Firm (with a copy thereof to the other Party), within five (5) Business Days after the first date on which both Parties have submitted their respective initial submissions to the Independent Accounting Firm. The Independent Accounting Firm shall thereafter be permitted to request additional or clarifying information from the Parties, and each of the Parties shall cooperate and shall cause its Representatives to cooperate with such requests of the Independent Accounting Firm. The Independent Accounting Firm shall determine, based solely on the materials so presented by the Parties and upon information received in response to such requests for additional or clarifying information and not by independent review, only those issues in dispute specifically set forth in the Dispute Notice or Additional Dispute Matters and shall, within thirty (30) calendar days of its retention, render a written report to the Ceding Company and the Reinsurer (each, an “Adjustment Report”) in which the Independent Accounting Firm shall, after considering all matters set forth in the Dispute Notice and the Additional Dispute Matters, determine what adjustments, if any, should be made to the amounts and computations set forth in the Subject Closing Statement solely as to the disputed items or amounts set forth in the Dispute Notice and the Additional Dispute Matters and shall determine the appropriate Initial Premium, Transferred Asset Value and the Initial Required Balance on that basis.
(ix)The Adjustment Report shall set forth, in reasonable detail, the Independent Accounting Firm’s determination with respect to each of the disputed items or amounts specified in the Dispute Notice and the Additional Dispute Matters, and the revisions, if any, to be made to the Subject Closing Statement, together with supporting calculations. In resolving any disputed item or amount, the Independent Accounting Firm (A) shall be bound to the principles of this Section 2.04 and the terms of this Agreement, (B) shall limit its review to matters specifically set forth in the Dispute Notice and the Additional Dispute Matters and (C) shall not assign a value to any matter
15



higher than the highest value for such matter claimed by either Party or less than the lowest value for such matter claimed by either Party.
(x)All fees and expenses relating to the work of the Independent Accounting Firm shall be borne equally by the Parties. Each Adjustment Report, absent Fraud or manifest error, shall be final, binding and conclusive upon the Parties and shall be expert determinations under New York law governing expert determination and appraisal proceedings. Any claim, dispute or controversy arising out of or relating to the final determinations of the Independent Accounting Firm, including enforcement of such final determinations, shall be resolved in accordance with Section 10.10.
(c)The final form of the Subject Closing Statement as finally determined pursuant to this Section 2.04 is referred to herein as the “Final Closing Statement,” the Initial Premium calculated therefrom is referred to as the “Final Initial Premium,” the final Adjusted Ceding Commission set forth therein is referred to herein as the “Final Adjusted Ceding Commission,” the aggregate Transferred Asset Value of all Transferred Assets calculated therefrom is referred to as the “Final Transferred Asset Value” and the Initial Required Balance calculated therefrom is referred to as the “Final Initial Required Balance.”
Upon the final determination of the Final Initial Required Balance, the Parties agree to promptly make any necessary adjustments under Section 5.8(c) of the Reinsurance Agreement to the extent not reflected in any prior adjustments.
Section 1.06The Reinsurer’s Additional Closing Date Deliveries. At the Closing, the Reinsurer shall deliver, or cause to be delivered, to the Ceding Company:
(f)the certificate referred to in Section 7.01(a)(iv);
(g)the duly executed counterpart by the applicable Reinsurer Party to each Transaction Agreement (other than this Agreement) to which a Reinsurer Party is a party;
(h)[***]
(i)such other agreements, documents, instruments or certificates as may be reasonably required to effectuate the transactions contemplated by this Agreement.
Section 1.07The Ceding Company’s Additional Closing Date Deliveries. At the Closing, the Ceding Company shall deliver, or cause to be delivered, to the Reinsurer:
(a)the certificate referred to in Section 7.02(a)(iv);
(b)the duly executed counterpart by the applicable Ceding Company Party to each Transaction Agreement (other than this Agreement) to which a Ceding Company Party is a party; and
(c)such other agreements, documents, instruments or certificates as may be reasonably required to effectuate the transactions contemplated by this Agreement.
Article III
REPRESENTATIONS AND WARRANTIES REGARDING THE CEDING COMPANY
Subject to and as qualified by the matters set forth in the Ceding Company Disclosure Schedule pursuant to Section 10.09, the Ceding Company hereby represents and warrants to the Reinsurer as follows as of the date hereof and as of the Closing Date (except for
16



such representations and warranties which address matters only as of a specific date, which representations and warranties shall be true and correct as of such specific date):
Section 1.01Incorporation and Authority of the Ceding Company
(a)The Ceding Company (i) is a New York-insurance company, duly incorporated and in good standing under the Laws of the State of New York; (ii) has full corporate power and authority to administer the Reinsured Contracts as .now conducted and to own, lease and operate its properties and assets relating to the Reinsured Contracts; and (iii) is duly qualified to do business as a foreign or alien corporation, as the case may be, in good standing in each jurisdiction in which administration of the Reinsured Contracts or the ownership, leasing or operation of its properties or assets relating to the Reinsured Contracts makes such qualification necessary, except, in the case of clause (iii), where the failure to so qualify, would not, individually or in the aggregate, reasonably be expected to have a Business Material Adverse Effect.
(b)Each Ceding Company Party has all requisite corporate or other entity power and authority to enter into, consummate the transactions contemplated by, and carry out its obligations under, the Transaction Agreements to which it is a party. The execution and delivery by each Ceding Company Party of the Transaction Agreements to which it is a party, and the consummation by such Ceding Company Party of the transactions contemplated by, and the performance by such Ceding Company Party of its obligations under, the Transaction Agreements have been and, with respect to the Transaction Agreements to be executed and delivered after the date of this Agreement, will be, duly authorized by all requisite corporate or other entity action on the part of such Ceding Company Party. Each of the Transaction Agreements to which a Ceding Company Party is or will be a party has been or, with respect to the Transaction Agreements to be executed and delivered after the date of this Agreement, will be, duly executed and delivered by such Ceding Company Party and, assuming due authorization, execution and delivery by each other party thereto, constitutes or, with respect to the Transaction Agreements to be executed and delivered after the date of this Agreement, will constitute, the legal, valid and binding obligation of such Ceding Company Party, enforceable against it in accordance with its terms, subject in each case to the effect of any applicable bankruptcy, reorganization, insolvency, moratorium, rehabilitation, liquidation, fraudulent conveyance or similar Laws relating to or affecting creditors’ rights generally and subject, as to enforceability, to the effect of general equitable principles (regardless of whether such enforceability is considered in a proceeding in equity or at law).
Section 1.01No Conflict. Provided that all consents, approvals, authorizations and other actions described in Section 3.03 and Section 4.03 have been obtained or taken, as applicable, except as set forth in Section 3.02 of the Ceding Company Disclosure Schedule and except as may result from any facts or circumstances solely relating to the Reinsurer or its Affiliates (as opposed to any other third party), the execution, delivery and performance by each Ceding Company Party of, and the consummation by such Ceding Company Party of the transactions contemplated by, the Transaction Agreements do not and will not, with or without the giving of notice or passage of time or both, (a) violate or conflict with any provision of the organizational documents of such Ceding Company Party, (b) violate or conflict with any Law, or other Governmental Order or any agreement with, or condition imposed by, any Governmental Authority applicable to such Ceding Company Party or by which any of such Ceding Company Party or any of its respective properties, assets or rights is bound or subject, (c) result in any breach or violation of, or constitute a default (or event which, with the giving of notice or lapse of time, or both, would become a default) under, or give to any Person any rights of termination, acceleration or cancellation of, or result in the creation of any Lien (other than a Permitted Lien) on any of the assets, properties or rights of such Ceding Company Party pursuant to, any contract to which such Ceding Company Party is a party, or (d) result in a breach or
17



violation of any terms or conditions of, or result in a default under, or otherwise cause an impairment or revocation of any Permit of any Ceding Company Party used in respect of the Reinsured Contracts or the administration thereof, other than, in the case of clauses (b), (c) or (d) any such conflicts, violations, breaches, defaults, rights or Liens that, individually or in the aggregate, do not have, and would not reasonably be expected to have, a Business Material Adverse Effect.
Section 1.02Consents and Approvals. Except as set forth in Section 3.03 of the Ceding Company Disclosure Schedule, the execution and delivery by each Ceding Company Party of the Transaction Agreements do not, and the performance by such Ceding Company Party of, and the consummation by such Ceding Company Party of the transactions contemplated by, the Transaction Agreements do not, require any Governmental Approval to be obtained or made by such Ceding Company Party prior to the Closing, except for such Governmental Approvals, the failure of which to obtained or made has not, and would not, individually or in the aggregate, reasonably be expected to be material to the Business or the administration of the Reinsured Contracts or the transactions contemplated by the Transaction Agreements. Except as set forth in Section 3.03 of the Ceding Company Disclosure Schedule, the execution and delivery by each Ceding Company Party of the Transaction Agreements do not, and the performance by such Ceding Company Party of, and the consummation by such Ceding Company Party of the transactions contemplated by, the Transaction Agreements do not, require any Governmental Approval from the New York Department of Financial Services to be obtained or made by such Ceding Company Party prior to the Closing.
Section 1.03Financial Statements.
(c)The Ceding Company has made available to the Reinsurer true, complete and correct copies of the audited annual statutory financial statements of such Ceding Company as of and for each of the years ended December 31, 2019, December 31, 2020 and December 31, 2021, as filed with the New York State Department of Financial Services, together with the exhibits, schedules and notes thereto and any affirmations and certifications filed therewith (collectively, the “Financial Statements”).
(d)The Financial Statements (1) were derived from the books and records of the Ceding Company, (2) have been prepared in all material respects in accordance with SAP applied consistently throughout the periods involved and (3) present fairly, in all material respects, the statutory financial position, statutory results of operations and capital and surplus of the Ceding Company, as of their respective dates and for the respective periods covered thereby in accordance with SAP. All assets that are reflected as admitted assets in the Financial Statements, to the extent applicable, comply in all material respects with all Laws applicable to admitted assets. No material weakness has been asserted by any Governmental Authority with respect to any of the Financial Statements, other than any such item that has been cured or otherwise resolved to the satisfaction of such Governmental Authority prior to the date hereof. Except as set forth in Section 3.04(b) of the Ceding Company Disclosure Schedule, the Ceding Company did not utilize any permitted practices in the preparation of the Financial Statements.
(e)With respect to the Business, the Ceding Company maintains books and records that (i) are in compliance with applicable Law in all material respects, and (ii) accurately present and reflect in all material respects the assets and liabilities of the Business and all transactions related thereto. The Ceding Company maintains, in all material respects, proper and adequate systems of internal accounting controls designed to provide reasonable assurance that: (A) transactions are executed with management’s general or specific authorization; (B) transactions are recorded as necessary to permit preparation of its financial statements in conformity in all material respects with SAP; (C) access to its assets is permitted only in accordance with management’s general or specific authorization; and (D) the recorded
18



accountability for assets is compared with existing assets at reasonable intervals and appropriate actions are taken with respect to any differences.
(f)The Ceding Company has made available to the Reinsurer true, complete and correct copies of the audited annual statutory financial statements of each of the Separate Accounts as of and for each of the years ended December 31, 2019, December 31, 2020 and December 31, 2021 (the “Separate Account Annual Statements”), in each case, as filed with the New York State Department of Financial Services, together with the exhibits, schedules and notes thereto and any affirmations and certifications filed therewith and the report of the applicable independent auditor thereon. The Separate Account Annual Statements (i) were derived from the books and records of the applicable Ceding Company, (ii) have been prepared in all material respects in accordance with SAP applied consistently throughout the periods involved and (iii) present fairly, in all material respects, the statutory financial position and results of operations, changes in surplus and cash flows of such Separate Accounts, as of their respective dates and for the respective periods covered thereby in accordance with SAP. No material weakness has been asserted by any Governmental Authority in respect of the Separate Account Annual Statements other than any such item that has been cured or otherwise resolved to the satisfaction of such Governmental Authority prior to the date hereof.
Section 1.02Absence of Certain Changes. Except as set forth in Section 3.05 of the Ceding Company Disclosure Schedule or as contemplated by the Transaction Agreements, from December 31, 2021 to the date of this Agreement, (a) the Ceding Company has conducted the Business in the ordinary course consistent with past practice, and (b) there has not occurred any event, change, circumstance, effect, development, condition or occurrence that, individually or in the aggregate, have had, or would reasonably be expected to have, a Business Material Adverse Effect. From December 31, 2021 to the date of this Agreement, the Ceding Company has not taken any action or failed to take any action that would have required the Reinsurer’s consent under Section 5.01 had such action or omission occurred during the period from the date hereof to Closing.
Section 1.03Absence of Litigation.
(g)Except as set forth in Section 3.06(a) of the Ceding Company Disclosure Schedule, as of the date hereof, there are no Actions (other than claims under the Reinsured Contracts within applicable policy limits in the ordinary course of business) reasonably expected to result in damages in excess of [***] dollars ($[***]) pending or, to the Knowledge of the Ceding Company, threatened against the Ceding Company in respect of the Business.
(h)There are no Actions pending or, to the Knowledge of the Ceding Company, threatened against the Ceding Company or any of its Affiliates that question the validity of, or seek injunctive relief with respect to, this Agreement or the right of any Ceding Company Party to enter into any of the Transaction Agreements or the transactions contemplated hereby or thereby.
Section 1.01Compliance with Laws.
(i)Except as set forth in Section 3.07(a) of the Ceding Company Disclosure Schedule, since January 1, 2020, (i) the Ceding Company is not and has not been in violation of any Laws or Governmental Orders or agreement with any Governmental Authorities, in each case, applicable to it in respect of the Business, except for violations that, individually or in the aggregate, would not reasonably be expected to have a Business Material Adverse Effect, and (ii) has not received any material written, or to the Knowledge of Ceding Company oral, notice or communication from any Governmental Authority regarding any actual, alleged or potential material violation of, or material failure to comply with, the terms or requirements of any
19



applicable Law with respect to the conduct of the Business (other than ordinary course notices involving claims for benefits arising under the Reinsured Contracts).
(j)Except as set forth in Section 3.07(b) of the Ceding Company Disclosure Schedule, the Ceding Company is not a party to, or bound by, any material Governmental Order or material agreement with any Governmental Authorities, in each case, applicable to the Business.
Section 1.04Governmental Licenses and Permits.
(k)The Ceding Company owns, holds or possesses and maintains in full force and effect all material Permits from all Governmental Authorities that are necessary for the performance of its obligations under the Transaction Agreements and for it to conduct the Business and to own or use its assets and properties, to the extent used in the Business, owned and used in each of the jurisdictions in which such Business is operated and conducted, in each case, with respect to the Reinsured Contracts in each jurisdiction in which such Business is operated and conducted.
(l)Except as set forth in Section 3.08(b) of the Ceding Company Disclosure Schedule, (i) all such material Permits are valid and in full force and effect in accordance with their terms, (ii) the Ceding Company in respect of the Business is not in default or violation, in any material respect, of any of the such material Permits, (iii) since January 1, 2020, the Ceding Company has not received any written, or to the Knowledge of Ceding Company oral, notice or communication from any Governmental Authority regarding any actual, alleged or potential violation of, or failure to comply with, the terms or requirements of any such material Permit in respect of the Business, and (iv) the Ceding Company is not the subject of any pending or, to the Knowledge of the Ceding Company, threatened Action seeking the revocation, withdrawal, suspension, limitation, termination, cancellation, modification, impairment or non-renewal of any such material Permit in respect of the Business. Subject to obtaining the consents set forth in Section 3.03 of the Ceding Company Disclosure Schedule, none of such material Permits will be subject to revocation, suspension, withdrawal, limitation, termination, cancellation, modification, impairment or non-renewal as a result of the consummation of the transactions contemplated hereby.
Section 1.04Insurance Regulatory Matters.
(m)The Ceding Company has made available to the Reinsurer (i) copies of all material reports and registrations (including registrations as a member of an insurance holding company system) and any supplements or amendments thereto filed since January 1, 2020 by the Ceding Company with respect to the Business with applicable Governmental Authorities, (ii) copies of all financial and market conduct examination reports of all applicable Governmental Authorities with respect to the Business issued since January 1, 2020, and (iii) copies of all other material correspondence, orders, inquiries, risk-based capital reports and other materials relating to the Ceding Company in respect of the Business received from or delivered to any Insurance Regulator including those relating to the Ceding Company’s accounting, actuarial, reporting and claims-handling practices since January 1, 2020 or that are in effect as of the date hereof, in each case to the extent in respect of the Business. All material deficiencies or violations noted in such examination reports have been cured or resolved to the satisfaction of the applicable Governmental Authority. Except as set forth in Section 3.09(a) of the Ceding Company Disclosure Schedule, to the Knowledge of the Ceding Company, the Ceding Company is not, as of the date hereof, subject to any pending financial or market conduct examination by any applicable Governmental Authorities in respect of the Business.
20



(n)The Ceding Company has made available to the Reinsurer copies of all policy forms, riders, supplements, amendments and endorsements on which any Reinsured Contract has been issued on Schedule C to the Reinsurance Agreement, and all rate filings, most recent actuarial memoranda and current or most recent (as applicable) marketing materials pertaining to the Reinsured Contracts. All marketing materials, application forms, brochures, certificates and illustrations used in connection with the sale and issuance of the Reinsured Contracts are, to the extent required under applicable Law, on forms and at rates approved by the applicable Insurance Regulator or filed and not objected to by such Insurance Regulator within the period provided for objection and all such policy forms and rates comply in all material respects with applicable Law, in each case, except as would not reasonably be expected to, individually or in the aggregate, result in a Business Material Adverse Effect. No material deficiencies have been asserted by any Governmental Authority with respect to any such filings which have not been cured or otherwise resolved. Since January 1, 2020, the Reinsured Contracts have been administered in compliance in all material respects with applicable Law.
(o)Since January 1, 2020, all benefits due, paid and payable, or required to be credited, by or on behalf of any Affiliate of the Ceding Company, on the Reinsured Contracts in force on such dates have in all material respects been paid or credited, as the case may be, in accordance with the terms of such Reinsured Contracts under which they arose, and such payments, credits or provisions were not materially delinquent, except for such claims for which the Ceding Company or any Affiliate of the Ceding Company believed there was a reasonable basis to contest payment.
(p)Since January 1, 2019, the Reinsured Contracts have been marketed, sold, issued and administered in compliance in all material respects with applicable Law.
(q)The terms of the Reinsured Contracts are consistent in all material respects with the terms and conditions set forth in the policy forms, riders, supplements and endorsements set forth on Schedule C to the Reinsurance Agreement, and all rate filings, most recent actuarial memoranda, current marketing materials, and any other document provided to any purchaser or policyholder pertaining to the Reinsured Contracts made available pursuant to this Section 3.09 and the Specified Data.
(r)The Reinsured Contracts do not contain any non-guaranteed elements or discretion with respect to future premiums or benefits under the Reinsured Contracts other than as set forth in the Reinsurance Agreement.
(s)Since January 1, 2020, each Reinsured Contract that is a security has been (i) offered and sold, and all purchase payments under such Reinsured Contract have been received, pursuant to an effective registration statement under the Securities Act or (ii) offered and sold in reasonable reliance upon an applicable exemption from the registration and prospectus delivery requirements of the Securities Act.
(t)The Ceding Company maintains unclaimed property and escheat policies, procedures and guidelines with respect to the Business which comply in all material respects with applicable Law, true and complete copies of which have been made available to the Reinsurer by the Ceding Company. Since January 1, 2020, the Ceding Company has been in compliance in all material respects with all such policies, procedures and guidelines as then in effect and any applicable Laws related thereto with respect to the Business.
(u)The Ceding Company maintains policies, procedures, and guidelines with respect to the Business related to its efforts to establish contact with annuitants for purposes of paying benefits or confirming any annuitant’s eligibility for such benefit payments, including with respect to any annuitant for which the Ceding Company has any inaccurate contact
21



information and any annuitant who does not initially respond to the Ceding Company’s outreach. True and complete copies of such policies, procedures and guidelines with respect to the Business have been made available to the Reinsurer by the Ceding Company. Since January 1, 2020, the Ceding Company has been in compliance in all material respects with all such policies, procedures and guidelines as then in effect and any applicable Laws related thereto with respect to the Business.
(v)As of the date hereof, the Ceding Company has not received written or, to the Knowledge of the Ceding Company, oral, notice of termination of any Reinsured Contract.
Section 1.10Actuarial Appraisal. The Ceding Company has delivered to the Reinsurer a true, complete and correct copy of the actuarial appraisal prepared by the Third Party Actuary with respect to the Reinsured Contracts, dated February 18, 2022 and titled “Actuarial Appraisal of Equi-Vest Group Variable Annuity Pre-2009 Business as of December 31, 2021” and all attachments, addenda, supplements and modifications thereto (the “Actuarial Appraisal”). The Third Party Actuary has not issued the Ceding Company any written revised Actuarial Appraisal, nor has it notified the Ceding Company in writing or, to the Knowledge of the Ceding Company, orally that the Actuarial Appraisal is inaccurate in any material respect. The Ceding Company is not aware to its Knowledge, of any omissions, errors or discrepancies in any factual information contained in the Actuarial Appraisal that would, when taken as a whole, materially affect the Actuarial Appraisal taken as a whole. The Third Party Actuary has not issued to the Ceding Company or any if its Affiliates, nor does the Ceding Company or any of its Affiliates have any pending request for, any new report or errata with respect to the Actuarial Appraisal. The factual information and data provided by the Ceding Company and its Affiliates to the Third Party Actuary expressly in connection with the preparation of the Actuarial Appraisal was (a) obtained from the Books and Records, (b) generated from the same underlying sources and systems that were utilized by the Ceding Company and its Affiliates to prepare its Financial Statements for the relevant periods, (c) (i) accurate in all material respects and (ii) did not omit any such factual information or data directly relevant to the calculations to be performed in and under the scope of the Actuarial Appraisal as such calculations and scope were defined therein, in each case as of the date so provided, subject in each case to any limitations and qualifications contained in the Actuarial Appraisal, (d) based upon an inventory of in-force Reinsured Contracts that were issued, reinsured or assumed by the Ceding Company that, at the time of preparation, was complete and accurate in all material respects and (e) to the extent applicable and involving within such factual information or data computation, computed in all material respects in accordance with generally accepted actuarial standards consistently applied; provided, that the Ceding Company does not guarantee the projected results included in the Actuarial Appraisal and, except as expressly provided in this Article III, makes no representation or warranty with respect to any estimates, projections, predictions, forecasts or assumptions in the Actuarial Appraisal.
Section 1.11Brokers. Except as provided in Section 3.11 of the Ceding Company Disclosure Schedule, the Ceding Company is solely responsible for the payment of the fees and expenses of any broker, investment banker, financial adviser or other Person acting in a similar capacity in connection with the transactions contemplated by the Transaction Agreements based upon arrangements made by or on behalf of the Ceding Company or any of its Affiliates.
Section 1.12Separate Accounts.
(w)Section 3.12(a) of the Ceding Company Disclosure Schedule sets forth a true, complete and correct list of all separate accounts established by or affiliated with the Ceding Company with respect to the Business as of the date hereof (collectively, the “Separate Accounts”) and all existing underlying funds available to the policyholders through the Separate Accounts under the Reinsured Contracts, including (x) an indication of whether each such
22



Separate Account is registered under the Investment Company Act (and, if applicable, the Investment Company Act registration file number applicable to such Separate Account) and (y) whether such Separate Account is commingled with any business other than the Business or is chargeable with liabilities arising from business other than the Business.
(x)Each Separate Account is, and has been, (i) duly and validly established and maintained in all material respects under applicable Law and (ii) since January 1, 2020, operated in compliance with applicable Law (including the conditions of any applicable exemptions obtained from provisions of the Investment Company Act), except, in each case, as would not reasonably be expected to, individually or in the aggregate, result in a Business Material Adverse Effect.
(y)Each Separate Account is either (i) registered as an investment company under the Investment Company Act (each, a “Registered Separate Account”), (ii) not an investment company within the meaning of the Investment Company Act, or (iii) not registered as an investment company in reasonable reliance upon the exclusion from the definition of an investment company in Section 3(c)(1), 3(c)(7) or 3(c)(11) of the Investment Company Act. In respect of such Separate Account that is registered as an investment company under the Investment Company Act, since becoming registered as an investment company under the Investment Company Act, each Registered Separate Account has been operated in material compliance with the portions of the Investment Company Act (including the conditions of any applicable exemptions obtained from provisions of the Investment Company Act) applicable to it, and its registration under the Investment Company Act is in full force and effect.
(z)Except as set forth in Section 3.12(d) of the Ceding Company Disclosure Schedule, as of the date hereof, neither the Ceding Company nor any of its Affiliates has received written (or, to the Ceding Company’s Knowledge, oral) notice of any examinations, investigations, reviews, inspections or formal or informal inquiries of the Separate Accounts, including periodic regulatory examinations of the Separate Accounts’ affairs and condition, civil investigative demands and market conduct examinations, by any Governmental Authority that have been conducted, or are pending or, to the Knowledge of the Ceding Company, threatened in writing, since January 1, 2020 through the date hereof.
(aa)(i) Each Separate Account is, and has been since January 1, 2020, in material compliance with its investment objectives, investment policies and restrictions (as they may be amended from time to time) and other contract terms; (ii) the value of the net assets of each Separate Account has been determined and is being determined using portfolio valuation methods that comply with the methods described in its offering or plan documents; and (iii) each of the Ceding Company and any Affiliate of the Ceding Company that has provided investment advisory services to any Separate Account has done so in material compliance with such Separate Account’s investment objectives, investment policies and restrictions (as they may be amended from time to time) and other contract terms.
(ab)Each Registered Separate Account has written policies and procedures adopted pursuant to Rule 38a-1 under the Investment Company Act that are reasonably designed to prevent material violations of the United States Federal Securities Laws, as such term is defined in Rule 38a-1(e)(1) under the Investment Company Act. Since January 1, 2020, except as set forth on Section 3.12(f) of the Ceding Company Disclosure Schedule, there have been no Material Compliance Matters (as such term is defined in Rule 38a-1 under the Investment Company Act) that would, individually or in the aggregate, reasonably be expected to be material to the Business, other than those, if any, which have been both (i) reported as required by Rule 38a-1(a)(4)(iii)(B), and (ii) satisfactorily remedied or in the process of being remedied.
23



(ac)The M&E Fees set forth on Schedule 3.12(g)(i) are true, complete and accurate and are the M&E Fees that are receivable by the Ceding Company during the term of the Reinsurance Agreement. Each of the Contracts with respect to M&E Fees is a legal, valid and binding obligation of the Ceding Company and, to the Knowledge of the Ceding Company, each other party thereto, and is enforceable against the Ceding Company and, to the Knowledge of the Ceding Company, each other party thereto, in accordance with its terms, and neither the Ceding Company nor, to the Knowledge of the Ceding Company, any of the other parties thereto is in default or breach or has failed to perform any material obligation under any such Contract and, to the Knowledge of the Ceding Company, there does not exist any event, condition or omission that would constitute such a breach or default (whether by lapse of time or notice or both). There are no modifications to M&E Fees (i) proposed by the Ceding Company or a counterparty to a Contract with respect to M&E Fees or (ii) that the Ceding Company or such a counterparty intends to propose. The 12b-1 Fees set forth on Schedule 3.12(g)(ii) are true, complete and accurate and are the 12b-1 Fees that are receivable by the Ceding Company or its applicable Affiliates during the term of the Reinsurance Agreement. Each of the Contracts with respect to 12b-1 Fees is a legal, valid and binding obligation of the Ceding Company or its applicable Affiliate and, to the Knowledge of the Ceding Company, each other party thereto, and is enforceable against the Ceding Company and, to the Knowledge of the Ceding Company, each other party thereto, in accordance with its terms, and neither the Ceding Company nor, to the Knowledge of the Ceding Company, any of the other parties thereto is in default or breach or has failed to perform any material obligation under any such Contract and, to the Knowledge of the Ceding Company, there does not exist any event, condition or omission that would constitute such a breach or default (whether by lapse of time or notice or both). As of the date hereof, other than the fund substitutions contemplated by Item 5 of Section 5.01 of the Ceding Company Disclosure Schedules, where the replacement funds have the same 12b-1 Fees as the substituted funds, there are no modifications to 12b-1 Fees (i) proposed by the Ceding Company or, as of the date hereof and to the knowledge of the Ceding Company, a counterparty to a Contract with respect to 12b-1 Fees or (ii) that the Ceding Company or, as of the date hereof and to the knowledge of the Ceding Company, such a counterparty intends to propose. The Revenue Sharing Fees set forth on Schedule 3.12(g)(iii) are a true, complete and accurate list of the Revenue Sharing Fees that were receivable by the Ceding Company or its applicable Affiliates (other than EIM) for the three months ended March 31, 2022. Each of the Contracts with respect to Revenue Sharing Fees is a legal, valid and binding obligation of the Ceding Company or its applicable Affiliate and, to the Knowledge of the Ceding Company, each other party thereto, and is enforceable against the Ceding Company and, to the Knowledge of the Ceding Company, each other party thereto, in accordance with its terms, and neither the Ceding Company nor, to the Knowledge of the Ceding Company, any of the other parties thereto is in default or breach or has failed to perform any material obligation under any such Contract and, to the Knowledge of the Ceding Company, as of the date hereof in respect of such matters in respect of any counterparty thereto, there does not exist any event, condition or omission that would constitute such a breach or default (whether by lapse of time or notice or both). As of the date hereof, other than (i) the fund substitution contemplated by Item 5 of Section 5.01 of the Ceding Company Disclosure Schedules, and (ii) the expense reductions approved by certain funds set forth in Section 3.12(g) of the Ceding Company Disclosure Schedules, there are no modifications to Revenue Sharing Fees (A) proposed by the Ceding Company or, as of the date hereof and to the Knowledge of the Ceding Company, a counterparty to a Contract with respect to Revenue Sharing Fees or (B) that the Ceding Company or, as of the date hereof and to the knowledge of the Ceding Company, such a counterparty intends to propose. For the avoidance of doubt, the representations in this Section 3.12(g) in respect of the Revenue Sharing Fees and the Contracts in respect of the Revenue Sharing Fees are as of the Closing Date or such earlier date as stated therein and not in respect of any period thereafter.
(ad)Set forth on Schedule 3.12(h) is a true, complete and accurate list of the EIM Administrative Fees in effect in respect of the Reinsured Contracts as of the date hereof.
24



Section 1.13Reserves. The statutory policy reserves required by SAP to be held by the Ceding Company in respect of the Reinsured Contracts as set forth in the Financial Statements for the year ended December 31, 2021, (a) were computed in all material respects in accordance with generally accepted actuarial standards, Law and SAP as applicable to the Ceding Company consistently applied, and were fairly stated, in accordance with sound actuarial principles as of December 31, 2021, (b) were based on actuarial assumptions which produce reserves at least as great as those called for in any Reinsured Contract as to reserve basis and method, and are accordance with all other applicable Reinsured Contract provisions, (c) met the requirements in all material respects of applicable Law and the provisions of the applicable Reinsured Contracts as to reserve basis and method, in each case except as otherwise noted in the Financial Statements or Separate Account Annual Statements and notes thereto, and are at least as great as the minimum aggregate amounts required by applicable Law, and (d) include provision for all actuarial reserves and related statement items which ought to be established by the Ceding Company pursuant to SAP. Notwithstanding the foregoing or anything herein to the contrary, neither the Ceding Company nor any of its Affiliates makes any representation or warranty in this Section 3.13 or in any other provision of this Agreement, any other Transaction Agreement or any other agreement, document or instrument to be delivered in connection with the transactions contemplated hereby or thereby with respect to (i) the adequacy or sufficiency of reserves of the Ceding Company, (ii) the effect of the adequacy or sufficiency of reserves on any line item, asset, liability or equity amount on any financial or other document (including the Financial Statements, the Separate Account Annual Statements or the Actuarial Appraisal), (iii) the future profitability of the Business, or (iv) except to the extent expressly provided in this Section 3.13, whether or not reserves were determined in accordance with any actuarial, statutory, regulatory or other standard.
Section 1.14Product Tax Matters.
(ae)The Tax treatment of each Reinsured Contract of the Ceding Company is not, and, since the time of issuance (or subsequent modification), has not been, materially less favorable to the purchaser, policyholder, participant or intended beneficiaries thereof, than the Tax treatment (i) that was purported to apply in any written materials provided to the purchaser (or policyholder, participant or intended beneficiaries) at the time of issuance (or any subsequent modification of such policy) or (ii) for which such policy was designed, intended or reasonably expected to qualify at the time of issuance (or subsequent modification). The Tax treatment of any plan under Section 403(b) of the Code that the Ceding Company or any of its Affiliates administers relating to the Reinsured Contracts (a “Related Plan”) has not been less favorable to the plan sponsor, purchaser, policyholder, participant or intended beneficiaries thereof than intended in respect of such Related Plan.
(af)The Ceding Company maintains, with respect to the Business, systems that are adequate to maintain the qualification for applicable Tax treatment of the Reinsured Contracts reinsured by it hereunder for which such Reinsured Contracts purported to qualify at the time of their issuance (or subsequent modification) or for which such policy was intended or reasonably expected to apply at the time of issuance (or subsequent modification).
(ag)The Ceding Company has monitored the Reinsured Contracts and each Related Plan for compliance with their intended Tax treatment under the Code and any applicable Treasury Regulations and administrative guidance issued thereunder and complied in all material respects with all product tax reporting, withholding and disclosure Laws that are applicable to the Reinsured Contracts and distributions thereunder.
(ah)To the Knowledge of the Company, no relief has been requested from the U.S. Internal Revenue Service (“IRS”) concerning the qualification of any Reinsured Contract under, or in compliance with, the Code and any applicable Treasury Regulations and
25



administrative guidance issued thereunder, and the IRS has not asserted in writing that any such Reinsured Contract or any Related Plan fails to so qualify or comply. To the Knowledge of the Company, there are no ongoing audits or material investigations by any Tax authority which relate to the failure or potential failure of any Reinsured Contract or any Related Plan to comply with the requirements of the Code applicable thereto and any Treasury Regulations and administrative guidance issued thereunder.
Section 1.1Specified Data. The Specified Data relating to the Business that was supplied by or on behalf of the Ceding Company or any of its Affiliates to the Reinsurer or any of its Affiliates in connection with this Agreement and the transactions contemplated hereby as of the date supplied (or if later corrected or supplemented prior to the date hereof, as of the date corrected or supplemented), (a) was derived from the Books and Records, (b) was generated from the same underlying sources and systems that were utilized to prepare the Financial Statements, (c) to the extent applicable to the Specified Data, was compiled in accordance with generally accepted actuarial principles and practices consistently applied given the intended purpose at the time compiled, (d) was accurate in all material respects as of the date prepared, and did not omit any such factual information or data directly relevant to the calculations to be performed in and under or scope of the particular, applicable data file component of the Specified Data as such calculations and scope were defined or reasonably described, as applicable, therein, in each case as of the date so provided, and (e) to the extent applicable, was based upon a complete inventory of Reinsured Contracts available as of the date delivered. The Ceding Company is not aware to its Knowledge of any omissions, errors or discrepancies that would materially affect such data since the respective dates on which such documents were prepared.
Section 1.2Producers. Each Producer, at the time such Producer solicited, negotiated, placed, sold or produced business constituting any of the Reinsured Contracts, to the extent required by applicable Law, was duly and appropriately licensed in all material respects as a Producer (for the type of business solicited, negotiated, sold or produced by such Producer), in each case in the particular jurisdiction in which such Producer solicited, negotiated, sold or produced such business for the Ceding Company and its Affiliates, as applicable. Each such Producer was duly and appropriately appointed by Ceding Company to act as a Producer for such company, except where the failure to be so appointed would not, individually or in the aggregate, reasonably be expected to be material to the Business as a whole.
Section 1.3Investment Assets. The Ceding Company or one of its Affiliates is the record and beneficial owner of, and has good, valid and marketable title to and in all of the Investment Assets on the Asset List, free and clear of all Liens other than Permitted Liens. At the Closing, all economic interests in the Transferred Assets to be transferred to a Trust Account pursuant to Article II will pass to the Reinsurer free and clear of any Liens other than Permitted Liens. None of the Investment Assets on the Asset List is in material default of payment of principal or interest or dividends or any other material payment or, to the Knowledge of the Ceding Company, performance obligation thereunder. Neither the Ceding Company nor any of its Affiliates who provide investment advisory or similar services to the Ceding Company in respect of the Business is aware to its Knowledge (in the case of the Ceding Company) or actual knowledge of the senior employees of such Affiliates with direct responsibility of the investment advisory or similar services in respect of the Ceding Company in respect of the Business (in the case of such Affiliates) (i) of any material breach or default under any covenants of any of the Investment Assets on the Asset List, (ii) that any Investment Assets on the Asset List are or should be classified as non-performing, non-accrual, ninety (90) days past due, still accruing and doubtful of collection, in foreclosure or any comparable classification or permanently impaired to any extent or (iii) that any Investment Assets on the Asset List are otherwise subject to impairment of carrying value under SAP.
26



Section 1.4Data Protection and Privacy.
(ai)The Ceding Company uses commercially reasonable measures to protect the secrecy of Non-Public Personal Information that it collects and maintains in connection with the Business and to prevent materially adverse unauthorized access to such Non-Public Personal Information by any Person. No Affiliate of the Ceding Company possesses or has access to Non-Public Personal Information in connection with the Business, other than any such Affiliate (if any) who uses commercially reasonable measures to protect the secrecy of Non-Public Personal Information that it collects and maintains in connection with the Business and to prevent materially adverse unauthorized access to such Non-Public Personal Information by any Person. With respect to the Business, the Ceding Company has implemented and maintains a security plan which (i) is reasonably designed to implement and monitor effective and commercially reasonable administrative, electronic and physical safeguards to ensure that confidential information and Non-Public Personal Information are protected against unauthorized access, disclosure, use, modification or misuse or misappropriation thereof and (ii) prescribes notification procedures in compliance in all material respects with applicable Law in the case of any breach of security compromising Non-Public Personal Information.
(aj)Since January 1, 2020, none of the Ceding Company or, to the Knowledge of the Ceding Company, any third Person working on behalf of any of them, has suffered a Data Breach or been required to notify any Person or Governmental Authorities of any Data Breach, except as set forth in Section 3.18(b) of the Ceding Company Disclosure Schedule.
Section 1.15ERISA. No underlying assets of any Reinsured Contract nor any assets transferred to the Reinsurer in connection with the Reinsurance Agreement, including any assets managed on its behalf, are or, at any time, will be treated as plan assets of any employee benefit plan or plan for any purpose of ERISA, Section 4975 of the Code, as determined pursuant to ERISA Sections 3(42) of ERISA, Section 401(b) or (c) of ERISA, Section 4975 of the Code or otherwise. Accordingly, and based upon the facts described in the preceding sentence and ERISA and related regulations as in effect on the date hereof, Reinsurer shall not become a “fiduciary” or “party in interest” subject to (and as these terms are defined in) ERISA with respect to any employee benefit plan subject to ERISA as a result of entering into the Reinsurance Agreement, the transactions contemplated thereby or the terms of the Reinsured Contracts, provided that the Ceding Company makes no representations or warranties as to whether Reinsurer has such status other than as a result of entering into the Reinsurance Agreement, the transactions contemplated thereby or the terms of the Reinsured Contracts.
Section 1.16Assumed and Ceded Reinsurance Agreements. There are no contracts, agreements, instruments or other legally binding and enforceable commitments under which the Ceding Company or an applicable counterparty has continuing rights or obligations and pursuant to which the Ceding Company assumes or cedes risks with respect to the Reinsured Contracts.
Section 1.17Participating Policies. No Reinsured Contract is a participating life insurance policy,
Section 1.18NO OTHER REPRESENTATIONS OR WARRANTIES. NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED IN THIS AGREEMENT, EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS ARTICLE III (AS MODIFIED BY THE CEDING COMPANY DISCLOSURE SCHEDULE), NEITHER THE CEDING COMPANY NOR ANY OTHER PERSON MAKES ANY OTHER EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY WITH RESPECT TO THE CEDING COMPANY, THE INVESTMENT ASSETS OR THE BUSINESS, AND THE CEDING COMPANY DISCLAIMS ANY OTHER
27



REPRESENTATIONS, WARRANTIES, FORECASTS, PROJECTIONS, STATEMENTS OR INFORMATION, WHETHER MADE BY THE CEDING COMPANY OR ANY OF ITS AFFILIATES, OFFICERS, DIRECTORS, EMPLOYEES OR REPRESENTATIVES, INCLUDING IN ANY CONFIDENTIAL INFORMATION MEMORANDUM, MANAGEMENT PRESENTATIONS OR SIMILAR SOURCES. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, EXCEPT AS EXPRESSLY SET FORTH IN THIS ARTICLE III, NO REPRESENTATION OR WARRANTY HAS BEEN OR IS BEING MADE WITH RESPECT TO ANY PROJECTIONS, FORECASTS, BUSINESS PLANS, ESTIMATES OR BUDGETS DELIVERED OR MADE AVAILABLE TO THE REINSURER OR ANY OTHER PERSON.
Article IV
REPRESENTATIONS AND WARRANTIES REGARDING THE REINSURER
The Reinsurer hereby represents and warrants to the Ceding Company as follows as of the date hereof and as of the Closing Date (except for such representations and warranties which address matters only as of a specific date, which representations and warranties shall be true and correct as of such specific date); provided that the Reinsurer makes additional representations and warranties as set forth in Schedule 4.01:
Section 1.05Incorporation and Authority of the Reinsurer.
(a)The Reinsurer (i) is a Massachusetts-domiciled insurance company duly incorporated, validly existing and in good standing under the Laws of Massachusetts; (ii) has full corporate power and authority to carry on its business as now conducted and to own, lease and operate its properties and assets relating to its business; and (iii) is duly qualified to do business as a foreign or alien corporation, as the case may be, in good standing in each jurisdiction in it conducts business or the ownership, leasing or operation of its properties or assets relating to its business makes such qualification necessary, except, in the case of clause (iii), where the failure to so qualify, would not, individually or in the aggregate, reasonably be expected to have a Reinsurer Material Adverse Effect.
(b)Each Reinsurer Party has all requisite corporate or other entity power to enter into, consummate the transactions contemplated by, and carry out its obligations under, the Transaction Agreements to which it is a party. The execution and delivery by each Reinsurer Party of the Transaction Agreements to which it is a party, and the consummation by such Reinsurer Party of the transactions contemplated by, and the performance by such Reinsurer Party of its obligations under, the Transaction Agreements have been and, with respect to the Transaction Agreements to be executed and delivered after the date of this Agreement, will be, duly authorized by all requisite corporate or other entity action on the part of such Reinsurer Party. Each of the Transaction Agreements to which a Reinsurer Party is or will be a party has been or, with respect to the Transaction Agreements, to be executed and delivered after the date of this Agreement, will be, duly executed and delivered by such Reinsurer Party and, assuming due authorization, execution and delivery by each other party thereto, constitutes or, with respect to the Transaction Agreements, to be executed and delivered after the date of this Agreement, will constitute, the legal, valid and binding obligation of such Reinsurer Party, enforceable against it in accordance with its terms, subject in each case to the effect of any applicable bankruptcy, reorganization, insolvency, moratorium, rehabilitation, liquidation, fraudulent conveyance or similar Laws relating to or affecting creditors’ rights generally and subject, as to enforceability, to the effect of general equitable principles (regardless of whether such enforceability is considered in a proceeding in equity or at law).
Section 1.05No Conflict. Provided that all consents, approvals, authorizations and other actions described in Section 3.03 and Section 4.03 have been obtained or taken, as
28



applicable and except as may result from any facts or circumstances solely relating to the Ceding Company or its Affiliates (as opposed to any other third party), the execution, delivery and performance by each Reinsurer Party of, and the consummation by such Reinsurer Party of the transactions contemplated by, the Transaction Agreements do not (a) violate or conflict with any provision of the organizational documents of such Reinsurer Party, (b) violate or conflict with any Law, Governmental Order or any other agreement with, or condition imposed by, any Governmental Authority applicable to such Reinsurer Party or by which it or its properties, assets or rights are bound or subject, (c) result in any breach or violation of, or constitute a default (or event which, with the giving of notice or lapse of time, or both, would become a default) under, or give to any Person any rights of termination, acceleration, or cancellation of, or result in the creation of any Lien (other than Permitted Liens) on any of the assets, properties or rights of such Reinsurer Party pursuant to any material note, bond, mortgage, indenture or contract to which such Reinsurer Party or any of its Subsidiaries is a party or by which any of such assets or properties is bound or subject, or (d) result in a breach or violation of any terms or conditions of, or result in a default under, or otherwise cause an impairment or revocation of any Permit of any Reinsurer Party, except, in the case of clauses (b), (c) and (d), any such conflicts, violations, breaches, defaults, rights or Liens that, individually or in the aggregate, do not have, and would not reasonably be expected to have, a Reinsurer Material Adverse Effect.
Section 1.06Consents and Approvals. Except as set forth in Section 4.03 of the Reinsurer Disclosure Schedule, the execution and delivery by each Reinsurer Party of the Transaction Agreements do not, and the performance by such Reinsurer Party of, and the consummation by such Reinsurer Party of the transactions contemplated by, the Transaction Agreements do not, require any Governmental Approval to be obtained or made by such Reinsurer Party or any of its Affiliates prior to the Closing. The execution and delivery by each Reinsurer Party of the Transaction Agreements do not, and the performance by such Reinsurer Party of, and the consummation by such Reinsurer Party of the transactions contemplated by, the Transaction Agreements do not, require any Governmental Approval from the New York Department of Financial Services to be obtained or made by such Reinsurer Party prior to the Closing.    
Section 1.07Absence of Litigation. As of the date hereof, there are no Actions pending or, to the Knowledge of the Reinsurer, threatened in writing against the Reinsurer that (i) question the validity of, or seek injunctive relief with respect to, this Agreement or the right of any Reinsurer Party to enter into any of the Transaction Agreements or (ii) could reasonably be expected, individually or in the aggregate, to have a material adverse effect on the business, results of operations or financial condition of the Reinsurer.
Section 1.08Solvency. Immediately after giving effect to the consummation of the transactions contemplated by the Transaction Agreements, the Reinsurer and its Subsidiaries will be Solvent. For purposes of this Section 4.05, “Solvent” means, with respect to any Person, that:
(c)the fair saleable value (determined on a going concern basis) of the assets of such Person shall be greater than the total amount of such Person’s liabilities (including all liabilities, whether or not reflected in a balance sheet prepared in accordance with SAP or GAAP, as applicable, and whether direct or indirect, fixed or contingent, secured or unsecured, disputed or undisputed);
(d)such Person shall be able to pay its debts and obligations in the ordinary course of business as they become due; and
(e)such Person shall have adequate capital to carry on its businesses and all businesses in which it is about to engage.
29



Section 1.06Regulatory Matters.
(f)Each of the Reinsurer and the Guarantor is in compliance with applicable Law, except as would not, individually or in the aggregate, reasonably be expected to materially and adversely affect its ability to timely perform its obligations under this Agreement.
(g)Except as would not, individually or in the aggregate, reasonably be expected to materially and adversely affect the ability of the Reinsurer, the Guarantor or any of their respective Affiliates executing any Transaction Agreement to timely perform their respective obligations under this Agreement and the Transaction Agreements, the Reinsurer, the Guarantor and any such Affiliates (i) hold and maintain in full force and effect all Permits from all Governmental Authorities necessary for the operation and conduct of its business as of the date hereof and to own or use its assets and properties owned and used on the date hereof in each of the jurisdictions in which such business is operated and conducted and (ii) are in compliance with all such Permits.
Section 1.02Financial Statements. True, complete and correct copies of the audited annual statutory financial statements of each of the Reinsurer and the Guarantor as of and for each of the years ended December 31, 2019, December 31, 2020 and December 31, 2021 (collectively, the “Reinsurer Financial Statements”) have been provided to the Ceding Company prior to the date hereof. The Reinsurer Financial Statements (1) were derived from the books and records of the Reinsurer, the Guarantor and their respective Subsidiaries, as applicable, (2) have been prepared in all material respects in accordance with SAP applied consistently throughout the periods involved and (3) present fairly, in all material respects, the statutory financial position, statutory results of operations, capital and surplus of the Reinsurer, the Guarantor and their respective Subsidiaries, as applicable, as of their respective dates and for the respective periods covered thereby in accordance with SAP. All assets that are reflected as admitted assets in the Reinsurer Financial Statements, to the extent applicable, comply in all material respects with all Laws applicable to admitted assets. No material weakness has been asserted by any Governmental Authority with respect to any of the Reinsurer Financial Statements, other than any such item that has been cured or otherwise resolved to the satisfaction of such Governmental Authority. The Reinsurer did not utilize any permitted practices in the preparation of the Reinsurer Financial Statements.
Section 1.03Financial Ability. The Reinsurer has and will have at the Closing, sufficient immediately available funds to pay, in cash, the Ceding Commission and all other amounts payable pursuant to this Agreement at Closing or otherwise necessary to timely consummate the transactions contemplated by the Transaction Agreements. The obligations of the Reinsurer to effect the transactions contemplated by the Transaction Agreements are not conditioned upon the availability to the Reinsurer or any of its Affiliates of any debt, equity or other financing in any amount whatsoever.
Section 1.04Brokers. The Ceding Company shall not be responsible for the payment of the fees and expenses, if any, of any broker, investment banker, financial adviser or other Person acting in a similar capacity in connection with the transactions contemplated by the Transaction Agreements, based upon arrangements made by or on behalf of the Reinsurer or any of its Affiliates.
Article V
ACTIONS PRIOR TO THE CLOSING DATE
Section 1.07Conduct of Business Prior to the Closing. Except as required by applicable Law or as required or expressly permitted by the terms of the Transaction Agreements, and except for matters set forth in Section 5.01 of the Ceding Company Disclosure
30



Schedule, from the date of this Agreement through the Closing Date (or any earlier termination of this Agreement in accordance with its terms), unless the Reinsurer otherwise consents in advance in writing (which consent shall not be unreasonably withheld, delayed or conditioned), the Ceding Company shall (a) conduct the Business in the ordinary course of business consistent with past practice, (b) use commercially reasonable efforts to preserve intact the Business, preserve its business organization intact and maintain its existing relations and goodwill with Customers and Governmental Authorities and (c) not:
(i)other than in the ordinary course and consistent with past practice, fail to pay or satisfy when due any material amount that after the Closing Date would constitute a Reinsured Liability under the Reinsurance Agreement (other than any such Reinsured Liability that is being contested in good faith);
(ii)other than as does not (A) impact the Quota Share of the Reinsurer under the Reinsurance Agreement, (B) violate any net retention requirement of the Ceding Company in respect of the Business, and (C) require any filing (of notice or for approval) with any Governmental Authority to be made prior to Closing, enter into any third party reinsurance Contracts with respect to the Business;
(iii)materially change any of its actuarial, financial, underwriting, reserving, pricing, claims, risk retention, reinsurance, investment, claims administration, hedging, risk management or accounting policies, practices or principles, except insofar as may be required by a concurrent change in applicable Law or SAP or as may be required by any Governmental Authority;
(iv)abandon, modify, waive, surrender, withdraw, terminate or allow to lapse any material Permit of the Ceding Company to the extent relating to the conduct of the Business;
(v)seek approval from any applicable Governmental Authority for the use of any accounting practices related to the Reinsured Contracts that depart from the accounting practices prescribed or permitted by applicable Law in the Ceding Company’s state of domicile;
(vi)take any action that would violate Section 2.9 of the Reinsurance Agreement as if the Reinsurance Agreement were in effect; and
(vii)enter into any Contract with respect to any of the foregoing.
Section 1.09Access to Information.
(a)From the date of this Agreement until the Closing Date, the Ceding Company shall give the Reinsurer and its authorized Representatives, upon reasonable advance written notice and during regular business hours and subject to the rules applicable to visitors at the Ceding Company’s offices generally, reasonable access to all Books and Records, personnel, officers and other facilities and properties of the Ceding Company solely to the extent in respect of the Business; provided that any such access shall be conducted at the Reinsurer’s expense, in accordance with applicable Law (including any applicable Law relating to antitrust, competition, employment or privacy issues), under the supervision of the Ceding Company’s or its Affiliates’ personnel and in such a manner as to maintain confidentiality and not to unreasonably interfere with the normal operations of the Ceding Company and its Affiliates.
(b)Notwithstanding anything to the contrary contained in this Agreement or any other agreement between the Reinsurer or any of its Affiliates and the Ceding Company or
31



any of its Affiliates executed on or prior to the date hereof, the Ceding Company and its Affiliates shall have no obligation to make available to the Reinsurer or its Representatives, or to provide the Reinsurer or its Representatives with access to or copies of (i) any personnel file, medical file or related records of any employees or independent contractors or similar Persons, (ii) any Tax Return (other than with respect to transfer Taxes, premium Taxes and similar Taxes that relate to the Reinsured Contracts and the Separate Accounts) or (iii) any other information if the Ceding Company determines, in its reasonable judgment, that making such information available would (A) jeopardize any attorney-client privilege, work product immunity or any other legal privilege or similar doctrine or (B) contravene any applicable Law, Governmental Order or any fiduciary duty, it being understood that the Ceding Company shall (x) cooperate with any requests for, and use its commercially reasonable efforts to obtain any, waivers and (y) use its commercially reasonable efforts to make other arrangements (including redacting information or entering into joint defense agreements), in each case that would enable any otherwise required disclosure to the Reinsurer to occur without so jeopardizing any such privilege or immunity or contravening such applicable Law, Governmental Order or fiduciary duty.
Section 1.08Reasonable Best Efforts.
(c)Upon the terms and subject to the conditions set forth in this Agreement, each of the Ceding Company and the Reinsurer agrees to use, and shall cause its Affiliates to use, reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, and to assist and cooperate with the other Parties in doing, all things necessary, proper or advisable to fulfill all conditions applicable to such Party pursuant to the Transaction Agreements and to consummate and make effective, in the most expeditious manner practicable, the Closing and the other transactions contemplated thereby, including (i) executing and delivering any additional agreements, documents or instruments necessary, proper or advisable to consummate the transactions contemplated by, and to fully carry out the purposes of, the Transaction Agreements and (ii) preparing and, within ten (10) Business Days of the date hereof, filing with, and obtaining from, the Massachusetts Division of Insurance the consents, approvals, waivers, authorizations, notices and filings listed on Schedule 7.02(c). The Parties shall bear their respective costs, if any, of making or obtaining any such consents, approvals, waivers, authorizations, notices and filings.
(d)The Reinsurer and the Ceding Company shall (i) promptly furnish, or cause to be furnished, all agreements, documents, instruments, affidavits or information that may be required or requested by the Massachusetts Division of Insurance in connection with the consents, approvals, waivers, authorizations, notices and filings listed on Schedule 7.02(c) and (ii) make available their respective Representatives to each other and, upon request, the Massachusetts Division of Insurance, in connection with (A) the preparation of the consents, approvals, waivers, authorizations, notices and filings listed on Schedule 7.02(c), or (B) any review or approval process by, the Massachusetts Division of Insurance in connection with the transactions contemplated by this Agreement, solely to the extent relating to the Business, or the Transaction Agreements.
(e)Notwithstanding anything to the contrary contained in this Agreement, the Reinsurer and the Ceding Company shall not be obligated to take or refrain from taking, and no Party shall agree to the Reinsurer, its Affiliates, the Ceding Company or its Affiliates from taking or refraining from taking any action, or to permit or suffer to exist any condition, limitation, restriction or requirement that, individually or in the aggregate with any other actions, conditions, limitations, restrictions or requirements would or would reasonably be likely to result in a Burdensome Condition; provided, further, that prior to any Party being entitled to assert that a Burdensome Condition has been imposed, such Party shall follow the Resolution Process. Any steps a Party agrees to take through the Resolution Process for the mitigation of any potential
32



Burdensome Condition shall not themselves constitute a Burdensome Condition hereunder, but shall be taken into account in determining whether any condition, limitation or qualification constitutes a Burdensome Condition hereunder. The Reinsurer’s or the Ceding Company’s breach of any of such Party’s obligations contained in this Section 5.03 that results in a failure of the Closing to occur shall constitute a Willful Breach of this Agreement by such Party.
(f)[***]
Article VI
ADDITIONAL AGREEMENTS
Section 1.01Confidentiality. The terms of the non-disclosure agreement, dated December 17, 2021 (the “Confidentiality Agreement”), between Equitable Financial Life Insurance Company and Global Atlantic Financial Company are incorporated into this Agreement by reference and shall continue in full force and effect until the Closing, at which time the confidentiality obligations under the Confidentiality Agreement shall terminate. If for any reason the transactions contemplated by the Transaction Agreements are not consummated, the Confidentiality Agreement shall continue in full force and effect in accordance with its terms (disregarding, however, any provision contained therein that provides for termination thereof upon the execution of this Agreement).
Section 1.02Non-Solicitation. For a period of twelve (12) months following the Closing Date, without the prior written consent of the other Party, neither Party nor any of its Affiliates who are direct or indirect Subsidiaries of such Party (or, in the case of the Reinsurer, the Guarantor and Global Atlantic Re Limited, and their direct or indirect Subsidiaries) shall, whether directly or indirectly, solicit for employment, employ or contract for the services of any person who is employed or engaged in any business of the other Party or any of the other Party’s Affiliates with whom it had or has contact in connection with the transactions contemplated by this Agreement; provided, however, that nothing in this Section 6.02 shall prohibit such Party or any of its Affiliates who are direct or indirect Subsidiaries of such Party (or, in the case of the Reinsurer, the Guarantor, Global Atlantic Re Limited and their direct or indirect Subsidiaries) from soliciting, employing or contracting for the services of any such person (A) who is already engaged in employment discussions with such Party or any of its Affiliates prior to the date hereof, (B) who responds to a general, non-targeted advertisement for employment, (C) who contacts such Party or one of its Affiliates on his or her own initiative without any direct or indirect solicitation, (D) who has been given notice of termination by the other Party or its Affiliate prior to commencement of employment discussions between such Party or one of its Affiliates, on the one hand, and such person, on the other hand, or (E) who is identified by an employee search firm who is not directed by such Party to solicit such persons.
Section 1.03Names and Marks. Except as expressly provided in the Transaction Agreements, in no event shall a Party or any of its Affiliates have any right to use, nor shall such Party or any of its Affiliates use, the trademarks of the other Party or its Affiliates (collectively, in the case of the Ceding Company, the “Ceding Company Names and Marks” and collectively, in the case of the Reinsurer, the “Reinsurer Names and Marks”), or any other mark that is confusingly similar to any of the Ceding Company Names and Marks or Reinsurer Names and Marks, as applicable, in any jurisdiction worldwide.
Section 1.04Further Action. Each of the Ceding Company and the Reinsurer shall keep each other reasonably apprised of the status of the matters relating to the completion of the transactions contemplated by the Transaction Agreements, including with respect to the satisfaction of the conditions set forth in Article VII hereof. From time to time following the Closing, the Ceding Company and the Reinsurer shall, and shall cause their respective Affiliates to, execute, acknowledge and deliver any further documents, conveyances, notices and
33



instruments, and shall take such reasonable actions as may be necessary or appropriate, to make effective the transactions contemplated by the Transaction Agreements as may be reasonably requested by the other Party; provided that any such additional documents, conveyances, notices and instruments must be reasonably satisfactory to each of the Parties and shall not impose upon either Party any material liability, risk, obligation, loss, cost or expense not contemplated by the Transaction Agreements.
Section 1.05Privilege Preservation. Recognizing that Willkie Farr & Gallagher LLP (“Willkie”) has acted as legal counsel to the Ceding Company and its Affiliates prior to the Closing, all communications involving attorney-client confidences between any of the Ceding Company and its Affiliates and Willkie in the course of the negotiation, documentation and consummation of the transactions contemplated hereby (to the extent that the Reinsurer or any of its Affiliates or Representatives are not party to and do not receive a copy of such communication) shall be deemed to be attorney-client confidences that belong solely to the Ceding Company and its Affiliates. Accordingly, the Reinsurer shall not have access to any such communications, or to the files of Willkie relating to such engagement, whether or not the Closing shall have occurred and such communications and files shall not constitute Books and Records for any purpose hereunder; it being understood that the Ceding Company shall use commercially reasonable efforts, without any requirement to incur or pay any out of pocket costs, expenses or fees, to obtain waivers or make other arrangements (including redacting information) that would enable any such item that would otherwise be included in the definition of “Books and Records” to be provided to the Reinsurer without impinging on the ability to assert such privilege. Without limiting the generality of the foregoing, upon and after the Closing, (a) the Ceding Company and its Affiliates (and not the Reinsurer) shall be the sole holders of the attorney-client privilege with respect to the Ceding Company’s engagement of Willkie, and the Reinsurer shall not be a holder thereof, (b) to the extent that files of Willkie in respect of such engagement constitute property of the client, only the Ceding Company and its Affiliates (and not the Reinsurer) shall hold such property rights and (c) Willkie shall have no duty whatsoever to reveal or disclose any such attorney-client communications or files to the Reinsurer with respect to such engagement.
Article VII
CONDITIONS TO CLOSING AND RELATED MATTERS
Section 1.06Conditions to Obligations of the Ceding Company. The obligation of the Ceding Company to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment or waiver by the Ceding Company, at or prior to the Closing, of each of the following conditions:
(a)Representations and Warranties; Covenants. (i) Reinsurer Fundamental Representations (other than the Reinsurer Fundamental Representation set forth in the second sentence of Section 4.03) shall be true and correct in all respects as of the date hereof and as of the Closing Date as if made on the Closing Date, (ii) the Reinsurer Fundamental Representation set forth in the second sentence of Section 4.03 shall be true and correct (other than in de minimis respects) as of the date hereof and as of the Closing Date as if made on the Closing Date, (iii) the other representations and warranties of the Reinsurer contained in Article IV shall be true and correct (without giving effect to any limitations as to materiality or Reinsurer Material Adverse Effect set forth therein) as of the date hereof and as of the Closing Date as if made on the Closing Date (other than any representation or warranty expressly made as of another date, which representation or warranty shall have been true and correct as of such date), except where the failure of such representations and warranties, individually or in the aggregate, to be true and correct has not had a Reinsurer Material Adverse Effect, (iv) the covenants contained in this Agreement to be complied with by the Reinsurer or its Affiliates at or before the Closing shall have been complied with in all material respects and (v) the Ceding Company shall
34



have received a certificate of the Reinsurer dated as of the Closing Date to such effect signed by a duly authorized executive officer of the Reinsurer.
(b)No Governmental Order. There shall be no Governmental Order in existence that prohibits the consummation of the transactions contemplated by this Agreement.
(c)Approvals of Governmental Authorities. The Governmental Approvals set forth on Schedule 7.02(c) shall have been received without the imposition of a Burdensome Condition and shall be in full force and effect and all statutory waiting periods in respect thereof shall have expired or shall have been terminated.
(d)No Reinsurer Material Adverse Effect. There shall not have occurred any event, circumstance or change that has had, or would reasonably be expected to have, a Reinsurer Business Material Adverse Effect.
Section 1.07Conditions to Obligations of the Reinsurer. The obligations of the Reinsurer to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment or waiver by the Reinsurer, at or prior to the Closing, of each of the following conditions:
(a)Representations and Warranties; Covenants. (i) The Ceding Company Fundamental Representations (other than the Ceding Company Fundamental Representation set forth in the second sentence of Section 3.03) shall be true and correct in all respects as of the date hereof and as of the Closing Date as if made on the Closing Date, (ii) the Ceding Company Fundamental Representation set forth in the second sentence of Section 3.03 shall be true and correct (other than in de minimis respects) as of the date hereof and as of the Closing Date as if made on the Closing Date, (iii) the other representations and warranties of the Ceding Company contained in Article III shall be true and correct (without giving effect to any limitations as to materiality or Business Material Adverse Effect set forth therein) as of the date hereof and as of the Closing Date as if made on the Closing Date (other than any representation or warranty expressly made as of another date, which representation or warranty shall have been true and correct as of such date), except where the failure of such representations and warranties, individually or in the aggregate, to be true and correct has not had a Business Material Adverse Effect, (iv) the covenants contained in this Agreement to be complied with by the Ceding Company or its Affiliates on or before the Closing shall have been complied with in all material respects and (v) the Reinsurer shall have received a certificate of the Ceding Company dated as of the Closing Date to such effect signed by a duly authorized executive officer of the Ceding Company.
(b)No Governmental Order. There shall be no Governmental Order in existence that prohibits the consummation of the transactions contemplated by this Agreement.
(c)Approvals of Governmental Authorities. The Governmental Approvals set forth on Schedule 7.02(c) shall have been received without the imposition of a Burdensome Condition and shall be in full force and effect and all statutory waiting periods in respect thereof shall have expired or shall have been terminated.
(d)No Business Material Adverse Effect. There shall not have occurred any event, circumstance or change that has had, or would reasonably be expected to have, a Business Material Adverse Effect.
Section 1.08Frustration of Closing Condition. Neither the Ceding Company nor the Reinsurer may rely on the failure of any condition set forth in this Article VII to be
35



satisfied if such failure was caused by such party’s failure to act in good faith or to comply with its obligations set forth in this Agreement.
Article VIII
TERMINATION AND WAIVER
Section 1.09Termination. This Agreement may be terminated prior to the Closing:
(e)by the mutual written consent of the Ceding Company and the Reinsurer;
(f)by either the Ceding Company or the Reinsurer if the Closing shall not have occurred prior to the first Business Day of the month following the date on which the three (3) month anniversary of this Agreement occurs (the “Outside Date”) or such later date as the Parties may mutually agree; provided that if on the Outside Date the condition set forth in Section 7.01(c) and Section 7.02(c) has not been satisfied and all other conditions set forth in Article VII have been satisfied or waived (other than those conditions that by their terms are to be satisfied at the Closing) then the Outside Date shall, without action by either Party, automatically be extended by one (1) month or such later date as the Parties may mutually agree; provided, further, that the right to terminate this Agreement under this Section 8.01(b) shall not be available to any Party whose failure to take any action required to fulfill any of such Party’s obligations under this Agreement shall have been the cause of, or shall have resulted in, the failure of the Closing to occur prior to such date;
(g)by either the Ceding Company or the Reinsurer in the event of the issuance of a final, nonappealable Governmental Order prohibiting the consummation of the transactions contemplated by this Agreement;
(h)by the Reinsurer in the event of a breach by the Ceding Company of any of the Ceding Company’s covenants, representations or warranties contained herein that would result in the conditions to the Closing set forth in Section 7.02(a) not being satisfied, and such breach is either not capable of being cured prior to the Outside Date or, if curable, the Ceding Company shall have failed to cure such breach within ten (10) Business Days after receipt of written notice thereof from the Reinsurer requesting such breach to be cured; provided, however, that the Reinsurer may not terminate this Agreement pursuant to this Section 8.01(d) at any time during which the Reinsurer is in breach of this Agreement such that the Ceding Company has the right to terminate this Agreement pursuant to Section 8.01(e);
(i)by the Ceding Company in the event of a breach by the Reinsurer of any of the Reinsurer’s covenants, representations or warranties contained herein that would result in the conditions to the Closing set forth in Section 7.01(a) not being satisfied, and such breach is either not capable of being cured prior to the Outside Date or, if curable, the Reinsurer shall have failed to cure such breach within ten (10) Business Days after receipt of written notice thereof from the Ceding Company requesting such breach to be cured; provided, however, that the Ceding Company may not terminate this Agreement pursuant to this Section 8.01(e) at any time during which the Ceding Company is in breach of this Agreement such that the Reinsurer has the right to terminate this Agreement pursuant to Section 8.01(d).
Section 1.010Notice of Termination. Any Party desiring to terminate this Agreement pursuant to Section 8.01 shall give written notice of such termination to the other Party.
Section 1.011Effect of Termination. In the event of the termination of this Agreement as provided in Section 8.01, this Agreement shall thereafter become void and there
36



shall be no liability on the part of any Party to this Agreement other than in respect of Section 6.02; provided that nothing in this Section 8.03 shall relieve the Ceding Company or the Reinsurer from liability for any Fraud or Willful Breach of this Agreement (it being acknowledged and agreed by the Parties that the failure to close the transactions contemplated by this Agreement by any Party that was otherwise obligated to do so under the terms of this Agreement shall be deemed to be a Willful Breach of this Agreement). The provisions of Section 1.01, Section 6.02, this Section 8.03 and Article X shall survive any termination hereof pursuant to Section 8.01. No termination of this Agreement shall affect the obligations contained in the Confidentiality Agreement, all of which obligations shall survive termination of this Agreement in accordance with their terms. The terms of the Confidentiality Agreement shall continue to survive any termination of this Agreement.
Article IX
SURVIVAL; INDEMNIFICATION
Section 1.012Survival of Representations, Warranties and Covenants.
(j)The representations and warranties of the Ceding Company and the Reinsurer in this Agreement shall survive the Closing solely for purposes of this Article IX (Survival; Indemnification) and shall terminate and expire on the date that is eighteen (18) months after the Closing Date; provided that the Ceding Company Fundamental Representations and the Reinsurer Fundamental Representations shall survive until the date that is thirty (30) days after the expiration of the applicable statute of limitations; provided, further, that the representations set forth in Section 3.12(g) shall survive until termination or expiration of the Reinsurance Agreement in accordance with its terms. Any claim for indemnification in respect of any representation or warranty that is not asserted by notice given as required herein prior to the expiration of the specified period of survival shall not be valid and any right to indemnification for such claim is hereby irrevocably waived after the expiration of such period of survival. Any claim properly made for an Indemnifiable Loss in respect of such a breach with respect to which sufficient notice pursuant to the terms hereof has been provided within such period of survival as herein provided (whether or not formal legal action shall have been commenced based upon such claim) will be timely made for purposes hereof. The Parties hereby waive and agree not to assert, solely as against each other in respect of any claim made by the other party pursuant to this Article IX and not as against any other Person, any defense to a claim made under this Article IX that such claim is barred as a result of any statute of limitations applicable to any such claim for indemnification obligations that would otherwise be time barred following the delivery of such notice if, and only to the extent of, such claim under this Article IX being validly made prior to the expiration of its survival under this Section 9.01(a).
(k)To the extent that it is to be performed after the Closing, each covenant in this Agreement will survive and remain in effect in accordance with its terms plus a period of six (6) months thereafter, after which no claim for indemnification with respect thereto may be brought hereunder.
Section 1.013Indemnification.
(a)The Ceding Company shall defend, indemnify and hold harmless the Reinsurer and its Affiliates (collectively, the “Reinsurer Indemnified Persons”) from and against any and all Indemnifiable Losses actually incurred or suffered by such Reinsurer Indemnified Persons to the extent resulting from or arising out of:
(i)any breach or failure to be true of any representations or warranties of the Ceding Company under Article III hereof, other than Section 3.12(g) and the Ceding Company Fundamental Representations;
37



(ii)any breach or failure to be true of any Ceding Company Fundamental Representations;
(iii)any breach, nonfulfillment or default in the performance of any agreement or covenant of the Ceding Company under this Agreement; or
(iv)(A) any breach or failure to be true of the representation and warranty of the Ceding Company under Section 3.12(g) and (B) any Excluded Liabilities (as defined in the Reinsurance Agreement, without any duplication of recovery under the Reinsurance Agreement).
(l)The Reinsurer shall defend, indemnify and hold harmless the Ceding Company and its Affiliates (collectively, the “Ceding Company Indemnified Persons”) from and against any and all Indemnifiable Losses actually incurred or suffered by the Ceding Company Indemnified Persons to the extent resulting from or arising out of:
(v)any breach or failure to be true of any representations or warranties of the Reinsurer under Article IV hereof, other than the Reinsurer Fundamental Representations;
(vi)any breach or failure to be true of any Reinsurer Fundamental Representations;
(vii)any breach, nonfulfillment or default in the performance of any agreement or covenant of the Reinsurer under this Agreement; or
(viii)any Reinsurer Extra-Contractual Obligations (as defined in the Reinsurance Agreement).
(a)For purposes of calculating the amount of any Indemnifiable Losses under this Article IX and for purposes of determining whether there has been a breach or failure to be true of any representation or warranty contained in this Agreement, each representation and warranty contained in this Agreement (other than in respect of Section 3.05 (Absence of Certain Changes)) shall be determined without regard to any materiality (including qualifiers as to “material,” “materially,” “in any material respect,” “in all material respects” or other derivations of the word “material” used alone or in a phrase) or Business Material Adverse Effect or Reinsurer Material Adverse Effect qualifier contained therein.
Section 1.014Certain Limitations.
(m)The Ceding Company shall not be obligated to indemnify and hold harmless its respective Indemnitees for any claims or Indemnifiable Losses arising under Section 9.02(a)(i), (i) with respect to any claim (or series of related claims arising from the same underlying facts, events or circumstances), unless such claim (or series of related claims arising from the same underlying facts, events or circumstances) involves Indemnifiable Losses in excess of $[***] (the “Threshold Amount”) (nor shall any claim that does not exceed the Threshold Amount be applied to or considered for purposes of calculating the amount of Indemnifiable Losses for which the Indemnitor is responsible under clause (ii) below) and (ii) unless and until the aggregate amount of all Indemnifiable Losses of the Indemnitees for such claims or Indemnifiable Losses arising under Section 9.02(a)(i) exceeds $[***] (the “Deductible”), at which point such Indemnitor shall be liable to its respective Indemnitees for the value of the Indemnitee’s claims for such claims or Indemnifiable Losses arising under Section 9.02(a)(i) that is in excess of the Deductible, subject to the limitations set forth in this Article IX. The Reinsurer shall not be obligated to indemnify and hold harmless its respective Indemnitees
38



for any claims or Indemnifiable Losses arising under Section 9.02(b)(i), (i) with respect to any claim (or series of related claims arising from the same underlying facts, events or circumstances), unless such claim (or series of related claims arising from the same underlying facts, events or circumstances) involves Indemnifiable Losses in excess of the Threshold Amount (nor shall any claim that does not exceed the Threshold Amount be applied to or considered for purposes of calculating the amount of Indemnifiable Losses for which the Indemnitor is responsible under clause (ii) below) and (ii) unless and until the aggregate amount of all Indemnifiable Losses of the Indemnitees for such claims or Indemnifiable Losses arising under Section 9.02(b)(i) exceeds the Deductible, at which point such Indemnitor shall be liable to its respective Indemnitees for the value of the Indemnitee’s claims for such claims or Indemnifiable Losses arising under Section 9.02(b)(i) that is in excess of the Deductible, subject to the limitations set forth in this Article IX.
(n)The maximum liability of the Ceding Company to the Reinsurer Indemnified Persons for any and all Indemnifiable Losses pursuant to this Agreement for claims pursuant to Sections 9.02(a)(i), (ii) and (iii) shall be $[***] in the aggregate; provided that the maximum aggregate liability of the Ceding Company to the Reinsurer Indemnified Persons for any and all Indemnifiable Losses pursuant to this Agreement for claims pursuant to Section 9.02(a)(i) shall be $[***] in the aggregate. The maximum liability of the Reinsurer to the Ceding Company Indemnified Persons for any and all Indemnifiable Losses pursuant to this Agreement for claims pursuant to Sections 9.02(b)(i), (ii) and (iii) shall be $[***] in the aggregate; provided that the maximum aggregate liability of the Reinsurer to the Ceding Company Indemnified Persons for any and all Indemnifiable Losses pursuant to this Agreement for claims pursuant to Section 9.02(b)(i) shall be $[***] in the aggregate.
(o)Each Indemnitee shall use commercially reasonable efforts to mitigate all Indemnifiable Losses for which indemnification is sought hereunder, including by using commercially reasonable efforts to collect the maximum amount recoverable with respect thereto under any direct insurance coverage or other applicable source of recovery with respect to Indemnifiable Losses incurred by such Indemnitee, failing which the Indemnitor shall be entitled, at its option, to assume such collection proceedings at the expense of the Indemnitee, provided that this sentence shall not be applicable to any reinsurance, retrocession or similar arrangement.
(p)Notwithstanding anything herein to the contrary, neither the Ceding Company nor any other Person shall be liable under Section 9.02(a) or otherwise for any Indemnifiable Losses as a result of any breach or failure to be true of the third or fourth sentence of Section 3.17 to the extent the matters affecting such applicable Investment Assets that are the subject of such breach or failure to be true were taken into account in determining the Fair Market Value and, to the extent applicable, Statutory Book Value (as defined in the Reinsurance Agreement) of such Investment Assets as part of the Transferred Asset Value.
Section 1.015Definitions.
(a)Indemnifiable Losses” means any and all Losses; provided, that any Indemnifiable Losses (i) shall in no event include any amounts constituting special, punitive or exemplary damages other than such damages actually paid to a non-Affiliated Person in respect of a Third Party Claim, (ii) shall in no event include any amounts constituting consequential, indirect or incidental damages (including any damages on a lost profits, lost revenue, diminution of value, multiples or similar basis) except to the extent (A) such types of damages are actually paid to a non-Affiliated Person in respect of a Third Party Claim, or (B) solely with respect to consequential, indirect or incidental damages (including (i) diminution of value, (ii) lost profits (iii) lost revenue, (iv) multiples or (v) similar damages, in each case as determined by application of the actuarial assumptions, methodologies and approaches used in the base case Actuarial
39



Appraisal, based upon the 9% discount rate referred to in the Actuarial Appraisal, in each case as of the date of the claim), (1) such damages are recoverable under the laws of the State of New York, (2) the Indemnitee satisfies all elements necessary for proof of such damages under such laws and (3) such damages result from or arise out of the Business as currently conducted and shall not take into account any current or future plans, including as to be initiated by the Reinsurer, for the Business following the Closing Date regardless of whether such plans are communicated to or known by the Ceding Company other than the requirements in the U.S. Securities and Exchange Commission order referenced on Schedule 3.06(a) of the Ceding Company Disclosure Schedules, and (ii) shall be net of any amounts actually recovered (after deducting related reasonable costs and expenses and premium increases) by the Indemnitee for the Indemnifiable Losses for which such Indemnity Payment is made under any insurance policy, warranty or indemnity or otherwise from any Person other than a party hereto or any Affiliate of a party hereto, with such recovered amounts reduced by the amount of the costs and expenses incurred by the Indemnitee in procuring such recovery and the costs of any premium increases as a result of such recovery, and the Indemnitee shall promptly reimburse the Indemnitor for any such amount in excess of the Indemnitee’s total Indemnifiable Losses that is received by it from any such other Person with respect to an Indemnifiable Losses to the extent of any indemnification with respect thereto has actually been paid pursuant to this Agreement. Indemnity Payments shall not be reduced for any amounts recovered under any reinsurance agreement. Notwithstanding anything herein to the contrary, and in any event excluding any Third Party Claim brought by any policyholder or other applicable Person, in no event shall Indemnifiable Losses include any amounts relating to, resulting from or arising out of the matter set forth on Section 9.04(a) of the Ceding Company Disclosure Schedule for lost profits, lost revenues, diminution of value or any similar theory for any lapse in, cancellation or other adverse policyholder behavior with respect to any Reinsured Contract, other than any Third Party Claim, to the extent such applicable Claim is brought by a Reinsurer Indemnified Person after the later of [***]
(b)Indemnitee” means any Person entitled to indemnification under this Agreement;
(c)Indemnitor” means any Person required to provide indemnification under this Agreement;
(d)Indemnity Payment” means any amount of Indemnifiable Losses required to be paid pursuant to this Agreement;
(e)Third Party Claim” means any claim, action, suit, or proceeding made or brought by any Person that is not a Party to this Agreement or any Affiliate of any Party to this Agreement. For the avoidance of doubt, claims, actions, suits or proceedings between or among Parties to this Agreement or their respective Affiliates will not be Third Party Claims hereunder.
Section 1.016Procedures for Third Party Claims.
(q)If any Indemnitee receives notice of assertion or commencement of any Third Party Claim against such Indemnitee in respect of which an Indemnitor may be obligated to provide indemnification under this Agreement, the Indemnitee shall give such Indemnitor reasonably prompt written notice (but in no event later than twenty (20) days after becoming aware) thereof (a “Claim Notice”) and such Claim Notice shall include a reasonable description of the claim and facts and circumstances with respect to the subject matter of the claim, to the extent such facts are available to the Indemnitee and any documents relating to the claim and an estimate of the Indemnifiable Loss to the extent known or estimable and shall, where applicable, reference the specific sections of this Agreement that form the basis of such claim; provided that no delay on the part of the Indemnitee in notifying any Indemnitor shall relieve the Indemnitor
40



from any obligation or otherwise affect the rights of any Indemnitee hereunder unless (and then solely to the extent) the Indemnitor is materially prejudiced by such delay. Thereafter, the Indemnitee shall deliver to the Indemnitor, within four (4) Business Days after the Indemnitee’s receipt thereof, copies of all notices and documents (including court papers) received by the Indemnitee relating to the Third Party Claim.
(r)The Indemnitor shall be entitled to participate in the defense of any Third Party Claim and, if it so chooses by giving written notice to the Indemnitee within thirty (30) days after its receipt of the Claim Notice with respect to such Third Party Claim, to assume the defense thereof with counsel selected by the Indemnitor and reasonably acceptable to the Indemnitee and at the Indemnitor’s expense. Should the Indemnitor so elect to assume the defense of a Third Party Claim, Indemnitee shall have the right but not the obligation to participate in any such defense with its own counsel, in a manner subordinate to the Indemnitor and its assumption of defense and with it being understood that the Indemnitor shall control such defense, and at its own expense, provided that the Indemnitor shall not as long as it conducts such defense be liable to the Indemnitee for legal expenses subsequently incurred by the Indemnitee in connection with the defense thereof; provided, however, that if the Indemnitee concludes in good faith based on advice of outside counsel that an actual conflict in interest between the Indemnitor and the Indemnitee exists with respect to such Third Party Claim, the Indemnitor shall be liable for the reasonable out-of-pocket legal expenses of one separate counsel that are incurred by the Indemnitee in connection with the defense thereof. The Indemnitor shall be liable for the reasonable fees and expenses of counsel employed by the Indemnitee for any period during which the Indemnitor has not assumed the defense thereof (other than during any period in which the Indemnitee shall have not yet given notice of the Third Party Claim as provided above). The Parties hereto shall cooperate in the defense of any Third Party Claim. Such cooperation shall include the retention and (upon the other Party’s request) the provision to the other Party of records and information that are relevant to such Third Party Claim and are in the possession of such Party, subject to any bona fide claims of attorney-client privilege, and making employees available on a mutually convenient basis to provide additional information and explanation of any material provided hereunder. Whether or not the Indemnitor shall have assumed the defense of a Third Party Claim, the Indemnitee shall not admit any liability with respect to, or pay, settle, compromise or discharge, such Third Party Claim without the Indemnitor’s prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed); provided that the Indemnitee may pay, settle, compromise or discharge such a Third Party Claim without the written consent of the Indemnitor if the sole relief granted is equitable relief for which the Indemnitor would have no direct or indirect liability and to which the Indemnitor would not be subject and no statement or admission of fault, culpability or failure to act by or on behalf of the Indemnitor or any of its Affiliates or Representatives is made. If the Indemnitor has assumed the defense of a Third Party Claim, the Indemnitor may pay, settle, compromise or discharge a Third Party Claim with the Indemnitee’s prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed); provided that the Indemnitor may pay, settle, compromise or discharge such a Third Party Claim without the written consent of the Indemnitee if (i) such settlement (A) includes a complete and unconditional release of the Indemnitee from all liability in respect of such Third Party Claim, (B) does not subject the Indemnitee to any injunctive relief or other equitable remedy, (C) does not include a statement or admission of fault, culpability or failure to act by or on behalf of the Indemnitee and (D) does not encumber any of the assets of the Indemnitee or include any restriction or condition that would apply to or adversely affect the Indemnitee and (ii) the Indemnitor shall pay or cause to be paid all amounts arising out of such settlement concurrently with the effectiveness of such settlement.
(s)Notwithstanding anything to the contrary in this Section 9.05, the Indemnitee (and not the Indemnitor) shall have the exclusive right to assume the defense and control of any Third Party Claim, if (A) the Indemnitor (i) does not notify the Indemnitee within
41



thirty (30) days following its receipt of the Claims Notice that it desires to assume the defense of such Third Party Claim in accordance with Section 9.05(b) or (ii) after assuming the defense of a Third Party Claim, fails to take reasonable steps to defend such Third Party Claim, (B) the Indemnitee in good faith determines that the nature of the Third Party Claim is such that it would reasonably be expected to involve criminal liability being imposed on the Indemnitee or its Affiliates or (C) such Third Party Claim seeks an injunction or other equitable relief against the Indemnitee that the Indemnitee reasonably determines, after consultation with its outside counsel, cannot be separated from any related claim for money damages; provided that if such Third Party Claim seeks an injunction or equitable relief against the Indemnitee that can be separated from a related claim for money damages, the Indemnitor may only be entitled to assume control of the defense of such Third Party Claim for money damages.
(t)The rights and remedies of any Party in respect of any inaccuracy or breach of any representation or warranty, covenant or agreement shall in no way be limited to the extent of such breached representation or warranty, covenant or agreement (and not any other representation or warranty, covenant or agreement) by the fact that the act, omission, occurrence or other state of facts or circumstances upon which any claim of any such inaccuracy or breach is based may also be the subject matter of any other representation, warranty, covenant or agreement as to which there is no inaccuracy or breach. The representations, warranties and covenants of the Ceding Company, and the Reinsurer Indemnified Persons’ rights to indemnification with respect thereto, shall not be affected or deemed waived by reason of (and any Indemnitees related to the Reinsurer shall be deemed to have relied upon the representations and warranties of the Ceding Company set forth herein notwithstanding) any investigation made by or on behalf of the Reinsurer or any of its Affiliates (including by any of their Representatives) or by reason of the fact that the Reinsurer or any of its Affiliates or Representatives knew or should have known that any such representation or warranty is, was or might be inaccurate, regardless of whether such investigation was made or such knowledge was obtained before or after the execution and delivery of this Agreement.
Section 1.017Direct Claims. The Indemnitor will have a period of thirty (30) days within which to respond in writing to any claim by an Indemnitee on account of an Indemnifiable Loss that does not result from a Third Party Claim. If the Indemnitor does not so respond within such thirty (30) day period, the Indemnitor will be deemed to have rejected such claim, in which event the Indemnitee will be entitled to pursue such remedies as may be available to the Indemnitee.
Section 1.018Sole Remedy. The Parties acknowledge and agree that, except (a) as provided in Section 10.13, (b) other equitable remedies that cannot be waived as a matter of law, or (c) in the event that a Party is finally determined by a court of competent jurisdiction to have committed a Fraud regarding such Party’s representations, warranties, covenants or other agreements set forth in this Agreement or in any certificate furnished in connection with the Closing, if the Closing occurs, the provisions set forth in this Article IX shall be the sole and exclusive remedy of the Parties hereto and their respective officers, directors, employees, agents and Affiliates for any breach of or inaccuracy in any representation or warranty or any breach, nonfulfillment or default in the performance of any of the covenants or agreements contained in this Agreement. For the avoidance of doubt, to the extent that the facts and circumstances underlying such a breach, inaccuracy, nonfulfillment or default give rise to a remedy under another Transaction Agreement, nothing in this Section 9.07 shall waive or foreclose the non-breaching Party’s right to such remedy under such other Transaction Agreement.
Section 1.019Treatment of Indemnity Payment. The Parties shall treat any Indemnity Payment as an adjustment to the amount of the Ceding Commission for U.S. federal income tax purposes, except as otherwise required by applicable Law.
42



Article X
GENERAL PROVISIONS
Section 1.020Expenses. Except as may be otherwise specified in this Agreement, all costs and expenses, including fees and disbursements of counsel, financial advisers and independent accountants, incurred in connection with this Agreement and the transactions contemplated herein shall be paid by the Person incurring such costs and expenses, whether or not the Closing shall have occurred.
Section 1.021Notices. All notices, requests, consents, claims, demands and other communications under this Agreement shall be in writing and shall be given or made (and shall be deemed to have been duly given or made upon receipt) by delivery in person, by overnight courier service, by electronic mail or by registered or certified mail (postage prepaid, return receipt requested) to the respective Parties hereto at the following respective addresses (or at such other address for a Party hereto as shall be specified in a notice given in accordance with this Section 10.02):
(u)if to the Ceding Company:
Equitable Financial Life Insurance Company
1290 Avenue of the Americas
New York, NY 10104
Attention:    Jose Gonzalez
Tel:    212-554-1234
E-mail:    jose.gonzalez@equitable.com

with a copy to:
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, New York 10019
Attention:    John Schwolsky
    Howard T. Block
Tel:    (212) 728-8232
    (212) 728-8977
E-mail:    jschwolsky@willkie.com
    hblock@willkie.com

(v)if to the Reinsurer:
First Allmerica Financial Life Insurance Company
c/o Global Atlantic Financial Company
30 Hudson Yard, 74th Floor
New York, New York 10001

Attention:    General Counsel and Secretary
E-mail:    reinsurance.notice@gafg.com

with a copy (which shall not constitute notice) to:
Debevoise & Plimpton LLP
919 Third Avenue
New York, New York 10022

43



Attention:    Marilyn A. Lion
E-mail:    malion@debevoise.com

Section 1.022Public Announcements. No Party or any Affiliate or Representative of such Party shall issue or cause the publication of any press release or public announcement or otherwise communicate with any news media in respect of the Transaction Agreements or the transactions contemplated thereby without the prior written consent of the other Party (which consent shall not be unreasonably withheld, conditioned or delayed), except as may be required by Law or applicable securities exchange rules, in which case the Party required to publish such press release or public announcement shall allow the other Party a reasonable opportunity to comment on such press release or public announcement in advance of such publication.
Section 1.023Severability. The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced under any Law or as a matter of public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated by the Transaction Agreements are not affected in any manner materially adverse to either Party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated by the Transaction Agreements be consummated as originally contemplated to the greatest extent possible. If any provision of this Agreement is so broad as to be unenforceable, such provision shall be interpreted to be only so broad as would be enforceable.
Section 1.024Entire Agreement. This Agreement (including all exhibits and schedules hereto), the Confidentiality Agreement (to the extent not in conflict with this Agreement) and the other Transaction Agreements constitute the entire agreement of the Parties with respect to the subject matter of this Agreement and supersede all prior agreements and undertakings, both written and oral, between or on behalf of the Ceding Company and/or its Affiliates, on the one hand, and the Reinsurer and/or its Affiliates, on the other hand, with respect to the subject matter of this Agreement and the other Transaction Agreements.
Section 1.025Assignment. This Agreement shall not be assigned by any Party without the prior written consent of the other Party. Any attempted assignment in violation of this Section 10.06 shall be void. This Agreement shall be binding upon, shall inure to the benefit of, and shall be enforceable by the Parties and their permitted successors and assigns.
Section 1.026No Third Party Beneficiaries. Except as otherwise provided herein, this Agreement is for the sole benefit of the Parties and their permitted successors and assigns, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other Person or entity any legal or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.
Section 1.027Amendment. No provision of this Agreement may be amended, supplemented or modified except by a written instrument signed by each Party.
Section 1.028Schedules. Any disclosure set forth in the Ceding Company Disclosure Schedule with respect to any Section of this Agreement shall be deemed to be disclosed for purposes of other Sections of this Agreement to the extent that such disclosure sets forth facts in sufficient detail so that the relevance of such disclosure to such other Sections
44



would be reasonably apparent on the face of such disclosure. Matters reflected in any Section of the Ceding Company Disclosure Schedule are not necessarily limited to matters required by this Agreement to be so reflected. Such additional matters are set forth for informational purposes and do not necessarily include other matters of a similar nature. No reference to or disclosure of any item or other matter in the Ceding Company Disclosure Schedule shall be construed as an admission or indication that such item or other matter is material or that such item or other matter is required to be referred to or disclosed in this Agreement. Without limiting the foregoing, no such reference to or disclosure of a possible breach or violation of any contract, Law or Governmental Order shall be construed as an admission or indication that a breach or violation exists or has actually occurred.
Section 1.10Submission to Jurisdiction.
(a)Each of the Ceding Company and the Reinsurer irrevocably and unconditionally submits for itself and its property in any Action arising out of or relating to this Agreement, the transactions contemplated hereby, the formation, breach, termination or validity of this Agreement or the recognition and enforcement of any judgment in respect of this Agreement, to the exclusive jurisdiction of the courts of the State of New York sitting in the County of New York, the federal courts for the Southern District of New York, and appellate courts having jurisdiction of appeals from any of the foregoing, and all claims in respect of any such Action shall be heard and determined in such New York courts or, to the extent permitted by Law, in such federal court.
(b)Any such Action may and shall be brought in such courts and each of the Ceding Company and the Reinsurer irrevocably and unconditionally waives any objection that it may now or hereafter have to the venue or jurisdiction of any such Action in any such court or that such Action was brought in an inconvenient court and shall not plead or claim the same.
(c)Service of process in any Action may be effected by mailing a copy of such process by registered or certified mail (or any substantially similar form of mail), postage prepaid, to such Party at its address as provided in Section 10.02.
(d)Nothing in this Agreement shall affect the right to effect service of process in any other manner permitted by the Laws of the State of New York.
Section 1.19Governing Law. This Agreement, and the formation, termination or validity of any part of this Agreement shall in all respects be governed by, and construed in accordance with, the Laws of the State of New York.
Section 1.20Waiver of Jury Trial. EACH PARTY HERETO IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, OR ITS PERFORMANCE UNDER OR THE ENFORCEMENT OF THIS AGREEMENT.
Section 1.21Specific Performance. The Parties agree that irreparable damage would occur in the event that any of the covenants or obligations contained in this Agreement are not performed in accordance with their specific terms or were otherwise breached. Accordingly, each of the Parties shall be entitled to injunctive or other equitable relief to prevent or cure any breach by the other Party of its covenants or obligations contained in this Agreement and to specifically enforce such covenants and obligations in any court referenced in Section 10.10(a) having jurisdiction, such remedy being in addition to any other remedy to which either Party may be entitled at law or in equity, and no other provision of this Agreement shall limit any Party’s
45



right to specific performance. Each of the Parties acknowledges and agrees that there is no adequate remedy at law for a breach of this Agreement and it shall not oppose the granting of an injunction, specific performance and other equitable relief when expressly available pursuant to the terms of this Agreement, and hereby waives (x) the defense that the other Parties have an adequate remedy at Law or an award of specific performance is not an appropriate remedy for any reason at Law or equity, and (y) any requirement under Law to post a bond, undertaking or other security as a prerequisite to obtaining equitable relief.
Section 1.22Waivers. Any term or provision of this Agreement may be waived, or the time for its performance may be extended, in writing at any time by the Party or Parties entitled to the benefit thereof. Any such waiver shall be validly and sufficiently authorized for the purposes of this Agreement if, as to any Party, it is authorized in writing by an authorized Representative of such Party. The failure or delay of any Party hereto to enforce at any time any provision of this Agreement or to exercise any right, power or privilege under this Agreement shall not be construed to be a waiver of such provision, right, power or privilege, nor in any way to affect the validity of this Agreement or any part hereof or the right of any Party thereafter to enforce each and every such provision and exercise each and every right, power and privilege under this Agreement. No waiver of any breach of this Agreement shall be held to constitute a waiver of any preceding or subsequent breach.
Section 1.23Rules of Construction. Interpretation of this Agreement shall be governed by the following rules of construction: (a) words in the singular shall be held to include the plural and vice versa, and words of one gender shall be held to include the other gender as the context requires; (b) references to Articles, Sections, paragraphs, Exhibits and Schedules are references to the Articles, Sections, paragraphs, Exhibits and Schedules to this Agreement unless otherwise specified; (c) references to “$” shall mean United States dollars; (d) the word “including” and words of similar import when used in this Agreement shall mean “including without limiting the generality of the foregoing,” unless otherwise specified; (e) the word “or” shall not be exclusive; (f) the table of contents, articles, titles and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement; (g) this Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting or causing any instrument to be drafted; (h) the Schedules and Exhibits referred to herein shall be construed with and as an integral part of this Agreement to the same extent as if they were set forth verbatim herein; (i) unless the context otherwise requires, the words “hereof,” “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement; (j) all terms defined in this Agreement shall have the defined meanings when used in any certificate or other document made or delivered pursuant hereto unless otherwise defined therein; (k) any agreement or instrument defined or referred to herein or any agreement or instrument that is referred to herein means such agreement or instrument as from time to time amended, modified or supplemented, including by waiver or consent, and references to all attachments thereto and instruments incorporated therein; (l) any statement that a document has been “delivered,” “provided” or “made available” to the Reinsurer means that such document has been uploaded to the Data Room not later than three (3) Business Days prior to the date of this Agreement; (m) any statute or regulation referred to herein means such statute or regulation as amended, modified, supplemented or replaced from time to time (and, in the case of any statute, includes any rules and regulations promulgated under such statute), and references to any section of any statute or regulation include any successor to such section; (n) all time periods within or following which any payment is to be made or act to be done shall be calculated by excluding the date on which the period commences and including the date on which the period ends and by extending the period to the first succeeding Business Day if the last day of the period is not a Business Day; (o) references to any Person include such Person’s predecessors or successors, whether by merger, consolidation, amalgamation, reorganization or otherwise; (p) references to
46



any contract (including this Agreement) or organizational document are to the contract or organizational document as amended, modified, supplemented or replaced from time to time, unless otherwise stated; (q) the word “will” shall be construed to have the same meaning and effect as the word “shall”; (r) all capitalized terms used without definition in the Schedules and Exhibits referred to herein shall have the meanings ascribed to such terms in this Agreement; and (s) where a word or phrase is defined herein, each of its grammatical forms shall have a corresponding meaning.
Section 1.24Reserves. Notwithstanding anything to the contrary in this Agreement, neither the Ceding Company nor any of its Affiliates makes any representation or warranty with respect to, and nothing contained in this Agreement, any other Transaction Agreement or any other agreement, document or instrument to be delivered in connection with the transactions contemplated hereby or thereby is intended or shall be construed to be a representation or warranty (express or implied) of the Ceding Company or any of its Affiliates, for any purpose of this Agreement, any other Transaction Agreement or any other agreement, document or instrument to be delivered in connection with the transactions contemplated hereby or thereby, with respect to (a) the adequacy or sufficiency of the reserves of the Ceding Company, (b) the future profitability of the Business or (c) the effect of the adequacy or sufficiency of the reserves of the Ceding Company on any “line item” or asset, liability or equity amount on any financial or other document.
Section 1.25Counterparts. This Agreement may be executed in two (2) or more counterparts, and by the different Parties to this Agreement in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by electronic mail or other means of electronic transmission utilizing reasonable image scan technology (including pdf, DocuSign or any electronic signature complying with the U.S. federal ESIGN Act of 2000) shall be as effective as delivery of a manually executed counterpart of this Agreement
Section 1.26Time of Essence. With regard to all dates and time periods set forth or referred to in this Agreement, time is of the essence.
Section 1.27Incontestability. In consideration of the mutual covenants and agreements contained herein, each Party agrees that this Agreement, and each and every provision hereof, is and shall be enforceable by and between them according to its terms, and each Party does hereby agree that it shall not contest the validity or enforceability hereof.
[THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK]
47



IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed on the date first written above by their respective duly authorized officers.
EQUITABLE FINANCIAL LIFE INSURANCE COMPANY
By    /s/ Robin M. Raju        
Name: Robin M. Raju
Title: Chief Financial Officer
FIRST ALLMERICA FINANCIAL LIFE INSURANCE COMPANY
By    /s/ Manu Sareen    
Name: Manu Sareen
Title: President



Exhibit 10.2


EXECUTION VERSION
COINSURANCE AND MODIFIED COINSURANCE AGREEMENT
Between
EQUITABLE FINANCIAL LIFE INSURANCE COMPANY
(referred to as the Ceding Company)
and
FIRST ALLMERICA FINANCIAL LIFE INSURANCE COMPANY
(referred to as the Reinsurer)



CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) PRIVATE OR CONFIDENTIAL. SUCH EXCLUDED INFORMATION IS IDENTIFIED HEREIN WITH “[***].” SCHEDULES AND EXHIBITS HAVE BEEN OMITTED PURSUANT TO ITEM 601(A)(5) OF REGULATION S-K.


1007933761v22


TABLE OF CONTENTS
Section 2.13.    [***]
22
- i -
1007933761v22


Section 8.7.    [***]
45
- ii -
1007933761v22



INDEX OF SCHEDULES AND EXHIBITS
Schedule AExpense Allowances
Schedule BInvestment Guidelines
Schedule CPolicy Forms
Schedule DSeriatim File
Schedule ERecapture Terminal Settlement
Schedule F-1Separate Accounts
Schedule F-2Experience Refund
Schedule F-3EIM Administrative Fee
Schedule G
Schedule H
Fair Market Value Methodologies
Projected Separate Account Values
Schedule ICompensation
Schedule JCeding Company Reports
Schedule K
Schedule L
Schedule M
Schedule N
Schedule O
Schedule P
Guaranty Fund Liabilities
Final IMR Amortization Schedule
Reinsurer Information
Exchanges and Roll-Overs
Unfloored CTE [***] Amount Methodologies
Morningstar Categories

Exhibit 1Form of Monthly Settlement Statement
Exhibit 2Form of Trust Agreement
- iii -
1007933761v22


COINSURANCE AND MODIFIED COINSURANCE AGREEMENT
THIS COINSURANCE AND MODIFIED COINSURANCE AGREEMENT (this “Agreement”) is made and entered into on October 3, 2022 (the “Closing Date”) and effective as of the Effective Time by and between Equitable Financial Life Insurance Company, a New York-domiciled insurance company (the “Ceding Company”), and First Allmerica Financial Life Insurance Company, a Massachusetts-domiciled insurance company (the “Reinsurer”). For purposes of this Agreement, the Ceding Company and the Reinsurer shall each be deemed a “Party” and together the “Parties.”
WHEREAS, the Ceding Company and the Reinsurer have entered into a Master Transaction Agreement dated as of August 16, 2022 (the “Master Transaction Agreement”);
WHEREAS, the Master Transaction Agreement provides, among other things, for the Ceding Company and the Reinsurer to enter into this Agreement;
WHEREAS, simultaneously with the execution and delivery of this Agreement on the date hereof, the Ceding Company, the Reinsurer and the Trustee (as defined below) will enter into the Trust Agreement (as defined below) pursuant to which the Trustee will hold assets as security for the satisfaction of the obligations of the Reinsurer to the Ceding Company under this Agreement; and
WHEREAS, simultaneously with the execution and delivery of this Agreement on the date hereof, Commonwealth Annuity and Life Insurance Company, a Massachusetts-domiciled insurance company (“CwA”), will enter into a Guarantee (as defined below) pursuant to which CwA and any other Guarantor (as defined below) under the Guarantee from time to time will guaranty all of the Reinsurer’s payment obligations under this Agreement and all of the Reinsurer’s obligations to transfer amounts to the Trust Account pursuant to Section 5.2(b) and Section 5.7(c)(i) of this Agreement;
NOW, THEREFORE, in consideration of the mutual and several promises and undertakings herein contained, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Ceding Company and the Reinsurer agree as follows:
Article I.

DEFINITIONS
Section 1.1.Definitions. The following terms have the respective meanings set forth below throughout this Agreement:
12b-1 Fees” has the meaning set forth in the Master Transaction Agreement.
Account Value” with respect to any Reinsured Contract means, as of any date of determination, the aggregate account value in the general account of the Ceding Company of such Reinsured Contract, as defined in and determined in accordance with the terms of such Reinsured Contract, and without regard to the transactions contemplated hereby, as of such date, including any increase in such account value related to the matter set forth on Section 9.04(a) of the Ceding Company Disclosure Schedule.
Accrued Interest” means the accumulated unpaid interest on an asset calculated in accordance with SAP.
- 1 -
1007933761v22


Action” means any claim, action, suit, litigation, arbitration, investigation, inquiry, hearing, charge, complaint, demand or other proceeding by or before any Governmental Authority or arbitrator or arbitration panel or similar Person or body.
Actual Spread Amount” has the meaning [***].
Additional Consideration” has the meaning set forth in Section 3.2.
Additional Reports” has the meaning set forth in Section 3.9(b).
Adjusted Ceding Commission” has the meaning set forth in the Master Transaction Agreement.
Administrative Services” has the meaning set forth in Section 4.1(a).
Affiliate” means, with respect to any specified Person, any other Person that, at the time of determination, directly or indirectly through one or more intermediaries, Controls, is Controlled by or is under common Control with such specified Person.
Affiliate Retrocessionaire” means any Retrocessionaire that is Affiliated with the Reinsurer at the time of the initial retrocession or any time thereafter.
Agreement” has the meaning set forth in the preamble.
Allocated Premium Taxes” means, in respect of any Monthly Accounting Period, Premium Taxes allocable to the Reinsured Contracts which shall be an amount equal to the Premiums received under the Reinsured Contracts in such Monthly Accounting Period multiplied by [***] basis points; provided, however, the Parties agree to increase or decrease this amount, as appropriate, to reflect changes in Premium Taxes should either (a) any jurisdictions which do not as of the Effective Time impose a Premium Tax on annuities adopt such a tax following the Effective Time or (b) any jurisdictions which do as of the Effective Time impose a Premium Tax on annuities change or no longer impose such a tax following the Effective Time; and provided, further, that this amount shall be reduced by the amount of any Premium Tax credits available to the Ceding Company and arising from any guaranty fund assessment borne by the Reinsurer pursuant to clause (d) of the definition of “General Account Liabilities”.
Annuitization” or “Annuitize” means an exchange of the entire accumulated Account Value of a Reinsured Contract for a series of periodic income payments, whether for a specific period of time or for the life of the annuitant or other beneficiary.
Applicable Privacy Laws” means any applicable Laws relating to the processing of Non-Public Personal Information gathered, collected or used by the Ceding Company or any of its Affiliates or their respective employees, agents or contractors in the course of the operations of the Reinsured Contracts.
Applicable Tax Gross-Up Percentage” means one minus the highest federal tax rate applicable to United States corporations as of the Effective Time with respect to Section 3.1(a)(iii) and the Closing Date with respect to Section 3.1(a)(iv), as applicable or, in the event of a recapture or termination, the Recapture Date.
Appraisal Date” has the meaning set forth in Section 3.1(a)(ii).
Asset Report” has the meaning set forth in Section 5.4.
- 2 -
1007933761v22


Bermuda Insurance Act” means the Bermuda Insurance Act of 1978, as amended, and the rules and regulations promulgated thereunder.
Books and Records” means all originals or copies of all books and records and other information in the possession, custody or control of the Ceding Company or any of its Affiliates that relate to the Reinsured Liabilities, the Reinsured Contracts or the Separate Accounts, including administrative records, claim records, contract files, sales records, underwriting records, financial and accounting (including investment accounting) records, actuarial reports, analyses and memoranda, reinsurance records, compliance records, records relating to the underlying investment funds in which the assets supporting reserves related to the Reinsured Contracts in the Separate Accounts are invested and other records, in whatever form maintained, but excluding certificates of incorporation, bylaws, corporate seals, minute books and other corporate records relating to the corporate organization or capitalization of the Ceding Company or its Affiliates, Tax returns or Tax records (other than with respect to transfer Taxes, Premium Taxes and similar Taxes that relate to the Reinsured Contracts and the Separate Accounts), records of any employee of the Ceding Company or its Affiliates, benefit plan records with respect to any employee of the Ceding Company or its Affiliates, and books and records that are subject to the attorney-client, work product, or other similar privilege or doctrine, it being understood that the Ceding Company shall use commercially reasonable efforts to obtain waivers or make other arrangements (including redacting information) that would enable any such item to be provided to the Reinsurer without impinging on the ability to assert such privilege.
Business Day” means any day that is not a Saturday, Sunday or other day on which commercial banks in the City of New York, New York or Boston, Massachusetts are required or authorized by Law to be closed.
Capital Reporting Deadline” means (a) with respect to an RBC Ratio, with respect to a calendar quarter other than the last quarter of a calendar year, the date that is [***] calendar days after the end of such calendar quarter, and with respect to the last calendar quarter of a calendar year, the date that is [***] calendar days after the end of such calendar quarter; (b) with respect to [***], with respect to a calendar quarter other than the last quarter of a calendar year, the date that is [***] calendar days after the end of such calendar quarter, and with respect to the last calendar quarter of a calendar year, the date that is [***]calendar days after the end of such calendar quarter and (c) with respect to any other capital adequacy ratio of [***] that is required to be reported pursuant to Section 3.8(b), (i) with respect to a calendar quarter other than the last quarter of a calendar year, the earlier of (i) the date that is [***] calendar days after the end of such calendar quarter and (ii) [***], and with respect to the last calendar quarter of a calendar year, the earlier of (i) the date that is [***] calendar days after the end of such calendar quarter and (ii) [***].
Cash Surrender Value” means, as of any date of determination, (a) the aggregate cash surrender value in the general account of the Ceding Company of all Reinsured Contracts in pre-payout status, as defined in and determined in accordance with the terms of the applicable Reinsured Contracts and determined without regard to the transactions contemplated hereby, less (without duplication with respect to any applicable Reinsured Contract) (b) the Policy Loan Balance with respect to such Reinsured Contracts, in each case of (a) and (b), as of such date.
Ceding Commission Ratio” means [***]%.
Ceding Company” has the meaning set forth in the preamble.
Ceding Company Disclosure Schedule has the meaning specified in the Master Transaction Agreement.
Ceding Company Domiciliary State” means the State of New York, or, if the Ceding Company changes its state of domicile to another state within the United States, such other state.
- 3 -
1007933761v22


Ceding Company Extra-Contractual Obligations” means all Extra-Contractual Obligations other than Reinsurer Extra-Contractual Obligations.
Ceding Company Indemnified Parties” has the meaning set forth in Section 9.1.
Ceding Company Report” has the meaning set forth in Section 5.7(b).
Ceding Company Statutory Reserves” means, as of any date of determination, the aggregate statutory reserve (including unearned premium reserves and other premium accruals) amount for the General Account Liabilities calculated in accordance with the Ceding Company Domiciliary State SAP that would be applicable to the Ceding Company (as would be reflected on Line 1, column 1 of the Liabilities section and Exhibit 5 and Line 3, column 1 of the Liabilities section and Exhibit 7 of the Ceding Company’s Statutory Financial Statement (or the equivalent exhibits or lines in the event of changes to the Ceding Company’s Statutory Financial Statement subsequent to December 31, 2021)), as calculated by the Ceding Company as of such date (without giving effect to this Agreement) determined in a manner consistent with the Ceding Company’s historical practices, methodologies and assumptions (unless deviation from such historical practices, methodologies and assumptions is required by Ceding Company Domiciliary State SAP as of such date of determination in which case the Ceding Company and the Reinsurer shall cooperate in good faith to update such practices, methodologies and assumptions to comply with Ceding Company Domiciliary State SAP): provided, however, that Ceding Company Statutory Reserves shall at all times be calculated on a stand-alone basis without regard to any other business of the Ceding Company (e.g., without regard to any diversification or aggregation benefits that may be available based on other business of the Ceding Company).
Ceding Company Valuation Policy” has the meaning set forth in Schedule G.
Closing” means the closing of the transactions contemplated by the Master Transaction Agreement, including entry into this Agreement and the Trust Agreement, to occur on the Closing Date.
Closing Date” has the meaning set forth in the preamble.
Code” means the United States Internal Revenue Code of 1986, as amended.
Collateral” has the meaning set forth in Section 5.9.
Company Action Level RBC” means, with respect to any insurance company, company action level risk based capital as calculated in accordance with the applicable Laws of such insurance company’s state of domicile in effect as of the date of determination.
Confidential Information” with respect to a Party, means any and all information provided by, made available by or provided or made available on behalf of such Party, any of its Affiliates or Representatives, on, before or after the date hereof, including, with respect to the Ceding Company, Non-Public Personal Information and all data relating to the Policyholders of the Reinsured Contracts which are maintained, processed or generated by the Ceding Company or, if applicable, the Reinsurer in connection with the Reinsured Liabilities and including the contents of this Agreement or the other Transaction Agreements not otherwise publicly disclosed, but shall not include the existence of this Agreement and the identity of the Parties; provided, that Confidential Information does not include information that (a) is generally available to the public other than as a result of a disclosure by the receiving Party in violation of its confidentiality obligation, (b) is independently developed by the receiving Party, its Affiliates or any of its Representatives without use or access to the disclosing Party’s Confidential Information, or (c) is rightfully obtained by the receiving Party from a third party without, to the knowledge of the receiving Party, breach by such third party of a duty of confidentiality of any nature to the disclosing Party.
- 4 -
1007933761v22


Contested Claim” has the meaning specified in Section 4.8.
Control” means, with respect to any Person, the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract or otherwise. The terms “Controlled,” “Controlled by,” “under common Control with” and “Controlling” shall have correlative meanings.
CwA” has the meaning specified in the recitals.
DAC Tax Election” has the meaning specified in Section 10.2(a).
Designated Administrative Account” means a sub-account of the Trust Account to be used by the Reinsurer to pay Net Settlements owed to the Ceding Company at the Ceding Company’s option in accordance with Section 3.3 and by the Ceding Company to withdraw such Net Settlements in satisfaction of such payments.
[***]
Effective Timemeans 12:01 a.m., New York City time, on October 1, 2022.
EIM” has the meaning set forth in Section 3.2(b).
EIM Administrative Fee” has the meaning set forth in Section 3.2(b).
Eligible Assets” has the meaning set forth in Section 5.4.
Estimated Closing Statement has the meaning specified in the Master Transaction Agreement.
Estimated Initial Premium has the meaning specified in the Master Transaction Agreement.
Estimated Initial Required Balance has the meaning specified in the Master Transaction Agreement.
Estimated Recapture Terminal Settlement” has the meaning set forth in Section 8.4(a).
Excess Roll-Over Amount” has the meaning set forth in Section 2.11.
Excluded Liabilities” means (a) any Ceding Company Extra-Contractual Obligations, (b) any Excess Roll-Over Amounts accepted by the Ceding Company without the prior written consent of the Reinsurer in accordance with Section 2.11, (c) any ex gratia payments (i.e., payments the Ceding Company is not required to make under the terms of the Reinsured Contracts) made by or on behalf of the Ceding Company without the prior written consent of the Reinsurer and (d) any changes to a Reinsured Contract not effected in accordance with Section 2.2.
Existing IMR Amount” means the amount of the Ceding Company’s existing IMR, calculated on an after-tax basis, that has been allocated by the Ceding Company to the Reinsured Risks as of the Effective Time (and prior to the transfer of assets by the Ceding Company pursuant to Section 3.1(b)), determined in accordance with SAP applicable to the Ceding Company, which amount shall be zero dollars ($0).
Expense Allowances” means, for each Monthly Accounting Period, an amount determined in accordance with Schedule A.
- 5 -
1007933761v22


Experience Refund” has the meaning set forth in Schedule F-2.
Extra-Contractual Obligations” means all Liabilities and any other related expenses (including attorneys’ fees) to any Person or Persons arising out of or relating to the Reinsured Contracts (other than Liabilities arising under the express terms and conditions and within the policy limits of the Reinsured Contracts, including such amounts that are finally determined by a court of competent jurisdiction to be owed to a Policyholder under the terms and conditions of a Reinsured Contract), including any loss in excess of the limits arising under or covered by any Reinsured Contract, any Liabilities for exemplary, punitive, compensatory, special or regulatory damages or interest, fines, penalties, Taxes, fees, forfeitures, bad faith, tort, statutory or other charges of a penal or disciplinary nature or any other form of extra-contractual damages, as well as all legal fees and expenses relating thereto, which Liabilities arise out of or result from any act, error or omission, whether or not intentional, negligent, fraudulent, in bad faith or otherwise, arising out of or relating to the Reinsured Contracts, including (a) the form, sale, marketing (including with respect to suitability and conflicts of interest), distribution, underwriting, production, issuance, cancellation or administration of the Reinsured Contracts, (b) the investigation, defense, prosecution, trial, settlement (including the failure to settle) or handling of claims, benefits, or payments under the Reinsured Contracts, (c) the failure to pay or the delay in payment or errors in calculating or administering the payment of benefits, claims or any other amounts due or alleged to be due under or in connection with the Reinsured Contracts, (d) any changes to, or conversions of, any administrative system or platform of the Ceding Company or any of its Affiliates or any other administrator permitted hereunder, (e) the failure of any Reinsured Contract to provide the purchaser, customer or other holder or intended beneficiaries thereof with tax treatment that is the same as or more favorable than the tax treatment (i) that was purported to apply in materials provided at the time of issuance, assumption, exchange, modification or sale of the applicable Reinsured Contract or (ii) for which policies or contracts of that type are intended to qualify under the Code or (f) the matter set forth on Section 9.04(a) of the Ceding Company Disclosure Schedule. For the avoidance of doubt, any Liability resulting from a change to the terms and conditions of the Reinsured Contracts in accordance with Section 2.2 shall not be deemed an Extra-Contractual Obligations.
Fair Market Value” means, with respect to any asset, the value thereof (including Accrued Interest) calculated in accordance with the methodology set forth on Schedule G.
Fault Recapture Event” means any recapture as a result of any of the occurrences described in clauses (c) or (d) of the definition of Recapture Triggering Event; provided that a Recapture Triggering Event described in clause (d) of the definition of Recapture Triggering Event shall not be a Fault Recapture Event solely in the event it is attributable to the Ceding Company’s failure to comply with its obligation to cooperate in good faith in accordance with the last sentence of Section 5.1(a).
Final IMR Amortization Schedule” has the meaning specified in the Master Transaction Agreement and, upon completion of the Final IMR Amortization Schedule in accordance with the terms of the Master Transaction Agreement, a copy thereof will be attached to this Agreement as Schedule L.
General Account Liabilities” means all of the following Liabilities of the Ceding Company (and with respect to clause (c) of this definition, all Liabilities of any of its Affiliates to the extent set forth on Schedule I) arising out of or resulting from all Reinsured Contracts for which the Quota Share of the applicable Cash Surrender Value was included in the calculation of the Initial Premium, except as otherwise set forth below in clauses (c) and (d), whether such Liabilities were incurred before, at or after the Effective Time, but excluding Separate Account Liabilities and Excluded Liabilities:
- 6 -
1007933761v22


(a)all (i) claims, benefits, interest on claims or unearned premiums, interest on policy funds, withdrawals, surrenders, policy loans, amounts payable for returns or refunds of premiums, guaranteed minimum death benefits, incurred but not reported claims, pending claims and benefits (including death benefits, lump sum payments, annuitization payments, deferred payments, payments in respect of market value adjustments, and any other settlement options), unearned premiums, and other contract benefits, in each case, arising under the express terms and conditions of, and subject to the limitations set forth in, the Reinsured Contracts (including all amounts that are finally determined by a court of competent jurisdiction to be owed to a Policyholder under the terms and conditions of a Reinsured Contract) and whether such amounts are escheated or paid to policyholders or beneficiaries of the Reinsured Contracts and (ii) all claim expenses (including reasonable litigation expenses related thereto) incurred by the Ceding Company in connection with Contested Claims in which the Reinsurer has chosen to participate in accordance with Section 4.8;
(a)all Liabilities arising out of the express terms and conditions of, and subject to the limitations set forth in, the Reinsured Contracts (including all amounts that are finally determined by a court of competent jurisdiction to be owed to a Policyholder under the terms and conditions of a Reinsured Contract), giving effect to changes to the terms and conditions of the Reinsured Contracts permitted or required by Section 2.2;
(b)all compensation and other amounts set forth on Schedule I that are incurred at or after the Effective Time;
(c)all assessments and similar charges that are incurred at or after the Effective Time with respect to the Reinsured Contracts in connection with participation by the Ceding Company or the Reinsurer, whether voluntary or involuntary, in any guaranty association established or governed by any state or other jurisdiction, arising on account of insolvencies, rehabilitations or similar proceedings, to the extent allocated to the Reinsured Contracts in accordance with Schedule K;
(d)all Allocated Premium Taxes;
(e)all Liabilities which relate to (i) amounts held in the general account of the Ceding Company pending transfer to the Separate Accounts, or (ii) Reinsured Contracts that contemplate payment from a Separate Account the amount of which exceeds the assets of such Separate Account (without duplication of the amounts set forth in clause (a) above), in each case in respect of the Reinsured Contracts; and
(f)all Reinsurer Extra-Contractual Obligations.
Governmental Authority” means any United States or non-United States federal, state or local or any supra-national, political subdivision, governmental, legislative, tax, regulatory or administrative authority, instrumentality, agency, body, board or commission, self-regulatory organization or any court, tribunal, or judicial or arbitral body having jurisdiction over a Party.
Governmental Order” means any binding and enforceable order, writ, judgment, injunction, decree, stipulation, determination or award entered by or with any Governmental Authority.
Guarantee” means the Guarantee, dated as of the Closing Date, by CwA in favor of the Ceding Company.
Guarantor” means CwA and any other “Guarantor” under the Guarantee from time to time.
IDC” has the meaning set forth in Schedule G.
- 7 -
1007933761v22


IMR” means an interest maintenance reserve.
Indemnifiable Losses” has the meaning specified in the Master Transaction Agreement.
Independent Accounting Firm” has the meaning set forth in Section 5.7(e).
Independent Actuary” has the meaning set forth in Section 8.4(c).
Initial Premium” has the meaning set forth in Section 3.1(a).
Initial Required Balance” means the Required Balance as of the Closing Date.
Insolvency” has the meaning set forth in Section 5.6.
Insurance Regulator” means, with respect to any jurisdiction, the Governmental Authority charged with the supervision of insurance companies in such jurisdiction.
Interest Rate” means the sum of (a) [***] basis points (expressed as a rate per annum) plus (b) the annual yield rate, on the date to which the [***]-Day Treasury Rate relates, of actively traded U.S. Treasury securities having a remaining duration to maturity of [***] months, as such rate is published under the “Treasury Constant Maturities” in Federal Reserve Statistical Release H.15(519).
Investment Guidelines” means the Investment Guidelines set forth in Schedule B, as may be modified on or after an Investment Guidelines Trigger Event Date (as defined in the Trust Agreement) pursuant to Section 7 of the Trust Agreement.
Investment Management Agreement” means the Discretionary Investment Advisory Agreement, dated as of the date hereof, by and between the Reinsurer and AllianceBernstein L.P.
Law” means any United States or non-United States federal, state or local statute, law, ordinance, rule, regulation, code, administrative interpretation or principle of common law or equity imposed by or on behalf of a Governmental Authority and any Governmental Order.
Liabilities” means any and all debts, liabilities, damages, expenses, commitments or obligations of any kind, character or description, whether direct or indirect, accrued or fixed, known or unknown, absolute or contingent, disputed or undisputed, liquidated or unliquidated, secured or unsecured, joint or several, due or to become due, vested or unvested, asserted or unasserted, matured or unmatured, or determined or determinable, whether arising in the past, present or future.
M&E Fees” has the meaning set forth in Section 3.2(b).
Market-to-Book Ratio” means, as of any date of determination, the ratio of (a) the aggregate Fair Market Value of the Eligible Assets in the Trust Account as of such date to (b) the aggregate Statutory Book Value of such Eligible Assets as of such date.
Master Transaction Agreement” has the meaning set forth in the Recitals.
Milliman Report” means the actuarial report dated February 18, 2022 prepared by Milliman, Inc. with respect to the Reinsured Contracts.
Month-End Required Balance Report” has the meaning set forth in Section 5.7(a).
Monthly Account Value” has the meaning set forth in Schedule F-2.
- 8 -
1007933761v22


Monthly Accounting Period” means each successive calendar month during the term of this Agreement or any fraction thereof, beginning at the Effective Time and ending on the Recapture Date or the date this Agreement is otherwise terminated in accordance with Article VIII, as applicable.
Monthly Settlement Statement” has the meaning set forth in Section 3.3(a).
Morningstar” means Morningstar, Inc. and its successors.
Morningstar Category” means the categories used by Morningstar to assist investors in making comparisons between mutual funds available for sale in the United States, as set forth on Schedule P and as updated by Morningstar in the course of its business, or any comparable categories from an investment research firm comparable to Morningstar in the event Morningstar ceases to provide such categories.
[***]
[***]
[***]
NAIC” has the meaning set forth in Schedule O.
Net Settlement” has the meaning set forth in Section 3.3(a).
Non-Guaranteed Elements means the cost of insurance charges, rider charges, credited interest rates, mortality and expense charges, administrative expense risk charges, premium loads, lump sum payment options, policy loads and any other policy features that are subject to change at the election of the Ceding Company, including such items set forth in Actuarial Standard of Practice 2-Non-Guaranteed Charges or Benefits for Life Insurance Policies and Annuity Contracts in effect as of the Effective Time and any successor rules for such Non-Guaranteed Elements as in effect from time to time.
Non-Public Personal Information” means any non-public personally identifiable information concerning or relating to the Ceding Company’s past, current or prospective applicants, customers, clients, policy owners, contract holders, insureds, claimants, and beneficiaries of Reinsured Contracts or other contracts issued by the Ceding Company, and its representatives that is protected by Applicable Privacy Law, including (a) “non-public personal information” as that term is defined in the Gramm-Leach-Bliley Act, as amended, and implementing regulations, 15 U.S.C. § 6809(4) or “protected health information” as defined in 45 C.F.R. § 160.103; and (b) “Personal Information” as defined in the California Consumer Privacy Act of 2018 (Cal. Civ. Code Division 3, Part 4, Title 1.81.5); provided, that information that is otherwise publicly available shall not be considered “Non-Public Personal Information”; and, provided, further, that “Non-Public Personal Information” does not include de-identified personal data, (i.e., information that does not identify, or could not reasonably be associated with, an individual).
Parties” has the meaning set forth in the preamble.
Party” has the meaning set forth in the preamble.
Person” means any natural person, general or limited partnership, corporation, limited liability company, limited liability partnership, firm, joint-stock company, trust, governmental, judicial or regulatory body, business unit, division (including a segregated account or cell), association or organization or other entity.
- 9 -
1007933761v22


Policy Loan Balance” means, with respect to any date of determination, the amount of contract loans in respect of the Reinsured Contracts, as of such date, to the extent such contract loans would be reflected in Line 6, column 1 of the “Assets” section of the Ceding Company’s Statutory Financial Statement (or the equivalent exhibits or lines in the event of changes to the Ceding Company’s Statutory Financial Statement subsequent to December 31, 2021) under SAP applicable to the Ceding Company, net of any unearned policy loan interest on such loans but including any due and accrued interest thereon.
Policyholder” means the holder of any Reinsured Contract, including any holder of any individual certificate issued under a Reinsured Contract.
Post-Closing Date IMR Amount” means the amount of IMR, calculated on an after-tax basis, that is created following the Closing Date with respect to the assets supporting the Reinsurer’s Quota Share of the Reinsured Liabilities ceded determined and amortized in accordance with the rules promulgated by the National Association of Insurance Commissioners.
Premium Taxes” means all taxes assessed in respect of the Premiums under the Reinsured Contracts by any Governmental Authority.
Premiums” means premiums, considerations, policy loan repayments, deposits and similar amounts collected by or on behalf of the Ceding Company in respect of the Reinsured Contracts.
Producer” means any broker, insurance producer, agent, general agent, managing general agent, master broker agency, broker general agency, financial specialist or other Person, including any employee of the Ceding Company or its Affiliates, responsible for writing, marketing, producing, selling or soliciting Reinsured Contracts.
Quota Share” means fifty percent (50%).
RBC Ratio” means, with respect to any U.S. domiciled insurance or reinsurance company, the percentage equal to (a) the quotient of the Total Adjusted Capital of such insurance or reinsurance company divided by the Company Action Level RBC, multiplied by (b) 100; provided, that any calculation of the RBC Ratio with respect to quarters other than the last quarter of a calendar year shall be based on such insurance company’s good faith estimate using, to the extent any factors are not reasonably available, amounts based on reasonable estimation and annualization.
Recapture Additional Payment Amount ” means, (i) in the case of a recapture due to a Fault Recapture Event, an amount equal to [***] percent ([***]%) of the Quota Share of the Cash Surrender Value as of the Recapture Date; and (ii) in the case of a recapture other than from a Fault Recapture Event, an amount equal to [***] percent ([***]%) of the Quota Share of the Cash Surrender Value as of the Recapture Date.
Recapture Date” has the meaning set forth in Section 8.3(b).
Recapture Notice” has the meaning set forth in Section 8.3(a).
Recapture Terminal Settlement” has the meaning set forth in Section 8.4(b).
Recapture Transaction IMR Amount” means the amount of realized gains or losses, calculated on an after-tax basis, created on the date of payment of the Recapture Terminal Settlement as a direct result of the transfer of assets by the Reinsurer to the Ceding Company pursuant to Section 8.4(a) or (d), calculated using the definition of “Fair Market Value”.
Recapture Triggering Event” means any of the following occurrences:
- 10 -
1007933761v22


(b)the RBC Ratio of the Reinsurer or of the Guarantor as of any calendar quarter-end is below [***]%, and the Reinsurer or the Guarantor has not cured such shortfall as of the applicable Capital Reporting Deadline;
(g)the [***] of any Affiliate Retrocessionaire as of any calendar quarter-end is below [***]% and such Affiliate Retrocessionaire has not cured such shortfall as of the applicable Capital Reporting Deadline; provided, that in the event that any Affiliate Retrocessionaire is not a [***] domiciled insurance company, the foregoing [***] shall refer to an equivalent capital adequacy ratio mutually agreed by the Ceding Company and the Reinsurer; and provided further, that with respect to any Affiliate Retrocessionaire, this event shall be deemed cured if the Reinsurer can demonstrate that neither the Reinsurer’s nor the Guarantor’s RBC Ratio as of such quarter-end is below [***]% assuming the Reinsured Risks retroceded to such Affiliate Retrocessionaire were recaptured by the Reinsurer as of such quarter-end;
(a)there has been a failure by the Reinsurer (i) to timely pay any undisputed Net Settlement amounts in accordance with Section 3.3(a) in an aggregate amount that, when added to the aggregate amount that the Reinsurer has failed to fund in accordance with Section 5.7(c)(i) that has not been cured, exceeds $[***]; or (ii)  to timely fund the Trust Account in accordance with Section 5.7(c)(i) in an aggregate amount that, when added to the aggregate amount of undisputed amounts that the Reinsurer has failed to timely pay in accordance with Section 3.3(a) that has not been cured, exceeds $[***], and, in each case of (i) and (ii), such failure has not been cured within [***] calendar days after written notice thereof from the Ceding Company;
(h)a Reserve Credit Event has occurred and the Reinsurer has not remedied such event in accordance with the timeframes set forth in Section 5.1; or
(i)(i) the Reinsurer, the Guarantor or [***] has been placed into liquidation, rehabilitation, conservation, supervision, receivership or similar proceedings (whether voluntary or involuntary), or (ii) there has been instituted against it proceedings for the appointment of a receiver, liquidator, rehabilitator, conservator, or trustee in bankruptcy, or other agent known by whatever name, to take possession of its assets or assume control of its operations.
Reinstatement” means, with respect to any Reinsured Contract that lapses or terminates, returning to active deferred status, including after the reversal of an Annuitization.
Reinsured Contracts” means those group variable annuity contracts, and all binders, slips, individual certificates, applications therefor, supplements, endorsements, settlement options and riders thereto issued or entered into in connection with such contracts, issued by the Ceding Company, that are described by their applicable policy number, plan code, product series code, market name/type of account, and policy specifications specified on the bordereaux comprising Schedule D, issued on the policy forms and riders set forth on Schedule C, and that are not in payout status as of the Effective Time.
Reinsured Liabilities” means, collectively, the General Account Liabilities and the Separate Account Liabilities.
Reinsured Risks” has the meaning set forth in Section 2.1.
Reinsurer” has the meaning set forth in the preamble.
Reinsurer Domiciliary State” means the State of Massachusetts, or, if the Reinsurer changes its domiciliary state to another state within the United States, such other state.
Reinsurer Extra-Contractual Obligations” means (a) all Extra-Contractual Obligations to the extent arising out of or related to any act, error or omission taken by the Reinsurer or any of its
- 11 -
1007933761v22


Affiliates or by the Ceding Company or any of its Affiliates at the prior written direction or request of the Reinsurer or any of its Affiliates and (b) the Quota Share of all Extra-Contractual Obligations to the extent arising out of or resulting from any Contested Claim in which the Reinsurer participates in accordance with Section 4.8; provided that, for the avoidance of doubt, with respect to subclause (a), the Reinsurer providing its consent to any action or omission under the terms of this Agreement shall not constitute a Reinsurer Extra-Contractual Obligation.
Reinsurer Indemnified Parties” has the meaning set forth in Section 9.2.
Reinsurer Statutory Reserves” means, as of any date of determination, the aggregate statutory reserve (including unearned premium reserves and other premium accruals) amount for the General Account Liabilities reinsured by the Reinsurer hereunder calculated under the Reinsurer Domiciliary State SAP (as would be reflected on Line 1, column 1 of the Liabilities section and Exhibit 5 and Line 3, column 1 of the Liabilities section and Exhibit 7 of the Reinsurer’s Statutory Financial Statement (or the equivalent exhibits or lines in the event of changes to the Reinsurer’s Statutory Financial Statement subsequent to December 31, 2021)), as calculated as of such date (without giving effect to any retrocession by the Reinsurer of any Reinsured Risks); provided, however, that Reinsurer Statutory Reserves shall at all times be calculated on a stand-alone basis without regard to any other business of the Reinsurer (e.g., without regard to any diversification or aggregation benefits that may be available based on other business of the Reinsurer).
Representative” of a Person means such Person’s Affiliates and the directors, officers, employees, advisors, agents, stockholders or other equity holders or investors, consultants, independent accountants, investment bankers, counsel, advisors or other representatives of such Person and of such Person’s Affiliates.
Required Balance” means [***]
Reserve Credit” means full statutory financial statement credit for the reinsurance ceded to the Reinsurer under this Agreement in the Ceding Company’s Statutory Financial Statements required to be filed by the Ceding Company with the Insurance Regulator in the Ceding Company Domiciliary State.
Reserve Credit Event” means any event that would cause the Ceding Company to not be permitted to receive Reserve Credit in the Ceding Company Domiciliary State.
Retrocessionaire” means any Person to whom the Reinsurer retrocedes any of the Reinsured Risks.
Revenue Sharing Fees” has the meaning set forth in Section 3.2(b).
SAP” means, with respect to either Party, the statutory accounting principles prescribed by the Insurance Regulator for the jurisdiction in which such insurance company is domiciled consistently applied.
Separate Account Change” has the meaning set forth in Section 2.9(b).
Separate Account Charges” has the meaning set forth in Section 3.2(b). “Separate Account Liabilities” has the meaning set forth in Section 2.9(a).
Separate Account Reserves” means, as of any date of determination, the aggregate amount of statutory reserves of the Ceding Company with respect to the Separate Account Liabilities (as would be described in Line 1, column 1 of the Liabilities section and Exhibit 3 of the Statutory Financial Statements related to separate accounts of the Ceding Company (or the equivalent exhibits or lines in the event of changes to the Ceding Company’s Statutory Financial Statement subsequent
- 12 -
1007933761v22


to December 31, 2021)), calculated in accordance with the Ceding Company Domiciliary State SAP.
Separate Account Values” means the aggregate account value in the Separate Accounts allocated to the Reinsured Contracts as defined in and determined in accordance with the terms of such Reinsured Contracts, as of such date, including any increase in such account value related to the matter set forth on Section 9.04(a) of the Ceding Company Disclosure Schedule.
Separate Accounts” means the registered and unregistered separate accounts of the Ceding Company applicable to the Reinsured Contracts identified in Schedule F-1.
Significant Subcontractor” has the meaning set forth in Section 4.1(c).
Spread Underperformance” has the meaning [***]
Statutory Book Value” means, with respect to any asset held in the Trust Account, the amount permitted to be carried by the Reinsurer as an admitted asset (including Accrued Interest) consistent with SAP applicable to the Reinsurer, consistently applied.
Statutory Financial Statements” means, with respect to any insurance company, the annual and quarterly statutory financial statements of such Person filed with the Insurance Regulator charged with supervision of such Person.
Target Spread Amount” has the meaning [***]
Tax” or “Taxes” has the meaning specified in the Master Transaction Agreement.
Termination Additional Payment Amount” means, in the case of a termination of this Agreement by the Reinsurer pursuant to Section 8.6, an amount equal to [***] percent ([***]%) of the Quota Share of the Cash Surrender Value as of the Recapture Date.
Third Party Claim” has the meaning set forth in the Master Transaction Agreement.
Third Party Pricing Services” has the meaning set forth in Schedule G.
Time-of-Annuitization Date” has the meaning set forth in Section 2.10(b).
Time-of-Annuitization Payment” means, as of any date of determination, the Quota Share of the accumulated Account Value of the applicable Reinsured Contract.
Total Adjusted Capital” means, with respect to any U.S. domiciled insurance company, as of any date of determination, total adjusted capital as calculated in accordance with the applicable Laws of such insurance company’s domiciliary state as of such date of determination.
Transaction Agreements” means, collectively, this Agreement, the Master Transaction Agreement, the Trust Agreement, the Guarantee and the Investment Management Agreement.
Transaction IMR Amount” means the amount of realized gains or losses, calculated on an after-tax basis, created on the Closing Date as a direct result of the transfer of assets by the Ceding Company to the Reinsurer pursuant to Section 3.1(a), calculated using the definition of “Fair Market Value”.
Transferred Assets” has the meaning set forth in the Master Transaction Agreement.
- 13 -
1007933761v22


Trust Account” means the trust account established by the Reinsurer for the benefit of the Ceding Company under the Trust Agreement.
Trust Agreement” means that certain Trust Agreement dated as of the date hereof by and among the Reinsurer, the Ceding Company and the Trustee, substantially in the form attached as Exhibit 2.
Trust Triggering Event” means any of the following occurrences:
(c)the RBC Ratio of the Reinsurer or of the Guarantor as of any calendar quarter-end is below [***]%, and the Reinsurer or the Guarantor has not cured such shortfall as of the applicable Capital Reporting Deadline;
(j)the [***] of any Affiliate Retrocessionaire as of any calendar quarter-end is below [***]% and such Affiliate Retrocessionaire has not cured such shortfall as of the applicable Capital Reporting Deadline; provided, that in the event that any Affiliate Retrocessionaire is not a [***] domiciled insurance company, the foregoing [***] shall refer to an equivalent capital adequacy ratio mutually agreed by the Ceding Company and the Reinsurer; and provided further, that with respect to any Affiliate Retrocessionaire, this event shall be deemed cured if the Reinsurer can demonstrate that neither the Reinsurer’s nor the Guarantor’s RBC Ratio as of such quarter-end is below [***]% assuming the Reinsured Risks retroceded to such Affiliate Retrocessionaire were recaptured by the Reinsurer as of such quarter-end;
(k)there has been a failure by the Reinsurer (i) to timely pay any undisputed Net Settlement amounts in accordance with Section 3.3(a) in an aggregate amount that, when added to the aggregate amount that the Reinsurer has failed to fund in accordance with Section 5.7(c)(i) that has not been cured, exceeds $[***]; or (ii) to timely fund the Trust Account in accordance with Section 5.7(c)(i) in an aggregate amount that, when added to the aggregate amount of undisputed amounts that the Reinsurer has failed to timely pay in accordance with Section 3.3(a) that has not been cured, exceeds $[***], and, in each case of (i) and (ii), such failure has not been cured within [***] calendar days after written notice thereof from the Ceding Company; or
(l)(i) the Reinsurer, the Guarantor or [***] has been placed into liquidation, rehabilitation, conservation, supervision, receivership or similar proceedings (whether voluntary or involuntary), or (ii) there has been instituted against it proceedings for the appointment of a receiver, liquidator, rehabilitator, conservator, or trustee in bankruptcy, or other agent known by whatever name, to take possession of its assets or assume control of its operations.
Trustee” means U.S. Bank National Association or another Person mutually agreed by the Ceding Company and the Reinsurer.
UCC” means the Uniform Commercial Code as in effect from time to time in the State of New York.
Unamortized Ceding Commission” means, as of any date of determination, the portion of the Adjusted Ceding Commission which remains unamortized as of such date, which amortization shall begin at the Effective Time and shall amortize to zero monthly on a straight-line basis over a seventeen (17) year period.
Unamortized IMR Amount” means, with respect to any date of determination, (a) the Reinsurer’s Quota Share of the Existing IMR Amount which remains unamortized as of such date, plus (b) the Transaction IMR Amount which remains unamortized as of such date, as amortized pursuant to the Final IMR Amortization Schedule, plus (c) the Post-Closing Date IMR Amount which remains unamortized as of such date.
- 14 -
1007933761v22


Unfloored CTE [***] Amount” means, as of any date of determination, an amount (which may be a negative number) equal to the arithmetic mean of the Quota Share of the statutory carrying value of assets required as of such date to satisfy contractholder obligations (or the greatest present value of accumulated deficiencies) in excess of the Quota Share of the Cash Surrender Value as defined in the VM-21 guidelines relating to the Reinsured Contracts (other than with respect to payout annuities) in the worst [***] of the 1,000 statutory stochastic capital market scenarios determined using the process and methodologies for modeling and assumptions as set forth on Schedule O; provided, however, that the Unfloored CTE [***] Amount shall be calculated (a) without requiring the scenario reserve for any given scenario to be equal to or in excess of the cash surrender value in aggregate for the group of Reinsured Contracts modeled in the projection and (b) on a stand-alone basis without regard to any other business of the Ceding Company (e.g., without regard to any diversification or aggregation benefits that may be available based on other business of the Ceding Company).
Variable Distribution Fee” means the applicable fee set forth in the “Variable Distribution Fee” column in Schedule 3.12(g)(ii) to the Master Transaction Agreement.
Article II.

BASIS OF REINSURANCE AND BUSINESS REINSURED
Section 1.2.Coverage. Upon the terms and subject to the conditions and other provisions of this Agreement, as of the Effective Time, the Ceding Company hereby cedes to the Reinsurer, and the Reinsurer hereby agrees to reinsure and indemnify the Ceding Company (a) on a coinsurance basis for the Quota Share of the General Account Liabilities and (b) on a modified coinsurance basis for the Quota Share of the Separate Account Liabilities, in each case, that have not been paid by the Ceding Company prior to the Effective Time (collectively, the “Reinsured Risks”). The reinsurance effective under this Agreement shall be maintained in force, without reduction, unless such reinsurance is terminated or recaptured as provided herein.
Section 1.3.Insurance Contract Changes. Except (a) as directed or agreed by the Reinsurer in advance in writing, (b) for any changes initiated by the applicable Policyholder of any Reinsured Contract pursuant to the terms of such Reinsured Contract or (c) for any changes mandated by any Governmental Authority or applicable Law, in which case the Ceding Company shall consult with the Reinsurer with respect to any such change, the Ceding Company shall not change the terms of any Reinsured Contract. This Section 2.2 shall not apply to (i) any changes to Non-Guaranteed Elements, which shall be governed exclusively by Section 2.7 or (ii) roll-overs of amounts from another retirement savings account into a Reinsured Contract, which shall be governed exclusively by Section 2.11. The Parties agree and acknowledge that the policies set forth on Schedule D as originally attached to this Agreement are the Reinsured Contracts in-force and not in payout status as of August 31, 2022, and that during the first sixty (60) calendar days following the Closing Date, the Ceding Company will prepare and deliver to the Reinsurer an updated version of Schedule D that has been updated solely to remove policies that are (x) no longer in force or (y) in payout status, in each case as of the Effective Time. The Reinsurer shall have sixty (60) calendar days after the date on which the updated Schedule D is delivered to it to review such schedule, and the provisions of Section 2.04(e) of the Master Transaction Agreement shall apply mutatis mutandis. Following the Parties’ agreement on the updated schedule, the Parties will attach such updated schedule to this Agreement as Schedule D, which updated schedule will replace Schedule D as originally attached to this Agreement.
Section 1.4.Liability. Subject to the terms and conditions of this Agreement, the Reinsurer’s liability under this Agreement shall attach as of the Effective Time and the Reinsurer’s Liability under this Agreement shall be subject in all respects to the same terms, rates and conditions with respect to the Reinsured Contracts as the Ceding Company, and, to the same modifications, alterations and cancellations of the Reinsured Contracts as the Ceding Company, the
- 15 -
1007933761v22


true intent of this Agreement being that the Reinsurer shall, subject to the terms and conditions of this Agreement, follow the fortunes of the Ceding Company with respect to the Reinsured Liabilities.
Section 1.5.Indemnity Reinsurance. This Agreement is an indemnity coinsurance agreement solely between the Ceding Company and the Reinsurer, and the performance of the obligations of each Party under this Agreement shall be rendered solely to the other Party. The Ceding Company shall be and shall remain the only Party hereunder that is liable to any insured, Policyholder, claimant or beneficiary under any policy reinsured hereunder.
Section 1.6.Territory. The territorial limits of this Agreement shall be identical with those of the Reinsured Contracts.
Section 1.7.Reinstatements. If any Reinsured Contract that lapses following the Effective Time is subsequently reinstated pursuant to the express terms of such Reinsured Contract prior to the termination of this Agreement, the reinsurance for such Reinsured Contract under this Agreement shall be reinstated automatically. The Ceding Company shall pay the Reinsurer the Quota Share of all amounts, including Premiums, received by the Ceding Company in connection with the Reinstatement of such Reinsured Contract.
Section 1.8.Non-Guaranteed Elements. From and after the Closing Date, the Reinsurer may, from time to time, make recommendations to the Ceding Company with respect to Non-Guaranteed Elements so long as the recommendations comply with the written terms of the Reinsured Contracts, applicable Law and Actuarial Standards of Practice promulgated by the Actuarial Standards Board governing redetermination of non-guaranteed charges. The Ceding Company shall fully consider any such recommendations and act reasonably and in good faith in determining whether any such recommendations should be accepted and shall not unreasonably delay implementation of any accepted recommendations. The Ceding Company shall (a) consult with the Reinsurer periodically on the setting of Non-Guaranteed Elements prior to making any material changes thereto and (b) unless otherwise agreed by the Parties, set Non-Guaranteed Elements in a manner consistent in all material respects with Exhibit C-I of the Trust Agreement.
Section 1.9.Retrocession.
(d)[***]
Section 1.10.Separate Accounts.
(a)Notwithstanding anything contained in this Agreement to the contrary, for each of the Reinsured Contracts that relate to the Separate Account Liabilities, the amount invested on a variable basis in accordance with the terms of such Reinsured Contracts shall be held by the Ceding Company in the Separate Accounts, and Premiums with respect to such Reinsured Contracts shall be deposited in the Separate Accounts to the extent required to be deposited therein by the terms and conditions of such Reinsured Contracts. From and after the Effective Time, the Ceding Company shall retain and own all assets contained in the Separate Accounts and shall hold the Separate Account Reserves with respect to the Reinsured Contracts that are funded, in whole or in part, by one or more of the Separate Accounts and such Separate Account Reserves shall be reported by the Ceding Company on its Separate Account balance sheets, consistent with the Ceding Company Domiciliary State SAP. For each Reinsured Contract that relates to the Separate Account Liabilities, the Reinsurer shall deposit, shall cause to be deposited, or shall transfer to the Ceding Company for deposit any additional amounts required to be deposited into the Separate Accounts after the Effective Time pursuant to the terms of the applicable Reinsured Contract, in each case, except to the extent that such amounts have been previously paid (or provided for) pursuant to the Net Settlement. All amounts to be paid with respect to surrenders, annuitization payments, death benefits, compensation or any other amounts with respect to such Reinsured
- 16 -
1007933761v22


Contracts that by the terms of such Reinsured Contracts contemplate payment from the Separate Accounts (excluding any Excluded Liabilities, the “Separate Account Liabilities”) shall be paid out of the Separate Accounts to the extent so contemplated. For the avoidance of doubt, Separate Account Liabilities exclude Ceding Company Extra-Contractual Obligations. As of the Closing Date, the Parties will record on their respective books and records an initial modified coinsurance reserve adjustment to the extent necessary to reflect the cession of the Quota Share of the Separate Account Liabilities hereunder on a modified coinsurance basis.
(b)Except as consented to in writing by the Reinsurer or as required by a vote of Policyholders, neither the Ceding Company nor its Affiliates (unless such Affiliates are required to so act under applicable Law (including, without limitation, common law or statutory fiduciary duties)) shall initiate, consent to or otherwise permit a change to the investment options or underlying investment funds available through the Separate Accounts under the Reinsured Contracts or the terms or conditions of any agreements between the Ceding Company and a variable investment trust or other investment vehicle offered as an investment option in the Separate Accounts with respect to the Reinsured Contracts (including any plan of operations for any Separate Accounts) that at the time of such change would reasonably be expected to have, in the aggregate considering all positive and adverse effects thereof [***], an adverse and non-de minimis effect on the Reinsurer or the Reinsurer’s liability hereunder (each, a “Separate Account Change”), other than for any Separate Account Change required by the terms of such Reinsured Contracts, any Governmental Order or any applicable Law, in which case the Ceding Company shall, to the extent practicable and legally permissible, consult with the Reinsurer as to any such Separate Account Change; provided, that with respect to any replacement of an investment option or underlying investment fund with another investment option or underlying investment fund within the same Morningstar Category, differences in the investment risk or performance profiles of said funds shall not in and of themselves constitute a Separate Account Change. The Parties agree that any actions taken by the board of directors, trustees or beneficial owners of an investment vehicle or investment option offered in a Separate Account shall not be subject to any right of the Reinsurer to consent to, or be consulted with respect to, such action, except to the extent the Ceding Company or any of its Affiliates (unless such Affiliates may not give effect to such Reinsurer consent or consultation right under applicable Law (including, without limitation, common law or statutory fiduciary duties)) has a right to consent to, or be consulted with respect to, such action. For the avoidance of doubt, the Reinsurer hereby provides its prior written consent to the fund substitutions set forth in Section 5.01 of the Ceding Company Disclosure Schedule.
(c)Except as required by any Governmental Order or applicable Law, there shall be no modification to the M&E Fees without the prior written consent of the Reinsurer. To the extent any counterparty seeks to modify M&E Fees, the Ceding Company shall consult with the Reinsurer as to any such proposed modifications and shall not encourage or accept a modification that would be adverse to the Reinsurer without the Reinsurer’s prior written consent.
Section 1.11.Annuitizations.
(e)The Reinsurer shall reinsure hereunder the Quota Share of all Reinsured Liabilities arising under all Reinsured Contracts that Annuitize after the Effective Time if the annuity benefits of such Reinsured Contract are determined under the minimum guaranteed annuity benefit rates as defined by the Table of Guaranteed Annuity Payments contained in such Reinsured Contract.
(f)With respect to each Reinsured Contract that Annuitizes during a Monthly Accounting Period, if a Reinsured Contract is annuitized using an annuity benefit rate that produces annuity benefits that exceed the minimum guaranteed annuity benefits as defined by applying the annuity contract value to the minimum guaranteed benefit rates contained in such Reinsured Contract, the Reinsurer shall pay to the Ceding Company in cash the aggregate Time-of-Annuitization Payments in respect of such Reinsured Contract as part of the net settlement in
- 17 -
1007933761v22


respect of such Monthly Accounting Period pursuant to the settlement provisions set forth in Section 3.3.
(g)All Reinsured Contracts with Policyholders reaching the age of ninety-five (95) that do not Annuitize on or before the date that is ninety (90) calendar days following the applicable Reinsured Contract’s anniversary immediately following the Policyholder’s ninety-fifth (95) birthday will be deemed annuitized on such ninetieth (90th) calendar day (the date of an Annuitization described in paragraph (b) of this Section 2.10 or a deemed Annuitization described in this paragraph with respect to any Reinsured Contract, a “Time-of-Annuitization Date”), and the Reinsurer shall pay to the Ceding Company in cash the aggregate Time-of-Annuitization Payments in respect of such Reinsured Contract as part of the net settlement in respect of the Monthly Accounting Period during which the Reinsured Contract is deemed annuitized pursuant to the settlement provisions set forth in Section 3.3. Following the Time-of-Annuitization Date of a Reinsured Contract, such Reinsured Contract shall cease to be ceded hereunder from and after such Time-of-Annuitization Date, provided, that the Reinsurer shall pay to the Ceding Company all Time-of-Annuitization Payments in respect thereof and nothing in this Section 2.10 shall relieve the Reinsurer of any liabilities or obligations in respect of such Reinsured Contract that were incurred hereunder prior to such Time-of-Annuitization Date but still unpaid on such date.
Section 1.12.Additional Roll-Overs. In the event that, without the Reinsurer’s prior written consent, the Ceding Company accepts a roll-over of amounts from another retirement savings account into a Reinsured Contract where the amount of such roll-over, when added to the Account Value of the Reinsured Contract at the time of such roll-over, would exceed $[***] (the amount of such roll-over in excess of $[***] being the “Excess Roll-Over Amount”), any Liability arising out of or related to the acceptance of such Excess Roll-Over Amount shall be an “Excluded Liability” hereunder. Any roll-over of amounts from another retirement savings account into a Reinsured Contract where the amount of such roll-over, when added to the Account Value of the Reinsured Contract at the time of such roll-over, would be equal to or less than $[***] shall be reinsured hereunder without the need for the Reinsurer’s prior written consent. For the avoidance of doubt, any Additional Consideration related to Excess Roll-Over Amounts shall be retained by the Ceding Company and shall not be owed to the Reinsurer.
Section 1.13.Net Retention. The Ceding Company, together with its Affiliates, shall retain, net and unreinsured, at their own risk and liability, a [***] percent ([***]%) quota share of the General Account Liabilities with respect to each Reinsured Contract.
Section 1.14.[***].
Article III.

PAYMENTS; ADDITIONAL CONSIDERATION
Section 1.15.Initial Reinsurance Premium.
(h)As initial consideration for the Reinsurer entering into this Agreement (the “Initial Premium”), the Reinsurer shall be entitled to cash and/or Eligible Assets having an aggregate Fair Market Value (excluding Accrued Interest) as of the Closing Date plus Accrued Interest as of the Effective Time equal to the sum of:
(i)the Quota Share of the Cash Surrender Value as of the Effective Time; plus
(ii)the Quota Share of the Existing IMR Amount as of the Effective Time to the extent such Existing IMR Amount was created on or prior to the date of the appraisal set forth in the Milliman Report (the “Appraisal Date”), plus
- 18 -
1007933761v22


(iii)the Quota Share of the Existing IMR Amount as of the Effective Time to the extent such Existing IMR Amount was created after the Appraisal Date, divided by, the Applicable Tax Gross-up Percentage, plus
(iv)the Transaction IMR Amount as of the Closing Date, divided by the Applicable Tax Gross-up Percentage, minus
(v)the Adjusted Ceding Commission.
(d)On the Closing Date, the Ceding Company shall transfer to the Trust Account, on behalf of the Reinsurer, (i) the Transferred Assets in an amount equal to the Estimated Initial Premium and (ii) amounts received between the Effective Time and the Closing Date, inclusive, in respect of calls, call premiums, principal repayments, make-whole payments, maturities and coupon payments in respect of the Transferred Assets, in each case pursuant to Section 2.03 of the Master Transaction Agreement and as set forth in the Estimated Closing Statement delivered thereunder. To the extent required pursuant to Section 5.2(b), the Reinsurer shall deposit additional Eligible Assets into the Trust Account concurrent with the Closing. Each of the Initial Premium, Transferred Assets and Initial Required Balance will be determined, adjusted, settled and paid in accordance with Article II of the Master Transaction Agreement.
(e)The Ceding Company and the Reinsurer agree that the Reinsurer’s Quota Share of the Existing IMR Amount and the Transaction IMR Amount shall be ceded to and held by the Reinsurer and the Ceding Company shall have no obligation to maintain any net IMR relating to the Reinsurer’s Quota Share of the Existing IMR Amount, the Transaction IMR Amount or the Post-Closing Date IMR Amount.
Section 1.16.Additional Consideration. As additional consideration for the Reinsurer entering into this Agreement, the Reinsurer shall be entitled to the Quota Share of the following amounts except, in the case of the amounts described in paragraphs (a), (b) and (c) of this Section 3.2, to the extent such amounts directly arise from an Excluded Liability (the “Additional Consideration”):
(i)Premiums received at or after the Effective Time by the Ceding Company;
(j)(i) all (x) mortality and expense risk charges, administrative expense charges, rider charges, contract maintenance charges, back-end sales loads and other considerations billed separately for the Reinsured Contracts, and any other charges, fees, and similar amounts from the Separate Accounts received or receivable by the Ceding Company with respect to the Reinsured Contracts (the “M&E Fees”), (y) 12b-1 Fees; provided that the Variable Distribution Fee used in calculating the 12b-1 Fees payable to the Reinsurer under clause (i)(y) of this Section 3.2(b) shall in no event exceed [***]%; and (z) all revenue sharing fees, service fees, distribution fees and other amounts, in each case excluding 12b-1 Fees payable under clause (i)(y) of this Section 3.2(b) but including 12b-1 Fees for which the Variable Distribution Fee used in calculating the 12b-1 Fees payable to the Reinsurer hereunder exceeds [***]% to the extent of such excess, from or in respect of any mutual fund organization’s mutual funds as funding vehicles to the extent attributable to the Reinsured Contracts received or receivable by the Ceding Company or any of its Affiliates other than (1) the administrative fees set forth on Schedule F-3, which are currently being paid to Equitable Investment Management LLC (“EIM”) (the “EIM Administrative Fee”), and (2) the sub-advisory fees and other expenses consistent with the calculation of the “Spread” column set forth on Schedule F-2 (all fees payable under clause (i)(z) of this Section 3.2(b), “Revenue Sharing Fees”), and (ii) all other amounts received or receivable at or after the Effective Time by the Ceding Company with respect to the Reinsured Contracts (other than with respect to the amounts described in clause (i) of this Section 3.2(b)) (collectively, the “Separate Account Charges”), in each case of (i) and (ii), excluding Separate Account Charges accrued prior to the Effective Time;
- 19 -
1007933761v22


(k)Without duplication of amounts described in paragraphs (a) or (b) of this Section 3.2, and excluding Separate Account Charges accrued prior to the Effective Time, all amounts that are transferrable from the Separate Accounts to the general account of the Ceding Company in respect of the Reinsured Contracts at or after the Effective Time; and
(l)Without duplication of the same amounts paid to the Reinsurer pursuant to this Agreement or any other Transaction Agreement, an amount equal to the amount of any increases in Account Value and any increases in Separate Account Value in each case in connection with the matter set forth on Section 9.04(a) of the Ceding Company Disclosure Schedule, provided that any such increase in the Separate Account Value shall be deposited by the Ceding Company directly into the applicable Separate Accounts.
(m)For the avoidance of doubt, the fees set forth on Schedule F-3 shall not be included in the calculation of Revenue Sharing Fees.
Section 1.17.Net Settlement.
(a)During the term of this Agreement, a settlement amount between the Ceding Company and the Reinsurer as of the last day of each Monthly Accounting Period (the “Net Settlement”) shall be calculated by the Ceding Company, and a statement setting forth details of such calculation (the “Monthly Settlement Statement”) reflecting in detail the Net Settlement determinations as contemplated in Exhibit 1, as well as the Ceding Company Statutory Reserves with respect to the Reinsured Contracts in payout status and Separate Account Reserves as of the last day of such Monthly Accounting Period, provided that if the Ceding Company Statutory Reserves or Separate Account Reserves as of the last day of such Monthly Accounting Period are not available, the Ceding Company will provide the Ceding Company Statutory Reserves or Separate Account Reserves, as applicable, as of the most recent calendar quarter-end, in the form of, and containing for such Monthly Accounting Period the information reflected in, Exhibit 1 shall be delivered by the Ceding Company to the Reinsurer no later than ten (10) Business Days following the end of such Monthly Accounting Period. If the amount of the Net Settlement for such Monthly Accounting Period is positive, the Ceding Company shall pay such amount in cash to the Reinsurer within five (5) Business Days after its delivery of the Monthly Settlement Statement for such period to the Reinsurer. If the amount of the Net Settlement for such Monthly Accounting Period is negative, the Reinsurer shall pay the absolute value of such amount in cash to the Ceding Company or, at the Ceding Company’s option, to the Designated Administrative Account pursuant to Section 4.4 within five (5) Business Days after its receipt of the Monthly Settlement Statement for such period.
(b)The Net Settlement with respect to each Monthly Accounting Period shall be an amount equal to the following:
(i)the Quota Share of the Additional Consideration received by the Ceding Company during such Monthly Accounting Period; minus
(ii)the Quota Share of the Reinsured Liabilities paid by the Ceding Company during such Monthly Accounting Period; minus
(iii)the Expense Allowances for such Monthly Accounting Period; minus
(iv) an amount equal to any Experience Refund due to the Ceding Company for such Monthly Accounting Period pursuant to Schedule F-2.
(n)In the event that the Reinsurer has an objection to the calculation of any items set forth in the Monthly Settlement Statement, then the Reinsurer, as applicable, may deliver written notice to the Ceding Company, and the Parties shall attempt in good faith to resolve such
- 20 -
1007933761v22


disagreement for a period of ten (10) Business Days. If the Parties do not resolve any such disagreement within such ten (10) Business Day period, the Parties shall jointly request the Independent Accounting Firm to make a determination with respect to all matters in dispute; provided, that, if no accounting firm is willing or able to serve, unless otherwise agreed by the Parties, such dispute shall be resolved in accordance with Section 11.8. The Parties shall instruct the Independent Accounting Firm to limit its review to matters that remain in dispute between the Parties and to render its decision within ten (10) Business Days after submission of such dispute to such Independent Accounting Firm. The Independent Accounting Firm shall not assign a value to any matter higher than the highest value for such matter claimed by either Party or less than the lowest value for such matter claimed by either Party. The Independent Accounting Firm’s determination of the disputed matters shall be final and binding upon the Parties absent manifest error. All fees and expenses relating to the work of the Independent Accounting Firm shall be allocated by the Independent Accounting Firm as between the Parties in proportion to the difference between each Party’s claimed value and the value decided by the Independent Accounting Firm. Notwithstanding any other provision of this Agreement to the contrary, a Party’s obligation to make payment pursuant to the second or third sentence, as applicable, of Section 3.3(a) shall become due on the date specified in the second or third sentence, as applicable, of Section 3.3(a), irrespective of the pendency of any dispute initiated pursuant to this Section 3.3(c). Any amounts paid by a Party that are subsequently determined not to be due shall be refunded to such Party with interest calculated thereon at the Interest Rate from the date of payment thereof to the date prior to the date of refund.
Section 1.18.Delayed Payments. If there is a delayed settlement of any payment due hereunder, interest will accrue on such overdue payment at the Interest Rate until settlement is made. For purposes of this Section 3.4, a payment will be considered overdue, and such interest will begin to accrue, on the first day immediately following the date such payment is due. For greater clarity, a payment shall be deemed to be due hereunder on the last date on which such payment may be timely made under the applicable provision.
Section 1.19.Defenses. The Reinsurer accepts, reinsures and assumes the Reinsured Risks subject to any and all defenses, set-offs and counterclaims to which the Ceding Company would be entitled with respect to the Reinsured Risks, it being expressly understood and agreed to by the Parties hereto that no such defenses, set-offs, or counterclaims are or shall be waived by the execution and delivery of this Agreement or the consummation of the transactions contemplated hereby and that the Reinsurer is and shall be fully subrogated in and to all such defenses, set-offs and counterclaims.
Section 1.20.Offset. Except as otherwise provided under applicable Law, any undisputed debits or credits incurred between the Parties on and after the Effective Time in favor of or against either the Ceding Company or the Reinsurer with respect to this Agreement are deemed mutual debits or credits, as the case may be, and shall be set off or recouped, and only the net balance shall be allowed or paid. In the event of any liquidation, insolvency, rehabilitation, conservatorship or comparable proceeding by or against the Ceding Company or the Reinsurer, the rights of offset and recoupment set forth in this Section 3.6 shall apply to the fullest extent permitted by applicable Law.
Section 1.21.Premium Taxes. For each Monthly Accounting Period, the Parties shall cooperate and provide the other with information regarding Allocated Premium Taxes which is reasonably necessary to calculate the Net Settlement. The amount of Allocated Premium Taxes included in Reinsured Liabilities is an allowance for any Premium taxes, and, notwithstanding anything to the contrary in this Agreement, the Reinsurer shall have no additional obligation to reinsure, indemnify or reimburse the Ceding Company for any Premium Taxes.
Section 1.22.Reports from the Reinsurer.
- 21 -
1007933761v22


(a)Each calendar quarter, the Reinsurer shall provide to the Ceding Company, by the relevant Capital Reporting Deadline, a calculation of the RBC Ratio of the Reinsurer and the Guarantor as of the last day of the immediately preceding calendar quarter, (x) with respect to quarters other than the last quarter of a calendar year, based on the Reinsurer’s or the Guarantor’s, as applicable, good faith estimate using, to the extent any factors are not reasonably available, amounts based on reasonable estimation and annualization and (y) with respect to the last quarter of a calendar year, as calculated by the Reinsurer or the Guarantor, as applicable. In addition, if the RBC Ratio of the Reinsurer or the Guarantor as of any calendar quarter-end is below the RBC Ratio described in clause (a) of either of the definitions of “Trust Triggering Event” or “Recapture Triggering Event” herein, as applicable, and has been cured, the Reinsurer shall provide to the Ceding Company evidence that such shortfall has been cured by the applicable Capital Reporting Deadline. Each such calculation shall include reasonable supporting detail with respect to such calculation and shall be treated as Confidential Information by the Ceding Company. In the event that the Reinsurer fails to provide a calculation of its or the Guarantor’s RBC Ratio as and when required pursuant to this Section 3.8(a) and such failure has not been cured within [***] calendar days after receipt of notice of such failure from the Ceding Company (such notice not to be provided prior to the applicable Capital Reporting Deadline), the RBC Ratio of the Reinsurer or the Guarantor, as applicable, shall be deemed to be less than the RBC Ratio set forth in clause (a) of the definition of “Trust Triggering Event”; provided, that (i) if the RBC Ratio of the Reinsurer or the Guarantor, as applicable, as of the Capital Reporting Deadline immediately preceding the Capital Reporting Deadline by which the Reinsurer failed to provide its or the Guarantor’s RBC Ratio was [***]% or lower and the Reinsurer fails to provide such calculation within [***] Business Days after receipt of notice of such failure from the Ceding Company (such notice not to be provided prior to the applicable Capital Reporting Deadline), the RBC Ratio of the Reinsurer or the Guarantor, as applicable, shall be deemed to be less than the RBC Ratio as forth in clause (a) of the definition of “Recapture Triggering Event” and (ii) if the RBC Ratio of the Reinsurer or the Guarantor, as applicable, as of the Capital Reporting Deadline immediately preceding the Capital Reporting Deadline by which the Reinsurer failed to provide its or the Guarantor’s RBC Ratio was in excess of [***]%, and the Reinsurer fails to provide a calculation of (x) its RBC Ratio twice consecutively or (y) the Guarantor’s RBC Ratio twice consecutively, in each case within [***] Business Days after receipt of notice of such failure from the Ceding Company (such notice not to be provided prior to the applicable Capital Reporting Deadline), the RBC Ratio of the Reinsurer or the Guarantor, as applicable, shall be deemed to be less than the RBC Ratio set forth in clause (a) of the definition of “Recapture Triggering Event”. Any such deemed RBC Ratio shall be cured by the Reinsurer providing the Ceding Company with reasonably satisfactory evidence that the Reinsurer or the Guarantor, as applicable, has an RBC Ratio at least equal to the RBC Ratio set forth in clause (a) of the definition of “Trust Triggering Event” or clause (a) of the definition of “Recapture Triggering Event,” as applicable.
(a)[***]
(b)The Reinsurer shall provide written notice to the Ceding Company of the occurrence of any Trust Triggering Event or Recapture Triggering Event within [***] Business Days after it becomes aware of such occurrence.
(c)Promptly after the Ceding Company’s request, the Reinsurer shall provide to the Ceding Company (i) a copy of the Reinsurer’s and the Guarantor’s most recent annual and quarterly Statutory Financial Statement and a copy of each of their most recent annual audited Statutory Financial Statements, along with the audit report thereon and (ii) for each Affiliate Retrocessionaire, a copy of the most recent annual and quarterly Statutory Financial Statements and a copy of the most recent annual audited Statutory Financial Statement of such Affiliate Retrocessionaire, along with the audit report thereon (or comparable financial statements).
(d)At the Ceding Company’s reasonable request at reasonable times upon reasonable prior notice, no more than once per calendar quarter, the Reinsurer shall make available
- 22 -
1007933761v22


appropriate personnel or its Representatives for a meeting (in person or via teleconference or telephone) with the Ceding Company to discuss (i) the Reinsurer’s, any Affiliate Retrocessionaire’s and the Guarantor’s then-current financial condition and continuing creditworthiness, (ii) the Reinsurer’s derivatives risk management policy applicable to the Reinsured Contracts and (iii) the Reinsurer’s valuation and other information reasonably requested by the Ceding Company with respect to the assets held in the Trust Account. In addition, upon the Ceding Company’s reasonable request, the Reinsurer shall provide the Ceding Company with the information and documentation set forth in Schedule M. Nothing herein shall (x) require the Reinsurer to disclose any information to the Ceding Company or its Representatives if such disclosure would jeopardize any attorney-client privilege, the work product immunity or any other legal privilege or similar doctrine or contravene any applicable Law or any contract (including any confidentiality agreement to which the Reinsurer or any of its Affiliates is a party); it being understood that the Reinsurer shall use its reasonable best efforts to enable such information to be furnished or made available to the Ceding Company or its Representatives without so jeopardizing privilege or contravening such applicable Law (including redacting information or entering into joint defense agreements with the Ceding Company on mutually agreeable terms) or (y) require the Reinsurer to disclose its Tax records or any personnel or related records (except with respect to transfer Taxes, Premium Taxes and similar Taxes that relate to the Reinsured Contracts).
Section 1.1.Reports from the Ceding Company.
(e)For so long as this Agreement remains in effect, the Ceding Company shall promptly provide to the Reinsurer the reports set forth on Schedule J within the applicable time periods listed therein.
(f)The Ceding Company shall prepare any other reports reasonably requested by the Reinsurer in connection with the Reinsured Contracts and Reinsured Liabilities, so long as the Ceding Company has the general ability to produce such other reports as reasonably determined by the Ceding Company with reference to its then current operations (“Additional Reports”). Except to the extent that the Ceding Company prepares such Additional Reports in the ordinary course of business, the Reinsurer shall reimburse the Ceding Company for any actual costs the Ceding Company incurs in preparing any such Additional Reports. Any Additional Reports required to be prepared by the Ceding Company shall be prepared and delivered to the Reinsurer within the time agreed by the Parties.
(g)The Ceding Company shall keep the Reinsurer apprised of any material developments in connection with the matter set forth on Section 9.04(a) of the Ceding Company Disclosure Schedule.
Article IV.
ADMINISTRATION
Section 1.23.Administration.
(a)The Ceding Company shall provide all administrative and related services with respect to the Reinsured Contracts, including, without limitation, the billing and collection of any Premiums and other Additional Consideration, the administration of claims and any required tax information reporting (collectively, “Administrative Services”). The Ceding Company shall be permitted to subcontract or assign such responsibility to any Affiliate or third party with industry expertise in administering annuity policies for the administration of the Reinsured Contracts, provided that no such subcontracting shall relieve the Ceding Company of its obligations or liabilities under this Agreement and the Ceding Company shall remain liable to the Reinsurer for the acts of any such subcontractor or assignee as if the Ceding Company was performing such Administrative Services itself. The Ceding Company will give written notice to the Reinsurer if it subcontracts or assigns responsibility for any material Administrative Service (e.g., accepting
- 23 -
1007933761v22


premiums or adjusting claims). At the Ceding Company’s reasonable request at reasonable times upon reasonable prior notice, no more than twice per calendar year, the Ceding Company shall participate in servicing and administration review calls with the Reinsurer to discuss issues (if any) that have arisen with respect to the administration and servicing of the Reinsured Contracts.
(b)The Ceding Company shall have full authority to determine liability on any Reinsured Liabilities reinsured hereunder and may pay or settle such liabilities as it deems appropriate; provided, that the Ceding Company, and each of its subcontractors and assignees authorized pursuant to Section 4.1(a), acts in accordance with the terms and conditions of this Agreement.
(c)The Ceding Company shall use commercially reasonable efforts to obtain from any unaffiliated subcontractor (i) which provides a material Administrative Service (e.g., accepting premiums or adjusting claims) with respect to the Reinsured Contracts and (ii) the financial controls of which are being relied upon by the Ceding Company (as they relate to the services such subcontractor is providing to the Ceding Company) in order to conclude that the Ceding Company’s controls over financial reporting are suitably designed and operate effectively to achieve the related control objectives (in each case, a “Significant Subcontractor”) any available copy of such Significant Subcontractor’s SSAE 18 SOC 1, Type I report or, if the Significant Subcontractor is able to provide, such Significant Subcontractor’s SSAE 18 SOC 1, Type II report, or any successor or other substantially similar report on an annual basis; it being understood that the Ceding Company shall seek to (i) obtain a waiver of any confidentiality restrictions under agreements with existing Significant Subcontractors and (ii) negotiate agreements with future Significant Subcontractors to seek to permit disclosure by the Ceding Company of the contents of such report for this purpose. A copy of any such reports obtained under this Section 4.1(c) and for which a waiver is obtained, shall be provided by the Ceding Company to the Reinsurer no later than ten (10) Business Days following the Ceding Company’s receipt of such report from such Significant Subcontractor. All such reports shall be considered Confidential Information of the Ceding Company. Following receipt by the Ceding Company of any such report that identifies one or more material weaknesses or significant deficiencies in financial controls in effect for such reporting period, the Ceding Company shall (i) promptly alert the Reinsurer thereof, (ii) cooperate with the Reinsurer to assist it in determining how each such material weakness or significant deficiency impacts it, and (iii) use its commercially reasonable efforts to require that such Significant Subcontractor promptly cure such material weakness or significant deficiency. For each such material weakness or significant deficiency which is described in any such report or any successor or other substantially similar report, the Ceding Company shall, on or before the [***] calendar day after receipt thereof from the Significant Subcontractor, deliver to the Reinsurer evidence that such material weakness or significant deficiency has been cured or a plan of the actions the Ceding Company has taken or will take in order to cure or mitigate such material weakness or significant deficiency in all material respects, and the Ceding Company shall keep the Reinsurer apprised of any developments in connection therewith. If such report is not available from such Significant Subcontractor, then the Ceding Company shall use reasonable best efforts to support the Reinsurer’s reasonable control testing.
(d)The Ceding Company shall provide the Reinsurer with written notice of any significant deficiency or material weakness in the Ceding Company’s financial controls that are relevant to the Reinsured Contracts, including with respect to related cybersecurity or privacy, identified by the Ceding Company or its internal and external auditors and resulting action plans, promptly and, in each case, within ten (10) Business Days after the Ceding Company becomes aware of such significant deficiency or material weakness or such actions plans becoming available, and shall provide the Reinsurer with executive summaries of any available management reports and executive summaries of the respective internal and external audit reports in respect of such significant deficiency or material weakness promptly upon and, in each case, within ten (10) Business Days of their issuance to the Ceding Company.  In the event the Ceding Company has notified the Reinsurer, or the Ceding Company otherwise becomes aware, of any such significant
- 24 -
1007933761v22


deficiency or material weakness in financial controls that are relevant to the Reinsured Contracts, the Reinsurer shall have the right, at the sole expense of the Reinsurer and subject to the Ceding Company’s security policies and procedures, to conduct on-site audits related to such significant deficiency or material weakness in financial controls, including related technology, security, data protection, compliance and privacy audits, and request documentation reasonably related to an audit or inquiry on the part of the Reinsurer (with which request the Ceding Company shall reasonably comply; provided that no such request shall require the Ceding Company to provide any privileged documents, reports, assessments or audits, it being understood that the Ceding Company shall use its reasonable best efforts to enable such information to be furnished or made available to the Reinsurer without jeopardizing privilege (including redacting information or entering into joint defense agreements with the Ceding Company on mutually agreeable terms), and the Ceding Company shall permit the Reinsurer’s certified public accountants to, subject to the Ceding Company’s security policies and procedures, conduct reasonable testing and audits with respect to the Ceding Company’s in scope operations in order to support the Reinsurer’s audit of its financial statements that are relevant to the Reinsured Contracts, in each case, during normal business hours and without unreasonable disruption to the business of the Ceding Company. The Reinsurer shall provide the Ceding Company with twenty (20) Business Days advance written notice of any such on-site audits or certified public accountants testing and audits; provided that the Reinsurer shall comply with such audit protocols as may be reasonably prescribed by the Ceding Company. The information obtained by the Reinsurer pursuant to such audits and testing shall be considered Confidential Information of the Ceding Company, and shall be used by Reinsurer only for purposes relating to the transactions contemplated under this Agreement, and the possession, use and disclosure of any such information will be subject to the restrictions set forth in Section 11.15.
Section 1.24.Performance Standards.
(f)The Ceding Company shall administer, or shall cause to be administered, the Reinsured Contracts (i) in a professional and timely manner, (ii) using a standard of care and policies and procedures generally that are, in the aggregate, at least as stringent as that employed by the Ceding Company and consistent with the Ceding Company’s practices and related policies and procedures (a) with respect to the Reinsured Contracts during the one (1)-year period immediately preceding the Effective Time and (b) to administer its other similar businesses, (iii) in accordance with the terms and conditions of the Reinsured Contracts and applicable Laws, including the maintenance by the Ceding Company of all permits from Governmental Authorities necessary to perform the administration contemplated by this Article IV, and (iv) in good faith and with the skill, diligence and expertise that would reasonably be expected from experienced and qualified personnel performing such duties in like circumstances.
(g)In the event that the Ceding Company is unable, for any reason, to perform all or a portion of the Administrative Services at the standard required by Section 4.2(a) or all or a portion of the Administrative Services for a period that could reasonably be expected to exceed five (5) consecutive Business Days, the Ceding Company shall promptly provide notice to the Reinsurer of the Ceding Company’s inability to so perform the applicable Administrative Services. The Ceding Company shall cooperate with the Reinsurer in obtaining an alternative means of providing such Administrative Services (which may include implementing a strategy to remedy the inability of the Ceding Company to perform such Administrative Services). The Ceding Company shall be responsible for all fees, costs and expenses incurred in order to obtain such alternative means of providing the applicable Administrative Services and in order to restore such Administrative Services.
Section 1.25.Administrative Expense Allowance. For each Monthly Accounting Period, the Reinsurer shall pay to the Ceding Company an amount equal to the Expense Allowances for such Monthly Accounting Period in consideration for the administration of the Reinsured Contracts. Such amount shall be paid as part of the Net Settlements pursuant to Section 3.3(a).
- 25 -
1007933761v22


Section 1.26.Designated Administrative Account. In accordance with the provisions set forth in Section 3.3, the Ceding Company, prior to the date that the Reinsurer makes a Net Settlement for a Monthly Accounting Period, may request the Reinsurer to make Net Settlement payments into the Designated Administrative Account in lieu of making such payments directly to the Ceding Company. Such payments shall be made to the Designated Administrative Account on or prior to the date that such amounts are due pursuant to Section 3.3. The funds in the Designated Administrative Account may be withdrawn by the Ceding Company at any time in accordance with the terms of the Trust Agreement. The parties agree and acknowledge that the assets in the Designated Administrative Account shall not be taken into account in calculating the Statutory Book Value or Fair Market Value of the assets in the Trust Account.
Section 1.27.Producer Agreements. The Ceding Company shall not agree to modify, terminate, amend or waive any of its rights or obligations under any agreement or portion thereof between it or any of its Affiliates, on the one hand, and any Producer who has solicited, sold, marketed, produced or serviced any of the Reinsured Contracts, on the other hand, to the extent such modification, termination, amendment or waiver would adversely impact the Reinsurer or the Reinsurer’s liability hereunder except (i) to the extent not related to the Reinsured Contracts or (ii) with the Reinsurer’s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed).
Section 1.28.Books and Records and Access. Each of the Ceding Company and the Reinsurer shall maintain its respective books and records relating to the Reinsured Contracts. During the term of this Agreement, upon any reasonable request from the Reinsurer or its Representatives, the Ceding Company shall (a) provide to the Reinsurer and its Representatives reasonable access during normal business hours to the Ceding Company’s Books and Records pertaining to the Reinsured Contracts, the Reinsured Liabilities, this Agreement or the Reinsurer’s rights hereunder, provided such access shall not unreasonably interfere with the conduct of the business of the Ceding Company, and (b) permit the Reinsurer and its Representatives to inspect and photocopy such Books and Records at their own cost, including as pertains to the payment of Reinsured Liabilities and the administration of the Reinsured Contracts. Nothing herein shall (x) require the Ceding Company to disclose any information to the Reinsurer or its Representatives if such disclosure would jeopardize any attorney-client privilege, the work product immunity or any other legal privilege or similar doctrine or contravene any applicable Law or any contract (including any confidentiality agreement to which the Ceding Company or any of its Affiliates is a party); it being understood that the Ceding Company shall use its reasonable best efforts to enable such information to be furnished or made available to the Reinsurer or its Representatives without so jeopardizing privilege or contravening such applicable Law (including redacting information or entering into joint defense agreements with the Reinsurer on mutually agreeable terms) or (y) require the Ceding Company to disclose its Tax records (except with respect to transfer Taxes, Premium Taxes and similar Taxes that relate to the Reinsured Contracts and the Separate Accounts) or any personnel or related records.
Section 1.29.Programs of Internal Replacement; Exchange Programs; Buy-Out Programs. Except as set forth in Schedule N, unless otherwise agreed by the Parties, the Ceding Company will not, and will cause its Affiliates not to, directly or indirectly, undertake, solicit, sponsor or support any exchange program in respect of the Reinsured Contracts or otherwise target in a directed, programmatic or systematic manner the Reinsured Contracts for replacement or take any actions with respect to the Reinsured Contracts designed or intended to cause Policyholders of the Reinsured Contracts to surrender, lapse or annuitize, including any “buy-out” or “enhanced surrender value” program. Notwithstanding anything in this Section 4.7 to the contrary, (a) the offering by the Ceding Company or any of its Affiliates to new clients and the Policyholders of the Reinsured Contracts of an insurance, annuity or investment product that offers then-market terms that are more favorable to the Policyholders of the Reinsured Contacts in the normal course of the Ceding Company’s or such Affiliate’s business shall not be a violation of this Section 4.7; provided that, except as set forth in Schedule N, 403(b) plan products shall not be offered to the
- 26 -
1007933761v22


Policyholders of the Reinsured Contracts other than in connection with a general solicitation not targeted at such Policyholders and (b) correspondence to Policyholders of the Reinsured Contracts informing them of settlement options available under their Reinsured Contracts in the ordinary course of business or as required by applicable Law shall not be a violation of this Section 4.7.
Section 1.30.Claims Contests. The Ceding Company will notify the Reinsurer in writing of its intention to contest, compromise, litigate or arbitrate any claim involving a Reinsured Contract (any such claim, a “Contested Claim”), including information with respect thereto as reasonably requested by the Reinsurer. The Reinsurer may elect to participate with the Ceding Company (including, in the Reinsurer’s discretion, by using separate legal counsel at its own expense) in the contest, compromise, litigation, arbitration or defense of any Contested Claim by delivering written notice thereof to the Ceding Company within ten (10) Business Days following the Ceding Company’s notification of such claim to the Reinsurer, and the Ceding Company shall consider in good faith any recommendations of the Reinsurer with respect thereto. If the Reinsurer so elects to participate with the Ceding Company in any Contested Claim, then (i) the Ceding Company will promptly advise the Reinsurer of all significant developments, including notice of legal or arbitral proceedings initiated in connection with such Contested Claim, (ii) the Reinsurer shall reimburse the Ceding Company for the Quota Share of the reasonable expenses of any contest, compromise, litigation, arbitration or defense of a Contested Claim (excluding any allocation of compensation to the Ceding Company’s or its Affiliates’ officers, employees or third party administrators, or any allocation of overhead), and will share in the liability in the same proportion, including any Extra-Contractual Obligations arising therefrom; and (iii) if the Ceding Company obtains any recoveries in respect of a Contested Claim previously paid by it in respect of any Reinsured Contract, the Ceding Company shall promptly pay to the Reinsurer the Quota Share of all such recoveries. If the Reinsurer chooses not to participate by either affirmatively notifying the Ceding Company or not providing notice of such election in writing within ten (10) Business Days following the Reinsurer’s receipt of notice of such Contested Claim, the Reinsurer will discharge its Reinsured Liabilities by payment to the Ceding Company of the Reinsured Liabilities with respect to such Reinsured Contract as if there was no contest, and will have no additional obligation to the Ceding Company for reimbursement of expenses related to the contest, compromise, litigation, arbitration or defense of such Contested Claim.
Article V.

LICENSES; RESERVE CREDIT; SECURITY
Section 1.31.Licenses; Reserve Credit. At all times during the term of this Agreement, the Reinsurer shall (a) use its commercially reasonable efforts to hold and maintain its license status in the Ceding Company Domiciliary State and (b) subject only to the Ceding Company’s obligation to cooperate in good faith in accordance with the last sentence of this Section 5.1, take all other actions necessary so that the Ceding Company may receive Reserve Credit. Should the Reinsurer fail to maintain such status, the Reinsurer shall, at its own expense, take such actions necessary so that the Ceding Company may receive Reserve Credit no later than the third (3rd) Business Day prior to the end of the calendar quarter during which such event occurred. The Reinsurer shall promptly notify the Ceding Company of any event or change in its licensing status in the Ceding Company Domiciliary State or other conditions that would be reasonably likely to result or have resulted in any loss of, or impairment to, Reserve Credit. In addition, in furtherance of the performance of the Reinsurer’s obligations under this Section 5.1, the Ceding Company and the Reinsurer agree to cooperate in good faith to amend this Agreement, the Trust Agreement or any other Transaction Agreement or execute such additional documents as may be reasonably required to ensure continued Reserve Credit in the Ceding Company Domiciliary State.
Section 1.32.Security.
- 27 -
1007933761v22


(a)On or prior to the Closing Date, the Reinsurer, as grantor, shall establish and thereafter shall maintain, at its sole cost and expense, the Trust Account with the Trustee, naming the Ceding Company as sole beneficiary thereof to secure the Reinsurer’s obligations hereunder and, to the extent required pursuant to Section 5.1, to provide Reserve Credit. The Reinsurer shall maintain the Trust Account in accordance with the terms of this Agreement and the Trust Agreement.
(b)Concurrently with the execution of this Agreement, the Trust Account is being funded with Eligible Assets in accordance with Section 3.1(b). In addition, if the Estimated Initial Required Balance exceeds the Estimated Initial Premium, on the Closing Date, the Reinsurer will be required to deposit additional Eligible Assets into the Trust Account having a Statutory Book Value at least equal to such excess.
(c)In accordance with the terms set forth herein and in the Trust Agreement, and subject to the provisions of Sections 5.6 and 5.7 hereof, the Reinsurer shall ensure that the Trust Account holds Eligible Assets in accordance with the terms hereof with an aggregate Statutory Book Value not less than the Required Balance. All transfers to and withdrawals from the Trust Account shall be in accordance with and subject to the requirements set forth herein and in the Trust Agreement.
(d)During the term of the Trust Agreement, the Reinsurer shall not, and shall direct that the Trustee shall not, grant or cause or permit to be created or granted in favor of any third person any security interest whatsoever in any of the assets in the Trust Account (whether by contract, applicable Law or otherwise), including without limitation in favor of any Governmental Authority.
Section 1.33.Trust Account and Settlements. The Trustee shall hold assets in the Trust Account pursuant to the terms of the Trust Agreement. All settlements of account under this Agreement between the Ceding Company and the Reinsurer shall be made in United States dollars in cash or its equivalent or other assets withdrawn by the Ceding Company from the Trust Account.
Section 1.34.Eligible Assets; Investment Management. The assets that may be held in the Trust Account in order to meet the Required Balance shall consist of cash or investments that comply with the Investment Guidelines and are issued by an institution that is not the parent, subsidiary or Affiliate of either the Reinsurer or the Ceding Company (“Eligible Assets”). Following the end of each Monthly Accounting Period, in accordance with Section 5.7(a), the Reinsurer shall provide to the Ceding Company a report listing each asset in the Trust Account and the Fair Market Value and Statutory Book Value of each such asset as of the end of the relevant Monthly Accounting Period and certify that each such asset is an Eligible Asset (an “Asset Report”); provided that any assets held in the Trust Account in excess of the Required Balance are not required to be Eligible Assets. The Parties acknowledge that the Reinsurer shall be entitled to select and replace the investment manager with respect to the assets held in the Trust Account, in accordance with the terms of the Trust Agreement. The Reinsurer may appoint additional or replacement investment managers or sub-advisors with respect to the assets held in the Trust Account, in accordance with the terms of the Trust Agreement.
Section 1.35.Deposit of Assets. Subject to the terms of the Trust Agreement, prior to depositing assets in the Trust Account, the Reinsurer will execute assignments or endorsements in blank, or transfer legal title to the Trustee of all shares, obligations or any other assets requiring assignments, in order that the Ceding Company, or the Trustee upon the direction of the Ceding Company, may whenever necessary negotiate any such assets without the consent or signature from the Reinsurer or any other entity.
Section 1.36.Withdrawal of Assets from the Trust Account. The Ceding Company and Reinsurer agree that the assets maintained in the Trust Account may be withdrawn by the Ceding
- 28 -
1007933761v22


Company (or any successor by operation of law of the Ceding Company, including any liquidator, rehabilitator, receiver or conservator of the Ceding Company) without diminution because of any insolvency, rehabilitation, conservatorship or comparable proceeding (an “Insolvency”) on the part of the Ceding Company or the Reinsurer, in accordance with the terms of the Trust Agreement, in order to (i) pay or reimburse the Ceding Company for any undisputed amounts due from the Reinsurer under this Agreement and not yet recovered from the Reinsurer, including the Quota Share of any Reinsured Liabilities or other amounts due under this Agreement, (A) which amounts have not been paid by the Reinsurer within [***] Business Days following its receipt of a specific written notice thereof or (B) otherwise with the consent of the Reinsurer or (ii) pay to the Ceding Company the Estimated Recapture Terminal Settlement (if such amount is positive) as contemplated by Section 8.4(a) if such amount has not been paid by the Reinsurer on the Recapture Date. The amount of any such withdrawal in excess of amounts then due to the Ceding Company hereunder shall be deemed maintained in trust by the Ceding Company for the benefit of the Reinsurer and promptly returned to the Trust Account, along with interest on such amounts at the Interest Rate for the period that such amounts are held by the Ceding Company. In addition, the Ceding Company and the Reinsurer agree that the assets maintained in the Designated Administrative Account may be withdrawn by the Ceding Company (or any successor by operation of law of the Ceding Company, including any liquidator, rehabilitator, receiver or conservator of the Ceding Company) without diminution because of any Insolvency on the part of the Ceding Company or the Reinsurer, at any time in accordance with the terms of the Trust Agreement.
Section 1.37.Adjustment of Security and Withdrawals.
(a)The Reinsurer shall furnish a report (a “Month-End Required Balance Report”) to the Ceding Company following the end of each Monthly Accounting Period containing (i) the Reinsurer’s calculation of the Required Balance as of the end of such Monthly Accounting Period, in each case taking into account the Ceding Company Report for such Monthly Accounting Period that is provided by the Ceding Company pursuant to Section 5.7(b) and the other terms and conditions of this Agreement and (ii) the Asset Report for such Monthly Accounting Period.
(b)The Reinsurer shall deliver each Month-End Required Balance Report, as applicable, no later than the eighteen (18) Business Day following the end of each Monthly Accounting Period. In order for the Reinsurer to prepare the Month-End Required Balance Report for each Monthly Accounting Period no later than six (6) Business Days following the end of each Monthly Accounting Period, the Ceding Company shall provide to the Reinsurer a report (the “Ceding Company Report”) following the end of each Monthly Accounting Period containing (i) the Ceding Company’s calculation of the Cash Surrender Value and (ii) the Separate Account Values as of the end of such Monthly Accounting Period; provided that, if the Ceding Company does not deliver the Ceding Company Report within such six (6) Business Day period, the time period for the Reinsurer’s delivery of the Month-End Required Balance Report shall be extended by such overdue period.
(c)The amount of security held in the Trust Account shall be adjusted as follows:
(i)If the aggregate Statutory Book Value of the Eligible Assets held in the Trust Account as of the close of business on the last Business Day of any month (after giving effect to (A) amounts released and transferred under Section 4(c) of the Trust Agreement after the close of business on the last Business Day of such month and (B) amounts deposited or withdrawn from the Trust Account after the close of business on the last Business Day of such month pursuant to this sub-clause (c)(i) or sub-clause (c)(ii) of this Section 5.7 in respect of the adjustment to the Trust Account for the prior month) is less than the Required Balance as of the close of business on the last Business Day of such month, then the Reinsurer shall, no later than five (5) Business
- 29 -
1007933761v22


Days after the Reinsurer delivers the Month-End Required Balance Report for such month, transfer additional Eligible Assets to the Trust Account so that the aggregate Statutory Book Value of the Eligible Assets held in the Trust Account immediately following such transfer is not less than the Required Balance contained in the Month-End Required Balance Report; and
(ii)If the aggregate Statutory Book Value of the Eligible Assets in the Trust Account as of the close of business on the last Business Day of any month (after giving effect to (A) amounts released and transferred under Section 4(c) of the Trust Agreement after the close of business on the last Business Day of such month and (B) amounts deposited or withdrawn from the Trust Account after the close of business on the last Business Day of such month pursuant to this sub-clause (c)(i) or sub-clause (c)(ii) of this Section 5.7 in respect of the adjustment to the Trust Account for the prior month) exceeds the Required Balance as of the close of business on the last Business Day of such month, then the Reinsurer shall have the right to withdraw such excess assets in accordance with the terms of the Trust Agreement so long as, immediately following such withdrawal, (x) the aggregate Statutory Book Value of the Eligible Assets held in the Trust Account is not less than the Required Balance contained in the Month-End Required Balance Report for such month and (y) the Market-to-Book Ratio of the Eligible Assets in the Trust Account does not decline as a result of the withdrawal; provided, however, that during the occurrence of any Recapture Triggering Event, the Ceding Company’s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed) will be required for any such withdrawal.
(iii)In addition to the withdrawal rights set forth above, if the Reinsurer seeks to cause the Trustee to substitute new Eligible Assets for Eligible Assets held in the Trust Account, then the Reinsurer shall have the right to cause (and shall only cause) the Trustee to effect such substitution in accordance with the procedures set forth in the Trust Agreement, provided (x) the new Eligible Assets have an aggregate Statutory Book Value as of the time of substitution that is at least equal to the aggregate Statutory Book Value as of the time of substitution of the substituted Eligible Assets and (y) the Market-to-Book Ratio of the Eligible Assets in the Trust Account will not decline as a result of the substitution; provided, further, however, that during the occurrence of any Recapture Triggering Event, the Ceding Company’s prior written consent (such consent not to be unreasonably withheld, conditioned or delayed) will be required for any such substitution.
(b)Without limiting the Reinsurer’s obligations to fund the Trust Account in accordance with the timelines required in Section 5.7(c), in the event that the Parties disagree with the calculation of the Required Balance or of the Statutory Book Value or Fair Market Value of any Eligible Asset or whether any asset in the Trust Account is an Eligible Asset, any Party may deliver written notice to the other Party of such disagreement and the Parties shall attempt in good faith to resolve such disagreement.
(c)Any resolution as to disagreements arising under Section 5.7(d) agreed to in writing by the Parties shall be final and binding upon the Parties. If the Parties do not resolve any disagreement as to the calculation of the Required Balance or of the Statutory Book Value or Fair Market Value, as applicable, of any Eligible Asset or whether any asset is an Eligible Asset within two (2) Business Days after either Party delivers written notice of any such disagreement to the other Party, the Parties shall jointly request an accounting firm of national reputation or any other Person mutually agreed by the Parties hereto (the “Independent Accounting Firm”) to make a
- 30 -
1007933761v22


determination with respect to all matters in dispute; provided, that, if no accounting firm is willing or able to serve, unless otherwise agreed by the Parties, such dispute shall be resolved in accordance with Section 11.8. The Parties shall instruct the Independent Accounting Firm to limit its review to matters that remain in dispute between the Parties and to render its decision within ten (10) Business Days after submission of such dispute to such Independent Accounting Firm. The Independent Accounting Firm shall not assign a value to any matter higher than the highest value for such matter claimed by either Party or less than the lowest value for such matter claimed by either Party. The Independent Accounting Firm’s determination of the Required Balance, the Statutory Book Value or Fair Market Value, as applicable, of the disputed Eligible Asset or whether the disputed asset is an Eligible Asset shall be final and binding upon the Parties absent manifest error. All fees and expenses relating to the work of the Independent Accounting Firm shall be allocated by the Independent Accounting Firm as between the Parties in proportion to the difference between each Party’s claimed value and the value decided by the Independent Accounting Firm. After a final and binding resolution of any dispute described in this Section 5.7(e) is reached, the Parties agree to promptly make any necessary adjustments under Section 5.7(c) so that the Statutory Book Value of the Eligible Assets held in the Trust Account is not less than the amount required pursuant to Section 5.7(c).
Section 1.38.Continuation of a Triggering Event. Upon the occurrence of any Trust Triggering Event, such Trust Triggering Event shall be deemed to be continuing unless (a) such Trust Triggering Event has been cured and (b) either (i) no other Trust Triggering Event has occurred during a period of [***] months commencing with the date of such cure or (ii) if such Trust Triggering Event that has been cured was an event described in clause (a) or (b) of the definition of “Trust Triggering Event”, the RBC Ratio, if applicable, of the Person that was subject to such event is at least [***]%, [***], if applicable, of the Person that was subject to such event is at least [***]% or other capital adequacy ratio as determined pursuant to the terms of this Agreement, if applicable, of the Person that was subject to such event is equivalent as mutually agreed by the Ceding Company and the Reinsurer.
Section 1.39.Security Interest.
The Parties hereto intend that, pursuant to the Trust Agreement, prior to depositing any assets in the Trust Account, and from time to time thereafter as required, the Reinsurer shall execute or cause the execution of assignments or endorsements in blank, or transfer legal title of all shares, obligations and other assets requiring assignments or endorsements to the Trustee as needed, so that the Ceding Company, or the Trustee upon direction to the Trustee by the Ceding Company, may, whenever necessary pursuant to the terms of the Trust Agreement, negotiate, deliver, transfer, assign or sell any such assets without the consent or signature from the Reinsurer or any other Person. Out of an excess of caution and in order to preserve the arrangements set forth in the Trust Agreement if, notwithstanding the intention of the parties expressed in the Trust Agreement, the Trustee is determined by a Governmental Authority of competent jurisdiction (i) not to have the authority to negotiate, deliver, transfer, assign or sell any assets credited to the Trust Account, in its capacity as Trustee, without the consent or signature from the Reinsurer, or any other Person, or (ii) the transfer of assets by the Reinsurer to the Trust Account shall for any reason be determined by a Governmental Authority of competent jurisdiction to be invalid or ineffective, the Reinsurer hereby grants to the Ceding Company as security for all obligations (whether absolute or contingent, matured or unmatured) of the Reinsurer to the Ceding Company arising under or in connection with the Transaction Agreements, including all reasonable attorneys’ fees and legal expenses incurred in connection with the collection and enforcement of the Transaction Agreements and security interest created hereunder, in each case, to the extent such obligations are required to be reimbursed to the Ceding Company by the Reinsurer under such Transaction Agreements, a first priority perfected security interest in all of the Reinsurer’s rights, titles and interests in, to and under all of the following property, whether now owned or existing or hereafter acquired or arising and wheresoever located (collectively, the “Collateral”): (a) the Trust Account and the assets credited to the Trust Account, including without limitation, investment property, securities, investments,
- 31 -
1007933761v22


instruments, cash, mortgage notes and all participation interests in mortgage notes, funds, general intangibles, accounts, receivables, chattel paper, letter-of-credit rights, documents and all other assets (x) held in or credited to the Trust Account or (y) otherwise conveyed to the Trustee by the Reinsurer; (b) all cash and other financial assets credited to the Trust Account and all security entitlements (within the meaning of Section 8-102(a) of the UCC) related to or arising therefrom; (c) all supporting obligations relating to, and all security interests, mortgages or other liens securing, any of the foregoing and (d) all proceeds of all of the foregoing, and agrees that this Agreement shall constitute a security agreement made by the Reinsurer in favor of the Ceding Company under applicable Law. Any amounts withdrawn from the Trust Account in accordance with the Trust Agreement shall be automatically released from, and withdrawn free and clear of, any security interest created herein. The Reinsurer hereby authorizes the Ceding Company to file any and all UCC-1 Financing Statements with respect to the Collateral, and any and all amendments, assignments and continuation statements with respect thereto, that are deemed necessary or desirable by the Ceding Company in order to perfect such security interest in the Collateral. All terms used in this Section 5.9 and defined in the UCC shall have the meanings given to such terms in the UCC. Nothing in this Section 5.9 is intended to affect the validity of, or the transfer of assets into, the Trust Account.
Article VI.

OVERSIGHTS; COOPERATION
Section 1.40.Oversights. Inadvertent delays, oversights, errors or omissions made in connection with this Agreement or any transaction hereunder shall not relieve either Party from any liability that would have attached had such delay, oversight, error or omission not occurred. The Parties shall nevertheless cooperate in good faith to rectify such delay, oversight, error or omission as soon as possible after discovery so that both Parties shall be restored as closely as possible to the positions they would have occupied if no delay, oversight, error or omission had occurred. Nothing in this Section 6.1 shall reduce the obligation of the Reinsurer with respect to any Reinsurer Extra-Contractual Obligation or the Ceding Company with respect to any Ceding Company Extra-Contractual Obligation. In the event of any errors or omissions in the information set forth in Schedule D which are individually non-de minimis, the Parties shall cooperate in good faith to rectify any such error or omission as soon as possible after discovery so that both Parties shall be restored as closely as possible to the positions, including with respect to economic benefits, they would have occupied if no such error or omission had occurred.
Section 1.41.Cooperation. The Ceding Company and the Reinsurer shall cooperate with each other in order to accomplish the objectives of this Agreement by furnishing additional information and executing and delivering any additional documents as may be reasonably requested by the other to further perfect or evidence the consummation of, or otherwise implement, any transaction contemplated by this Agreement or the other Transaction Agreements, or to aid in the preparation of any regulatory filing or financial statement; provided, however, that any such additional documents must be reasonably satisfactory to each Party and not impose upon either Party any liability, risk, obligation, loss, cost or expense not contemplated by this Agreement or the other Transaction Agreements.
Section 1.42.Changes to RBC Ratio and [***].
(e)In the event of a material change to or elimination by applicable Law of the requirement for the Reinsurer or the Guarantor to calculate risk-based capital or in the event there is a material change relating to the framework, factors and/or formulae prescribed by the Insurance Regulator in the Reinsurer Domiciliary State or the state of domicile of the Guarantor that are used to calculate RBC Ratios from those in effect at the Effective Time, the Parties shall cooperate in good faith to amend this Agreement to adjust the RBC Ratios required under this Agreement so that such adjusted RBC Ratios or any replacement formula as determined after such material change or
- 32 -
1007933761v22


elimination will reasonably correspond to the relevant RBC Ratio requirements in effect as of the Effective Time, and, if the Parties do not agree on any such adjustments, the Reinsurer and the Guarantor, as applicable, shall continue to calculate its RBC Ratio as if such material change or elimination had not occurred.
(f)In the event of a material change to or elimination by applicable Law of the requirement [***] or in the event there is a material change relating to the framework, factors and/or formulae prescribed by the Insurance Regulator in the jurisdiction of domicile of [***] from those in effect at the Effective Time, the Parties shall cooperate in good faith to amend this Agreement to adjust [***] required under this Agreement so that such [***] or any replacement formula as determined after such material change or elimination will reasonably correspond to [***] requirements in effect as of the Effective Time, and, if the Parties do not agree on any such adjustments, [***], as applicable, shall continue to calculate [***] as if such material change or elimination had not occurred.
Article VII.

INSOLVENCY
Section 1.1.Insolvency of the Ceding Company.
(a)In the event of the insolvency of the Ceding Company, all reinsurance made, ceded, renewed or otherwise becoming effective under this Agreement shall be payable by the Reinsurer directly to the Ceding Company or its statutory liquidator, receiver or statutory successor on the basis of the liability of the Ceding Company under the Reinsured Contracts filed and allowed in the liquidation proceeding without diminution because of the insolvency of the Ceding Company.
(b)It is understood, however, that in the event of such an insolvency of the Ceding Company, the liquidator, receiver or statutory successor of the Ceding Company shall give written notice of the pendency of a claim against the Ceding Company on a Reinsured Contract within a reasonable period of time after such claim is filed in the applicable insolvency proceedings and that during the pendency of such claim the Reinsurer may investigate such claim and interpose, at its own expense, in the proceeding where such claim is to be adjudicated, any defense or defenses which it may deem available to the Ceding Company or its liquidator, receiver or statutory successor. It is further understood that the expense thus incurred by the Reinsurer will be chargeable, subject to applicable Law and court approval, against the Ceding Company as part of the expense of liquidation to the extent of a proportionate share of the benefit which may accrue to the Ceding Company solely as a result of the defense undertaken by the Reinsurer.
Article VIII.

DURATION; RECAPTURE
Section 1.1.Duration. This Agreement shall commence at the Effective Time and continue in force until such time as (i) the Ceding Company’s Liability arising out of or related to all Reinsured Contracts is terminated in accordance with their respective terms and each Party has received payments which discharge the other Party’s liabilities incurred hereunder prior to such termination, or (ii) in accordance with Section 8.3 if the Ceding Company has elected to recapture the reinsurance of the Reinsured Contracts or in accordance with Section 8.6 if the Reinsurer has provided notice of termination and each Party has received payments which discharge the other Party’s liability in full in accordance with Section 8.4 and the other terms of this Agreement.
Section 1.2.Survival. Notwithstanding the other provisions of this Article VIII, the terms and conditions of Articles I , VIII and IX, and the provisions of Sections 3.6, 11.1, 11.2, 11.3, 11.4,
- 33 -
1007933761v22


11.5, 11.6, 11.8, 11.9, 11.10, 11.11, 11.13 and 11.15 shall remain in full force and effect after the termination of this Agreement.
Section 1.3.Recapture.
(a)Subject to the terms of this Section 8.3, following the occurrence of a Recapture Triggering Event, the Ceding Company shall have the right (but not the obligation) to recapture all, and not less than all, of the Reinsured Risks ceded under this Agreement by providing the Reinsurer with written notice of its intent to effect such a recapture (a “Recapture Notice”); provided that a Recapture Triggering Event must be continuing on the date that the Recapture Notice is delivered in order for such recapture to be consummated. In the case of a recapture for any Recapture Triggering Event other than a Recapture Triggering Event described in clause (e) of the definition of Recapture Triggering Event, the Recapture Notice shall be provided to the Reinsurer within [***] calendar days after the Ceding Company becomes aware that such Recapture Triggering Event has occurred, and if not so delivered then such recapture right shall be deemed to have been waived, except that with respect to any new Recapture Triggering Event described in clause (a) or (b) of the definition of “Recapture Triggering Event”, a new Recapture Triggering Event shall be deemed to have occurred if subsequently, (i) the RBC Ratio of the Reinsurer or the Guarantor as of any calendar quarter-end is reduced below [***]% and the Reinsurer has not cured such shortfall as of the applicable Capital Reporting Deadline or (ii) [***]. For the avoidance of doubt, if the Ceding Company does not exercise its recapture right with respect to any Recapture Triggering Event, the Ceding Company shall subsequently have the right to recapture all, and not less than all, of the Reinsured Risks ceded under this Agreement in accordance with this Section 8.3 following the occurrence of any new Recapture Triggering Event.
(b)Any recapture pursuant to Section 8.3(a) shall be effective (i) as of 11:59 p.m. (New York time) on the last Business Day of the calendar month during which the Ceding Company delivers a Recapture Notice to the Reinsurer; provided, that if such Recapture Notice was delivered less than seven (7) Business Days prior to the end of such calendar month, then as of 11:59 p.m. (New York time) on the last Business Day of the following calendar month (unless an early effective date and time is necessary in order to effectuate the recapture prior to any loss of Reserve Credit hereunder, in which case any recapture pursuant to Section 8.3(a) shall be effective as of such earlier date and time) or (ii) on such later date and time as set forth in the Ceding Company’s Recapture Notice (provided such later date is the last day of a calendar month and is not later than ninety (90) calendar days following the delivery by the Ceding Company of its Recapture Notice) (the “Recapture Date”).
(c)Following any recapture of all Reinsured Risks pursuant to Section 8.3(a), subject to the satisfaction of payment obligations described in Section 8.4, (i) both the Ceding Company and the Reinsurer will be fully and finally released from all rights and obligations under this Agreement in respect of the Reinsured Risks other than (w) any payment obligations due hereunder prior to the Recapture Date but still unpaid on such date, (x) any obligations under the provisions that expressly survive termination as provided in Section 8.2, (y) liability of the Reinsurer for Reinsurer Extra-Contractual Obligations and (z) liability of the Ceding Company for Ceding Company Extra-Contractual Obligations and (ii) no Additional Consideration shall be payable to the Reinsurer with respect to the Reinsured Risks.
(d)Notwithstanding the remedies contemplated by this Article VIII or the other Transaction Agreements, either Party may, in its sole discretion, require direct payment by the other Party of any sum in default under this Agreement or any other Transaction Agreement or pursue any other remedy to which such Party may be entitled hereunder or at law or in equity in lieu of exercising the remedies in this Article VIII, and it shall be no defense to any such claim that such Party might have had other recourse.
Section 1.4.Recapture Payments
- 34 -
1007933761v22


(g)No later than seven (7) Business Days prior to the Recapture Date (subject to the shorter time frame that may be contemplated by Section 8.4(e)), (i) following any notice of recapture pursuant to Section 8.3, the Ceding Company shall prepare and provide to the Reinsurer and (ii) following any notice of termination pursuant to Section 8.6, the Reinsurer shall prepare and provide to the Ceding Company, a settlement statement setting forth an estimated calculation of the terminal settlement with respect to the recapture calculated in accordance with Schedule E (the “Estimated Recapture Terminal Settlement”) with respect to the recaptured Reinsured Risks. The Reinsurer or the Ceding Company, as applicable, shall provide to the other Party such assistance, information and documents as may be reasonably requested by such Party in preparing such calculation. On the Recapture Date, an amount equal to the Estimated Recapture Terminal Settlement shall be due from the Reinsurer to the Ceding Company or from the Ceding Company to the Reinsurer, as applicable. If the amount of the Estimated Recapture Terminal Settlement is positive, then on the Recapture Date (i) the Reinsurer shall withdraw from the Trust Account and transfer to the Ceding Company Eligible Assets having a Fair Market Value equal to the Estimated Recapture Terminal Settlement (or, if the Eligible Assets in the Trust Account are insufficient for such payment, shall withdraw and transfer to the Ceding Company all Eligible Assets remaining in the Trust Account) and (ii) if the Eligible Assets in the Trust Account are insufficient for payment of such amount, the Reinsurer shall pay any shortfall to the Ceding Company in cash. If the amount of the Estimated Recapture Terminal Settlement is negative, then, on the Recapture Date, the Ceding Company shall transfer to the Reinsurer cash or Eligible Assets having an aggregate Fair Market Value equal to the absolute value of the Estimated Recapture Terminal Settlement.
(h)No later than sixty (60) days after the Recapture Date, (i) following any notice of recapture pursuant to Section 8.3, the Ceding Company shall prepare and provide to the Reinsurer and (ii) following any notice of termination pursuant to Section 8.6, the Reinsurer shall prepare and provide to the Ceding Company, a statement setting forth a calculation of the terminal settlement with respect to the recapture calculated in accordance with Schedule E (the “Recapture Terminal Settlement”).
(i)In the event that the Reinsurer or the Ceding Company, as applicable, disagrees with any portion of the calculation of the Recapture Terminal Settlement, the Reinsurer or the Ceding Company, as applicable, shall within thirty (30) days after its receipt of such report deliver written notice to the Ceding Company or the Reinsurer, as applicable, setting forth, in reasonable detail, each disputed item, the amount in dispute and the basis of such disagreement and the Parties shall attempt in good faith to resolve such disagreement. Any resolution agreed to in writing by the Parties shall be final and binding upon the Parties. If the Parties do not resolve any disagreement within ten (10) Business Days after the Reinsurer or the Ceding Company, as applicable, delivers written notice of any such disagreement to the other Party, either Party may request (i) an Independent Accounting Firm to make a determination with respect to all matters in dispute, other than with respect to the calculation of the Unfloored CTE [***] Amount and (ii) with respect to the calculation of the Unfloored CTE [***] Amount, an actuarial firm of national reputation mutually agreed by the Parties hereto (the “Independent Actuary”) to determine the matters in dispute; provided, that, if no accounting firm or actuarial firm, as applicable, is willing or able to serve, unless otherwise agreed by the Parties, such dispute shall be resolved in accordance with Section 11.8. The Independent Accounting Firm’s and/or Independent Actuary’s determination, as applicable, shall be final and binding upon the Parties. All fees and expenses relating to the work of the Independent Accounting Firm and the Independent Actuary shall be allocated by the Independent Accounting Firm as between the Parties in proportion to the difference between each Party’s claimed value and the value decided by the Independent Accounting Firm.
(j)Within five (5) Business Days after a final and binding resolution of any dispute described in Section 8.4(c) is reached, the Parties agree to make any necessary adjustments to the amounts paid pursuant to Section 8.4(a). On the date on which the payments set forth in this Section 8.4(d) are made, (i) if the final Recapture Terminal Settlement as determined pursuant to Section 8.4(c) exceeds the Estimated Recapture Terminal Settlement paid pursuant to Section
- 35 -
1007933761v22


8.4(a), the Reinsurer shall pay to the Ceding Company an amount equal to such excess; and (ii) if the final Recapture Terminal Settlement as determined pursuant to Section 8.4(c) is less than the Estimated Recapture Terminal Settlement paid pursuant to Section 8.4(a), the Ceding Company shall pay to the Reinsurer an amount equal to such excess. Any payment required to be made by any Party pursuant to this Section 8.4(d) shall incur interest at the Interest Rate for the period from and including the Recapture Date to but not including the date of payment, and will be made by wire transfer of immediately available funds to an account or accounts designated by the recipient in writing prior to such payment.
(k)Notwithstanding the timelines set forth in this Section 8.4, if the recapture is due to a Reserve Credit Event, the Parties shall use their reasonable best efforts to expedite or amend the procedures set forth in this Section 8.4 in order to effectuate the recapture and complete the payment of the Estimated Recapture Terminal Settlement prior to any loss of Reserve Credit; provided, that such change to the procedures set forth in Section 8.4 shall not affect the right of the Reinsurer to subsequently dispute any calculation related to such recapture consistent with Section 8.4(c).
Section 1.5.Termination of Trust Account. Following the recapture of all Reinsured Risks hereunder pursuant to Section 8.3 and the payment in full of the Recapture Terminal Settlement thereof, the Trust Account shall be terminated and any remaining amounts or amount held in trust pursuant to Article V shall be released to the Reinsurer. The Ceding Company shall promptly take all actions, including providing written consent to the Trustee in a joint notice with the Reinsurer pursuant to Section 12 of the Trust Agreement, to permit such termination of the Trust Account and release of such assets to the Reinsurer.
Section 1.6.Reinsurer Termination for Non-Payment. In the event the Ceding Company (or any successor by operation of law of the Ceding Company, including any receiver, liquidator, rehabilitator, conservator or similar Person of the Ceding Company) has failed to timely pay to the Reinsurer undisputed Net Settlement amounts in accordance with Section 3.3(a) in an aggregate amount that exceeds $[***] and such failure has not been cured within [***] calendar days after written notice from the Reinsurer, the Reinsurer shall have the right to terminate all, and not less than all, of the reinsurance coverage hereunder by providing the Ceding Company with written notice of its intent to effect such a termination; provided that such failure must be continuing on the date that the Reinsurer delivers such notice of intent to effect such a termination in order for such termination to be consummated. In such event, such failure to pay shall be treated by the Parties as a Recapture Triggering Event and the Reinsurer shall tender to the Ceding Company an amount equal to the Recapture Terminal Settlement in accordance with the procedures for terminal accounting set forth in Section 8.4, the applicable Recapture Date being the date of such notice of termination. Following the recapture of all Reinsured Risks hereunder pursuant to Section 8.3 and the payment in full of the Recapture Terminal Settlement thereof, the Trust Account shall be terminated and any remaining amounts or amount held in trust pursuant to Article V shall be released to the Reinsurer in accordance with Section 8.5.
Section 1.7.[***]
Article IX.

INDEMNIFICATION
Section 1.8.Reinsurer’s Obligation to Indemnify. The Reinsurer hereby agrees to indemnify, defend and hold harmless the Ceding Company and its Affiliates (collectively, the “Ceding Company Indemnified Parties”) from and against any and all Indemnifiable Losses incurred by the Ceding Company Indemnified Parties to the extent arising from (a) any breach or nonfulfillment by the Reinsurer of the covenants and agreements of the Reinsurer contained in this Agreement; (b) the Ceding Company’s enforcement of the Guarantee; (c) Reinsurer Extra-
- 36 -
1007933761v22


Contractual Obligations or (d) any successful enforcement of this indemnity; provided, however, that in no event shall any Indemnifiable Losses incurred by or asserted against any Ceding Company Indemnified Party give rise to any right to indemnification under this Section 9.1 to the extent that such Indemnifiable Losses were expressly assumed by any Ceding Company Indemnified Party pursuant to the terms and conditions of the Master Transaction Agreement.
Section 1.9.Ceding Company’s Obligation to Indemnify. The Ceding Company hereby agrees to indemnify, defend and hold harmless the Reinsurer and its Affiliates (collectively, the “Reinsurer Indemnified Parties”) from and against any and all Indemnifiable Losses incurred by the Reinsurer Indemnified Parties to the extent arising from (a) any breach or nonfulfillment by the Ceding Company of the covenants and agreements of the Ceding Company contained in this Agreement; (b) Ceding Company Extra-Contractual Obligations; and (c)  any successful enforcement of this indemnity; provided, however, that in no event shall any Indemnifiable Losses incurred by or asserted against any Reinsurer Indemnified Party give rise to any right to indemnification under this Section 9.2 to the extent that such Indemnifiable Losses were expressly assumed by any Reinsurer Indemnified Party pursuant to the terms and conditions of the Master Transaction Agreement. For the avoidance of doubt, any Liability of the Ceding Company for Indemnifiable Losses incurred by the Reinsurer Indemnified Parties to the extent arising from Ceding Company Extra-Contractual Obligations hereunder shall be determined without duplication of recovery by reason of the same Indemnifiable Loss under the Master Transaction Agreement. Notwithstanding anything herein to the contrary, and in any event excluding any Third Party Claim brought by any policyholder or other applicable Person, in no event shall Indemnifiable Losses include any amounts relating to, resulting from or arising out of the matter set forth on Section 9.04(a) of the Ceding Company Disclosure Schedule for lost profits, lost revenues, diminution of value or any similar theory for any lapse in, cancellation or other adverse policyholder behavior with respect to any Reinsured Contract, other than any Third Party Claim, to the extent such applicable claim is brought by a Reinsurer Indemnified Party after the later of [***]

Section 1.10.Applicability of Master Transaction Agreement. The procedures set forth in Section 9.05 (Procedures for Third Party Claims) and Section 9.06 (Direct Claims) of the Master Transaction Agreement shall apply to Indemnifiable Losses under this Article IX.
Section 1.11.Good Faith. The Ceding Company and the Reinsurer each hereby covenants and agrees that from and after the Closing Date it shall act in good faith and deal fairly with each other in order to accomplish the objectives of this Agreement and the other Transaction Agreements; provided, that each Party absolutely and irrevocably waives resort to the duty of “utmost good faith” or any similar principle solely in connection with the formation of this Agreement or any other Transaction Agreement (but, for the avoidance of doubt, not relating to the conduct of the Parties after the date hereof).
Article X.

TAXES
Section 1.12.Withholding. Each Party and any of their agents shall be entitled to deduct and withhold from any amount otherwise payable pursuant to this Agreement such amounts as it is required to deduct and withhold with respect to the making of such payment under any provision of federal, state, local or foreign applicable Tax Law. If a Party determines that an amount is required to be deducted or withheld, such Party shall use reasonable best efforts to: (i) provide written notice to the other Party, at least five (5) Business Days before the relevant payment of such deduction or withholding, (ii) cooperate in good faith with the other Party to reduce or eliminate the deduction or withholding of such amount and (iii) provide the other Party a reasonable opportunity to provide forms or documentation that would exempt such amounts from withholding. If any amount is so withheld and paid over to the applicable Governmental Authority, such amounts paid to the
- 37 -
1007933761v22


applicable Governmental Authority shall be treated for all purposes of this Agreement as having been paid to the Person with respect to which such deduction or withholding was imposed. Without limiting the generality of the foregoing, each Party agrees to provide to the other on or before the date hereof an accurate and complete copy of IRS Form W-9 and shall deliver renewals or additional copies of such forms (or successor forms) to the other Party on or before the date that such forms expire or become obsolete.
Section 1.13.DAC Tax Adjustment.
(a)To the extent that Section 848 of the Code and corresponding Treasury Regulations Section 1.848-2 are applicable to the Reinsured Contracts, the Ceding Company and the Reinsurer hereby make the joint election provided for in Treasury Regulations Section 1.848-2(g)(8) (the “DAC Tax Election”) and agree as follows:
(i)The Parties will attach a schedule to their respective U.S. federal income tax returns identifying this Agreement as a reinsurance agreement for which the DAC Tax Election has been made, and will otherwise file their respective federal income tax returns in a manner consistent with the DAC Tax Election. Such schedule shall be attached to each Party’s U.S. federal income tax return filed for the first taxable year ending after the DAC Tax Election becomes effective.
(ii)The Party with the net positive consideration for this Agreement for each taxable year will capitalize specified policy acquisition expenses with respect to this Agreement without regard to the general deductions limitation of Section 848(c)(1) of the Code.
(iii)The Parties agree to exchange information pertaining to the amount of the net consideration under this Agreement each year to ensure consistency or as otherwise required by the Code or the Internal Revenue Service.
(iv)The DAC Tax Election shall be effective for the first taxable year in which this Agreement is effective and for all years for which this Agreement remains in effect.
(l)As used in this Article X, the terms “net consideration,” “net positive consideration,” “specified policy acquisitions expenses” and “general deductions limitation” are defined by reference to Treasury Regulations Section 1.848-2 and Section 848 of the Code, in effect as of the Effective Time.
(m)Each of the Parties represents and warrants that it is subject to U.S. taxation under the provisions of Subchapter L of Chapter 1 of Subtitle A of the Code.
Article XI.

MISCELLANEOUS
Section 1.1.Expenses. Except as may be otherwise specified in this Agreement, all costs and expenses, including fees and disbursements of counsel, financial advisers and independent accountants, incurred in connection with this Agreement and the transactions contemplated herein shall be paid by the Person incurring such costs and expenses.
Section 1.2.Notices. All notices, requests, consents, claims, demands and other communications under this Agreement shall be in writing and shall be given or made (and shall be deemed to have been duly given or made upon receipt) by delivery in person, by overnight courier
- 38 -
1007933761v22


service, by electronic mail or by registered or certified mail (postage prepaid, return receipt requested) to the respective Parties hereto at the following respective addresses (or at such other address for a Party hereto as shall be specified in a notice given in accordance with this Section 11.2).
(a)if to the Ceding Company:
Equitable Financial Life Insurance Company
1290 Avenue of the Americas
New York, NY 10104
Attention:    Jose Gonzalez
Tel:    212-554-1234
E-mail:    jose.gonzalez@equitable.com
with a copy (which shall not constitute notice) to:
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, New York 10019
Attention:     John M. Schwolsky
    Elizabeth B. Bannigan
Tel:    (212) 728-8232
    (212) 728-8135
E-mail:    jschwolsky@willkie.com
    ebannigan@willkie.com
(b)if to the Reinsurer:
First Allmerica Financial Life Insurance Company
c/o Global Atlantic Financial Company
30 Hudson Yard, 74th Floor
New York, New York 10001
Attention: General Counsel and Secretary
Email:       reinsurance.notice@gafg.com

with a copy (which shall not constitute notice) to:
Debevoise & Plimpton LLP
919 Third Avenue
New York, New York 10022
Attention: Marilyn A. Lion
Email:       malion@debevoise.com

Section 1.1.Severability. The provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced under any Law or as a matter of public policy, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated herein is not affected in any manner materially adverse to either Party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated herein be consummated as originally
- 39 -
1007933761v22


contemplated to the greatest extent possible. If any provision of this Agreement is so broad as to be unenforceable, such provision shall be interpreted to be only so broad as would be enforceable.
Section 1.2.Entire Agreement. This Agreement (including all exhibits and schedules hereto) and the other Transaction Agreements constitute the entire agreement of the Parties with respect to the subject matter of this Agreement and the other Transaction Agreements and supersede all prior agreements and undertakings, both written and oral, between or on behalf of the Ceding Company and/or its Affiliates, on the one hand, and the Reinsurer and/or its Affiliates, on the other hand, with respect to the subject matter of this Agreement and the other Transaction Agreements.
Section 1.3.Assignment. This Agreement shall not be assigned by any Party without the prior written consent of the other Party; provided that this Section 11.5 shall not be construed to prohibit the Reinsurer from retroceding Reinsured Liabilities in accordance with Section 2.8 or hedging its obligations hereunder without the Ceding Company’s consent. Any attempted assignment in violation of this Section 11.5 shall be void. This Agreement shall be binding upon, shall inure to the benefit of, and shall be enforceable by the Parties and their permitted successors and assigns.
Section 1.4.No Third Party Beneficiaries. Except as otherwise provided herein, this Agreement is for the sole benefit of the Parties and their permitted successors and assigns, and nothing in this Agreement, express or implied, is intended to or shall confer upon any other Person or entity any legal or equitable right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.
Section 1.5.Amendment. No provision of this Agreement may be amended, supplemented or modified except by a written instrument signed by each Party.
Section 1.6.Submission to Jurisdiction.
(c)Each of the Ceding Company and the Reinsurer irrevocably and unconditionally submits for itself and its property in any Action arising out of or relating to this Agreement, the transactions contemplated hereby, the formation, breach, termination or validity of this Agreement or the recognition and enforcement of any judgment in respect of this Agreement, to the exclusive jurisdiction of the courts of the State of New York sitting in the County of New York, the federal courts for the Southern District of New York, and appellate courts having jurisdiction of appeals from any of the foregoing, and all claims in respect of any such Action shall be heard and determined in such New York courts or, to the extent permitted by Law, in such federal court.
(d)Any such Action may and shall be brought in such courts and each of the Ceding Company and the Reinsurer irrevocably and unconditionally waives any objection that it may now or hereafter have to the venue or jurisdiction of any such Action in any such court or that such Action was brought in an inconvenient court and shall not plead or claim the same.
(e)Service of process in any Action may be effected by mailing a copy of such process by registered or certified mail (or any substantially similar form of mail), postage prepaid, to such Party at its address as provided in Section 11.2.
(f)Nothing in this Agreement shall affect the right to effect service of process in any other manner permitted by the Laws of the State of New York.
Section 1.3.Governing Law. This Agreement, and the formation, termination or validity of any part of this Agreement shall in all respects be governed by, and construed in accordance with, the Laws of the State of New York.
- 40 -
1007933761v22


Section 1.4.Waiver of Jury Trial. EACH PARTY HERETO IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, OR ITS PERFORMANCE UNDER OR THE ENFORCEMENT OF THIS AGREEMENT.
Section 1.5.Specific Performance. The Parties agree that irreparable damage would occur in the event that any of the covenants or obligations contained in this Agreement are not performed in accordance with their specific terms or were otherwise breached. Accordingly, each of the Parties shall be entitled to injunctive or other equitable relief to prevent or cure any breach by the other Party of its covenants or obligations contained in this Agreement and to specifically enforce such covenants and obligations in any court referenced in Section 11.8(a) having jurisdiction, such remedy being in addition to any other remedy to which either Party may be entitled hereunder or at law or in equity, and no other provision of this Agreement shall limit any Party’s right to specific performance. Each of the Parties acknowledges and agrees that (i) there is no adequate remedy at law for a breach of this Agreement and (ii) it shall not oppose the granting of an injunction, specific performance and other equitable relief when expressly available pursuant to the terms of this Agreement, and hereby waives (x) any defense that the other Parties have an adequate remedy at Law or an award of specific performance is not an appropriate remedy for any reason at Law or equity, and (y) any requirement under Law to post a bond, undertaking or other security as a prerequisite to obtaining equitable relief.
Section 1.6.Waivers. Any term or provision of this Agreement may be waived, or the time for its performance may be extended, in writing at any time by the Party or Parties entitled to the benefit thereof. Any such waiver shall be validly and sufficiently authorized for the purposes of this Agreement if, as to any Party, it is authorized in writing by an authorized Representative of such Party. The failure or delay of any Party hereto to enforce at any time any provision of this Agreement or to exercise any right, power or privilege under this Agreement shall not be construed to be a waiver of such provision, right, power or privilege, nor in any way to affect the validity of this Agreement or any part hereof or the right of any Party thereafter to enforce each and every such provision and exercise each and every right, power and privilege under this Agreement. No waiver of any breach of this Agreement shall be held to constitute a waiver of any preceding or subsequent breach.
Section 1.7.Rules of Construction. Interpretation of this Agreement shall be governed by the following rules of construction: (a) words in the singular shall be held to include the plural and vice versa, and words of one gender shall be held to include the other gender as the context requires; (b) references to Articles, Sections, paragraphs, Exhibits and Schedules are references to the Articles, Sections, paragraphs, Exhibits and Schedules to this Agreement unless otherwise specified; (c) references to “$” shall mean United States dollars; (d) the word “including” and words of similar import when used in this Agreement shall mean “including without limiting the generality of the foregoing,” unless otherwise specified; (e) the table of contents, articles, titles and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement; (f) this Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the Party drafting or causing any instrument to be drafted; (g) the Schedules and Exhibits referred to herein shall be construed with and as an integral part of this Agreement to the same extent as if they were set forth verbatim herein; (h) unless the context otherwise requires, the words “hereof,” “herein” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement; (i) all terms defined in this Agreement shall have the defined meanings when used in any certificate or other document made or delivered pursuant hereto unless otherwise defined therein; (j) any agreement or instrument defined or referred to herein or any agreement or instrument that is referred to herein means such agreement or instrument as from time to time amended, modified or supplemented, including by waiver or consent, and references to all attachments thereto and instruments incorporated therein; (k) unless otherwise
- 41 -
1007933761v22


specified herein, any statute or regulation referred to herein means such statute or regulation as amended, modified, supplemented or replaced from time to time (and, in the case of any statute, includes any rules and regulations promulgated under such statute), and references to any section of any statute or regulation include any successor to such section; (l) all time periods within or following which any payment is to be made or act to be done shall be calculated by excluding the date on which the period commences and including the date on which the period ends and by extending the period to the first succeeding Business Day if the last day of the period is not a Business Day; (m) references to any Person include such Person’s predecessors or successors, whether by merger, consolidation, amalgamation, reorganization or otherwise; (n) references to any contract (including this Agreement) or organizational document are to the contract or organizational document as amended, modified, supplemented or replaced from time to time, unless otherwise stated; (o) the word “will” shall be construed to have the same meaning and effect as the word “shall”; (p) all capitalized terms used without definition in the Schedules and Exhibits referred to herein shall have the meanings ascribed to such terms in this Agreement; (q) the word “or” need not be disjunctive; and (r) where a word or phrase is defined herein, each of its grammatical forms shall have a corresponding meaning.
Section 1.8.Counterparts. This Agreement may be executed in two (2) or more counterparts, and by the different Parties to this Agreement in separate counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by facsimile or other means of electronic transmission utilizing reasonable image scan technology (including pdf, DocuSign or any electronic signature complying with the U.S. federal ESIGN Act of 2000) shall be as effective as delivery of a manually executed counterpart of this Agreement.
Section 1.9.Treatment of Confidential Information.
(g)The Ceding Company and the Reinsurer agree to hold each other’s Confidential Information in strict confidence and to take all commercially reasonable steps to ensure that Confidential Information is not disclosed in any form by any means by such Party, its Affiliates, by any of its Representatives or subcontractors to third parties of any kind, other than the Representatives performing services for such Party who need access to such Confidential Information in the course and scope of providing such services, except as is authorized by the other Party in advance and in compliance with all applicable Law. If any Confidential Information needs to be disclosed as required by applicable Law or court order, the disclosing Party shall (if permitted by applicable Law) provide prompt notice to the other Party prior to such disclosure so that such other Party may (at its expense) seek a protection order or other appropriate remedy which is necessary to protect its interest.
(h)The Ceding Company will not transfer, disclose, share, furnish, or provide Non-Public Personal Information to Reinsurer under this Agreement, and the Reinsurer shall have no right to access any Non-Public Personal Information, except to the extent necessary for purposes of administration of this Agreement. In the event that any Non-Public Personal Information is provided to the Reinsurer, the Reinsurer will (i) comply in all material respects with applicable Laws with respect to the processing of such Non-Public Personal Information; (ii) retain, use, process, and disclose all Non-Public Personal Information created by Reinsurer on behalf of the Ceding Company only to monitor and ensure the Ceding Company’s compliance with the terms of this Agreement, perform the services or its obligations under this Agreement, or as otherwise instructed by the Ceding Company or permitted by this Agreement; (iii) refrain from selling such Non-Public Personal Information or using such Non-Public Personal Information for reasons unrelated to Reinsurer’s business relationship with the Ceding Company; (iv) subject to applicable Law and the terms of the Reinsurer’s record retention policies, take commercially reasonable steps to comply with the provisions of this Agreement and the reasonable instructions of the Ceding Company to return or destroy the Non-Public Personal Information; and (v) take commercially
- 42 -
1007933761v22


reasonable steps to limit access to and possession of non-Public Personal Information in a manner consistent with the nature and sensitivity of such information.
(i)If either Party receives a third party demand pursuant to subpoena, summons, or court or Governmental Order or request, to disclose Confidential Information provided by the other Party, the receiving Party shall, if legally permitted, provide the disclosing Party with prompt written notice of any subpoena, summons, or court or Governmental Order or request, within a reasonable time prior to such release or disclosure. Unless the disclosing Party has given its prior permission to release or disclose the proprietary information, the receiving Party shall not comply with the subpoena prior to the actual date required by the subpoena. If a protective order or appropriate remedy is not obtained, the receiving Party may disclose only that portion of the proprietary information that it is legally obligated to disclose and shall use reasonable best efforts to treat such proprietary information as confidential. However, notwithstanding anything to the contrary in this Agreement, this Section 11.15(c) shall not be construed as requiring the receiving Party to act in any way that would not comply with the subpoena, summons, or court or Governmental Order.
(j)The Reinsurer shall establish and maintain (i) administrative, technical, and physical safeguards designed to protect against the destruction, loss, or alteration of Confidential Information and Non-Public Personal Information, and (ii) appropriate security measures designed to protect Non-Public Personal Information in compliance with the requirements of all applicable Laws relating to personal information security.
(k)As needed to comply with applicable Laws concerning the processing of Non-Public Personal Information, the Parties agree to work cooperatively and in good faith to amend this Agreement in a mutually agreeable and timely manner, or to enter into further mutually agreeable agreements to the extent required by Law to comply with any such applicable Laws applicable to the Parties.
Section 1.1.Incontestability. In consideration of the mutual covenants and agreements contained herein, each Party agrees that this Agreement, and each and every provision hereof, is and shall be enforceable by and between them according to its terms, and each Party does hereby agree that it shall not contest the validity or enforceability hereof.
[The rest of this page intentionally left blank.]

- 43 -
1007933761v22


EXECUTION VERSION
IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be duly executed on the day and year first above written.
EQUITABLE FINANCIAL LIFE INSURANCE COMPANY
By:        /s/ Robin Raju    
    Name: Robin M. Raju
    Title: Chief Financial Officer
FIRST ALLMERICA FINANCIAL LIFE INSURANCE COMPANY
By:        /s/ Manu Sareen    
    Name: Manu Sareen
    Title: President



1007933761v22
Exhibit 31.1


CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Mark Pearson, President and Chief Executive Officer of Equitable Holdings, Inc., certify that:

1) I have reviewed this Quarterly Report on Form 10-Q of Equitable Holdings, Inc. (the “Registrant”);
2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4) The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5) The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
Date: November 3, 2022

/s/ Mark Pearson
Mark Pearson
President and Chief Executive Officer



Exhibit 31.2


CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Robin M. Raju, Chief Financial Officer of Equitable Holdings, Inc., certify that:

1) I have reviewed this Quarterly Report on Form 10-Q of Equitable Holdings, Inc. (the “Registrant”);
2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4) The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and
5) The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.
Date: November 3, 2022

/s/ Robin M. Raju
Robin M. Raju
Chief Financial Officer


Exhibit 32.1


CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report on Form 10-Q of Equitable Holdings, Inc. (the “Company”) for the quarter ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark Pearson, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 3, 2022
/s/ Mark Pearson
Mark Pearson
President and Chief Executive Officer


Exhibit 32.2


CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report on Form 10-Q of Equitable Holdings, Inc. (the “Company”) for the quarter ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robin M. Raju, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 3, 2022
/s/ Robin M. Raju
Robin M. Raju
Chief Financial Officer